Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Amgen Inc. |
F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH and Hoffmann LaRoche Inc. |
Fresenius Medical Care Holdings, Inc. (FMC) and DaVita, Inc. |
Ortho Biotech Products, L.P. |
Robert B. Collings |
1:2005cv12237 |
November 8, 2005 |
US District Court for the District of Massachusetts |
Patent Office |
Suffolk |
William G Young |
Patent |
28 U.S.C. § 1338 Patent Infringement |
Defendant |
Docket Report
This docket was last retrieved on August 19, 2010. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 1786 Judge William G. Young: ORDER entered. STIPULATION AND ORDER(Paine, Matthew) |
Filing 1785 STIPULATION and [Proposed] Order by Amgen Inc., F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc., Roche Diagnostics GmbH. (Gottfried, Michael) |
Filing 1784 Judge William G. Young: ORDER entered. STIPULATION AND ORDER(Paine, Matthew) |
Filing 1783 STIPULATION AND [PROPOSED] ORDER by Amgen Inc., F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc., Roche Diagnostics GmbH. (Gottfried, Michael) |
Judge William G. Young: Electronic ORDER entered granting 1782 MOTION for Extension of Time to April 21, 2010 to comply with the Protective Order (Paine, Matthew) |
Filing 1782 MOTION for Extension of Time to April 21, 2010 to comply with the Protective Order by Amgen Inc..(Gottfried, Michael) |
Filing 1781 NOTICE of Withdrawal of Appearance by Nicole E. Gage (Gage, Nicole) |
Judge William G. Young: Electronic ORDER entered granting 1778 MOTION for Extension of Time to February 20, 2010 to To Comply With The Protective Order (Paine, Matthew) |
E-Mail Notice re Electronic Order originally issued on 1/22/2010 returned as undeliverable. Name of Addressee: Krista Rycroft. The ECF Help Desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorneys email address has been removed from the database to prevent the return of additional undeliverable email notices. (Burgos, Sandra) |
Filing 1780 DECLARATION re 1778 MOTION for Extension of Time to February 20, 2010 to To Comply With The Protective Order of Patricia A. Carson by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Smith, Nicole) |
Filing 1779 MEMORANDUM in Support re 1778 MOTION for Extension of Time to February 20, 2010 to To Comply With The Protective Order filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Smith, Nicole) |
Filing 1778 MOTION for Extension of Time to February 20, 2010 to To Comply With The Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Smith, Nicole) |
Filing 1777 OPINION of USCA. Opinion issued in the USCA 9/15/2009 (Attachments: # 1 part 2, # 2 part 3)(Ramos, Jeanette) |
Filing 1776 MANDATE of USCA for the Federal Circuit as to 1768 Notice of Appeal to the Federal Circuit filed by Amgen Inc., 1748 Notice of Appeal to the Federal Circuit, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. Appeal 1768 , 1748 Terminated. This cause having been heard and considered, it is ORDERED and ADJUDGED: AFFIRMED-IN-PART, VACATED-IN-PART, and REMANDED. Mandate issued in the USCA for the Federal Circuit 12/17/2009 (Ramos, Jeanette) |
Filing 1775 Judge William G. Young: ORDER entered. STIPULATION AND ORDER(Paine, Matthew) |
E-Mail Notice re Order originally issued on 12/22/2009 returned as undeliverable. Name of Addressee: Keith Toms. The ECF Help Desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorneys email address has been removed from the database to prevent the return of additional undeliverable email notices. (Burgos, Sandra) |
Filing 1774 STIPULATION and [PROPOSED] ORDER by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc., Amgen Inc.. (Gottfried, Michael) |
Filing 1773 NOTICE of Withdrawal of Appearance by Nicole Rizzo Smith as to Julia Huston (Smith, Nicole) |
Filing 1772 NOTICE of Withdrawal of Appearance by Nicole A. Rizzo Smith Notice of Withdrawal of Appearance of Lee Carl Bromberg (Rizzo Smith, Nicole) |
Filing 1771 NOTICE of Change of Address or Firm Name by Nicole A. Rizzo Smith (Rizzo Smith, Nicole) |
Filing 1770 USCA Case Number 09-1096 for 1768 Notice of Appeal to the Federal Circuit filed by Amgen Inc. (Attachments: # 1 attachment, # 2 attachment)(Ramos, Jeanette) |
Filing 1769 Certified and Transmitted Notice of Appeal & Judgment to US Court of Appeals for the Federal Circuit re 1768 Notice of Appeal to the Federal Circuit (Ramos, Jeanette) |
Notice of correction to docket made by Court staff. Correction: Docket Entry 1767 Notice of Cross Appeal Corrected Because: The Appeal Was Filed Under the Wrong Event in CM/ECF and was Refiled Under the Corrected Event, Notice of Appeal to the Federal Circuit. See Docket Entry 1768 for the Notice of Cross Appeal to the Federal Circuit. (Paine, Matthew) |
Filing 1768 NOTICE OF CROSS APPEAL to the Federal Circuit as to 1756 Judgment by Amgen Inc.. Filing fee $ 455, receipt number 01010000000002192813 Appeal Record due by 12/8/2008. (Paine, Matthew) Modified on 11/18/2008 (Paine, Matthew). |
Filing 1767 NOTICE OF CROSS APPEAL by Amgen Inc.. Filing fee $ 455, receipt number 01010000000002192813. NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov/clerks/transcript.htm MUST be completed and submitted to the Court of Appeals. Appeal Record due by 12/8/2008. (Gottfried, Michael) |
Filing 1766 TRANSCRIPT ORDER FORM by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. for proceedings held on 5/10/2006-4/2/2008 before Judge William G. Young, (Toms, Keith) |
Judge William G. Young: Electronic ORDER entered granting 1762 MOTION to Withdraw pro hac vice admission of Kathleen McDermott. (Paine, Matthew) |
Motions terminated: (SEE ORDER DATED OCTOBER 31, 2008) re 1764 MOTION to Make Findings Under Fed R. Civ. P. 52 and Motion for New Trial Under Fed. R. Civ. P. 59 Regarding Judgment Related to '933 Claims 11 and 14 filed by Amgen Inc., 1763 MOTION Pursuant to Rules 52(a) and 52(b) for Entry of Findings of Fact and Conclusions of Law Relating to Inequitable Conduct filed by Amgen Inc.. (Paine, Matthew) |
Filing 1765 William G. Young: NOTICE "After now carefully reviewing Roches notice of appeal, the Court gives notice that it will not be entering any supplementary findings of fact or rulings of law. Nothing has been left unresolved in the district court, Amgen, Inc. v. F. Hoffman-Laroche, Ltd., Civ. No. 05-12237, 2008 WL 4452 454, at *1 (D. Mass. October 2, 2008) ([A]ll motions not already granted and not resolved herein are denied.) Rulings on motions require no further explication, Fed R. Civ. P. 52(a)(3), and are clear in context. The one possible issue that might be subject to Fed. R. Civ. P. 52(a) is the Courts conclusion, expressed from the bench on October 23, 2007, that Roche had failed to prove Amgen had engaged in inequitable conduct. On that issue, it suffices to state that the Court was persuaded by Amgens evidence on the point and does not find Roches contrary conclusions credible." (Paine, Matthew) |
Filing 1764 MOTION to Make Findings Under Fed R. Civ. P. 52 and Motion for New Trial Under Fed. R. Civ. P. 59 Regarding Judgment Related to '933 Claims 11 and 14 by Amgen Inc..(Gottfried, Michael) |
Filing 1763 MOTION Pursuant to Rules 52(a) and 52(b) for Entry of Findings of Fact and Conclusions of Law Relating to Inequitable Conduct by Amgen Inc..(Gottfried, Michael) |
Filing 1762 MOTION to Withdraw pro hac vice admission of Kathleen McDermott by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(McDermott, Kathleen) |
Filing 1761 Supplemental Record on Appeal transmitted to US Court of Appeals for the Federal Circuit re 1748 Notice of Appeal to the Federal Circuit, Documents included: 1758 Supplemental Notice of Appeal (Ramos, Jeanette) |
Filing 1760 MANDATE of USCA as to 1703 Notice of Appeal to the Federal Circuit filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. This cause having been heard and considered, it is ORDERED and ADJUDGED. AFFIRMED. Mandate issued in the USCA 10/21/2008 (Attachments: # 1 attachment)(Ramos, Jeanette) |
Filing 1759 ORDER of USCA for the Federal Circuit as to 1747 Notice of Appeal, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. Issued in the USCA for the Federal Circuit 9/30/2008. (Ramos, Jeanette) |
Filing 1758 Supplemental NOTICE OF APPEAL to the Federal Circuit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. Filing fee $ 455, receipt number 01010000000002157728. Appeal Record due by 11/10/2008. (Bromberg, Lee) |
Filing 1757 USCA Case Number 09-1020 for 1748 Notice of Appeal to the Federal Circuit, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Ramos, Jeanette) |
Filing 1756 Judge William G. Young: ORDER entered. JUDGMENT in favor of Plaintiff against Defendants(Smith, Bonnie) |
Case Reopened (Smith, Bonnie) |
Filing 1755 MOTION for Leave to File a Reply to Amgen's Opposition to Roche's Motion to Reopen Case for Entry of Final Judgment by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1 - Proposed Reply, # 2 Exhibit A)(Toms, Keith) |
Filing 1754 NOTICE OF MANUAL FILING by Amgen Inc. of Exhibit C to Amgen's Opposition to Roche's Motion for Immediate Entry of Final Judgment (Gottfried, Michael) |
Filing 1753 Opposition re 1750 MOTION to Reopen Case For Entry of Final Judgment filed by Amgen Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Gottfried, Michael) |
Filing 1752 DECLARATION re 1750 MOTION to Reopen Case For Entry of Final Judgment (by Keith E. Toms) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Toms, Keith) |
Filing 1751 MEMORANDUM in Support re 1750 MOTION to Reopen Case For Entry of Final Judgment filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1750 MOTION to Reopen Case For Entry of Final Judgment by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1749 Certified and Transmitted Notice of Appeal, Docket Sheet, Memorandum and Order to US Court of Appeals For the Federal Circuit re 1748 Notice of Appeal to the Federal Circuit, (Ramos, Jeanette) |
Filing 1748 NOTICE OF APPEAL to the Federal Circuit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..Filing fee $ 455, receipt number 01010000000002138765 NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov/clerks/transcript.htm MUST be completed and submitted to the Court of Appeals. Appeal Record due by 10/27/2008. (Paine, Matthew) |
Filing 1747 NOTICE OF APPEAL by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Filing fee $ 455, receipt number 01010000000002138765 NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov/clerks/transcript.htm MUST be completed and submitted to the Court of Appeals. Appeal Record due by 10/27/2008. (Fleming, Thomas) |
Notice of correction to docket made by Court staff. Correction: Docket Entry 1747 Notice of Appeal Corrected Because: The Appeal Was Filed Under the Wrong Event in CM/ECF and was Refiled Under the Corrected Event, Notice of Appeal to the Federal Circuit. See Docket Entry 1748 for the Notice of Appeal to the Federal Circuit. (Paine, Matthew) |
Filing 1746 Judge William G. Young: ORDER entered. MEMORANDUM AND ORDER(Paine, Matthew) |
E-Mail Notice originally issued on 10/2/08 returned as undeliverable. Name of Addressee: Deborah Fishman. The ECF Help Desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorneys email address has been removed from the database to prevent the return of additional undeliverable email notices. (Hassett, Kathy) |
E-Mail Notice originally issued on 10/2/08 returned as undeliverable. Name of Addressee: Nicole Gage. The ECF Help Desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorneys email address has been removed from the database to prevent the return of additional undeliverable email notices. (Hassett, Kathy) |
Civil Case Administratively Closed. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 1745 Declaration,,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Filing 1745 DECLARATION re 1744 Response by Linda A. Sasaki-Baxley In Support of Amgen, Inc.'s Response to Roche's May 29, 2008 Proposal by Amgen Inc.. (Attachments: # 1 Exhibit 1 (part 1), # 2 Exhibit 1 (part 2), # 3 Exhibit 1 (part 3), # 4 Exhibit 1 (part 4), # 5 Exhibit 1 (part 5), # 6 Exhibit 1 (part 6), # 7 Exhibit 1 (part 7), # 8 Exhibit 1 (part 8), # 9 Exhibit 2 (part 1), # 10 Exhibit 2 (part 2), # 11 Exhibit 2 (part 3), # 12 Exhibit 2 (part 4), # 13 Exhibit 2 (part 5), # 14 Exhibit 3)(Gottfried, Michael) |
Filing 1744 Response by Amgen Inc. to 1743 Proposed Document(s) submitted, Proposed Document(s) submitted. (Gottfried, Michael) |
Filing 1743 Proposed Document(s) submitted by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. Document received: Roche's Proposal in Satisfaction of the Court's Terms for Making MIRCERA Available to American Patients in Lieu of a Permanent Injunction. (Toms, Keith) |
Filing 1742 Supplemental Record on Appeal transmitted to US Court of Appeals for the Federal Circuit re 1703 Notice of Appeal to the Federal Circuit Documents included: 121, 445, 613, 631, 1284, 1341, 1467, 1484, 1542, 1488, 1666, 1707 (Ramos, Jeanette) |
Filing 1741 TRANSCRIPT of Jury Trial Day Nine held on September 24, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1740 TRANSCRIPT of Evidentiary Hearing In Re: Remedy Phase (Day Four) held on December 7, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1739 TRANSCRIPT of Evidentiary Hearing In Re: Remedy Phase (Day Three) held on December 6, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1738 TRANSCRIPT of Evidentiary Hearing In Re: Remedy Phase held on December 5, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1737 TRANSCRIPT of Evidentiary Hearing In Re: Remedy Phase held on November 15, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1736 TRANSCRIPT of Scheduling Conference held on October 30, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1735 TRANSCRIPT of Jury Trial Day Twenty Four held on October 23, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1734 TRANSCRIPT of Jury Trial Day Twenty Three held on October 22, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1733 TRANSCRIPT of Jury Trial Day Twenty Two held on October 19, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1732 TRANSCRIPT of Hearing In Re: Inequitable Conduct held on October 18, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1731 TRANSCRIPT of Jury Trial Day Twenty One held on October 18, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1730 TRANSCRIPT of Jury Trial Day Twenty held on October 17, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1729 TRANSCRIPT of Jury Trial Day Nineteen held on October 16,2 007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1728 TRANSCRIPT of Jury Trial Day Eighteen held on October 15, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1727 TRANSCRIPT of Jury Charge Conference held on October 10, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1726 TRANSCRIPT of Hearing In re: Obviousness - Type Double Patenting - Day Two held on October 4, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1725 TRANSCRIPT of Jury Trial Day Seventeen held on October 4, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1724 TRANSCRIPT of Jury Trial Day Sixteen held on October 3, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1723 TRANSCRIPT of Jury Trial Day Fifteen held on October 2, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1722 TRANSCRIPT of Hearing in re: Obviousness - Type Double Patenting held on October 1, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1721 TRANSCRIPT of Jury Trial Day Fourteen held on October 1, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1720 TRANSCRIPT of Jury Trial Day Thirteen held on September 28, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1719 TRANSCRIPT of Jury Trial Day Twelve held on September 27, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1718 TRANSCRIPT of Jury Trial Day Eleven held on September 26, 2007 before Judge Young. Court Reporter: Donald E, Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1717 TRANSCRIPT of Jury Trial Day Ten held on September 25, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1716 TRANSCRIPT of Jury Trial Day Eight held on September 14, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1715 TRANSCRIPT of Jury Trial Day Seven held on September 12, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1714 TRANSCRIPT of Jury Trial Day Six held on September 11, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1713 TRANSCRIPT of Jury Trial Day Five held on September 10, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1712 TRANSCRIPT of Jury Trial Day Four held on September 7, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1711 TRANSCRIPT of Jury Trial - Day Three held on September 6, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1710 TRANSCRIPT of Jury Trial - Day Two held on September 5, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1709 TRANSCRIPT of Jury Trial Day One held on September 4, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1708 TRANSCRIPT ORDER FORM Identifying Transcripts in Connection With Roche's Notice of Appeal 1703 Filed on April 9, 2008 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. for proceedings held on 5/10/2006-4/2/2008 before Judge William G. Young.. (Huston, Julia) |
Filing 1707 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re 1703 Notice of Appeal to the Federal Circuit List of Court Orders Identified in Notice of Appeal Filed by Roche on April 9, 2008 (Huston, Julia) |
Judge William G. Young: Electronic ORDER entered re 1693 MOTION for Permanent Injunction OR, IN THE ALTERNATIVE, LEAVE TO SUPPLEMENT ITS COMPLAINT UNDER FED. R. CIV. P. 15(d). "Motion denied as beyond the subject matter jurisdiction of this Court in view of the pendency of the appeal." (Paine, Matthew) |
Filing 1706 USCA Case Number 08-1300 for 1703 Notice of Appeal to the Federal Circuit filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Ramos, Jeanette) |
Filing 1705 Certified and Transmitted Notice of Appeal, Docket Sheet, Document #'s 613, 1542, 1670, 1671, 1673, 1674, 1675, 1689 to US Court of Appeals for the Federal Circuit re 1703 Notice of Appeal to the Federal Circuit (Ramos, Jeanette) |
Filing 1704 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Filing of Joint Submission of Candidates Pursuant to Court's Order for Appointment of a Special Master on March 26, 2008 (Bromberg, Lee) |
Filing 1703 NOTICE OF APPEAL to the Federal Circuit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. Filing fee $ 455, receipt number 01010000000001920895. Appeal Record due by 4/29/2008. (Bromberg, Lee) |
Filing 1702 Opposition re 1693 MOTION for Permanent Injunction OR, IN THE ALTERNATIVE, LEAVE TO SUPPLEMENT ITS COMPLAINT UNDER FED. R. CIV. P. 15(d) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1701 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to Amgen's Bench Memorandum Regarding Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc., No. 2007-1271 (Fed. Cir. March 7, 2008). (Bromberg, Lee) |
Filing 1700 TRANSCRIPT of Telephone Conference held on April 2, 2008 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Judge William G. Young: Electronic ORDER entered granting 1699 Motion for telephone conference (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young: Telephone Conference held on 4/2/2008. The Court Denies the request to extend the time for appeal. (Court Reporter: Womack.)(Attorneys present: Day,Whiteford,Fleming,Ben-Ami) (Smith, Bonnie) |
Filing 1699 Emergency MOTION for a Teleconference with the Court Before Roche's April 10, 2008 Deadline to File a Notice of Appeal to Avoid the Possibility of Loss of Jurisdiction Over the Preliminary Injunction Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1698 Opposition re 1695 MOTION to Strike Amgen's "Data from Secondary Sources" in Support of Amgen's Request for Permanent Injunctive Relief (D.N. 1683), the Declaration of William G. Gaede, III, in Support of Amgen's "Data from Secondary Sou MOTION to Strike Amgen's "Data from Secondary Sources" in Support of Amgen's Request for Permanent Injunctive Relief (D.N. 1683), the Declaration of William G. Gaede, III, in Support of Amgen's "Data from Secondary Sou MOTION to Strike Amgen's "Data from Secondary Sources" in Support of Amgen's Request for Permanent Injunctive Relief (D.N. 1683), the Declaration of William G. Gaede, III, in Support of Amgen's "Data from Secondary Sou AND ALTERNATIVE CROSS MOTION TO STRIKE THE DECLARATION OF PETER FRATANGELO IN SUPPORT OF ROCHE'S MEMORANDUM IN SUPPORT OF THIS COURT MODIFYING THE PRELIMINARY INJUNCTION AND STATISFYING THE COURT'S CONDITIONS TO HAVE MIRCERA AVAILABLE FOR AMERICAN PATIENTS (D.N. 1685) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1697 Opposition re 1691 MOTION to Strike the Declarations of B. Douglas Bernheim, Ph.D (D.N. 1680) and John A. Lubina, Ph.D (D.N. 1681) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1696 NOTICE of Withdrawal of Appearance by Kregg T. Brooks (Brooks, Kregg) |
Filing 1695 MOTION to Strike Amgen's "Data from Secondary Sources" in Support of Amgen's Request for Permanent Injunctive Relief (D.N. 1683), the Declaration of William G. Gaede, III, in Support of Amgen's "Data from Secondary Sources" in Support of Amgen's Request for Permanent Injunctive Relief (D.N. 1687 and 1688), and the Declaration of Linda A. Sasaki-Baxley in Support of Amgen Inc.'s Brief in Suppurt of Permanent Injunctive Relief (D.N. 1682) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1694 MEMORANDUM in Support re 1693 MOTION for Permanent Injunction OR, IN THE ALTERNATIVE, LEAVE TO SUPPLEMENT ITS COMPLAINT UNDER FED. R. CIV. P. 15(d) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1693 MOTION for Permanent Injunction OR, IN THE ALTERNATIVE, LEAVE TO SUPPLEMENT ITS COMPLAINT UNDER FED. R. CIV. P. 15(d) by Amgen Inc..(Gottfried, Michael) |
Filing 1692 Judge William G. Young: ORDER entered. "Before the Court is Amgen's request for a permanent injunctive relief barring the sale of Mircera in the United States for the life of the patents in suit found to be infringed. The Court continues to grapple with complex issues related to Amgen's request. Per a discussion with counsel at the post trial oral arguments held on February 28, 2008, the Court now orders the appointment of a special master to make recommended findings regarding price parity as well as the respective dose conversion ratios for Micera and Epogen. The parties shall have 15 days to submit to the Court a list of agreed upon candidates, and the special master shall have 60 days from the date of appointment to make the requested findings." SO ORDERED... (Paine, Matthew) |
Filing 1691 MOTION to Strike the Declarations of B. Douglas Bernheim, Ph.D (D.N. 1680) and John A. Lubina, Ph.D (D.N. 1681) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1690 Objection to 1669 Memorandum in Support of Motion, by Amgen Inc. = Amgens Objection To Roche's Opposition And Counter-Proposal (D.N. 1669) Of Findings Of Fact And Conclusions Of Law Relating To Roches Failure To Prove Inequitable Conduct [LEAVE TO FILE GRANTED ON 03/18/2008]. (Gottfried, Michael) |
Filing 1689 Judge William G. Young: ORDER entered re 1686 Emergency Motion for 10-Day Extension of Time to File a Notice of Appeal. "It is hereby ORDERED that Defendant's time to file its notice of appeal from the February 29, 2008 issuance of the preliminary injunction be extended for 10 days from March 31, 2008 to April 10, 2008." (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered granting 1678 MOTION for Leave to File to File Objection to Roche's Opposition and Counter-Proposal (D.N. 1669) of Findings of Fact and Conclusions of Law Relating to Roche's Failure to Prove Inequitable Conduct; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 1688 EXHIBIT re 1687 Declaration, = EXHIBITS 16-25 TO THE DECLARATION OF WILLIAM G. GAEDE, III (DOCKET NUMBER 1687) by Amgen Inc.. (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25)(Gottfried, Michael) |
Filing 1687 DECLARATION re 1683 Brief OF WILLIAM G. GAEDE, III by Amgen Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Errata 8, # 9 Exhibit 9 (part 1 of 2), # 10 Exhibit 9 (part 2 of 2), # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Gottfried, Michael) |
Filing 1686 MOTION for Extension of Time to April 10, 2008 to File a Notice of Appeal (Emergency Motion for 10-Day Extension of Time to File a Notice of Appeal) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Seluga, Kimberly) |
Filing 1685 DECLARATION re 1684 Brief, in Support of This Court Modifying the Preliminary Injunction and Satisfying the Courts Conditions to Have MIRCERA Available for American Patients (Declaration of Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5 (part 1 of 2), # 6 Exhibit 5 (part 2 of 2), # 7 Exhibit 6)(Seluga, Kimberly) |
Filing 1684 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. in Support of This Court Modifying the Preliminary Injunction and Satisfying the Courts Conditions to Have MIRCERA Available for American Patients. (Seluga, Kimberly) |
Filing 1683 BRIEF by Amgen Inc. to 1679 Brief = DATA FROM SECONDARY SOURCES. (Gottfried, Michael) |
Filing 1682 DECLARATION re 1679 Brief OF LINDA A. SASAKI-BAXLEY by Amgen Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Errata 14, # 15 Exhibit 15)(Gottfried, Michael) |
Filing 1681 DECLARATION re 1679 Brief OF JOHN A. LUBINA, PH.D. by Amgen Inc.. (Gottfried, Michael) |
Filing 1680 DECLARATION re 1679 Brief OF B. DOUGLAS BERNHEIM, PH.D. by Amgen Inc.. (Gottfried, Michael) (Additional attachment(s) added on 3/21/2008: # 1 Corrected Bernheim Declaration) (Paine, Matthew). |
Filing 1679 BRIEF by Amgen Inc. In Support of Permanent Injunctive Relief. (Gottfried, Michael) |
Filing 1678 MOTION for Leave to File to File Objection to Roche's Opposition and Counter-Proposal (D.N. 1669) of Findings of Fact and Conclusions of Law Relating to Roche's Failure to Prove Inequitable Conduct by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1677 BRIEF by Amgen Inc. = Bench Memorandum Regarding Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc., No. 2007-1271 (Fed. Cir. March 7, 2008). (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1676 TRANSCRIPT of Motion Hearing held on February 28, 2008 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 1675 Judge William G. Young: ORDER and PRELIMINARY INJUNCTION, entered.(Smith, Bonnie) |
Judge William G. Young: Electronic ORDER entered denying 1668 MOTION to Strike 1653 Proposed Findings of Fact And Conclusion of Law Relating to Roche's Failure to Prove Inequitable Conduct. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered denying 1666 Motion TO DRAW AN INFERENCE OF NO IRREPARABLE HARM AND THAT MONETARY DAMAGES ARE ADEQUATE BASED ON AMGEN AND ORTHO'S BELATEDLY DISCLOSED AND UNPRODUCED DAMAGES AGREEMENT (Emergency Motion). (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered denying 1665 MOTION for Leave to File Publicly a Letter from FDA to Amgen that is Allegedly Confidential to Amgen in Support of Roche's Response to Amgen's Post-Trial Brief for the Remedy Phase, or, in the Alternative, for the Court to Draw an Inference as to What the Letter Shows. (Paine, Matthew) |
Filing 1674 DECLARATION re 1673 Opposition to Motion, OF LINDA A. SASAKI-BAXLEY by Amgen Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gottfried, Michael) (Additional attachment(s) added on 3/3/2008: # 3 Corrected Exhibit B - Part 1, # 4 Corrected Exhibit B - Part 2, # 5 Corrected Exhibit B - Part 3, # 6 Corrected Exhibit B - Part 4) (Paine, Matthew). |
Filing 1673 Opposition re 1666 MOTION TO DRAW AN INFERENCE OF NO IRREPARABLE HARM AND THAT MONETARY DAMAGES ARE ADEQUATE BASED ON AMGEN AND ORTHO'S BELATEDLY DISCLOSED AND UNPRODUCED DAMAGES AGREEMENT (Emergency Motion) MOTION TO DRAW AN INFERENCE OF NO IRREPARABLE HARM AND THAT MONETARY DAMAGES ARE ADEQUATE BASED ON AMGEN AND ORTHO'S BELATEDLY DISCLOSED AND UNPRODUCED DAMAGES AGREEMENT (Emergency Motion) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1672 Response by Amgen Inc. to 1661 Reply to Response to Motion,, Amgen's Response to Appendix B to Roche's Reply to Amgen's Oppositionto Roche's Post-Trial Motion for Judgment as a Matter of Law or New Trial. (Attachments: # 1 Appendix B)(Rich, Patricia) |
Filing 1671 AFFIDAVIT in Support re 1670 Opposition to Motion,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Rich, Patricia) |
Filing 1670 Opposition re 1665 MOTION for Leave to File Publicly a Letter from FDA to Amgen that is Allegedly Confidential to Amgen in Support of Roche's Response to Amgen's Post-Trial Brief for the Remedy Phase, or, in the Alternative, for the Court to Draw an Inferen ce as to What the Letter Shows filed by Amgen Inc.. (Rich, Patricia) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young: Motion Hearing held on 2/28/2008 re 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infri filed by Amgen Inc., 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4 filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH BEFORE HEARING argument, the Court makes some preliminary rulings.The Court rules for Amgen on Obviousness and Double patenting. The Court rules the jury verdict is appropriate. The Court hears from the Defendant and the Plaintiff. The Court takes the matter UNDER ADVISEMENT but offers to come back on the bench at 2PM for further hearing. 2:00 PM HEARING....With respect to the Judgment notwithstanding the verdict and new trial motions the Court rules denying 1482 Motion for Judgment as a Matter of Law; denying 1623 Motion for New Trial; denying 1624 Motion for Judgment as a Matter of Law; With Respect to the Remedy Phase, the Court enters a PRELIMINARY INJUNCTION and makes FINDINGS as follows: 1) There is a likelihood of Amgen's success2) anything other than a permanent injunction on entry of final judgment would inadequately compensate Amgen,therefore it would do irreparable harm to Amgen.3) There would be a hardship to Amgen.4) as to the issue of whether a permanent injunction would cause a disservice to the public interest, upon the record before the Court now, the Court preliminary enjoins Roche. The Court is considering that within 30 days a modification of the preliminary injunction. Counsel have 2 weeks from 3/3/08 to file further briefs re: issue of modification. The Court ORDERS ROCHE PRELIMINARY ENJOINED. See transcript for details. An order to issue. (Court Reporter: Womack.)(Attorneys present: Day, Ben-Ami) (Smith, Bonnie) |
Filing 1669 MEMORANDUM in Support re 1668 MOTION to Strike 1653 Proposed Findings of Fact And Conclusion of Law Relating to Roche's Failure to Prove Inequitable Conduct and, Alternatively, Roche's Opposition and Counter-Proposal to Amgen's Proposal filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1668 MOTION to Strike 1653 Proposed Findings of Fact And Conclusion of Law Relating to Roche's Failure to Prove Inequitable Conduct by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1667 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1659 Amicus brief filed, by Ortho Biotech Products. (Seluga, Kimberly) |
Filing 1666 MOTION TO DRAW AN INFERENCE OF NO IRREPARABLE HARM AND THAT MONETARY DAMAGES ARE ADEQUATE BASED ON AMGEN AND ORTHO'S BELATEDLY DISCLOSED AND UNPRODUCED DAMAGES AGREEMENT (Emergency Motion) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1665 MOTION for Leave to File Publicly a Letter from FDA to Amgen that is Allegedly Confidential to Amgen in Support of Roche's Response to Amgen's Post-Trial Brief for the Remedy Phase, or, in the Alternative, for the Court to Draw an Inference as to What the Letter Shows by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 1664 DECLARATION re 1662 Response to Amgen's Post-Trial Brief for the Remedy Phase and Response to Defendants' January 28, 2008 Proposal (by Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Bromberg, Lee) |
Filing 1663 DECLARATION re 1662 Response to Amgen's Post-Trial Brief for the Remedy Phase and Response to Defendants' January 28, 2008 Proposal (by Einer Elhauge) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bromberg, Lee) |
Filing 1662 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1656 Brief -Response to Amgen's Post-Trial Brief for the Remedy Phase and Response to Defendants' January 28, 2008 Proposal. (Bromberg, Lee) |
Filing 1661 REPLY to Response to 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial (Leave Granted to File on February 26, 2008) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Appendix A, # 2 Appendix B)(Bromberg, Lee) |
Filing 1660 MOTION for Leave to File Reply to Amgen's Opposition to Roche's Post-Trial Motion (DN 1618) for Judgment as a Matter of Law or New Trial by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A - Proposed Reply to Amgen's Opposition to Roche's Post-Trial Motion for Judgment as a Matter of Law or New Trial, # 2 Appendix A to Proposed Reply, # 3 Appendix B to Proposed Reply)(Bromberg, Lee) |
Judge William G. Young: Electronic ORDER entered granting 1660 MOTION for Leave to File Reply to Amgen's Opposition to Roche's Post-Trial Motion (DN 1618) for Judgment as a Matter of Law or New Trial; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 1659 AMICUS BRIEF filed by Ortho Biotech Products, L.P. (Brief of Amicus Curiae Ortho Biotech Products, L.P. in Support of Plaintiff's Request for a Permanent Injunction)(Leave to File Granted on 2/25/08). (Attachments: # 1 Declaration of Harman Avery Grossman, # 2 Declaration of Kim Taylor, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Certificate of Service)(Zalesin, Steven) |
Judge William G. Young: Electronic ORDER entered granting 1658 MOTION for Leave to File Brief of Amicus Curiae in Support of Amgen's Request for a Permanent Injunction; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 1658 MOTION for Leave to File Brief of Amicus Curiae in Support of Amgen's Request for a Permanent Injunction by Ortho Biotech Products, L.P.. (Attachments: # 1 Proposed Brief of Amicus Curiae Ortho Biotech Products, L.P. in Support of Plaintiff's Request for a Permanent Injunction, # 2 Exhibit 1 to Proposed Amicus Brief, # 3 Exhibit 2 to Proposed Amicus Brief, # 4 Exhibit 3 to Proposed Amicus Brief, # 5 Exhibit 4 to Proposed Amicus Brief, # 6 Exhibit 5 to Proposed Amicus Brief, # 7 Exhibit 6 to Proposed Amicus Brief, # 8 Exhibit 7 to Proposed Amicus Brief, # 9 Declaration of Harman Avery Grossman, # 10 Declaration of Kim Taylor, # 11 Certificate of Service)(Zalesin, Steven) |
Filing 1657 DECLARATION re 1656 Brief OF B. DOUGLAS BERNHEIM, PH.D. by Amgen Inc.. (Gottfried, Michael) |
Filing 1656 BRIEF by Amgen Inc. FOR THE REMEDY PHASE AND RESPONSE TO DEFENDANTS' JANUARY 28, 2008 PROPOSAL. (Gottfried, Michael) |
ELECTRONIC NOTICE issued requesting courtesy copy for 1646 Opposition to Motion, 1638 Opposition to Motion, 1655 Reply to Response to Motion, 1649 Opposition to Motion,, 1639 Declaration, 1656 Brief, 1657 Declaration, 1647 Memorandum in Opposition to Motion, 1651 Brief, 1653 Proposed Findings of Fact, 1650 Declaration,,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Filing 1655 REPLY to Response to 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infri (LEAVE TO FILE GRANTED ON 02-13-2008) filed by Amgen Inc.. (Gottfried, Michael) |
Judge William G. Young: Electronic ORDER entered granting 1654 MOTION for Leave to File A Reply in Support of Its Motion for New Trial and Judgment of Literal Infringement of Claims 9 and12 of '933 Patent, Alternative Motion to Reinstate the Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infringement of '349 Claim 7; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 1654 MOTION for Leave to File A Reply in Support of Its Motion for New Trial and Judgment of Literal Infringement of Claims 9 and12 of '933 Patent, Alternative Motion to Reinstate the Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infringement of '349 Claim 7 by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1653 Proposed Findings of Fact by Amgen Inc.. (Gottfried, Michael) |
Filing 1652 NOTICE of Withdrawal of Appearance by Vladimir Drozdoff (Drozdoff, Vladimir) |
Judge William G. Young: Electronic ORDER entered finding as moot 331 Motion to Compel; finding as moot 345 Motion ; finding as moot 346 Motion to Compel; finding as moot 352 Motion for Leave to File; ; finding as moot 387 Motion for Leave to File; ; finding as moot 449 Motion ; finding as moot 538 Motion for Extension of Time; finding as moot 555 Motion ; denying 652 Motion ; denying 657 Motion ; denying 720 Motion to Strike ; denying 727 Motion (Smith, Bonnie) |
Filing 1651 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. - Memorandum in Support of Roche's Proposal Pursuant to the Court's Instruction of December 7, 2007. (Attachments: # 1 Appendix A)(Bromberg, Lee) |
Filing 1650 DECLARATION re 1649 Opposition to Motion,, BY JONATHAN D. LOEB IN SUPPORT OF AMGEN INC.'S OPPOSITION TO ROCHE'S POST-TRIAL MOTION (D.N. 1618) FOR JUDGMENT AS A MATTER OF LAW OR NEW TRIAL by Amgen Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7 (part 1 of 2), # 8 Exhibit 7 (part 2 of 2), # 9 Exhibit 8 (part 1 of 5), # 10 Exhibit 8 (part 2 of 5), # 11 Exhibit 8 (part 3 of 5), # 12 Exhibit 8 (part 4 of 5), # 13 Exhibit 8 (part 5 of 5), # 14 Exhibit 9 (part 1 of 2), # 15 Exhibit 9 (part 2 of 2))(Gottfried, Michael) |
Filing 1649 Opposition re 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial filed by Amgen Inc.. (Attachments: # 1 Appendix A, # 2 Appendix B)(Gottfried, Michael) |
Filing 1648 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1566 Brief - Amgen's Proposed Findings of Fact and Conclusions of Law Regarding No Obviousness-Type Double Patenting. (Bromberg, Lee) |
Filing 1647 MEMORANDUM in Opposition re 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infri ngement of '349 Claim 7 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bromberg, Lee) |
Filing 1646 Opposition re 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4 filed by Amgen Inc.. (Gottfried, Michael) |
Judge William G. Young: Electronic ORDER entered denying 1633 MOTION to Strike the Trial Testimony and Expert Reports of Amgen's Experts John Lubina and Glenn Chertow. (Paine, Matthew) |
Filing 1645 DECLARATION re 1644 Opposition to Motion BY SUSAN M. KRUMPLITSCH by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1644 Opposition re 1633 MOTION to Strike the Trial Testimony and Expert Reports of Amgen's Experts John Lubina and Glenn Chertow filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1643 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re 1620 Declaration,, -Supplemental Notice of Filing with Clerk's Office of Exhibits to Declaration of Kregg T. Brooks in Support of Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Roche's Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial (Brooks, Kregg) |
Filing 1642 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1632 Brief Regarding Inapplicability of Patent Misuse to the Facts of This Case. (Brooks, Kregg) |
ELECTRONIC NOTICE of Hearing on Motion 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial, 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infri : Motion Hearing set for 2/28/2008 02:00 PM before Judge William G. Young. (Smith, Bonnie) |
Judge William G. Young: Electronic ORDER entered re 1622 Motion Roche's Motion For The Court To Draw an Inference in Roches Favor As To What Documents Withheld By Amgen Show, Or, In The Alternative, For Leave To Publicly File Documents In Support of Roches JMOL Motion That Are Allegedly Confidential To Amgen. "The Court will draw no such inference. The Court appreciates the parties efforts to agree upon redactions.All documents are to be filed with the Court as public records. The protocol for exhibits admitted during the course of the trial is well established." (Paine, Matthew) |
Filing 1641 REPLY to Response to Motion re 1622 MOTION Roche's Motion For The Court To Draw an Inference in Roches Favor As To What Documents Withheld By Amgen Show, Or, In The Alternative, For Leave To Publicly File Documents In Support of Roches JMOL Motion That Are Allegedly Confidential To (Leave to File Granted January 11, 2008) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1640 MOTION for Leave to File Reply in Support of Motion (D.N. 1622) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit Roche's [Proposed] Reply in Further Support of Its Motion for the Court to Draw an Inference in Roche's Favor as to What Documents Withheld by Amgen Show, or, in the Alternative, for Leave to Publicly File Doucments in Support of Roche's JMOL Motion)(Huston, Julia) |
Judge William G. Young: Electronic ORDER entered granting 1640 MOTION for Leave to File Reply in Support of Motion (D.N. 1622); Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered granting 1617 MOTION to Strike 1164 Declaration, of Harvey F. Lodish, Ph.D. Regarding Obviousness-Type Double Patenting. (Paine, Matthew) |
Filing 1639 DECLARATION re 1638 Opposition to Motion, (= DECLARATION BY PATRICIA R. RICH) by Amgen Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Rich, Patricia) |
Filing 1638 Opposition re 1622 MOTION Roche's Motion For The Court To Draw an Inference in Roches Favor As To What Documents Withheld By Amgen Show, Or, In The Alternative, For Leave To Publicly File Documents In Support of Roches JMOL Motion That Are Allegedly Confidential To Amgen filed by Amgen Inc.. (Rich, Patricia) |
Filing 1637 Opposition re 1617 MOTION to Strike 1164 Declaration, of Harvey F. Lodish, Ph.D. Regarding Obviousness-Type Double Patenting filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1636 MEMORANDUM in Opposition re 1284 MOTION for Directed Verdict Regarding Invalidity (LEAVE TO FILE GRANTED ON OCTOBER 18, 2007) filed by Amgen Inc.. (Rich, Patricia) |
Filing 1635 DECLARATION re 1633 MOTION to Strike the Trial Testimony and Expert Reports of Amgen's Experts John Lubina and Glenn Chertow -of Kregg T. Brooks by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Brooks, Kregg) |
Filing 1634 MEMORANDUM in Support re 1633 MOTION to Strike the Trial Testimony and Expert Reports of Amgen's Experts John Lubina and Glenn Chertow filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 1633 MOTION to Strike the Trial Testimony and Expert Reports of Amgen's Experts John Lubina and Glenn Chertow by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 1632 BRIEF by Amgen Inc. = Bench Memorandum Regarding the Inapplicability of Patent Misuse to the Facts of this Case. (Rich, Patricia) |
Judge William G. Young: Electronic ORDER entered re 1606 Motion to Preclude Roche from Introducing Dr. Jeffrey Borer's Inadmissable Testimony and from Disavowing Prior Representations to the Court Regarding FDA Communications. "Motion denied. The Court will review the designations and counter designations of the Borer deposition transcript as though Amgen had submitted it, albeit mindful of Amgen's other objections." (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered denying 1612 MOTION to Strike the First Expert Report of Professor Einer Elhauge (Exhibit 42) and to Strike Additional Expert Testimony Due to Lack of Qualification. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered denying 1610 MOTION to Strike the Testimony of Dr. Glenn Chertow Regarding Slide 25. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered. "Denied. The matter has already been fully briefed and argued and is now under advisement." re 1626 MOTION for Hearing re 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered. "Motion DENIED. The protocol on exhibits has been established." re 1613 Motion To Redact Information From Amgen's Admitted Remedy Hearing Exhibits Which Pertains To Roche's Foreign Products And Marketing Strategies And Which Is Not Relevant To This Case. (Paine, Matthew) |
Filing 1631 Opposition re 1612 MOTION to Strike the First Expert Report of Professor Einer Elhauge (Exhibit 42) and to Strike Additional Expert Testimony Due to Lack of Qualification filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Huston, Julia) |
Filing 1630 Opposition re 1613 MOTION To Redact Information From Amgen's Admitted Remedy Hearing Exhibits Which Pertains To Roche's Foreign Products And Marketing Strategies And Which Is Not Relevant To This Case filed by Amgen Inc.. (Rich, Patricia) |
Filing 1629 Opposition re 1610 MOTION to Strike the Testimony of Dr. Glenn Chertow Regarding Slide 25 filed by Amgen Inc.. (Rich, Patricia) |
Filing 1628 Response by Amgen Inc. to 1556 Proposed Findings of Fact and Conclusions of Law for Bench Trial on Obviousness-Type Double Patenting submitted by Roche on November 6, 2007. (Gottfried, Michael) |
Filing 1627 MEMORANDUM in Support re 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infri ngement of '349 Claim 7 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1626 MOTION for Hearing re 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Bromberg, Lee) |
Filing 1625 MEMORANDUM in Support re 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bromberg, Lee) |
Filing 1624 MOTION for Judgment as a Matter of Law In Favor Of Roche On Obviousness-Type Double Patenting Theories 3 and 4 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Bromberg, Lee) |
Filing 1623 MOTION for New Trial and Judgment of Literal Infringement of Claims 9 and 12 of the '933 Patent, Alternative Motion to Reinstate Verdict of Infringement of '933 Claim 12 Under the Doctrine of Equivalents, and Motion for New Trial on Infringement of '349 Claim 7 by Amgen Inc..(Gottfried, Michael) |
Filing 1622 MOTION Roche's Motion For The Court To Draw an Inference in Roches Favor As To What Documents Withheld By Amgen Show, Or, In The Alternative, For Leave To Publicly File Documents In Support of Roches JMOL Motion That Are Allegedly Confidential To Amgen by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 1621 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re 1620 Declaration,, -Filing with Clerk's Office of Exhibits to Declaration of Kregg T. Brooks in Support of Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial (Bromberg, Lee) |
Filing 1620 DECLARATION re 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial -of Kregg T. Brooks by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bromberg, Lee) |
Filing 1619 MEMORANDUM in Support re 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bromberg, Lee) |
Filing 1618 MOTION for Judgment as a Matter of Law -Roche's Renewed Motion, Pursuant to Fed. R. Civ. P. 50(b), for Judgment as a Matter of Law and Motion, in the Alternative, Pursuant to Fed. R. Civ. P. 50(b) and 59, for a New Trial by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Bromberg, Lee) |
Filing 1617 MOTION to Strike 1164 Declaration, of Harvey F. Lodish, Ph.D. Regarding Obviousness-Type Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 1616 DECLARATION re 1615 Memorandum in Opposition to Motion, to Preclude Introduction of Dr. Jeffrey Borer's Testimony and from Disavowing Prior Representations to the Court Regarding FDA Communications - by Peter Fratangelo by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Brooks, Kregg) |
Filing 1615 MEMORANDUM in Opposition re 1606 MOTION to Preclude Roche from Introducing Dr. Jeffrey Borer's Inadmissable Testimony and from Disavowing Prior Representations to the Court Regarding FDA Communications filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 1614 BRIEF by Amgen Inc. = Amgen's Bench Memorandum Concerning Post-Trial Briefing for Adjudications on Which Amgen Prevailed. (Gottfried, Michael) |
Filing 1613 MOTION To Redact Information From Amgen's Admitted Remedy Hearing Exhibits Which Pertains To Roche's Foreign Products And Marketing Strategies And Which Is Not Relevant To This Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 1612 MOTION to Strike the First Expert Report of Professor Einer Elhauge (Exhibit 42) and to Strike Additional Expert Testimony Due to Lack of Qualification by Amgen Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Rich, Patricia) |
Filing 1611 DECLARATION re 1610 MOTION to Strike the Testimony of Dr. Glenn Chertow Regarding Slide 25 -by Peter Fratangelo by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Brooks, Kregg) |
Filing 1610 MOTION to Strike the Testimony of Dr. Glenn Chertow Regarding Slide 25 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Judge William G. Young: Electronic ORDER entered. "The Court allows Amgen's motion for reconsideration as it acted prematurely. Nevertheless, upon reconsideration, the Court adheres to its earlier ruling." re 1607 Opposition re 1600 MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE REMEDY HEARING (REDACTED VERSION) And MOTION for Reconsideration of the Court's December 12, 2007 Order. (Paine, Matthew) |
Judge William G. Young: Electronic ORDER entered re 1602 Motion for Leave to Subpoena Documents and to Depose Ms. Parsons. "Denied. The Court has read Ms. Parsons deposition but will not rely on it as her individual reactions are simply not probitive to a meaningful comparison of these two drugs." (Paine, Matthew) |
Filing 1609 DECLARATION re 1608 Memorandum in Opposition to Motion for Leave to Subpoena Documents and to Depose Ms. Parsons-by Christopher T. Jagoe by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Brooks, Kregg) |
Filing 1608 MEMORANDUM in Opposition re 1602 MOTION for Leave to Subpoena Documents and to Depose Ms. Parsons filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 1607 Opposition re 1600 MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE REMEDY HEARING (REDACTED VERSION) And MOTION for Reconsideration of the Court's December 12, 2007 Order filed by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1606 MOTION to Preclude Roche from Introducing Dr. Jeffrey Borer's Inadmissable Testimony and from Disavowing Prior Representations to the Court Regarding FDA Communications by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young: Electronic ORDER entered. "Amgen's post-hearing motion to admit exhibits is allowed in part and denied in part. The proffered documents are admitted, save for Amgen's post-hearing exhibits: GYN,BFC,EXJ,BFO,GZU,GYZ,GZN,GZV,HAA,GZF,GZP,GYQ,BIB,GZD,HAD,BBP,GYR,GZS. Amgen shall submit two additional binders with the admitted exhibits as soon as possible."(Smith, Bonnie) |
Filing 1605 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. DEFENDANTS' NOTICE OF SUBMISSION TO THE COURT OF THE UNREDACTED VERSION OF APPENDIX A TO AMGEN'S MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE INJUNCTION HEARING (Rizzo, Nicole) |
Filing 1604 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. ROCHES MEMORANDUM IN OPPOSITION TO AMGENS MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE INJUNCTION HEARING (WITH REDACTED APPENDIX A). (Attachments: # 1 Appendix A)(Rizzo, Nicole) |
Filing 1603 DECLARATION re 1602 MOTION for Leave to Subpoena Documents and to Depose Ms. Parsons OF DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3# 4 Exhibit 4# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7)(Gottfried, Michael) |
Filing 1602 MOTION for Leave to Subpoena Documents and to Depose Ms. Parsons by Amgen Inc.. (Attachments: # 1 Appendix A)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered re 1600 Motion TO ADMIT EXHIBITS INTO EVIDENCE FOR THE REMEDY HEARING (REDACTED VERSION). "The following documents are admitted in evidence: AYG, PBF, POC, PSQ, PVV, PVX, PWD, RBN, RBO, RBS, RBW, RCB, RCC, RCD, RCG, RCL, RCM, RED, REE, REF, REK, REW, RFJ, RFL, RFN, RFP, RFS, RGA, RHO, RHP, RHT, RIH, RII, RIK, RIQ, RIS, RJC, RJE, RJN, RJO, RJP, RKC, RKD, RKK, RKR, RLB, RLH, and RLX The motion is otherwise denied save that the denial is without prejudice with respect to RCF, RCH, RHJ, RID, and RMD supported by a detailed evidentiary foundation. Roche shall promptly submit two additional exhibit books with the admitted exhibits." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1597 Motion to: (1) Admit Exhibits Into Evidence or Consider Evidence in Response to Issues Raised by the Court During the November 6, 2007 Injunction Hearing, and (2) Motion to Admit Rebuttal Evidence. "Exhibit EUL is admitted in evidence. The remainder of the proffered exhibits are excluded." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1594 Motion to Preclude Testimony of Barbara Senich Relying On Documents Withheld in Fact Discovery (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1593 Motion To Preclude Roche from Submitting Deposition Transcripts of Witnesses that have Testified Live at the Remedy Hearing (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1592 Motion To Preclude Roche from Presenting Expert Testimony of Drs. Besarab and Schmidt and Requesting Enforcement of the Court's Order Precluding Reliance Upon Document Withheld in Fact Discovery. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot. See transcript re 1591 MOTION to Modify Order. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1595 Motion to Preclude Roche from Offering Exhibits into Evidence Through Deposition Designations (Paine, Matthew) |
Filing 1601 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. OF SUBMISSION TO THE COURT OF ROCHE'S MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE REMEDY HEARING AND THE DECLARATION OF NICOLE A. RIZZO (Rizzo, Nicole) |
Filing 1600 MOTION TO ADMIT EXHIBITS INTO EVIDENCE FOR THE REMEDY HEARING (REDACTED VERSION) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Rizzo, Nicole) |
Filing 1599 Witness / Exhibit List for the Remedy Phase Trail. (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Evidentiary Hearing Day 4 held on 12/7/2007. Defendant's evidence continues. Defendant Rests. CLosing arguments by Defendant, by Plaintiff. The Court takes the Matter Under Advisement. (Court Reporter: Womack.)(Attorneys present: Day, Ben-Ami) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Hearing held on 12/7/2007. The Court answers questions of counsel. TheCourt encourages settlement. (Court Reporter: Womack.)(Attorneys present: Day,Ben-Ami) (Smith, Bonnie) |
Filing 1598 NOTICE by Amgen Inc. re 1597 MOTION to: (1) Admit Exhibits Into Evidence or Consider Evidence in Response to Issues Raised by the Court During the November 6, 2007 Injunction Hearing, and (2) Motion to Admit Rebuttal Evidence MOTION to: (1) Admit Exhibits Into Evidence or Consider Evidence in Response to Issues Raised by the Court During the November 6, 2007 Injunction Hearing, and (2) Motion to Admit Rebuttal Evidence Notice of Manual Submission to the Court of Delcaration of Linda Baxley and Exhibits Thereto in Connection with Amgen's Motion to Admit (Rich, Patricia) |
Filing 1597 MOTION to: (1) Admit Exhibits Into Evidence or Consider Evidence in Response to Issues Raised by the Court During the November 6, 2007 Injunction Hearing, and (2) Motion to Admit Rebuttal Evidence by Amgen Inc.. (Attachments: # 1 Exhibit A)(Rich, Patricia) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Evidentiary Hearing Day 3 held on 12/6/2007. Plaintiff's evidence continues. Plaintiff rests. Defendant orally moves for judgment as matter of law. Motion Denied. Defendant's evidence commences. (Court Reporter: Womack.)(Attorneys present: Day, Ben-Ami) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Hearing re: exhibits held on 12/6/2007. (Court Reporter: Womack.)(Attorneys present: Gottfried, Jagoe) (Smith, Bonnie) |
Filing 1596 EXHIBIT re 1590 Declaration,,, of Alfred H. Heckel in Support of Defendants' Memorandum in Opposition to Amgen's Request for a Permanent Injunction by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 4# 2 Exhibit 5# 3 Exhibit 6# 4 Exhibit 7# 5 Exhibit 8 (part 1 of 2)# 6 Exhibit 8 (part 2 of 2)# 7 Exhibit 9# 8 Exhibit 10# 9 Exhibit 11# 10 Exhibit 12# 11 Exhibit 13# 12 Exhibit 14# 13 Exhibit 15# 14 Exhibit 16# 15 Exhibit 17# 16 Exhibit 18# 17 Exhibit 19# 18 Exhibit 20# 19 Exhibit 21# 20 Exhibit 22# 21 Exhibit 23# 22 Exhibit 24# 23 Exhibit 25# 24 Exhibit 26# 25 Exhibit 27# 26 Exhibit 28)(Seluga, Kimberly) |
Filing 1595 MOTION to Preclude Roche from Offering Exhibits into Evidence Through Deposition Designations by Amgen Inc..(Rich, Patricia) |
Filing 1594 MOTION to Preclude Testimony of Barbara Senich Relying On Docuemnts Withheld in Fact Discovery by Amgen Inc..(Rich, Patricia) |
Filing 1593 MOTION To Preclude Roche from Submitting Deposition Transcripts of Witnesses that have Testified Live at the Remedy Hearing by Amgen Inc..(Rich, Patricia) |
Filing 1592 MOTION To Preclude Roche from Presenting Expert Testimony of Drs. Besarab and Schmidt and Requesting Enforcement of the Court's Order Precluding Reliance Upon Document Withheld in Fact Discovery by Amgen Inc..(Rich, Patricia) |
Filing 1591 MOTION to Modify Order by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
Filing 1590 DECLARATION of Alfred H. Heckel in Support of Defendants' Memorandum in Opposition to Amgen's Request for a Permanent Injunction by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2 Part 1# 3 Exhibit 2 Part 2# 4 Exhibit 2 Part 3# 5 Exhibit 2 Part 4# 6 Exhibit 3 Part 1# 7 Exhibit 3 Part 2# 8 Exhibit 3 Part 3# 9 Errata 3 Part 4# 10 Exhibit 3 Part 5# 11 Exhibit 3 Part 6# 12 Exhibit 3 Part 7# 13 Exhibit 3 Part 8# 14 Exhibit 3 Part 9# 15 Exhibit 3 Part 10# 16 Exhibit 3 Part 11# 17 Exhibit 3 Part 12# 18 Exhibit 3 Part 13# 19 Exhibit 3 Part 14# 20 Exhibit 3 Part 15# 21 Exhibit 3 Part 16# 22 Exhibit 3 Part 17# 23 Exhibit 3 Part 18# 24 Exhibit 3 Part 19# 25 Errata 3 Part 20# 26 Errata 3 Part 21)(Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denying 1587 Motion to preclude Schmidt and Besarab from testifying (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Hearing re RE: evidence offered at injunction hearing held on 12/5/2007. The Court hears from Fresenius lawyer re: confidentiality of Exhibit QAA. After hearing, the court admits the document as Exhibit 20. The Court will hold the exhibit and will be in the custody of the court only. Once the trial is over, the Court will return the exhibit to the lawyers. The Court orders that Ms. Parsons deposition is to go forward. The designation will be given to the court for consideration. The Court rules doc. #1583 is denied. (Court Reporter: Womack.)(Attorneys present: Day, Ben-Ami, Hebert) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Evidentiary Hearing Day 2 held on 12/5/2007. Plainitff's evidence continues. (Court Reporter: Womack.)(Attorneys present: Day, Ben-Ami) (Smith, Bonnie) |
Filing 1589 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1578 Brief Defendant's Memorandum in Opposition to Amgen's Request for a Permanent Injunction. (Fleming, Thomas) |
Filing 1588 Opposition re 1587 Emergency MOTION To Preclude Roche's Late Disclosed Witnesses Dr. Rebecca Schmidt and Dr. Anatole Besarb From Testifying at the Injunction Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Fleming, Thomas) |
Filing 1587 Emergency MOTION To Preclude Roche's Late Disclosed Witnesses Dr. Rebecca Schmidt and Dr. Anatole Besarb From Testifying at the Injunction Hearing by Amgen Inc.. (Attachments: # 1 Exhibit A)(Rich, Patricia) |
Filing 1586 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1583 Brief Roche's Opposition to Amgen's Bench Memorandum to Prevent Roche From Introducing Alleged Antitrust Evidence to Support an Unclean Hands or Patent Misuse Defense. (Fleming, Thomas) |
Filing 1585 MOTION for Leave to File Reply to Roche's Opposition to Fresenius' Motion to Maintain Confidentiality of Certain Terms in the Fresenius/Amgen Supply Agreement by Fresenius Medical Care Holdings, Inc. (FMC). (Attachments: # 1 Non-Party Fresenius' Reply to Roche's Opposition to Fresenius' Motion to Maintain Confidentiality of Certain Terms in the Fresenius/Amgen Supply Agreement# 2 Declaration of Mark J. Hebert)(Hebert, Mark) |
Filing 1584 Opposition re 1580 MOTION Unopposed Motion to Maintain Confidentiality of Fresenius/Amgen Agreement filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Judge William G. Young : Electronic ORDER entered re 1580 Motion Unopposed Motion to Maintain Confidentiality of Fresenius/Amgen Agreement. "Denied without prejudice to its renewal should Roche seek to introduce this agreement." (Paine, Matthew) |
Judge George A. O'Toole Jr.: Electronic ORDER entered re 1582 Emergency MOTION to Quash Subpoena Served on Third Party Debbie Parson. "Granted. The matter may be further considered by Judge Young when the parties appear before him on Wednesday, December 5." (Paine, Matthew) |
Filing 1583 BRIEF by Amgen Inc. Bench Memorandum to Prevent Roche From Introducing Alleged Antitrust Evidence to Support an Unclean Hands or Patent Misuse Defense. (Gottfried, Michael) |
Filing 1582 Emergency MOTION to Quash Subpoena Served on Third Party Debbie Parson by Amgen Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Rich, Patricia) |
Filing 1581 MEMORANDUM in Support re 1580 MOTION Unopposed Motion to Maintain Confidentiality of Fresenius/Amgen Agreement filed by Fresenius Medical Care Holdings, Inc. (FMC). (Hebert, Mark) |
Filing 1580 MOTION Unopposed Motion to Maintain Confidentiality of Fresenius/Amgen Agreement by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
Notice of correction to docket made by Court staff. Exhibit (5) to docket entry (1579) Declaration, was replaced with a correct version of the exhibit. (Paine, Matthew) |
Filing 1579 DECLARATION re 1578 Brief of Aaron R. Hand in Support of Amgen's Memorandum in Support of Its Request for a Permanent Injunction by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3# 4 Exhibit 4# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7# 8 Exhibit 8# 9 Exhibit 9# 10 Exhibit 10)(Gottfried, Michael) Additional attachment(s) added on 11/28/2007 (Paine, Matthew). |
Filing 1578 BRIEF by Amgen Inc. = Memorandum in Support of Amgen's Request for a Permanent Injuction. (Gottfried, Michael) |
Filing 1577 Response by Amgen Inc. to 1557 Brief, Roche's Supplemental Bench Memorandum Regarding Obviousness-Type Double Patenting. (Gottfried, Michael) |
Filing 1576 Letter/request (non-motion) from Lloyd R. Day, Jr.. (Gottfried, Michael) |
Filing 1575 DECLARATION re 1574 Opposition to Motion, Declaration of Patricia R. Rich in Support of Amgen's Opposition by Amgen Inc.. (Attachments: # 1 Exhibit A (part 1)# 2 Exhibit A (part 2)# 3 Exhibit A (part 3)# 4 Exhibit A (part 4)# 5 Exhibit B (part 1)# 6 Exhibit B (part 2)# 7 Exhibit B (part 3))(Rich, Patricia) |
Filing 1574 Opposition re 1567 MOTION in Limine to Preclude Amgen from Introducing Evidence or Argument During the Remedy Phase Regarding the Safety, Efficacy or Dosing of Aranesp for Failure to Produce Discovery Related to Aranesp and Because It Is Irrelevant filed by Amgen Inc.. (Rich, Patricia) |
Filing 1573 Opposition re 1565 MOTION To Admit Stricken Injunction Testimony of Leslie Z. Benet Into Injunction Phase of the Case filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1572 MOTION to Strike The Third Expert Report of Dr. Glenn Chertow and To Preclude Dr. Chertow From Testifying on Subject Matter Contained Therein by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 1571 MOTION in Limine To Preclude Dr. Glenn Chertow From Offering His Personal Opinions As Those of The Broader Medical Community Regarding Efficacy or Dosing of Aranesp by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Huston, Julia) |
Filing 1570 MOTION in Limine To Preclude Dr. Glenn Chertow From Offering Opinions On Topics About Which He Has Expressly Disclaimed Expertise by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Huston, Julia) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present. The Court orders the parties re: filing of confidential documents. See transcript for full order. The Court rules on motions in limine granting 1565 Motion ; denying 1567 Motion in Limine; denying 1570 Motion in Limine; denying 1571 Motion in Limine; denying 1572 Motion to Strike ; Evidentiary Hearing held on 11/15/2007. Opening remarks by Plainitff. The Defendant reserves the right to make opening remarks at a later time. Plaintiff's evidence commences. Evidentairy hearing is continued to 12/5/07.(Court Reporter Womack.) (Smith, Bonnie) |
Filing 1569 Opposition re 1564 MOTION Requesting Leave to File Documents Publicly filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1568 DECLARATION re 1567 MOTION in Limine to Preclude Amgen from Introducing Evidence or Argument During the Remedy Phase Regarding the Safety, Efficacy or Dosing of Aranesp for Failure to Produce Discovery Related to Aranesp and Because It Is Irrelevant (Declaration of Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C)(Seluga, Kimberly) |
Filing 1567 MOTION in Limine to Preclude Amgen from Introducing Evidence or Argument During the Remedy Phase Regarding the Safety, Efficacy or Dosing of Aranesp for Failure to Produce Discovery Related to Aranesp and Because It Is Irrelevant by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1566 BRIEF by Amgen Inc. PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW REGARDING NO OBVIOUSNESS-TYPE DOUBLE PATENTING. (Gottfried, Michael) |
Filing 1565 MOTION To Admit Stricken Injunction Testimony of Leslie Z. Benet Into Injunction Phase of the Case by Amgen Inc..(Gottfried, Michael) |
Filing 1564 MOTION Requesting Leave to File Documents Publicly by Amgen Inc..(Rich, Patricia) |
Filing 1563 NOTICE by Amgen Inc. Of Submission to The Court Regarding Amgen's Pre-Hearing Memorandum in Support of Amgen's Request for Permanent Injunction (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered. The Order of Oct. 25, 2007 is hereby VACATED. NOTHING IS TO BE FILED UNDER SEAL.(Smith, Bonnie) |
Filing 1562 Amgen's Letter/request (non-motion) from Michael R. Gottfried regarding submission of deposition designations to the court. (Gottfried, Michael) |
Filing 1561 Roche's Response to Amgen's Claim for Declaratory Judgment of Inducement of Infringement of Claims 11 and 14 of U.S. Patent No. 5,547,933 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
ELECTRONIC NOTICE OF RESCHEDULINGEvidentiary Hearing reset to continue in December on Wed. 12/5/2007 -12/7/07 09:00 AM in Courtroom 18 before Judge William G. Young. The Court will not sit on Tue. Dec. 4.(Smith, Bonnie) |
Filing 1560 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1559 Response by Amgen Regarding the Courts Appointment of Ernst Berndt As a Technical Consultant. (Seluga, Kimberly) |
Notice of correction to docket made by Court staff. Docket entry (1557) brief was replaced with a corrected copy due to typographical errors in the document. (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing : Evidentiary Hearing re: remedy set for Thursday 11/15/ 2007 from 9:00 AM to 3:30 PM, Tuesday,12/4/2007, Wednesday, 12/5/07,Thursday, 12/6/07 from 09:00 AM To 1:00PM each day before Judge William G. Young. (Smith, Bonnie) |
Filing 1559 Response by Amgen Inc. to the Court's Request to Appoint Ernst Berndt as a Technical Consultant. (Gottfried, Michael) |
Filing 1558 DECLARATION re 1557 Brief IN SUPPORT OF ROCHE'S BENCH MEMORANDUM ADDRESSING AMGEN'S RESPONSE (D.N. 1555) REGARDING OBVIOUSNESS-TYPE DOUBLE PATENTING (of Nicole A. Rizzo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3)(Rizzo, Nicole) |
Filing 1557 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. ROCHE'S BENCH MEMORANDUM ADDRESSING AMGEN'S RESPONSE (D.N. 1555) REGARDING OBVIOUSNESS-TYPE DOUBLE PATENTING. (Rizzo, Nicole) Additional attachment(s) added on 11/9/2007 (Paine, Matthew). |
Filing 1556 Amended Proposed Findings of Fact by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Scheduling Conference/Status Conferene held on 10/30/2007,. The defendant Roche orally moves for judgment notwithstanding the verdict with respect to the '933 patent, claim 12,infringed under the doctrine of equivalents. The Court ALLOWS the motion. After consulting with counsel, the Court will keep Under Advisement the Motion for Summary Judgment as to antitrust. Counsel inform the Court that the remedy phase of the case will take 4 days to try. The jury waived trial will commence at 9AM on Nov.15, 2007 and go to 3:30 PM. It will continue for 3 days thereafter on a schedule that the court can accomodate. Counsel are advised to keep in touch with the clerk for more definitive dates available after Nov. 15. Plaintiff has 3 weeks from Dec. 23, 2007, the date the motion is due, to respond to the Defendant's Motion JNOV. The Court discloses it is thinking of using a technical economics advisor for the remedy portion of the case. The Court distributes the resume of Dr.Berndt who charges $600 per hour. The Court would split the cost between parties. Counsel are to notify the Court by Nov. 7, 2007 as to whether there are any objections to the Court using Dr.Berndt. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1555 Response by Amgen Inc. to 1550 Brief, 1548 Brief = Roche's Bench Memoranda on Obviousness-type Double Patenting. (Gottfried, Michael) |
Filing 1554 BRIEF by Amgen Inc. to 1553 Proposed Findings of Fact = Memorandum in Support of Amgen's Proposed Findings of Fact and Conclusions of Law in Support of Declaratory Judgment of Inducement of Infringement of '933 Claim 14. (Gottfried, Michael) |
Filing 1553 Proposed Findings of Fact by Amgen Inc.. (Gottfried, Michael) |
Filing 1552 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1551 Notice (Other) of Submission. (Brooks, Kregg) |
Judge William G. Young : Electronic ORDER entered denying as moot 1299 MOTION in Limine TO PRECLUDE INFRINGEMENT TESTIMONY BY DR. LODISH WHICH IS IRRELEVANT AND BEYOND HIS EXPERTISE. (Paine, Matthew) |
Filing 1551 NOTICE by Amgen Inc. of Submission of Documents to Court (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered denied as moot 1288 MOTION in Limine to Preclude Testimony By Dr. Vladimir Torchilin Regarding Issues Pertaining Strictly to Invalidity. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denied as moot re 1243 BRIEF: Roche's Motion In Limine To Preclude Expert Testimony By Dr. Lodish Regarding The Conduct Of Drs. Lin and Goldwasser Which Is Spectulative, And Outside His Competence As An Expert , by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot re 1246 MOTION in Limine to Preclude Testimony by Dr. Lodish on Amgen's Validity Case on Matters that Are of No Relevance to this Case. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1261 MOTION in Limine to Preclude Amgen's Expert Witness Dr. Leslie Benet from Offering Testimony on Infringement. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denied as moot re 1242 BRIEF: Roche's Motion in Limine To Preclude Dr. Lodish From Opining Improperly Regarding Prior Art References , by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1292 MOTION in Limine to Preclude Amgen's Expert Dr. Torchilin From Offering Testimony on Literal Infringement or Infringement Under the Doctrine of Equivalents. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1290 MOTION in Limine To Preclude Drs. Lodish and Torchilin From Presenting Animations Not Discussed in Their Expert Reports. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1297 MOTION in Limine to Preclude Amgen From Proffering Testimonial or Documentary Evidence Concerning Infringement Testing Under Federal Rules of Evidence 602,901 and 702/703. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1196 Motion to Authenticate by Declaration in Lieu of the Live Testimony of Charles Kung. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1284 MOTION for Directed Verdict Regarding Invalidity. (Paine, Matthew) |
Filing 1550 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum on Obviousness-Type Double Patenting of the '868 and '698 Patents Over the '008 Patent (Theory 3) and the '933, '422 and '349 Patents Over the '868 and '698 Patents (Theory 4). (Schaffer, Emily) |
Filing 1549 Proposed Findings of Fact by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Schaffer, Emily) |
Filing 1548 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum on Consonance and on the Inapplicability of Section 121 to Obviousness-Type Double Patenting Theory 4. (Schaffer, Emily) |
Judge William G. Young : Electronic ORDER entered denied as moot 1523 MOTION to Strike Antitrust Evidence From Roche's Submission On Inducement. (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing :Counsel are notified that the hearing scheduled for 10/30/07 on the Motion JNOV/JMOL has been revised. The Court will NOT hold argument on motions BUT will hold a STATUS CONFERENCE for the purpose of setting a schedule.Scheduling Conference set for 10/30/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Counsel need NOT prepare for argument on post trial motions.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1522 MOTION for Judgment as a Matter of Law on Roche's Anticipation Defenses. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1528 AEmergency Motion To Enforce Prior Orders Regarding Confidentiality of Admitted Trial Exhibits. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1533 Motion to Exclude Antitrust-Related Documents from Roche's Submission on Inducement (Paine, Matthew) |
Filing 1546 Opposition re 1533 MOTION to Exclude Antitrust-Related Documents from Roche's Submission on Inducement filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1545 Opposition re 1539 MOTION Amgen's Objections to Roche's Motion to Correct TRX 2012 and for Admission of Documents into Evidence filed by Amgen Inc.. (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered denying as moot 1532 Motion to Supplement the Record on Inequitable Conduct with a Limited Number of Documents that Directly Address and Provide Context for the Evidence Offered by Roche at the Inequitable Conduct Hearing. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying as moot 1547 Amgen's Omnibus Motion to Admit Documents Into Evidence Solely for the Inequitable Conduct Phase of the Trial that are Relevant to State of Mind. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1539 Roche's Motion to Correct TRX 2012 and For Admission of Documents into Evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered finding as moot 1369 Motion in Limine (Smith, Bonnie) |
Filing 1544 Witness List for Bench trial. (Smith, Bonnie) |
Filing 1543 Witness List. (Smith, Bonnie) |
Filing 1542 JURY VERDICT in favor of Plaintiff against Defendant. (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present. Jury Trial Day 24 held on 10/23/2007. The 10 members of the jury continue its deliberations. Jury question #4 asked. The Court instructs via telephone the answer to the question. Counsel agree to an answer and the question is answered. The Jury returns a verdict for the plaintiff. The Court will hold a hearing on Motions for judgment notwithstanding the verdict. The hearing is set for Oct 30, 2007 at 2PM. The parties have 60 days from today to file briefing re: the motions. (Court Reporter Womack.) (Smith, Bonnie) Modified on 10/23/2007 (Smith, Bonnie). |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's attorney Day and Defendant's attorney Ben-Ami are present.Jury Trial 23 held on 10/22/2007. The 10 deliberating jurors are present. Deliberations continue. Question #3 is asked. The Court hears via telephone counsel's argument on the question. TheCourt answers the question. (Court Reporter Womack.) (Smith, Bonnie) . |
Filing 1541 TRIAL BRIEF Regarding Inequitable Conduct by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2)(Fleming, Thomas) |
Filing 1540 DECLARATION of Krista M. Rycroft in support re 1539 Roche's Motion to Correct TRX 2012 and For Admission of Documents into Evidence by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2 part 1 of 2# 3 Exhibit 2 part 2 of 2# 4 Exhibit 3# 5 Exhibit 4# 6 Exhibit 5# 7 Exhibit 6# 8 Exhibit 7# 9 Exhibit 8# 10 Exhibit 9# 11 Exhibit 10# 12 Exhibit 11 part 1 of 2# 13 Exhibit 11 part 2 of 2# 14 Exhibit 12)(Fleming, Thomas) Modified on 10/23/2007 (Paine, Matthew). |
Filing 1539 Roche's Motion to Correct TRX 2012 and For Admission of Documents into Evidence . (Fleming, Thomas) Modified on 10/23/2007 (Paine, Matthew). |
Filing 1538 BRIEF by Amgen Inc. = Amgen's Supplemental Bench Memorandum Regarding No Obviousness-Type Double Patenting. (Gottfried, Michael) |
Filing 1537 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Supplemental Memorandum of Law in Support of Roche's October 15, 2007 Oral Motion for Judgment of Non-Infringment as a Matter of Law (Leave to File Granted on October 18, 2007). (Schaffer, Emily) |
Filing 1536 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. in Support of Roche's October 15, 2007 Oral Motion for Judgment of Non-Infringement as a Matter of Law (Leave to file granted October 16, 2007). (Schaffer, Emily) |
Filing 1535 Opposition re 1532 MOTION to Supplement the Record on Inequitable Conduct with a Limited Number of Documents that Directly Address and Provide Context for the Evidence Offered by Roche at the Inequitable Conduct Hearing filed by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1534 BRIEF by Amgen Inc. Requesting Judgment of No Inequitable Conduct. (Rich, Patricia) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's attorney Day and Defendant's attorney Ben-Ami are present. Jury Trial 22 held on 10/19/2007. The Court inquires of the 10 deliberating jurors as to whether they have discussed the case with anyone. The jurors answer in the negative. Jury questions #2 asked and answered. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1533 MOTION to Exclude Antitrust-Related Documents from Roche's Submission on Inducement by Amgen Inc..(Gottfried, Michael) |
Filing 1532 MOTION to Supplement the Record on Inequitable Conduct with a Limited Number of Documents that Directly Address and Provide Context for the Evidence Offered by Roche at the Inequitable Conduct Hearing by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1531 RESPONSE to Motion re 1528 Emergency MOTION To Enforce Prior Orders Regarding Confidentiality of Admitted Trial Exhibits filed by Amgen Inc.. (Rich, Patricia) |
Filing 1530 Opposition re 1523 MOTION to Strike Antitrust Evidence From Roche's Submission On Inducement filed by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1529 Opposition re 1522 MOTION for Judgment as a Matter of Law on Roche's Anticipation Defenses (LEAVE TO FILE GRANTED ON 10/18/2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Schaffer, Emily) |
Filing 1528 Emergency MOTION To Enforce Prior Orders Regarding Confidentiality of Admitted Trial Exhibits by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 1527 Exhibit List by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc., Amgen Inc.Re: the Non jury OBVIOUSNESS DOUBLE PATENTING TRIAL.. (Smith, Bonnie) |
Filing 1526 Witness and Exhibit List for the Evidentiary hearing re: Inequitable Conduct. (Smith, Bonnie) |
Filing 1525 NOTICE by Amgen Inc. OF SUBMISSION TO THE COURT REGARDING AMGEN'S MOTION TO ADMIT ROCHE'S PRIOR ADMISSIONS RELATED TO ROCHE'S INDUCEMENT OF INFRINGEMENT (Gottfried, Michael) |
Filing 1524 RESPONSE to Motion re 1442 MOTION for Leave to File Roche's Motion for Leave to File a Supplemental Memorandum of Law in Excess of the Page Limit in Support of Its Motion for Judgment of Non-Infringement as a Matter of Law, 1414 MOTION for Leave to File Roches Motion for Leave to File a Brief in Excess of the Page Limit in Support of Its Motion for Judgment of Non-Infringement as a Matter of Law (= MEMORANDUM OF AMGEN INC. IN RESPONSE TO ROCHE'S MOTION FOR JUDGMENT AS A MATTER OF LAW REGARDING INFRINGEMENT, per leave to file granted on 10/18/07) filed by Amgen Inc.. (Rich, Patricia) |
Filing 1523 MOTION to Strike Antitrust Evidence From Roche's Submission On Inducement by Amgen Inc..(Gottfried, Michael) |
Filing 1522 MOTION for Judgment as a Matter of Law on Roche's Anticipation Defenses (LEAVE TO FILE GRANTED ON 10/18/2007) by Amgen Inc..(Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered denying 1516 MOTION for Reconsideration and Objection To The Courts Granting Roches Cross Motion To Admit Exhibits POZ And PZG Into Evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1385 MOTION To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Term "Human Erythropoietin" ; denied as moot 1391 MOTION in Limine To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Claim Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Terms "Isolating" and "Comprising," As Set Forth In The Asserted '698 And '868 Claims (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1520 Motion For Confirmation That TX 2012a Is Admitted For Purposes Of The Obviousness-Type Double Patenting Bench Trial. (Paine, Matthew) |
Filing 1547 Amgen's Omnibus MOTION to Admit Documents Into Evidence Solely for the Inequitable Conduct Phase of the Trial that are Relevant to State of Mind. by Amgen Inc.. (Attachments: # 1 Exhibit - A)(Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 21 held on 10/18/2007.TheCourt further charges the jury as to the law. Closing arguments by Defendant, by Plainitff. Jury commences deliberations. Jury question #1 asked and answered. Jury adjourns until 9AM on Fri. Oct. 19, 2007. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1521 RESPONSE to Motion re 1434 MOTION for Judgment as a Matter of Law Defendant's Motion for Judgment of Non-Infringement as a Matter of Law for Claim 9 of the '933 Patent and Motion to Strike '933 Claim 9 From the Jury Verdict Sheet Leave to File Granted on 10/18/07 filed by Amgen Inc.. (Rich, Patricia) |
Filing 1520 MOTION For Confirmation That TX 2012a Is Admitted For Purposes Of The Obviousness-Type Double Patenting Bench Trial by Amgen Inc..(Rich, Patricia) |
Filing 1519 BRIEF by Amgen Inc. = Bench Memorandum To Explain The Lack Of Materiality Of References Regarding uEPO And rEPO In Response To Roches Allegations Of Inequitable Conduct Based Thereon. (Gottfried, Michael) |
Filing 1518 Opposition re 1512 MOTION To Exclude Previously Undisclosed Exhibits Admitted After The Close Of The ODP Case filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1517 NOTICE by Amgen Inc. Of Manual Filing Of Its Omnibus Motion To Admit Documents Into Evidence Solely For The Inequitable Conduct Phase Of The Trial That Are Relevant To State Of Mind (Gottfried, Michael) |
Filing 1516 MOTION for Reconsideration and Objection To The Courts Granting Roches Cross Motion To Admit Exhibits POZ And PZG Into Evidence by Amgen Inc..(Gottfried, Michael) |
Filing 1515 BRIEF by Amgen Inc. =Bench Brief To Explain The Lack Of Materiality Of Thomas Stricklands Declarations Submitted In European Proceedings In Response To Roches Allegations Of Inequitable Conduct Based Thereon. (Gottfried, Michael) |
Filing 1514 BRIEF by Amgen Inc. = Bench Memorandum To Explain Roches Factually And Legally Unsupported Allegations That Amgen Buried References Submitted To The PTO. (Gottfried, Michael) |
Filing 1513 BRIEF by Amgen Inc. = Bench Memorandum To Explain The Lack Of Materiality Of Rejections In A Co-Pending Application In Response To Roches Allegations Of Inequitable Conduct Based Thereon. (Gottfried, Michael) |
Filing 1512 MOTION To Exclude Previously Undisclosed Exhibits Admitted After The Close Of The ODP Case by Amgen Inc..(Rich, Patricia) |
Filing 1511 BRIEF by Amgen Inc. BENCH MEMORANDUM THAT IT SHOULD BE ALLOWED TO COMPLETE THE RECORD UNDER FRE 106 IF ROCHE SEEKS TO MOVE EXHIBIT GUK INTO EVIDENCE DURING THE INEQUITABLE CONDUCT PHASE OF THE TRIAL. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1510 Opposition re 1482 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) On Roche's List of Alleged Prior Art filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1509 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Response to Amgen's Request for Judicial Notice of Sections of the Manual of Patent Examining Procedure and Motion for Their Entry into Evidence (D.I. 1499). (Fleming, Thomas) |
Filing 1508 Opposition re 1486 MOTION to Preclude Roche from Referring to Government Funding of Dr. Goldwasser's Urinary EPO Research During the Closing Argument Opposition to Amgen's Motion to Preclude Roche from Referring to Government Funding of Dr. Goldwasser's Urinary EPO Research During Closing Argument (D.I. 1486) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1507 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Objection to Amgen's Proposed Instruction for Infringement of '868 Claims 1-2 and '698 Claims 6-9. (Fleming, Thomas) |
Filing 1506 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Objections to Amgen's Proposed Supplemental Jury Instructions on Obviousness. (Fleming, Thomas) |
Filing 1505 Opposition re 1469 MOTION in Limine Roche's Motion In Limine to Preclude Amgen from Arguing that Statements Made During Interference Proceedings Were Merely Recitations of Fritsch's Statements filed by Amgen Inc.. (Rich, Patricia) |
Filing 1504 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Bench Memorandum in Support of Roche's Request, Pursuant to FED. R. CIV. P. 37(c), To Preclude Expert Testimony By Amgen's Dr. Thomas Strickland (Previously Filed With the Court on September 27, 2007.). (Fleming, Thomas) |
Filing 1503 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Bench Memorandum in Support of Roche's Request to Preclude Amgen From Introducing, in Connection With the Testimony of Dr. Thomas Strickland, Laboratory Notebooks or Portions Thereof Which Do Not Reflect His Work (Previously Filed With the Court on September 27, 2007.). (Fleming, Thomas) |
Filing 1502 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Defendants' Motion to Admit Exhibits into Evidence Relevant to Non-Infringement (Previously Filed With the Court on October 15, 2007. A list of exhibits filed with this motion is included within the document.). (Fleming, Thomas) |
Filing 1501 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Defendants' Motion To Admit Exhibits Into Evidence (Previously Filed in Open Court on September 24, 2007. A list of exhibits filed with this motion is included within the document.). (Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denied as moot 1368 MOTION to Preclude Roche's Experts from Claiming Unproven and Undisclosed FDA Certification ; denied as moot 1384 MOTION To Preclude Roche's Expert Dr. Gregory D. Longmore From Offering Opinions Based On An Infringement Analysis That Is Inconsistent With Federal Circuit Precedent And With The Court's Claim Construction Ruling That Amgen's Claims Are Open-Ended (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Madrid and Defendant's counsel Suh are present.Evidentiary Hearing re: Inequitable conduct held on 10/18/2007.Defendant Roche evidence commences. Cross examination by Amgen. Redirect examination, Recross examination. The Court takes the matter Under Advisement. The Court will accept final arguments in writing without the 20 page limit. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered "Allowed for the inequitable conduct portion of the case." re 1499 Motion Request for Judicial Notice of Sections of the Manual of Patent Examining Procedure and Motion for Their Entry Into Evidence (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1477 MOTION for Reconsideration of the Court's Order Granting Judgment of Non-Infringement as to '349 Claim 7 in Order to Allow Jury to Consider Infringement Under Doctrine of Equivalents. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1495 MOTION for Leave to File A Brief In Excess Of The Page Limit In Support Of Its Opposition To Roches Motion For Judgment As A Matter Of Law Regarding Infringement; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1397 Motion to Withdraw 1397 MOTION to Withdraw 1360 Brief, Without Prejudice Amgen's Bench Memorandum to Explain the Relevance of Exhibits GXD and EYV to Issues of Infringement (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. "Denied as moot." re 1488 BRIEF: Defendants' Motion For Proper Jury Instruction On Its Patent In Evidence As Exhibit 2109 by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1486 Motion to Preclude Roche from referring to Govt funding of Dr.Goldwasser's urinary EPO research during closing argument. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 1501 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD,DENIED AS MOOT 1503 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, DENIED AS MOOT 1504 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, DENIED AS MOOT 1509 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, "THE COURT WILL TAKE JUDICIAL NOTICE OF MPEP" 1502 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD DENIED AS MOOT SAVE INSOFAR AS I'VE RULED ON PARTICULAR EXHIBITS.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered finding as moot 1466 Motion ; denying 1467 Motion for Judgment as a Matter of Law on the Comercial Viability test for material change. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1469 Motion in Limine to preclude Amgen from arguing that statements made during interference proceedings were merely recitations of Fritsch's statements.; finding as moot 1470 Motion to preclude Amgen from offering additional evidence and argument re: secondary considerations of non-obviousness. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1434 Motion for Judgment as a Matter of Law (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1441 MOTION for Leave to File Excess Pages in Support of its Motion for Judgment as a Matter of Law on Roche's Anticipation Defenses. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1442 MOTION for Leave to File Roche's Motion for Leave to File a Supplemental Memorandum of Law in Excess of the Page Limit in Support of Its Motion for Judgment of Non-Infringement as a Matter of Law; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1417 MOTION in Limine Regarding Flavell No. 3: to Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Claim Construction of the '933 Patent Claim Term "Non-Naturally Occurring; denied as moot 1421 MOTION in Limine Regarding Flavell No. 7: To Preclude Richard Flavell From Offering Opinions Based on a Claim Construction that Requires That the Term "Obligate" Glycoprotein Be Read into the Asserted '933 Claim; denied as moot 1422 MOTION in Limine Regarding Flavell No. 8: To Preclude Richard A. Flavell from Offering Opinions that were Rejected by this Court's Holding that PEG-EPO Infringes Claim 1 of Dr. Lin's '422 Patent. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered finding as moot 1410 Motion ; finding as moot 1411 Motion in Limine; granting 1412 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; finding as moot 1415 Motion in Limine; finding as moot 1416 Motion in Limine; finding as moot 1417 Motion in Limine; finding as moot 1418 Motion in Limine; finding as moot 1419 Motion in Limine; finding as moot 1420 Motion in Limine; finding as moot 1421 Motion in Limine; finding as moot 1422 Motion in Limine; finding as moot 1423 Motion in Limine; denying 1429 Motion to Correct (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denied as moot 1455 MOTION in Limine To Preclude Roche From Offering The Deposition Testimony Of Thomas Boone Because It Is Related Solely To The Issue Of Amgens Pegylation Of EPO, Which This Court Has Ruled Is Irrelevant. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1468 MOTION in Limine Roche's Motion In Limine to Preclude Stephen G. Kunin from Testifying in the Inequitable Conduct Portion of this Trial. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1451 Motion to Preclude "Rebuttal" Evidence in Infringement Case. (Paine, Matthew) |
Filing 1500 MEMORANDUM in Opposition re 1468 MOTION in Limine Roche's Motion In Limine to Preclude Stephen G. Kunin from Testifying in the Inequitable Conduct Portion of this Trial filed by Amgen Inc.. (Attachments: # 1 Exhibit 1)(Gottfried, Michael) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plainitff's counsel Day and Defendant's counsel Ben-Ami are present. Hearing re Objections to the charge held on 10/17/2007. The Court hears from the Defendant and the Plainitiff. The Court makes rulings on the objections. After consulting with the attorneys it is decided that a hearing on inducement is not needed. The parties will rest on the submitted pleadings. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's attorney Day and Defendant's attorney Ben-Ami are present. Hearing prior to start of trial re: article in NY Times and the jury verdict form. Court inquires of jury as whether anyone has seen the Times article. One juror answers in the affirmative. Voir Dire of juror. Juror to remain.Jury Trial Day 20 held on 10/17/2007. Defendant's evidence continues. Defendant Rests. Plaintiff Rests. Plaintiff orally moves for directed verdict. Defendant orally renews motion for directed verdict. The Court orders defendant's motion Denied. Plaintiff's motion is allowed as to the reverse doctrine of equivalents, otherwise denied. The Court charges the jury as to the law. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1499 MOTION Request for Judicial Notice of Sections of the Manual of Patent Examining Procedure and Motion for Their Entry Into Evidence by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3# 4 Exhibit 4# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7# 8 Exhibit 8# 9 Exhibit 9# 10 Exhibit 10# 11 Exhibit 11# 12 Exhibit 12# 13 Exhibit 13# 14 Exhibit 14# 15 Exhibit 15# 16 Exhibit 16# 17 Exhibit 17# 18 Exhibit 18# 19 Exhibit 19# 20 Exhibit 20# 21 Exhibit 21)(Gottfried, Michael) |
Filing 1498 DECLARATION re 1497 MOTION to Correct the Record Regarding Dr. Harvey Lodish's Trial Testimony OF ROBERT M. GALVIN by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3)(Gottfried, Michael) |
Filing 1497 MOTION to Correct the Record Regarding Dr. Harvey Lodish's Trial Testimony by Amgen Inc..(Gottfried, Michael) |
Filing 1496 MOTION to Confirm the Court's October 4, 2007 Ruling from the Bench Granting Docket Number 1313 by Amgen Inc..(Rich, Patricia) |
Filing 1495 MOTION for Leave to File A Brief In Excess Of The Page Limit In Support Of Its Opposition To Roches Motion For Judgment As A Matter Of Law Regarding Infringement by Amgen Inc.. (Attachments: # 1 Exhibit A - [Proposed] Opposition To Roches Motion For Judgment As A Matter Of Law Regarding Infringement)(Rich, Patricia) |
Filing 1494 Opposition/ Response by Amgen Inc. to 1343 Proposed Jury Instructions /Roches Bench Memorandum In Support Of Roches Proposed Jury Instruction On Inherent Obviousness. (Gottfried, Michael) |
Filing 1493 MOTION in Limine To Preclude Roche From Calling Antitrust Witnesses To Testify During The Inducement Stage Of This Trial by Amgen Inc..(Gottfried, Michael) |
Filing 1492 RESPONSE to Motion re 1467 MOTION for Judgment as a Matter of Law Roche's Motion for Judgment as a Matter of Law on the Commercial Viability Test for Material Change under U.S.C. § 271(g) MOTION for Judgment as a Matter of Law Roche's Motion for Judgment as a Matter of Law on the Commercial Viability Test for Material Change under U.S.C. § 271(g) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1491 Objection by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Objections To Amgen's [Proposed] Revised Final Jury Instructions. (Fleming, Thomas) |
Filing 1490 DECLARATION re 1488 Brief Of Patricia Carson In Support of Defendants' Motion For Proper Jury Instruction On Its Patent In Evidence As Exhibit 2109 by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Fleming, Thomas) |
Filing 1489 Proposed Jury Verdict by Amgen Inc.. (Rich, Patricia) |
Filing 1488 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Defendants' Motion For Proper Jury Instruction On Its Patent In Evidence As Exhibit 2109. (Fleming, Thomas) |
Filing 1487 BRIEF by Amgen Inc. = Bench Memorandum And Proposed Jury Instruction Regarding Roches Reverse Doctrine Of Equivalents Defense. (Rich, Patricia) |
Filing 1486 MOTION to Preclude Roche from Referring to Government Funding of Dr. Goldwasser's Urinary EPO Research During the Closing Argument by Amgen Inc..(Rich, Patricia) |
Filing 1485 Proposed Document(s) submitted by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. Document received: Defendants' Second Amended Proposed Jury Verdict Form. (Huston, Julia) |
Filing 1484 MOTION in Limine To Avoid Jury Confusion and Verdict Error By Precluding the Use of Amgen's Proposed Verdict Form by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Huston, Julia) |
Filing 1483 Objection to 1343 Proposed Jury Instructions by Amgen Inc.. (Gottfried, Michael) |
Filing 1482 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) On Roche's List of Alleged Prior Art by Amgen Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Rich, Patricia) |
Filing 1481 Opposition re 1465 MOTION to Strike Roche's Motion to Strike Portions of Dr. Torchilin's Testimony Related to Pegylation of Non-EPO Compounds to Conform with the Court's Order, or Alternatively, to Submit Contrary Testimony from the Deposition of Dr. L Lin filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1480 Opposition re 1470 MOTION Roche's Motion to Preclude Amgen from Offering Additional Evidence and Argument Regarding Secondary Considerations of Non-Obviousness (= AMGEN'S OPPOSITION TO ROCHE'S DEUPLICATIVE MOITON REGARDING EVIDENCE OF SECONDARY CONSIDERATIONS OF NON-OBVIOUSNESS) filed by Amgen Inc.. (Rich, Patricia) |
Filing 1479 BRIEF by Amgen Inc. = Bench Memorandum To Prevent Roche From Presenting Testimony From Dr. Klibanov About Changes To Small Molecules That Are Not EPO, Non-EPO Pegylated Molecules, And Amgens Pegylation Efforts. (Attachments: # 1 Exhibit 1)(Gottfried, Michael) |
Filing 1478 Response by Amgen Inc. to 1273 Brief, 1344 Brief, = AMGEN'S OPPOSITION TO ROCHE'S DUPLICATIVE BENCH MEMORANDUM REQUESTING AN ERRONEOUS JURY INSTRUCTION ON NEXUS OF SECONDARY CONSIDERATIONS OF NON-OBVIOUSNESS. (Rich, Patricia) |
Filing 1477 MOTION for Reconsideration of the Court's Order Granting Judgment of Non-Infringement as to '349 Claim 7 in Order to Allow Jury to Consider Infringement Under Doctrine of Equivalents by Amgen Inc..(Rich, Patricia) |
Filing 1476 Response by Amgen Inc. to 1452 Brief, 1466 MOTION Roche's Motion to Preclude Amgen from Offering Additional Evidence and Argument Regarding Invention Date Prior to the Effective Filing Date of the Patents-In-Suit (= Amgen's Respons to Roche's Memorandum and Opposition to Roche's Motion Regarding Date of Invention). (Rich, Patricia) |
Filing 1475 Opposition re 1451 MOTION Motion to Preclude "Rebuttal" Evidence in Infringement Case filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1474 BRIEF by Amgen Inc. = Bench Memorandum Regarding Proposed Jury Charge on Material Change and 35 U.S.C. Sec. 271(g). (Attachments: # 1 Exhibit A)(Rich, Patricia) |
Filing 1473 DECLARATION re 1472 Response OF DANIEL A. CURTO IN SUPPORT OF AMGEN'S RESPONSE TO ROCHE'S MEMORANDUM REGARDING THE INADMISSIBILITY OF EXHIBIT EWW by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered denying 1463 Motion for Clarification...."Motion denied.The Court has concluded that the record in this case would not allow a reasonable jury to determine Dr. Fritsch was the first inventor of the claims in suit.Upon this record, the other proposed uses of this testimony are either (1) not adequately supported by the evidentiary record or,(2) inadequately supported by expert opinion." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying as moot 1484 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1493 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1413 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1425 Motion in Limine; denying 1465 Motion to Strike (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 1461 Declaration,, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH b " POZ and PZG are admitted in the non-jury inequitable conduct case".(Smith, Bonnie) |
Notice of correction to docket made by Court staff. Docket Entry (1440) was replaced because the wrong document was attached to the entry and Docket Entry (1443) corrected because the wrong version of the document was attached to the entry. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 19 held on 10/16/2007.Plaintiff's evidence continues. Plaintiff Rests. Defendant orally moves for Directed Verdict. The Motion is Allowed as to patent'349, claim 7, otherwise Denied. Defendant's evidence commences. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1472 Response by Amgen Inc. to 1438 Brief Regarding the Inadmissibility of Exhibit EWW. (Gottfried, Michael) |
Filing 1471 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Bench Memorandum Concerning Amgens Proposed Jury Instructions Regarding Infringement of Process Claims and "Additional Elements" that is Contrary to Federal Circuit Law. (Fleming, Thomas) |
Filing 1470 MOTION Roche's Motion to Preclude Amgen from Offering Additional Evidence and Argument Regarding Secondary Considerations of Non-Obviousness by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1469 MOTION in Limine Roche's Motion In Limine to Preclude Amgen from Arguing that Statements Made During Interference Proceedings Were Merely Recitations of Fritsch's Statements by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1468 MOTION in Limine Roche's Motion In Limine to Preclude Stephen G. Kunin from Testifying in the Inequitable Conduct Portion of this Trial by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1467 MOTION for Judgment as a Matter of Law Roche's Motion for Judgment as a Matter of Law on the Commercial Viability Test for Material Change under U.S.C. § 271(g) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1466 MOTION Roche's Motion to Preclude Amgen from Offering Additional Evidence and Argument Regarding Invention Date Prior to the Effective Filing Date of the Patents-In-Suit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1465 MOTION to Strike Roche's Motion to Strike Portions of Dr. Torchilin's Testimony Related to Pegylation of Non-EPO Compounds to Conform with the Court's Order, or Alternatively, to Submit Contrary Testimony from the Deposition of Dr. Lin by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1464 Opposition re 1425 MOTION in Limine to Preclude Roche from Introducing Theories and Evidence Concerning Inequitable Conduct Allegations Not Pled By Roche in Its First Amended Answer filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1463 MOTION Roche's Renewed Motion for Clarification of the Court's October 15, 2007 Order Precluding Roche from Offering Additional Evidence and Argument Regarding the Genetics Institute and Request for Guidance Prior to Closing Arguments by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1462 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Bench Memorandum in Support of Roche's Proposed Jury Instruction on Inherent Obviousness. (Attachments: # 1 Exhibit A)(Fleming, Thomas) |
Filing 1461 DECLARATION re 1460 Opposition to Motion, Amgen's Motion in Limine to Preclude Roche's Purported FRE 406 Witness, Mr. Solocleous, and Patent Law Experts Generally, From Testifying in the Inequitable Conduct Case (D.I. 1413), and Roche's Cross Motin to Admit Exhibits POZ and PZG Into Evidence Pursuant to Fed. R. Evid. 201, 803(8) and 902(5) (Krista Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit Ex 1-1# 2 Exhibit Ex 1-2# 3 Exhibit Ex 1-3# 4 Exhibit Ex 1-4# 5 Exhibit Ex 1-5# 6 Exhibit Ex 2-1# 7 Exhibit Ex 2-2)(Fleming, Thomas) |
Filing 1460 Opposition re 1413 MOTION in Limine to Preclude Roche's Purported FRE 406 Witness, Mr. Sofocleous, And Patent Law Experts Generally, From Testifying In The Inequitable Conduct Phase Of The Trial and Roche's Cross Motion to Admit Exhibits POZ and PZG Into Evidence Pursuant to Fed. R. Evid. 201, 803(8) and 902(5) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1459 Reply to Roches Opposition to Amgens Bench Memorandum Regarding Evidence of Infringement of 349 Claim 7 Response by Amgen Inc. to 1361 Response, 1339 Brief Leave to File Granted on 10/16/07. (Gottfried, Michael) |
Filing 1458 Opposition re 1434 MOTION for Judgment as a Matter of Law Defendant's Motion for Judgment of Non-Infringement as a Matter of Law for Claim 9 of the '933 Patent and Motion to Strike '933 Claim 9 From the Jury Verdict Sheet filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1457 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Bench Memorandum Regarding Proposed Jury Charge On Material Change. (Fleming, Thomas) |
Filing 1456 DECLARATION re 1455 MOTION in Limine To Preclude Roche From Offering The Deposition Testimony Of Thomas Boone Because It Is Related Solely To The Issue Of Amgens Pegylation Of EPO, Which This Court Has Ruled Is Irrelevant of Daniel A. Curto by Amgen Inc.. (Attachments: # 1 Exhibit A)(Gottfried, Michael) |
Filing 1455 MOTION in Limine To Preclude Roche From Offering The Deposition Testimony Of Thomas Boone Because It Is Related Solely To The Issue Of Amgens Pegylation Of EPO, Which This Court Has Ruled Is Irrelevant by Amgen Inc..(Gottfried, Michael) |
Filing 1454 Opposition/ Response by Amgen Inc. to 1445 Proposed Jury Verdict Submitted by Roche. (Rich, Patricia) |
Filing 1453 Response by Amgen Inc. Amgen's Opposition to Roche's Motion to Admit Exhibits Into Evidence Relevant to Non-Infringement (which Motion Roche Manually Filed with the Court on 10/15/07). (Rich, Patricia) |
Filing 1452 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Regarding Amgen's Failure to Meet Its Heavy Burden to Demonstrate that the Invention Date is Earlier than the Filing Date of the Patents-In-Suit. (Fleming, Thomas) |
Filing 1451 MOTION Motion to Preclude "Rebuttal" Evidence in Infringement Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1450 MOTION for Clarification Roche's Motion for Clarification of the Court's October 15, 2007 Order Granting Amgen's "Motion to Preclude Roche from Offering Additional Evidence and Argument Regarding the Genetics Institute" by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1449 Opposition re 1416 MOTION in Limine Regarding Flavell No. 2: To Preclude Richard A. Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Claim Terms "Isolating" and "Comprising," as set forth in the Asserted & filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1448 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Demonstrating Inappropriateness of "Commercial Viability" Test for Material Change under 35 U.S.C. §271(g). (Fleming, Thomas) |
Filing 1447 Opposition re 1417 MOTION in Limine Regarding Flavell No. 3: to Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Claim Construction of the '933 Patent Claim Term "Non-Naturally Occurrin filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1446 Amended Proposed Jury Verdict by Amgen Inc.. (Gottfried, Michael) |
Filing 1445 Amended Proposed Jury Verdict by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1444 Opposition re 1421 MOTION in Limine Regarding Flavell No. 7: To Preclude Richard Flavell From Offering Opinions Based on a Claim Construction that Requires That the Term "Obligate" Glycoprotein Be Read into the Asserted '933 Claim filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1443 Opposition re 1422 MOTION in Limine Regarding Flavell No. 8: To Preclude Richard A. Flavell from Offering Opinions that were Rejected by this Court's Holding that PEG-EPO Infringes Claim 1 of Dr. Lin's '422 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) Additional attachment(s) added on 10/17/2007 (Paine, Matthew). |
Filing 1442 MOTION for Leave to File Roche's Motion for Leave to File a Supplemental Memorandum of Law in Excess of the Page Limit in Support of Its Motion for Judgment of Non-Infringement as a Matter of Law by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Fleming, Thomas) |
Filing 1441 MOTION for Leave to File Excess Pages in Support of its Motion for Judgment as a Matter of Law on Roche's Anticipation Defenses by Amgen Inc.. (Attachments: # 1 Exhibit A)(Rich, Patricia) |
Filing 1440 Response by Amgen Inc. to 1340 Response AMGEN INC.'S RESPONSE TO ROCHE'S LIST OF ALLEGED ANTICIPATORY PRIOR ART. (Gottfried, Michael) Additional attachment(s) added on 10/17/2007 (Paine, Matthew). |
Filing 1439 MOTION Defendants' Motion to Admit Exhibits into Evidence by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit SP# 2 Exhibit QHZ# 3 Exhibit QIA - 1# 4 Errata QIA - 2# 5 Exhibit QIB -1# 6 Exhibit QIB - 2# 7 Exhibit QIB - 3# 8 Exhibit GUK -1# 9 Exhibit GUK -2# 10 Exhibit GUK - 3# 11 Exhibit GUK - 4# 12 Exhibit GUK - 5# 13 Exhibit GUK - 6# 14 Exhibit GUK - 6# 15 Exhibit QIL - 1# 16 Exhibit QIL -2# 17 Exhibit QEC)(Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denying 1450 Motion for Clarification "There is no need for clarification, the Court's ruling on Amgen's motion was intended to have precisely the effect sought" (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1439 D's Motion to admit exhibits into evidence...."Allowed on the issue of obviousness double patenting only" (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. "In reconsideration,TRX 2012A is ruled inadmissible"(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1432 Motion to supplement exhibit 2017 (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1414 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (10/16/07)- in the caption of the document. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1377 MOTION for Leave to File A Reply to Roche's Opposition to Amgen's Bench Memorandum Regarding Evidence of Infringement of '349 Claim 7 ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denying re 1363 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Requesting Jury Instruction Regarding Amgen's Failure to Proffer Secondary Consideration Evidence of the Failure of Others Similarl y Situated to the Inventor. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denying re 1362 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Requesting That the Jury be Instructed that the Processes of Claims '868 1 and 2 and '698 4-9 Culminate in Isolation, Not Puri fication, of the Recited Polypeptide.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denying re 1238 BRIEF by Amgen Inc. BENCH MEMORANDUM TO PRECLUDE ROCHE FROM ARGUING OR PRESENTING EVIDENCE THAT MIRCERA DOES NOT CONTAIN HUMAN ERYTHROPOIETIN. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1313 Motion To PROVIDE THE COURT WITH ADDITIONAL DOCUMENTS FROM THE INTERFERENCE PROCEEDINGS THAT ARE NECESSARY FOR COMPLETENESS AND TO PROVIDE A COMPLETE UNDERSTANDING OF THE PROCEEDINGS. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1311 MOTION to Correct the File History of the '868 Patent by Adding a Document that was Missing. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Denied as moot." re 1257 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum to Preclude Amgen From Introducing Belatedly Produced Documents Relating to Its Experiments with Pegylation and COS-EPO as Untimely and Prejudicial. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's attorney Day and Defendant's attorney Ben-Ami are present.Hearing re Defendant's Oral Motion for Directed Verdict as to infringement. held on 10/15/2007. After hearing the Court takes the matter UNDER ADVISEMENT. Counsel will file briefs on the issue. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's attorney Day and Defendant's attorney Ben-Ami are present.Jury Trial Day 18 held on 10/15/2007. Plaintiff's evidence as to infringement continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1438 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Memorandum Regarding the Inadmissibility of Exhibit EWW as Hearsay. (Fleming, Thomas) |
Filing 1437 Opposition re 1420 MOTION in Limine Regarding Flavell No. 6: To Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Construction of '868 Claim Term "Isolated DNA Sequence Encoding Human Er filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1436 Opposition re 1415 MOTION in Limine Regarding Flavell No. 1: To Preclude Richard A. Flavell From Testifying During the Infringement Stage on Issues Pertaining to Invalidity filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1435 Opposition re 1423 MOTION in Limine Regarding Flavell No. 9: To Preclude Richard Flavell from Offering Opinions Regarding "Isolated DNA Sequence Encoding Human Erythropoietin" Based on His Refusal to Provide the Basis for Those Opinions at Deposition filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1434 MOTION for Judgment as a Matter of Law Defendant's Motion for Judgment of Non-Infringement as a Matter of Law for Claim 9 of the '933 Patent and Motion to Strike '933 Claim 9 From the Jury Verdict Sheet by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1433 Reply to Amgen's Opposition to Roche's Motion For Reconsideration of the Court's October 4, 2007 Order Regarding The '868 File History Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1386 Response. (Fleming, Thomas) |
Filing 1432 MOTION Roche's Motion to Supplement Trial Exhibit 2017 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1431 Opposition re 1419 MOTION in Limine Regarding Flavell No. 5: To Preclude Richard Flavell from Offering Opinions Based on an Infringement Analysis that is Inconsistent with Federal Circuit Precedent and with the Court's Claim Construction Ruling that Amgen's Claims are Open Ended filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1430 DECLARATION re 1429 MOTION to Correct The Record Regarding Carlo Brugnaras Trial Testimony of Susan Krumplitsch by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3)(Gottfried, Michael) |
Filing 1429 MOTION to Correct The Record Regarding Carlo Brugnaras Trial Testimony by Amgen Inc..(Gottfried, Michael) |
Filing 1428 Opposition re 1418 MOTION in Limine Regarding Flavell No. 4: To Preclude Richard Flavell from Offering Opinions Regarding the Asserted '933 Claims that are Based on a Construction that is Inconsistent with the Court's Claim Construction of the Claim Term &q filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1427 Opposition re 1411 MOTION in Limine to Preclude Roche's Expert Dr. Klibanov From Offering Opinions Based On A Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Term "Human Erythropoietin" filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1426 Opposition re 1410 MOTION to Preclude Roche's Expert Dr. Klibanov From Offering Opinions Based on an Infringement Analysis That Is Inconsistent With Federal Circuit Precedent And With The Court's Claim Construction Ruling that Amgen's Claims Are Open-Ende filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1425 MOTION in Limine to Preclude Roche from Introducing Theories and Evidence Concerning Inequitable Conduct Allegations Not Pled By Roche in Its First Amended Answer by Amgen Inc..(Gottfried, Michael) |
Filing 1424 DECLARATION re 1420 MOTION in Limine Regarding Flavell No. 6: To Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Construction of '868 Claim Term "Isolated DNA Sequence Encoding Human Er, 1415 MOTION in Limine Regarding Flavell No. 1: To Preclude Richard A. Flavell From Testifying During the Infringement Stage on Issues Pertaining to Invalidity, 1423 MOTION in Limine Regarding Flavell No. 9: To Preclude Richard Flavell from Offering Opinions Regarding "Isolated DNA Sequence Encoding Human Erythropoietin" Based on His Refusal to Provide the Basis for Those Opinions at Deposition, 1421 MOTION in Limine Regarding Flavell No. 7: To Preclude Richard Flavell From Offering Opinions Based on a Claim Construction that Requires That the Term "Obligate" Glycoprotein Be Read into the Asserted '933 Claim, 1419 MOTION in Limine Regarding Flavell No. 5: To Preclude Richard Flavell from Offering Opinions Based on an Infringement Analysis that is Inconsistent with Federal Circuit Precedent and with the Court's Claim Construction Ruling that Amgen's, 1416 MOTION in Limine Regarding Flavell No. 2: To Preclude Richard A. Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Claim Terms "Isolating" and "Comprising," as set forth in the Asserted &, 1417 MOTION in Limine Regarding Flavell No. 3: to Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Claim Construction of the '933 Patent Claim Term "Non-Naturally Occurrin, 1418 MOTION in Limine Regarding Flavell No. 4: To Preclude Richard Flavell from Offering Opinions Regarding the Asserted '933 Claims that are Based on a Construction that is Inconsistent with the Court's Claim Construction of the Claim Term &q of Linda Sasaki-Baxley by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3)(Gottfried, Michael) |
Filing 1423 MOTION in Limine Regarding Flavell No. 9: To Preclude Richard Flavell from Offering Opinions Regarding "Isolated DNA Sequence Encoding Human Erythropoietin" Based on His Refusal to Provide the Basis for Those Opinions at Deposition by Amgen Inc..(Gottfried, Michael) |
Filing 1422 MOTION in Limine Regarding Flavell No. 8: To Preclude Richard A. Flavell from Offering Opinions that were Rejected by this Court's Holding that PEG-EPO Infringes Claim 1 of Dr. Lin's '422 Patent by Amgen Inc..(Gottfried, Michael) |
Filing 1421 MOTION in Limine Regarding Flavell No. 7: To Preclude Richard Flavell From Offering Opinions Based on a Claim Construction that Requires That the Term "Obligate" Glycoprotein Be Read into the Asserted '933 Claim by Amgen Inc..(Gottfried, Michael) |
Filing 1420 MOTION in Limine Regarding Flavell No. 6: To Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Construction of '868 Claim Term "Isolated DNA Sequence Encoding Human Erythropoietin" by Amgen Inc..(Gottfried, Michael) |
Filing 1419 MOTION in Limine Regarding Flavell No. 5: To Preclude Richard Flavell from Offering Opinions Based on an Infringement Analysis that is Inconsistent with Federal Circuit Precedent and with the Court's Claim Construction Ruling that Amgen's Claims are Open-Ended by Amgen Inc..(Gottfried, Michael) |
Filing 1418 MOTION in Limine Regarding Flavell No. 4: To Preclude Richard Flavell from Offering Opinions Regarding the Asserted '933 Claims that are Based on a Construction that is Inconsistent with the Court's Claim Construction of the Claim Term "Human Erythropoietin" by Amgen Inc..(Gottfried, Michael) |
Filing 1417 MOTION in Limine Regarding Flavell No. 3: to Preclude Richard Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Court's Claim Construction of the '933 Patent Claim Term "Non-Naturally Occurring" by Amgen Inc..(Gottfried, Michael) |
Filing 1416 MOTION in Limine Regarding Flavell No. 2: To Preclude Richard A. Flavell from Offering Opinions Based on a Claim Construction that is Inconsistent with the Claim Terms "Isolating" and "Comprising," as set forth in the Asserted '698 and '868 Claims by Amgen Inc..(Gottfried, Michael) |
Filing 1415 MOTION in Limine Regarding Flavell No. 1: To Preclude Richard A. Flavell From Testifying During the Infringement Stage on Issues Pertaining to Invalidity by Amgen Inc..(Gottfried, Michael) |
Filing 1414 MOTION for Leave to File Roches Motion for Leave to File a Brief in Excess of the Page Limit in Support of Its Motion for Judgment of Non-Infringement as a Matter of Law by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Fleming, Thomas) |
Filing 1413 MOTION in Limine to Preclude Roche's Purported FRE 406 Witness, Mr. Sofocleous, And Patent Law Experts Generally, From Testifying In The Inequitable Conduct Phase Of The Trial by Amgen Inc..(Gottfried, Michael) |
Filing 1412 MOTION for Leave to File a Brief in Excess of the Page Limit in Support of its Opposition to Roche's Judgment as a Matter of Law and Amgen Inc.'s Cross-Motion for Judgment as a Matter of Law by Amgen Inc.. (Attachments: # 1 Exhibit A - [Proposed] Memorandum in Opposition to Roche's Motion for Judgment as a Matter of Law Regarding Invalidity and Cross-Motion)(Rich, Patricia) |
Filing 1411 MOTION in Limine to Preclude Roche's Expert Dr. Klibanov From Offering Opinions Based On A Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Term "Human Erythropoietin" by Amgen Inc..(Gottfried, Michael) |
Filing 1410 MOTION to Preclude Roche's Expert Dr. Klibanov From Offering Opinions Based on an Infringement Analysis That Is Inconsistent With Federal Circuit Precedent And With The Court's Claim Construction Ruling that Amgen's Claims Are Open-Ended by Amgen Inc..(Gottfried, Michael) |
Filing 1409 Response by Amgen Inc. to 1398 Brief, Roches Bench Memorandum (D.I. 1398) Offering Opinions Based On A Claim Construction That Is Inconsistent With The Courts Claim Construction Of The Claim Terms Isolating And Comprising,. (Gottfried, Michael) |
Filing 1408 Judge William G. Young : Electronic ORDER entered granting 1341 Motion for a bench trial on inequitable conduct defenses (Smith, Bonnie) |
Filing 1407 Opposition re 1388 MOTION For A Corrective Instruction Regarding Roche's Patent on Pegylated Erythropoietin filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1406 Opposition re 1385 MOTION To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Term "Human Erythropoietin" filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1405 Opposition re 1391 MOTION in Limine To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Claim Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Terms "Isolating" and "Comprising," As Set Fo filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1404 Opposition re 1392 MOTION in Limine to Preclude Roche from Offering Evidence Regarding Amgen's Efforts to Pegylate Molecules, Including EPO, as it is Irrelevant to the Infringement Inquiry filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1403 Opposition re 1384 MOTION To Preclude Roche's Expert Dr. Gregory D. Longmore From Offering Opinions Based On An Infringement Analysis That Is Inconsistent With Federal Circuit Precedent And With The Court's Claim Construction Ruling That Amgen's Claims Ar filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1402 Opposition re 1368 MOTION to Preclude Roche's Experts from Claiming Unproven and Undisclosed FDA Certification filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1401 NOTICE by Amgen Inc. of Submission to the Court for Ruling Its Motion to Admit Into Evidence Admissions of Roche Related to Infringement Prior to Close of Amgen's Case in Infringement Phase of Trial and the Exhibits Thereto (CORRECTED NOTICE) (Gottfried, Michael) |
Filing 1400 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1394 Brief, Roches Response to Amgens Bench Memorandum to Preclude Roche from Examining Dr. Torchilin on Evidence Regarding Patient Choice and the Safety and Dosing Benefits of MIRCERA in Contravention of the Courts Previous Rulings. (Fleming, Thomas) |
Filing 1399 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Bench Memorandum that the Doctrine of Equivalents Does not Apply to Infringement Under Section 271(g) and Therefore to the Asserted Claims of the 868, 698 of 349 Patents. (Fleming, Thomas) |
Filing 1398 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Bench Memorandum in Support of its Argument that Roches Epoetin Beta Starting Material Used to Synthesize CERA Fails to Meet the Expressed by Said Cells Limitation in the Asserted Claims of the 698 Patent. (Fleming, Thomas) |
Filing 1397 MOTION to Withdraw 1360 Brief, Without Prejudice Amgen's Bench Memorandum to Explain the Relevance of Exhibits GXD and EYV to Issues of Infringement by Amgen Inc..(Gottfried, Michael) |
Filing 1396 NOTICE by Amgen Inc. of Manual Filing of Its Motion to Admit Into Evidence Admissions of Roche Related to Infringement Prior to Close of Amgen's Case In Infringement Phase of Trial and the Exhibits Thereto (Gottfried, Michael) |
Filing 1395 BRIEF by Amgen Inc. = Bench Memorandum that Roche Should Be Precluded From Questioning Dr. Torchilin About Comparisons Between PEG-EPO and Amgen's Aranesp Product Because Such Comparisons Are Irrelevant to Whether PEG-EPO Infringes Amgen's Patents-in-Suit. (Gottfried, Michael) |
Filing 1394 BRIEF by Amgen Inc. = Bench Memorandum to Preclude Roche from Examining Dr. Torchilin on Evidence Regarding Patient Choice and the Safety and Dosing Benefits of Mircera in Contravention with the Court's Previous Rulings. (Gottfried, Michael) |
Filing 1393 BRIEF by Amgen Inc. = Bench Memorandum to Prevent Roche from Cross Examining Dr. Torchilin About Amgen's Efforts to Pegylate Molecules, Including EPO, and the Predictability of Pegylation in General as it is Irrelevant to the Infringement Inquiry. (Gottfried, Michael) |
Filing 1392 MOTION in Limine to Preclude Roche from Offering Evidence Regarding Amgen's Efforts to Pegylate Molecules, Including EPO, as it is Irrelevant to the Infringement Inquiry by Amgen Inc..(Gottfried, Michael) |
Filing 1391 MOTION in Limine To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Claim Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Terms "Isolating" and "Comprising," As Set Forth In The Asserted '698 And '868 Claims by Amgen Inc..(Gottfried, Michael) |
Filing 1390 Roche's Response to Amgen's Bench Memorandum to Preclude Roche From Introducing Testimony of Dr. Longmore That is Contrary to the Court's Prior Orders Regarding Safety, Dosing, Undisclosed FDA Communications, and Whether MIRCERA Contains Human EPO Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1378 Brief,. (Fleming, Thomas) |
Filing 1389 Roche's Bench Memorandum in Response to Amgen's Bench Memorandum concerning the Appropriate Jury Instruction on 35 U.S.C. Section 271(g) Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to 1358 Brief. (Attachments: # 1 Exhibit A)(Fleming, Thomas) |
Filing 1388 MOTION For A Corrective Instruction Regarding Roche's Patent on Pegylated Erythropoietin by Amgen Inc..(Gottfried, Michael) |
Filing 1387 Response by Amgen Inc. to 1342 Brief, = Amgen's Opposition to Roche's Bench Memorandum Regarding Its Proposed Jury Instruction That Contemporaneous Invention By Others Is A Consideration Favoring Obviousness. (Gottfried, Michael) |
Filing 1386 Response by Amgen Inc. to #1354 Opposition to Motion = Amgen's Opposition to Roche's Motion for Reconsideration of The Court's October 4, 2007 Order Regarding The '868 File History. (Rich, Patricia) |
Filing 1385 MOTION To Preclude Gregory D. Longmore, M.D. From Offering Opinions Based On A Construction That Is Inconsistent With The Court's Claim Construction Of The Claim Term "Human Erythropoietin" by Amgen Inc..(Gottfried, Michael) |
Filing 1384 MOTION To Preclude Roche's Expert Dr. Gregory D. Longmore From Offering Opinions Based On An Infringement Analysis That Is Inconsistent With Federal Circuit Precedent And With The Court's Claim Construction Ruling That Amgen's Claims Are Open-Ended by Amgen Inc..(Gottfried, Michael) |
Filing 1383 MOTION in Limine To Preclude Roche From Undermining The Court's Prior Rulings And Unduly Prejudicing Amgen By Agruing Its ODP-Related Inequitable Conduct Theory To The Jury by Amgen Inc..(Rich, Patricia) |
Filing 1382 MOTION in Limine To Preclude Roche From Arguing To The Jury That Amgen Committed Inequitable Conduct Through Its Characterization Of The Chugai ITC Decision, The PTO Interference Actions, And Articulation Of The Test For ODP by Amgen Inc..(Gottfried, Michael) |
Filing 1381 Roche's Opposition to Amgen's Bench Memorandum To Explain the Relevance of Exhibit EYV Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1360 Brief,. (Fleming, Thomas) |
Filing 1380 Opposition re #1371 MOTION in Limine to Preclude Amgen from Introducing Testimony of Vladimir Torchilin Related to Pegylation of Non-EPO Compounds filed by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5)(Gottfried, Michael) |
Filing 1379 Response by Amgen Inc. to #1363 Brief, = Amgen's Response to Roche's Bench Memorandum Requesting Jury Instruction Regarding Amgen's "Failure to Proffer Secondary Consideration Evidence of the Failure of Others Similarly Situated to the Inventor". (Gottfried, Michael) |
Filing 1378 BRIEF by Amgen Inc. = Bench Memorandum to Preclude Roche From Introducing Testimony of Dr. Longmore That Is Contrary To The Court's Prior Orders Regarding Safety, Dosing, Undisclosed FDA Commuincations, And Whether MIRCERA Contains Human EPO. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered finding as moot re 906 Motion for Leave to File; 912 Motion for Leave to File; 929 Motion in Limine; 931 Motion in Limine; 934 Motion for Leave to File; 936 Motion in Limine; 948 Motion for Leave to File; 952 Motion for Leave to File; 954 Motion for Leave to File; 965 Motion 966 Motion for Leave to File; 967 Motion for Leave to File; 974 Motion for Leave to File; 977 Motion for Leave to File; 978 Motion for Leave to File; 979 Motion for Leave to File; 986 Motion in Limine; 1003 Motion for Leave to File; 1005 Motion in Limine; 1008 Motion for Leave to File; 1014 Motion for Leave to File; 1026 Motion in Limine; 1036 Motion in Limine; 1046 Motion in Limine; 1047 Motion in Limine; 1149 Motion in Limine. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 1376 Brief, filed by Amgen Inc. ALLOWED(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1388 Motion FOR A CORRECTIVE INSTRUCTION... (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 841 MOTION in Limine No. 8: Exclude Roche from Relying on Comparisons Between Roche's PEG-EPO Product and Amgen's ARANESP Product filed by Amgen Inc.Motion....ALLOWED, 1363 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH.....DENIED 1378 Brief, filed by Amgen Inc., DENIED..... 1362 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH DENIED(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1333 Motion to preclude Roche from offering additional evidence and argument re: the Genetics Institute (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 908 Motion for Reconsideration ; denying 1061 Motion for Reconsideration. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying as moot 1371 Motion in Limine; granting 1375 Motion for Clarification "in clarification, yes, it does"; denying as moot 1382 Motion in Limine; denying as moot 1383 Motion in Limine; granting 1392 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered: "Motions denied as moot in light of the course of the trial and the ruling on supervening motions." re 811 Motion in Limine; 814 Motion in Limine; 816 Motion in Limine; 820 Motion in Limine; 826 Motion in Limine; 830 Motion in Limine; 832 Motion in Limine; 835 Motion in Limine; 841 Motion in Limine; 845 Motion in Limine; 851 Motion in Limine; 854 Motion in Limine; 860 Motion in Limine; 863 Motion in Limine; 865 Motion in Limine; 891 Motion in Limine (Paine, Matthew) |
Filing 1377 MOTION for Leave to File A Reply to Roche's Opposition to Amgen's Bench Memorandum Regarding Evidence of Infringement of '349 Claim 7 by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1376 BRIEF by Amgen Inc. = Amgen's Bench Memorandum That Roche Should Be Precluded From Relying On Comparisons Between Peg-EPO and Amgen's Aransep Product Because Such Comparisons Are Irrelevant To Whether Peg-EPO Infringes Amgen's Patents-In-Suit. (Gottfried, Michael) |
Filing 1375 MOTION for Clarification Defendants' Motion for Clarification on Whether the Court's Prior Rulings Preclude Defendants From Arguing Non-Infringement of '933 Claims 9 and 12 Based on the Markush Group Limitations by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1374 Supplemental Proposed Jury Instructions by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1373 Opposition re #1341 MOTION and Supporting Memorandum Requesting That This Court Try Roche's Inequitable Conduct Defenses filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1372 MEMORANDUM in Support re #1371 MOTION in Limine to Preclude Amgen from Introducing Testimony of Vladimir Torchilin Related to Pegylation of Non-EPO Compounds filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1371 MOTION in Limine to Preclude Amgen from Introducing Testimony of Vladimir Torchilin Related to Pegylation of Non-EPO Compounds by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1370 DECLARATION re #1369 MOTION in Limine To Preclude Roche From Using Unreliable Computer-Generated Models Of Peg-EPO At Trial Due To Roche's Selective Production Only Of Models That Were Created For This Litigation (=DECLARATION OF RENEE DUBORD BROWN) by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Errata 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13#14 Exhibit 14#15 Exhibit 15#16 Exhibit 16)(Gottfried, Michael) |
Filing 1369 MOTION in Limine To Preclude Roche From Using Unreliable Computer-Generated Models Of Peg-EPO At Trial Due To Roche's Selective Production Only Of Models That Were Created For This Litigation by Amgen Inc..(Gottfried, Michael) |
Filing 1368 MOTION to Preclude Roche's Experts from Claiming Unproven and Undisclosed FDA Certification by Amgen Inc..(Gottfried, Michael) |
Filing 1367 Response by Amgen Inc. to #1315 Memorandum in Support of Motion, #1343 Proposed Jury Instructions, #1332 Brief, #1291 Brief, #1232 Brief, (Response to Various Filings by Roche Regarding Date of Invention). (Gottfried, Michael) |
Filing 1366 Amended Proposed Jury Verdict by Amgen Inc.. (Gottfried, Michael) |
Filing 1365 Roche's Opposition to Amgen's Bench Memorandum For Further Jury Instruction Regarding Inherent Written Description Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1326 Brief. (Fleming, Thomas) |
Filing 1364 Amended Proposed Jury Verdict by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1363 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Requesting Jury Instruction Regarding Amgen's Failure to Proffer Secondary Consideration Evidence of the Failure of Others Similarly Situated to the Inventor. (Fleming, Thomas) |
Filing 1362 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Requesting That the Jury be Instructed that the Processes of Claims '868 1 and 2 and '698 4-9 Culminate in Isolation, Not Purification, of the Recited Polypeptide. (Fleming, Thomas) |
Filing 1361 Roche's Opposition to Amgen's Bench Memorandum Regarding Evidence of Infringement of Claim 7 of the '349 Patent (D.I. 1339) Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1339 Brief. (Fleming, Thomas) |
Filing 1360 BRIEF by Amgen Inc. = Bench Memorandum to Explain the Relevance of Exhibits GXD and EYV to Issues of Infringement. (Attachments: #1 Exhibit 1 (part 1 of 2)#2 Exhibit 1 (part 2 of 2)#3 Exhibit 2 (part 1 of 3)#4 Exhibit 2 (part 2 of 3)#5 Exhibit 2 (part 3 of 3))(Rich, Patricia) |
Filing 1359 BRIEF by Amgen Inc. = Bench Memorandum Responding to Roche's Bench Memorandum Regarding Jury Consideration of Prior Art Evidence. (Gottfried, Michael) |
Filing 1358 BRIEF by Amgen Inc. = Bench Memorandum Regarding Application of the Doctrine of Equivalents to Establish Infringement Under 35 U.S.C. sec. 271(g). (Rich, Patricia) |
Judge William G. Young : Electronic ORDER re: Veng-Pederson Deposition entered. "These rulings are made on the assumption that it is Amgen who is calling this witness. On that assumption, the Court sustains ALL the Roche objections to the Amgen designations. This leaves the remaining designations irrelevant. The deposition may not be played."(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re #1317 Defendant's Motion to Submit Demonstratives From the October 4, 2007 Hearing on Obviousness-Type Double Patenting. "Allowed. The demonstratives will be treated as a brief." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1317 Defendant's Motion to Submit Demonstratives From the October 4, 2007 Hearing on Obviousness-Type Double Patenting. "Allowed. The demonstratives will be treated as a brief." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER re: Veng-Pederson Deposition entered. "These rulings are made on the assumption that it is Amgen who is calling this witness. On that assumption, the Court sustains ALL the Roche objections to the Amgen designations. This leaves the remaining designations irrelevant. The deposition may not be played."(Smith, Bonnie) |
Filing 1357 Roche's Opposition to Amgen's Bench Memorandum Regarding Resolution of Definiteness As A Matter of Law (DI 1334) Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1334 Brief. (Fleming, Thomas) |
Filing 1356 Roche's Opposition to Amgen's Bench Memorandum Regarding Its Proposed Jury Instruction on Obviousness (DI 1335) Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1335 Brief. (Fleming, Thomas) |
Filing 1355 DECLARATION re #1354 Opposition to Motion Declaration of Krista M. Rycroft in Support of Roche's Opposition to Amgen's Motion to Correct the File History of the '868 Patent by Adding a Document That Was Missing by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1 (part 1)#2 Exhibit 1 (part 2 of 3)#3 Exhibit 1 (part 3 of 3)#4 Exhibit 2 (part 1 of 3)#5 Exhibit 2 (part 2 of 3)#6 Exhibit 2 (part 3 of 3))(Schaffer, Emily) |
Filing 1354 Opposition re #1311 MOTION to Correct the File History of the '868 Patent by Adding a Document that was Missing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Schaffer, Emily) |
Filing 1353 Objection to #1325 Brief by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Opposition to Amgen's Bench Memorandum for a Jury Instruction that Subsequent Art Cannot Be Considered for Validity. (Schaffer, Emily) |
Filing 1352 Opposition re #1333 MOTION To Prclude Roche from Offering Additional Evidence and Argument Regarding the Genetics Institute filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Schaffer, Emily) |
Filing 1351 Response by Amgen Inc. to #1273 Brief = Opposition to Roche's Bench Memorandum Regarding Amgen's Demonstration of the Requisite Nexus Regarding Secondary Considerations of Non-Obviousness. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1350 MOTION to Submit Supplemental Demonstratives from the October 4, 2007 Hearing on Obviousness-Type Double Patenting by Amgen Inc.. (Attachments: #1 Supplement Demonstratives)(Rich, Patricia) |
Filing 1349 Opposition re #1222 MOTION in Limine to Preclude Amgen from Introducing a Declaration of Dr. Harvey Lodish in Connection with the Hearing on Obviousness-Type Double Patenting filed by Amgen Inc.. (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered. VACATING the October 4, 2007 electronic ORDER entered granting 1281 Motion [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence. THE MOTION 1281 [RENEWED] TO ADMIT EXHIBIT BWZa (REDACTED FORM) INTO EVIDENCE IS DENIED. BWZa IS INADMISSIBLE. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Exhibits BAH and FJX are not admitted." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1336 Motion To Shift Burden of Proof For '349 Claim 7 Pursuant to 35 U.S.C. s. 295. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1336 Motion To Shift Burden of Proof For '349 Claim 7 Pursuant to 35 U.S.C. s. 295. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Exhibits BAH and FJX are not admitted." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. VACATING the October 4, 2007 electronic ORDER entered granting #1281 Motion [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence. THE MOTION #1281 [RENEWED] TO ADMIT EXHIBIT BWZa (REDACTED FORM) INTO EVIDENCE IS DENIED. BWZa IS INADMISSIBLE. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff counsel Day and Defendant counsel Fleming are present.Hearing re Charge Conference held on 10/10/2007.The Court informs counsel of a revised trial schedule. Tue, court will start at 11:15. Wed the Court will sit 9-1. The Court reviews the proposed verdict slips submitted by both plaintiff and the defendant. The Court hears from both sides re: verdict form. The Court informs counsel it will charge the jury prior to closing arguments. The Court intends on sending a copy of the jury charge into the jury room. Discussion is held on whether the jury will deliberate Oct 22, 23 in the absence of Judge Young. The matter is Under Advisement. The Court Orders by Monday Oct 15, a list of each claim in dispute. As to the validity claims, the Court wants the defenses claim by claim. The Court will hold a Nonjury trial on inducement. The trial will be conducted on Friday Oct 19 at 10AM, while the jury is deliberating. A remedy hearing, if necessary will be held Nov. 15, 2007 at 9AM. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff counsel Day and Defendant counsel Fleming are present.Hearing re Charge Conference held on 10/10/2007.The Court informs counsel of a revised trial schedule. Tue, court will start at 11:15. Wed the Court will sit 9-1. The Court reviews the proposed verdict slips submitted by both plaintiff and the defendant. The Court hears from both sides re: verdict form. The Court informs counsel it will charge the jury prior to closing arguments. The Court intends on sending a copy of the jury charge into the jury room. Discussion is held on whether the jury will deliberate Oct 22, 23 in the absence of Judge Young. The matter is Under Advisement. The Court Orders by Monday Oct 15, a list of each claim in dispute. As to the validity claims, the Court wants the defenses claim by claim. The Court will hold a Nonjury trial on inducement. The trial will be conducted on Friday Oct 19 at 10AM, while the jury is deliberating. A remedy hearing, if necessary will be held Nov. 15, 2007 at 9AM. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1348 Receipt to defendant Roche for documents returned on October 10, 2007. (Paine, Matthew) |
Filing 1347 Objection to #1318 Proposed Jury Instructions by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Roche's Preliminary Objections to Amgen's [Proposed] Revised Final Jury Instructions). (Rizzo, Nicole) |
Filing 1346 Response by Amgen Inc. to #1340 Response = Amgen's Response to Roche's Lists of Prior Art and Chart Identifying Claims by Category Requested by the Court at the October 4, 2007 Afternoon Hearing. (Gottfried, Michael) |
Filing 1345 Opposition/ Response by Amgen Inc. to #1329 Brief /Bench Memo of Roche Requesting a Jury Instruction that Statements in the Specifications are Binding Admissions on Amgen. (Rich, Patricia) |
Filing 1344 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Bench Memorandum Requesting Jury Instruction Regarding Amgens Failure to Demonstrate the Requisite Nexus Regarding Secondary Considerations of Non-Obviousness. (Drozdoff, Vladimir) |
Filing 1343 Supplemental Proposed Jury Instructions by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Drozdoff, Vladimir) |
Filing 1342 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Bench Memorandum Regarding its Proposed Jury Instructions that Contemporaneous Invention by Others is a Consideration Favoring Obviousness. (Attachments: #1 Exhibit Exhibit A)(Drozdoff, Vladimir) |
Filing 1341 MOTION and Supporting Memorandum Requesting That This Court Try Roche's Inequitable Conduct Defenses by Amgen Inc..(Gottfried, Michael) |
Filing 1340 Roches List of Prior Art and Chart Identifying Claims by Category Requested by the Court at the October 4, 2007 Afternoon Hearing Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Drozdoff, Vladimir) |
Filing 1339 BRIEF by Amgen Inc. Amgen's Bench Memorandum Concerning Amgen's Evidence of Infringement of '349 Claim 7. (Gottfried, Michael) |
Filing 1338 DECLARATION of Cullen N. Pendleton in Support of Amgen Inc.'s Motion To Shift Burden of Proof for '349 Claim 7 Pursuant to 35 U.S.C. s. 295 by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Gottfried, Michael) |
Filing 1337 MEMORANDUM in Support re #1336 MOTION To Shift Burden of Proof For '349 Claim 7 Pursuant to 35 U.S.C. s. 295 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1336 MOTION To Shift Burden of Proof For '349 Claim 7 Pursuant to 35 U.S.C. s. 295 by Amgen Inc..(Gottfried, Michael) |
Filing 1335 BRIEF by Amgen Inc. = Bench Memorandum Regarding its Proposed Jury Instruction on Obviousness. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1334 BRIEF by Amgen Inc. = Bench Memorandum Regarding Resolution of Definiteness by the Court as a Matter of Law. (Gottfried, Michael) |
Filing 1333 MOTION To Prclude Roche from Offering Additional Evidence and Argument Regarding the Genetics Institute by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 1332 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. ROCHES BENCH MEMORANDUM REGARDING AMGENS (AND DR. LINS) FAILURE TO ESTABLISH AN INVENTION DATE PRIOR TO THE EFFECTIVE FILING DATE OF THE PATENTS-IN-SUIT. (Drozdoff, Vladimir) |
Filing 1331 Opposition to Amgen's Bench Memorandum In Support of Proposed Jury Instruction For Inequitable Conduct (D.I. 1323) Response by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. to #1323 Brief. (Fleming, Thomas) |
Filing 1330 ROCHES OPPOSITION TO AMGENS BENCH MEMORANDUM REQUESTING A JURY INSTRUCTION REGARDING THE HEIGHTENED PRESUMPTION OF VALIDITY WHEN ROCHE DID NOT PRESENT ANY ART THAT WAS NOT CONSIDERED BY THE PTO Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1319 Brief. (Drozdoff, Vladimir) |
Filing 1329 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Bench Memorandum Requesting A Jury Instruction That Statements In The Specification Are Binding Admissions On Amgen. (Fleming, Thomas) |
Filing 1328 ROCHES OPPOSITION TO AMGENS BENCH MEMORANDUM CONCERNING PROPOSED JURY INSTRUCTIONS REGARDING SOURCE AND PROCESS LIMITATIONS Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1320 Brief. (Fleming, Thomas) |
Filing 1327 Objection to #917 Proposed Jury Instructions by Amgen Inc.. (Gottfried, Michael) |
Filing 1326 BRIEF by Amgen Inc. = Bench Memorandum For Further Jury Instruction Regarding Inherent Written Description. (Gottfried, Michael) |
Filing 1325 BRIEF by Amgen Inc. = Bench Memorandum For A Jury Instruction That Subsequent Art Cannot Be Considered For Validity. (Gottfried, Michael) |
Filing 1324 BRIEF by Amgen Inc. = Bench Memorandum Requesting That The Court Issue A Corrective Instruction That Remedies And Patent Choice Are Irrelevant To The Issues The Jury Must Decide. (Gottfried, Michael) |
Filing 1323 BRIEF by Amgen Inc. = Bench Memorandum In Support of Proposed Jury Instruction For Inequitable Conduct. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1322 BRIEF by Amgen Inc. = Bench Memorandum Concerning The Appropriate Jury Instruction On Infringement and "Additional Elements". (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1321 BRIEF by Amgen Inc. = Bench Memorandum Concerning The Appropriate Jury INstruction On 35 U.S.C. Sec. 271(g). (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1320 BRIEF by Amgen Inc. = Bench Memorandum Concerning Proposed Jury Instructions Regarding Source and Process Limitations. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1319 BRIEF by Amgen Inc. = Bench Memorandum Requesting A Jury Instruction Regarding The Hightened Presumption of Validity When Roche Did Not Present Any Art That Was Not Considered By The PTO. (Gottfried, Michael) |
Filing 1318 Final Proposed Jury Instructions by Amgen Inc.. (Gottfried, Michael) |
Notice of correction to docket made by Court staff. Docket Entry (1308) Opposition to (1290) MOTION in Limine To Preclude Drs. Lodish and Torchilin From Presenting Animations Not Discussed in Their Expert Reports was replaced with a corrected version due to a typographical error. (Paine, Matthew) |
Filing 1317 MOTION Defendants' Motion to Submit Demonstratives From the October 4, 2007 Hearing on Obviousness-Type Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix part 1 of 4#2 Appendix part 2 of 4#3 Appendix part 3 of 4#4 Appendix part 4 of 4)(Fleming, Thomas) |
Filing 1316 NOTICE of Appearance by Erik Paul Belt on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Belt, Erik) |
Filing 1315 MEMORANDUM in Support re #1284 MOTION for Directed Verdict Regarding Invalidity (Leave to file granted on October 4, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 1314 REPLY to Response to Motion re #1217 MOTION to Admit Exhibits into Evidence Leave to File Granted on 10/4/07 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1313 MOTION To PROVIDE THE COURT WITH ADDITIONAL DOCUMENTS FROM THE INTERFERENCE PROCEEDINGS THAT ARE NECESSARY FOR COMPLETENESS AND TO PROVIDE A COMPLETE UNDERSTANDING OF THE PROCEEDINGS by Amgen Inc..(Gottfried, Michael) |
Filing 1312 DECLARATION re #1311 MOTION to Correct the File History of the '868 Patent by Adding a Document that was Missing of Steven M. Odre by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3 Part One#4 Exhibit 3 Part Two#5 Exhibit 3 Part Three#6 Exhibit 4)(Gottfried, Michael) |
Filing 1311 MOTION to Correct the File History of the '868 Patent by Adding a Document that was Missing by Amgen Inc..(Gottfried, Michael) |
Filing 1310 BRIEF by Amgen Inc. Bench Memorandum Regarding No Obviousness-type Double Patenting. (Rich, Patricia) |
Filing 1309 Opposition re #1249 MOTION to Strike EVIDENCE REGARDING ROCHES ALLEGATION THAT CLAIM 7 OF THE 349 PATENT IS NOT ENABLED BECAUSE ROCHE DID NOT PREVIOUSLY IDENTIFY SUCH DEFENSE IN INTERROGATORY RESPONSES filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1308 Opposition re #1290 MOTION in Limine To Preclude Drs. Lodish and Torchilin From Presenting Animations Not Discussed in Their Expert Reports filed by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 10/9/2007 (Paine, Matthew). |
Filing 1307 Opposition re #1288 MOTION in Limine to Preclude Testimony By Dr. Vladimir Torchilin Regarding Issues Pertaining Strictly to Invalidity filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1306 Opposition re #1292 MOTION in Limine to Preclude Amgen's Expert Dr. Torchilin From Offering Testimony on Literal Infringement or Infringement Under the Doctrine of Equivalents filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1305 Objection to #1078 Brief by Amgen Inc. and Response to Defendants' Offer of Proof Regarding the Testimony of Michael Sofocleous. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1304 DECLARATION re #1303 Brief of Andrew A. Kumamoto in Support of Amgen's Bench Memorandum as to the Admissability of Exhibit EYU as a Roche Party Admission by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5)(Gottfried, Michael) |
Filing 1303 BRIEF by Amgen Inc. Bench Memorandum as to the Admissability of Exhibit EYU as a Roche Party Admission. (Gottfried, Michael) |
Filing 1302 Opposition/ Response by Amgen Inc. to #1257 Brief, Roche's Bench Memorandum to Preclude Amgen from Introducing Belatedly Produced Documents Relating to Its Experiments with Pegylation. (Rich, Patricia) |
Filing 1301 DECLARATION re #1299 MOTION in Limine TO PRECLUDE INFRINGEMENT TESTIMONY BY DR. LODISH WHICH IS IRRELEVANT AND BEYOND HIS EXPERTISE (of Patricia A. Carson) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Rizzo, Nicole) |
Filing 1300 MEMORANDUM in Support re #1299 MOTION in Limine TO PRECLUDE INFRINGEMENT TESTIMONY BY DR. LODISH WHICH IS IRRELEVANT AND BEYOND HIS EXPERTISE filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 1299 MOTION in Limine TO PRECLUDE INFRINGEMENT TESTIMONY BY DR. LODISH WHICH IS IRRELEVANT AND BEYOND HIS EXPERTISE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 1298 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to Amgen's Bench Memorandum Regarding Pegylation of Non-EPO Compounds. (Fleming, Thomas) |
Filing 1297 MOTION in Limine to Preclude Amgen From Proffering Testimonial or Documentary Evidence Concerning Infringement Testing Under Federal Rules of Evidence 602,901 and 702/703 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1296 Opposition re #1265 MOTION to Preclude Roche from Introducing Evidence or Testimony Regarding the Safety or Efficacy of PEG-EPO Because Roche has Asserted that these Topics are Irrelevant and on that Basis Denied Amgen Fulsome Discovery filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1295 Opposition re #1281 MOTION [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1294 Opposition re #1276 MOTION TO ADMIT TRIAL EXHIBIT NUK INTO EVIDENCE filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1293 BRIEF by Amgen Inc. = Bench Memorandum Requesting That The Court Enforce Its Order On Motion In Limine No. 12 And Issue A Corrective Instruction To Remedy Roche's Improper Argument That The Jury Consider "Patient Choice" Because Such Argument Was Tantamount To Requesting Jury Nullification. (Gottfried, Michael) |
Filing 1292 MOTION in Limine to Preclude Amgen's Expert Dr. Torchilin From Offering Testimony on Literal Infringement or Infringement Under the Doctrine of Equivalents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1291 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Regarding Amgen's Failure to Establish an Invention Date Prior to the Effective Filing Date of the Patents-In-Suit. (Fleming, Thomas) |
Filing 1290 MOTION in Limine To Preclude Drs. Lodish and Torchilin From Presenting Animations Not Discussed in Their Expert Reports by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1289 Opposition re #1261 MOTION in Limine to Preclude Amgen's Expert Witness Dr. Leslie Benet from Offering Testimony on Infringement filed by Amgen Inc.. (Rich, Patricia) |
Filing 1288 MOTION in Limine to Preclude Testimony By Dr. Vladimir Torchilin Regarding Issues Pertaining Strictly to Invalidity by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1287 Roche's Opposition to Amgen's Bench Memorandum (D.I. 1267) That It Is Appropriate for Dr. Lodish To use Computer-Modeled Demonstratives Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1286 Opposition Response by Amgen Inc. to #1258 Brief of Defendants' to Strike Portions of Dr. Lin's Testimony for Lackof Personal Knowledge. (Rich, Patricia) |
Filing 1285 MOTION for Leave to File A BRIEF IN EXCESS OF THE PAGE LIMIT IN SUPPORT OF ITS MOTION FOR A DIRECTED VERDICT OF INVALIDITY by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 1284 MOTION for Directed Verdict Regarding Invalidity by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 1283 BRIEF by Amgen Inc. = BENCH MEMORANDUM CONCERNING THE RELEVANCE OF U.S. PATENT 4,776,075 TO ROCHE'S OBVIOUSNESS DEFENSE. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered. re 1303 Brief filed by Amgen Inc re: EXHIBIT EYU...."Exhibit EYU is excluded without prejudice upon the ground that the relevance of the document is not apparent". (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #1262 MOTION for Leave to File a Reply in Support of its Motion to Admit Documents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Ami are present.Bench Trial Day 2 held on 10/4/2007. P's evidence continues. Argument by defendant and plaintiff. The Court takes the matter UNDER ADVISEMENT. The Court informs counsel that it wants(1) a list of each exhibit claimed to anticipate any claims in suit. (2) A list of all trial exhibits which constitute prior art.(3) A breakdown of the claims in suit and identify them as product claims, process claims and product-process claims. The Court orders the list to be provided by Roche to Amgen by cob Monday Oct 8 and by Amgento Roche by cob Tue Oct. 9. The Court rules on #1313- allowed in the jury waived hearing and #1311 Allowed. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day and D's counsel Ben-Ami are present. Jury Trial Day 17 held on 10/4/2007. Plaintiff's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. "Treated as a motion, motion denied." re #1258 BRIEF: Defendants' Motion to Strike Portions of Dr. Lin's Testimony for Lack of Personal Knowldege, by F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1285 MOTION for Leave to File A BRIEF IN EXCESS OF THE PAGE LIMIT IN SUPPORT OF ITS MOTION FOR A DIRECTED VERDICT OF INVALIDITY; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1281 Motion [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1280 MOTION in Limine Roche's Motion in Limine to Preclude Amgen's Expert Witness Dr. Harvey F. Lodish from Offering Testimony Regarding the Expert Statements of Richard D. Kolodner and Donald W. McLawhon, PH.D. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Denied without prejudice to its renewal upon the close of the evidence." #1278 MOTION in Limine TO PRECLUDE AMGEN FROM OFFERING ARGUMENTS AND EXPERT TESTIMONY ON OBVIOUSNESS-TYPE DOUBLE PATENTING THAT IT FAILED TO DISCLOSE IN ITS INTERROGATORY RESPONSES AND EXPERT REPORTS (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Allowed for the purpose of the non-jury proceedings only." #1276 Motion to admit trial exhibit NUK into evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1265 Motion to Preclude Roche from Introducing Evidence or Testimony Regarding the Safety or Efficacy of PEG-EPO Because Roche has Asserted that these Topics are Irrelevant and on that Basis Denied Amgen Fulsome Discovery. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re #1303 Brief filed by Amgen Inc re: EXHIBIT EYU...."Exhibit EYU is excluded without prejudice upon the ground that the relevance of the document is not apparent". (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1262 MOTION for Leave to File a Reply in Support of its Motion to Admit Documents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Ami are present.Bench Trial Day 2 held on 10/4/2007. P's evidence continues. Argument by defendant and plaintiff. The Court takes the matter UNDER ADVISEMENT. The Court informs counsel that it wants(1) a list of each exhibit claimed to anticipate any claims in suit. (2) A list of all trial exhibits which constitute prior art.(3) A breakdown of the claims in suit and identify them as product claims, process claims and product-process claims. The Court orders the list to be provided by Roche to Amgen by cob Monday Oct 8 and by Amgento Roche by cob Tue Oct. 9. The Court rules on #1313- allowed in the jury waived hearing and #1311 Allowed. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day and D's counsel Ben-Ami are present. Jury Trial Day 17 held on 10/4/2007. Plaintiff's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: Docket entry (1237) BRIEF by Amgen Inc. bench memorandum clarifying case law concerning source and process limitations was replaced with a corrected version due to typographical errors. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Treated as a motion, motion denied." re 1258 BRIEF: Defendants' Motion to Strike Portions of Dr. Lin's Testimony for Lack of Personal Knowldege, by F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1281 Motion [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1280 MOTION in Limine Roche's Motion in Limine to Preclude Amgen's Expert Witness Dr. Harvey F. Lodish from Offering Testimony Regarding the Expert Statements of Richard D. Kolodner and Donald W. McLawhon, PH.D. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Denied without prejudice to its renewal upon the close of the evidence." 1278 MOTION in Limine TO PRECLUDE AMGEN FROM OFFERING ARGUMENTS AND EXPERT TESTIMONY ON OBVIOUSNESS-TYPE DOUBLE PATENTING THAT IT FAILED TO DISCLOSE IN ITS INTERROGATORY RESPONSES AND EXPERT REPORTS (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Allowed for the purpose of the non-jury proceedings only." 1276 Motion to admit trial exhibit NUK into evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1265 Motion to Preclude Roche from Introducing Evidence or Testimony Regarding the Safety or Efficacy of PEG-EPO Because Roche has Asserted that these Topics are Irrelevant and on that Basis Denied Amgen Fulsome Discovery. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1285 MOTION for Leave to File A BRIEF IN EXCESS OF THE PAGE LIMIT IN SUPPORT OF ITS MOTION FOR A DIRECTED VERDICT OF INVALIDITY; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Jury Trial 16 held on 10/3/2007.Plaintiff's evidence continues. Plaintiff Rests. Plaintiff files a renewed motion for for judgment as matter of law as to validity. Motion UA. Court gives preliminary charge as to infringement. Opening remarks by Plaintiff as to Infringement. Opening remarks by Defendant as to Infringement. Plaintiff evidence as to infringement commences. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Jury Trial 16 held on 10/3/2007.Plaintiff's evidence continues. Plaintiff Rests. Plaintiff files a renewed motion for for judgment as matter of law as to validity. Motion UA. Court gives preliminary charge as to infringement. Opening remarks by Plaintiff as to Infringement. Opening remarks by Defendant as to Infringement. Plaintiff evidence as to infringement commences. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1282 DECLARATION re #1278 MOTION in Limine TO PRECLUDE AMGEN FROM OFFERING ARGUMENTS AND EXPERT TESTIMONY ON OBVIOUSNESS-TYPE DOUBLE PATENTING THAT IT FAILED TO DISCLOSE IN ITS INTERROGATORY RESPONSES AND EXPERT REPORTS (of Patricia A. Carson) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Rizzo, Nicole) |
Filing 1281 MOTION [RENEWED] To Admit Exhibit BWZa (In Redacted Form) Into Evidence by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1280 MOTION in Limine Roche's Motion in Limine to Preclude Amgen's Expert Witness Dr. Harvey F. Lodish from Offering Testimony Regarding the Expert Statements of Richard D. Kolodner and Donald W. McLawhon, PH.D by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1279 MEMORANDUM in Support re #1278 MOTION in Limine TO PRECLUDE AMGEN FROM OFFERING ARGUMENTS AND EXPERT TESTIMONY ON OBVIOUSNESS-TYPE DOUBLE PATENTING THAT IT FAILED TO DISCLOSE IN ITS INTERROGATORY RESPONSES AND EXPERT REPORTS filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 1278 MOTION in Limine TO PRECLUDE AMGEN FROM OFFERING ARGUMENTS AND EXPERT TESTIMONY ON OBVIOUSNESS-TYPE DOUBLE PATENTING THAT IT FAILED TO DISCLOSE IN ITS INTERROGATORY RESPONSES AND EXPERT REPORTS by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 1277 Opposition re #1239 MOTION to ADMIT EXHIBITS INTO EVIDENCE FOR INFRINGEMENT PHASE OF TRIAL filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1276 MOTION TO ADMIT TRIAL EXHIBIT NUK INTO EVIDENCE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 1275 MOTION in Limine TO PRECLUDE DR. BENET FROM TESTIFYING REGARDING ISSUES PERTAINING TO INVALIDITY by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 1274 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. TO AMGEN'S BENCH MEMORANDUM REGARDING THE ADMISSIBILITY OF POST-FILING EVIDENCE OF STRUCTURAL AND FUNCTIONAL DIFFERENCES (DN 1235). (Rizzo, Nicole) |
Filing 1273 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. BENCH MEMORANDUM REGARDING AMGEN'S FAILURE TO DEMONSTRATE THE REQUISITE NEXUS REGARDING SECONDARY CONSIDERATIONS OF NON-OBVIOUSNESS. (Rizzo, Nicole) |
Filing 1272 Opposition/ Response by Amgen Inc. to #1260 Brief Roche's Bench Memorandum to Preclude Amgen from Introducing Testimony Related to Pegylation of Non-EPO Compounds. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5)(Gottfried, Michael) |
Filing 1271 Response by Amgen Inc. to #1232 Brief, AMGENS RESPONSE TO ROCHES BENCH MEMORANDUM REGARDING UNCONTROVERTED EVIDENCE OF RECORD THAT DR. FRITSCH ISOLATED THE EPO GENE PRIOR TO THE EFFECTIVE FILING DATE OF THE PATENTS-IN-SUIT". (Rich, Patricia) |
Filing 1270 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) - RENEWED by Amgen Inc..(Rich, Patricia) |
Filing 1268 DECLARATION re #1267 Brief of Daniel A. Curto in Support of Amgen's Bench Memorandum that it is Appropriate for Dr. Lodish to use Computer-Modeled Demonstratives that will assist the Jury in Understanding His Infringement Testimony by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 1267 BRIEF by Amgen Inc. Bench Memorandum That it is Appropriate for Dr. Lodish to use Computer-Modeled Demonstratives that will assist the Jury in Understanding His Infringement Testimony. (Gottfried, Michael) |
Filing 1266 Response by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Response To Amgen's Bench Memorandum That Documents Showing That Amgen's Competitors In 1984 Acknowledged That Amgen Was The First To Clone The EPO Gene, That Amgen's Cloning Was Patentable And That They Sought To Copy Amgen Are Relevant To Secondary Considerations Of Non-Obviousness. (Fleming, Thomas) |
Filing 1265 MOTION to Preclude Roche from Introducing Evidence or Testimony Regarding the Safety or Efficacy of PEG-EPO Because Roche has Asserted that these Topics are Irrelevant and on that Basis Denied Amgen Fulsome Discovery by Amgen Inc..(Gottfried, Michael) |
Filing 1264 BRIEF by Amgen Inc. Bench Memorandum Regarding Roche's Defense of Non-Infringement Under "The Reverse Doctrine of Equivalents". (Gottfried, Michael) |
Filing 1263 Opposition re #1255 MOTION Defendants' Request for Permission to File Opposition to Amgen's In Limine Motion Regarding MIRCERA European Approval and Label re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCER MOTION Defendants' Request for Permission to File Opposition to Amgen's In Limine Motion Regarding MIRCERA European Approval and Label re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCER MOTION Defendants' Request for Permission to File Opposition to Amgen's In Limine Motion Regarding MIRCERA European Approval and Label re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCER MOTION Defendants' Request for Permission to File Opposition to Amgen's In Limine Motion Regarding MIRCERA European Approval and Label re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCER filed by Amgen Inc.. (Rich, Patricia) |
Filing 1262 MOTION for Leave to File a Reply in Support of its Motion to Admit Documents by Amgen Inc.. (Attachments: #1 Exhibit A - [Proposed] Reply)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered. re Order on Motion to Strike, #1249..."The Court is reconsidering this ruling and will entertain a Roche submission on the point." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #1259 MOTION to Strike the ODP Testimony of Roche's Expert Thomas Kadesch that was not Previously Disclosed in any of his Three Expert Reports. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1239 Motion to admit exhibits into evidence for infringement phase of trial. "The Court is satisfied from counsel's representations, that these documents are authentic and constitute admissions. The Court expresses no opinion as to whether any of these documents are relevant." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1206 Motion To Preclude the Testimony of Dr. Thomas Kadesch Based on Roche's Representation That It Would Not Call Dr. Kadesch At Trial, Or, In The Alternative, To Limit His Testimony Regarding Obviousness-Type Double Patenting To the Two Sentences On This Issue Contained In His Expert Report. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1221 MOTION in Limine to Exclude Amgen's Offer of Proof on Obviousness-Type Double Patenting. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot re 1219 Motion to Streamline and Expedite the Live Testimony of Dr. Thomas Strickland. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1218 Motion to Admit Exhibit BWZa into Evidence. "Denied without prejudice to receiving a redacted copy. Another motion must be filed." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1259 MOTION to Strike the ODP Testimony of Roche's Expert Thomas Kadesch that was not Previously Disclosed in any of his Three Expert Reports. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: Docket Entry (1218) Motion to admit exhibit BWZa into evidence corrected because the document had a typographical error in the title of the motion. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #1239 Motion to admit exhibits into evidence for infringement phase of trial. "The Court is satisfied from counsel's representations, that these documents are authentic and constitute admissions. The Court expresses no opinion as to whether any of these documents are relevant." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re Order on Motion to Strike, #1249..."The Court is reconsidering this ruling and will entertain a Roche submission on the point." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denied as moot #1206 Motion To Preclude the Testimony of Dr. Thomas Kadesch Based on Roche's Representation That It Would Not Call Dr. Kadesch At Trial, Or, In The Alternative, To Limit His Testimony Regarding Obviousness-Type Double Patenting To the Two Sentences On This Issue Contained In His Expert Report. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1221 MOTION in Limine to Exclude Amgen's Offer of Proof on Obviousness-Type Double Patenting. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot re #1219 Motion to Streamline and Expedite the Live Testimony of Dr. Thomas Strickland. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #1218 Motion to Admit Exhibit BWZa into Evidence. "Denied without prejudice to receiving a redacted copy. Another motion must be filed." (Paine, Matthew) |
Filing 1269 Judge William G. Young : ORDER entered re #1217 Motion to Admit Exhibits into Evidence. "Motion allowed in part and denied in part. Where allowed, the allowance is subjected to particularized objection by Roche. Where denied, the denial is without prejudice. See particularized notations herein. Exhibits FTF and GUR, however, are not admissible. The Chugai and G1 documents are not admissible for the reasons advance by Roche notwithstanding their antiquity." (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day andD's counselBen-Ami are present. Jury Trial Day 15 held on 10/2/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day andD's counselBen-Ami are present. Jury Trial Day 15 held on 10/2/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1261 MOTION in Limine to Preclude Amgen's Expert Witness Dr. Leslie Benet from Offering Testimony on Infringement by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1260 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum to Preclude Amgen from Introducing Testimony Related to Pegylation of Non-EPO Compounds. (Fleming, Thomas) |
Filing 1259 MOTION to Strike the ODP Testimony of Roche's Expert Thomas Kadesch that was not Previously Disclosed in any of his Three Expert Reports by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1258 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Motion to Strike Portions of Dr. Lin's Testimony for Lack of Personal Knowldege. (Fleming, Thomas) |
Filing 1257 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum to Preclude Amgen From Introducing Belatedly Produced Documents Relating to Its Experiments with Pegylation and COS-EPO as Untimely and Prejudicial. (Fleming, Thomas) |
Filing 1256 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum to Preclude Plaintiff From Introducing Evidence of Offers to Compromise. (Fleming, Thomas) |
Filing 1255 MOTION Defendants' Request for Permission to File Opposition to Amgen's In Limine Motion Regarding MIRCERA European Approval and Label re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCERA DOES NOT COMPRISE HUMAN EPO, IN CONTRADICTION OF THIS COURTS FINDING OF INFRINGEMENT ON CLAIM 1 OF THE 422 PATENT AND (2) THAT EUROPEAN REGULATORY APPROV MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCERA DOES NOT COMPRISE HUMAN EPO, IN CONTRADICTION OF THIS COURTS FINDING OF INFRINGEMENT ON CLAIM 1 OF THE 422 PATENT AND (2) THAT EUROPEAN REGULATORY APPROV by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) Additional attachment(s) added on 10/3/2007 (Paine, Matthew). |
Filing 1254 Opposition re #1217 MOTION to Admit Exhibits into Evidence Roche's Opposition to Amgen's Motion to Admit Exhibits Into Evidence filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1253 NOTICE by Amgen Inc. re #1218 MOTION to Admit Exhibit BWZ into Evidence Notice of Manual filing of Exhibit BWZa (Rich, Patricia) |
Filing 1252 DECLARATION re #1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCERA DOES NOT COMPRISE HUMAN EPO, IN CONTRADICTION OF THIS COURTS FINDING OF INFRINGEMENT ON CLAIM 1 OF THE 422 PATENT AND (2) THAT EUROPEAN REGULATORY APPROV MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCERA DOES NOT COMPRISE HUMAN EPO, IN CONTRADICTION OF THIS COURTS FINDING OF INFRINGEMENT ON CLAIM 1 OF THE 422 PATENT AND (2) THAT EUROPEAN REGULATORY APPROV Declaration by Daniel A. Curto by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1251 MOTION in Limine TO PRECLUDE ROCHE FROM CLAIMING DURING THE INFRINGEMENT CASE THAT (1) MIRCERA DOES NOT COMPRISE HUMAN EPO, IN CONTRADICTION OF THIS COURTS FINDING OF INFRINGEMENT ON CLAIM 1 OF THE 422 PATENT AND (2) THAT EUROPEAN REGULATORY APPROVAL HAS ANY RELEVANCE TO THE CLAIMS IN THIS LAWSUIT by Amgen Inc..(Gottfried, Michael) |
Filing 1250 DECLARATION re #1249 MOTION to Strike EVIDENCE REGARDING ROCHES ALLEGATION THAT CLAIM 7 OF THE 349 PATENT IS NOT ENABLED BECAUSE ROCHE DID NOT PREVIOUSLY IDENTIFY SUCH DEFENSE IN INTERROGATORY RESPONSES Declaration of Daniel A. Curto by Amgen Inc.. (Attachments: #1 Exhibit A (part 1)#2 Exhibit A (part two)#3 Exhibit A (part three))(Gottfried, Michael) |
Filing 1249 MOTION to Strike EVIDENCE REGARDING ROCHES ALLEGATION THAT CLAIM 7 OF THE 349 PATENT IS NOT ENABLED BECAUSE ROCHE DID NOT PREVIOUSLY IDENTIFY SUCH DEFENSE IN INTERROGATORY RESPONSES by Amgen Inc..(Gottfried, Michael) |
Filing 1248 DECLARATION re #1246 MOTION in Limine to Preclude Testimony by Dr. Lodish on Amgen's Validity Case on Matters that Are of No Relevance to this Case (of Julia Huston) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Huston, Julia) |
Filing 1247 MEMORANDUM in Support re #1246 MOTION in Limine to Preclude Testimony by Dr. Lodish on Amgen's Validity Case on Matters that Are of No Relevance to this Case filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1246 MOTION in Limine to Preclude Testimony by Dr. Lodish on Amgen's Validity Case on Matters that Are of No Relevance to this Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 1245 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Bench Memorandum That The U.S. Patent No. 4,766,075 Is Relevant Prior Art That is Presumed To Be Enabled. (Fleming, Thomas) |
Filing 1244 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Motion In Limine To Preclude Amgen Expert Harvey Lodish From Giving Irrelevant Testimony Related To Cell Lines. (Fleming, Thomas) |
Filing 1243 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Motion In Limine To Preclude Expert Testimony By Dr. Lodish Regarding The Conduct Of Drs. Lin and Goldwasser Which Is Spectulative, And Outside His Competence As An Expert. (Fleming, Thomas) |
Filing 1242 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Motion in Limine To Preclude Dr. Lodish From Opining Improperly Regarding Prior Art References. (Fleming, Thomas) |
Filing 1241 BRIEF by Amgen Inc. BENCH MEMORANDUM THAT DOCUMENTS SHOWING THAT AMGEN'S COMPETITORS IN 1984 ACKNOWLEDGED THAT AMGEN WAS THE FIRST TO CLONE THE EPO GENE, THAT AMGEN'S CLONING WAS PATENTABLE AND THAT THEY SOUGHT TO COPY AMGEN ARE RELEVANT TO SECONDARY CONSIDERATIONS OF NON-OBVIOUSNESS. (Gottfried, Michael) |
Filing 1240 Response by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Opposition to Amgen's Bench Memorandum For A Clarifying Preliminary Jury Instruction on Infringement of "422 Patent, Claim 1 To Provide The Jury With Procedural Context And Minimize Confusion. (Fleming, Thomas) |
Filing 1239 MOTION to ADMIT EXHIBITS INTO EVIDENCE FOR INFRINGEMENT PHASE OF TRIAL by Amgen Inc.. (Attachments: #1 Appendix A (Attachment A- Chart of Documents to be Admitted))(Gottfried, Michael) |
Filing 1238 BRIEF by Amgen Inc. BENCH MEMORANDUM TO PRECLUDE ROCHE FROM ARGUING OR PRESENTING EVIDENCE THAT MIRCERA DOES NOT CONTAIN HUMAN ERYTHROPOIETIN. (Gottfried, Michael) |
Filing 1237 BRIEF by Amgen Inc. BENCH MEMORANDUM CLARIFYING CASE LAW CONCERNING SOURCE AND PROCESS LIMITATIONS. (Rich, Patricia) Additional attachment(s) added on 10/4/2007 (Paine, Matthew). |
Filing 1236 Response by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Opposition to Amgen's Bench Memorandum Requesting A Clarifying Preliminary Jury Instruction Relating to Roche's Patent On Pegylated Erythropoietin. (Fleming, Thomas) |
Filing 1235 BRIEF by Amgen Inc. BENCH MEMORANDUM REGARDING ADMISSIBILITY OF POST-FILING EVIDENCE OF FUNCTIONAL AND STRUCTURAL DIFFERENCES TO REBUT ROCHES INVALIDITY ALLEGATIONS. (Rich, Patricia) |
Filing 1234 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Opposition to Amgens Motion to Admit Exhibit BWZ in Evidence. (Drozdoff, Vladimir) |
Filing 1233 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum Clarifying That Product by Process Claims are Limited Only by Limitations Recited in the Claims or the Specification. (Fleming, Thomas) |
Filing 1232 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roches Bench Memorandum Regardubg Uncontroverted Evidence of Record that Dr. Fritsch Isolated the EPO Gene Prior to the Effective Filing Date of the Patents-in-Suit. (Drozdoff, Vladimir) |
Judge William G. Young : Electronic ORDER entered denying #1249 Motion to Strike #1249 MOTION to Strike EVIDENCE REGARDING ROCHES ALLEGATION THAT CLAIM 7 OF THE 349 PATENT IS NOT ENABLED BECAUSE ROCHE DID NOT PREVIOUSLY IDENTIFY SUCH DEFENSE IN INTERROGATORY RESPONSES (Smith, Bonnie) |
E-Mail Notice re 1253 originally issued on 10/2/07 returned as undeliverable. Name of Addressee: Firasat Ali. The ECF help desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorney's email address has been removed from the database to prevent the return of additional undelivered email notices. (Jones, Sherry) |
Judge William G. Young : Electronic ORDER entered granting #1251 Motion in Limine"Motion allowed as to (2) and as to (1) only insofar as the claim may relate to claim 1 of the '422 patent. Moreover, it is still open to Roche to argue reverse doctrine of equivalents should there come to be evidentiary support for such a conclusion." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #1208 Motion supplement trial exhibit 2011 (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1208 Motion supplement trial exhibit 2011 (Smith, Bonnie) |
E-Mail Notice re 1253 originally issued on 10/2/07 returned as undeliverable. Name of Addressee: Firasat Ali. The ECF help desk has contacted the law firm on record, who advised that the attorney is no longer employed by that firm. The attorney's email address has been removed from the database to prevent the return of additional undelivered email notices. (Jones, Sherry) |
Judge William G. Young : Electronic ORDER entered denying 1249 Motion to Strike 1249 MOTION to Strike EVIDENCE REGARDING ROCHES ALLEGATION THAT CLAIM 7 OF THE 349 PATENT IS NOT ENABLED BECAUSE ROCHE DID NOT PREVIOUSLY IDENTIFY SUCH DEFENSE IN INTERROGATORY RESPONSES (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1251 Motion in Limine"Motion allowed as to (2) and as to (1) only insofar as the claim may relate to claim 1 of the '422 patent. Moreover, it is still open to Roche to argue reverse doctrine of equivalents should there come to be evidentiary support for such a conclusion." (Smith, Bonnie) |
Filing 1231 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum That Correspondence Between Chugai and Genetics Institute is Inadmissible Under the "Ancient Documents" Exception Because those Documents are not Authenticated, Contain Hearsay Within Hearsay, and are Misleading, Confusing and Unduly Prejudicial. (Fleming, Thomas) |
Filing 1230 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Opposition to Amgen's Motion to Supplement Trial Exhibit 2011. (Fleming, Thomas) |
Filing 1229 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Opposition to Amgen's Bench memorandum Regarding Showing the Jury Photographs Contained in a Learned Treatise. (Fleming, Thomas) |
Filing 1228 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1212 Brief Roche's Opposition to Amgen's Bench Memorandum That Trial Exhibit FTF is Admissible After Dr. Ajit Varki Explains the Relevance of Dr. Catlin's Experiment. (Fleming, Thomas) |
Filing 1227 BRIEF by Amgen Inc. Bench Memorandum for a Clarifying Preliminary Jury Instruction on Infringement of '422 Patent, Claim 1, to Provide the Jury with Procedural Context and to Minimize Jury Confusion. (Gottfried, Michael) |
Filing 1226 BRIEF by Amgen Inc. Bench Memorandum for a Clarifying Preliminary Jury Instruction Relating to Roche's Patent on Pegylated Erthropoietin. (Attachments: #1)(Gottfried, Michael) |
Filing 1225 SUR-REPLY to Motion re #876 MOTION in Limine No. 17: to Exclude Roche from Presenting Evidence to Challenge the Non-obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983 (Leave to File Granted on October 1, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1224 NOTICE by Amgen Inc. re #1217 MOTION to Admit Exhibits into Evidence OF MANUAL FILING (Gottfried, Michael) |
Filing 1223 Opposition re #1206 MOTION To Preclude the Testimony of Dr. Thomas Kadesch Based on Roche's Representation That It Would Not Call Dr. Kadesch At Trial, Or, In The Alternative, To Limit His Testimony Regarding Obviousness-Type Double Patenting To the Two Sentences On filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1222 MOTION in Limine to Preclude Amgen from Introducing a Declaration of Dr. Harvey Lodish in Connection with the Hearing on Obviousness-Type Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Schaffer, Emily) |
Filing 1221 MOTION in Limine to Exclude Amgen's Offer of Proof on Obviousness-Type Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Schaffer, Emily) |
Filing 1220 DECLARATION re #1219 MOTION to Streamline and Expedite the Live Testimony of Dr. Thomas Strickland of Patricia R. Rich by Amgen Inc.. (Attachments: #1 Exhibit A)(Rich, Patricia) |
Filing 1219 MOTION to Streamline and Expedite the Live Testimony of Dr. Thomas Strickland by Amgen Inc..(Rich, Patricia) |
Filing 1218 MOTION to Admit Exhibit BWZa into Evidence by Amgen Inc..(Gottfried, Michael) Additional attachment(s) added on 10/3/2007 (Paine, Matthew). Modified on 10/3/2007 (Paine, Matthew). |
Filing 1217 MOTION to Admit Exhibits into Evidence by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 1216 Opposition/ Response by Amgen Inc. to #1204 Brief Roche's Bench Memorandum Regarding Expected Cumulative Testimony by Amgen's Expert Carlo Brugnara. (Rich, Patricia) |
Filing 1215 DECLARATION re #1214 Emergency MOTION To Preclude Amgen From Publicly Disclosing Roche's Trade Secrets Without Prior Notice to Roche By Julia Huston by F. Hoffmann-LaRoche LTD. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Huston, Julia) |
Filing 1214 Emergency MOTION To Preclude Amgen From Publicly Disclosing Roche's Trade Secrets Without Prior Notice to Roche by F. Hoffmann-LaRoche LTD.(Huston, Julia) |
Filing 1213 Opposition re #1205 MOTION in Limine Defendants' Motion in Limine to Preclude Amgen from presenting Testimony of Attorney Ian Crawford filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1212 BRIEF by Amgen Inc. Bench Memorandum that the Digital Photograph of Dr. Catlin's IEF Experiment (Trial Exhibit FTF) is Admissable After Dr. Ajit Varki Explains the Relevance of Dr. Catlin's Experiment. (Gottfried, Michael) |
Filing 1211 BRIEF by Amgen Inc. Bench Memorandum Regarding Showing Jury Photographs Contained in Learned Treatise. (Gottfried, Michael) |
Filing 1210 MOTION for Leave to Play a Designation for Leroy Hood which was Designated by Roche, Allowed by the Court, and Subsequently Withdrawn by Roche by Amgen Inc..(Rich, Patricia) |
Filing 1209 MOTION for Clarification Defendants' Motion For Clarification of the Court's Ruling on Roche's Motion to Admit Exhibits Into Evidence by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Fleming, Thomas) |
Filing 1208 MOTION TO SUPPLEMENT TRIAL EXHIBIT 2011 by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered granting #1209 Motion for Clarification "Actually, this is a motion for reconsideration. Upon reconsideration, exhibit NZR is admitted but PRX is not." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1205 Motion in Limine to preclude Amgen from presenting testimony of Attorney Ian Crawford. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1202 MOTION for Judgment as a Matter of Law That The Baron-Goldwasser EPO Studies and Their NIH and FDA Grant Applications Are Not Prior Art. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Denied. The deposition is to be returned to the parties." #1063 Motion to Remove the "Confidential" Designation from the June 21, 2007 Deposition Transcript of Roche's Expert Dr. Thomas Kadesch. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. denying re #1182 BRIEF: Defendants' Motion in Limine to Restrict Goldwasser To Testifying Only to Opinions Consistent With His Expert Report by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.(Paine, Matthew) |
Motions terminated: #1214 Emergency MOTION To Preclude Amgen From Publicly Disclosing Roche's Trade Secrets Without Prior Notice to Roche filed by F. Hoffmann-LaRoche LTD. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered entered #1214 Motion to preclude Amgen from publicly disclosing Roche's trade secrets... "Treated as a motion for clarification, the Court simply ordered that nothing further be submitted to it under seal or for in camera review. Otherwise, all prior orders remain in full force and effect." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 1070 A SUR-REPLY IN RESPONSE TO PLAINTIFF AMGEN INC.S PROPOSED REPLY IN FURTHER SUPPORT OF ITS MOTION IN LIMINE NO. 17: TO EXCLUDE ROCHE FROM PRESENTING EVIDENCE TO CHALLENGE THE NON-OBVIOUSNESS OF THE DNA SEQUENCE ENCODING FOR HUMAN ERYTHROPOIETIN IN 1983; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel carson are present. Bench Trial Day 1 held on 10/1/2007. D's evidence re; obviousness/double patenting commences. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Amia re pesent.Jury Trial Day 14 held on 10/1/2007. P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Motions terminated: 1214 Emergency MOTION To Preclude Amgen From Publicly Disclosing Roche's Trade Secrets Without Prior Notice to Roche filed by F. Hoffmann-LaRoche LTD. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re #1204 Brief filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH The motion to preclude is Denied.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #1205 Motion in Limine to preclude Amgen from presenting testimony of Attorney Ian Crawford. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 1204 Brief filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH The motion to preclude is Denied.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #1202 MOTION for Judgment as a Matter of Law That The Baron-Goldwasser EPO Studies and Their NIH and FDA Grant Applications Are Not Prior Art. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered entered 1214 Motion to preclude Amgen from publicly disclosing Roche's trade secrets... "Treated as a motion for clarification, the Court simply ordered that nothing further be submitted to it under seal or for in camera review. Otherwise, all prior orders remain in full force and effect." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. denying re 1182 BRIEF: Defendants' Motion in Limine to Restrict Goldwasser To Testifying Only to Opinions Consistent With His Expert Report by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.(Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Amia re pesent.Jury Trial Day 14 held on 10/1/2007. P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel carson are present. Bench Trial Day 1 held on 10/1/2007. D's evidence re; obviousness/double patenting commences. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #1070 A SUR-REPLY IN RESPONSE TO PLAINTIFF AMGEN INC.S PROPOSED REPLY IN FURTHER SUPPORT OF ITS MOTION IN LIMINE NO. 17: TO EXCLUDE ROCHE FROM PRESENTING EVIDENCE TO CHALLENGE THE NON-OBVIOUSNESS OF THE DNA SEQUENCE ENCODING FOR HUMAN ERYTHROPOIETIN IN 1983; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Denied. The deposition is to be returned to the parties." 1063 Motion to Remove the "Confidential" Designation from the June 21, 2007 Deposition Transcript of Roche's Expert Dr. Thomas Kadesch. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1209 Motion for Clarification "Actually, this is a motion for reconsideration. Upon reconsideration, exhibit NZR is admitted but PRX is not." (Smith, Bonnie) |
Filing 1207 DECLARATION re #1206 MOTION To Preclude the Testimony of Dr. Thomas Kadesch Based on Roche's Representation That It Would Not Call Dr. Kadesch At Trial, Or, In The Alternative, To Limit His Testimony Regarding Obviousness-Type Double Patenting To the Two Sentences On This Issue Contained in His Expert Report, Declaration Of Aaron R. Hand by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3)(Gottfried, Michael) |
Filing 1206 MOTION To Preclude the Testimony of Dr. Thomas Kadesch Based on Roche's Representation That It Would Not Call Dr. Kadesch At Trial, Or, In The Alternative, To Limit His Testimony Regarding Obviousness-Type Double Patenting To the Two Sentences On This Issue Contained In His Expert Report by Amgen Inc..(Gottfried, Michael) |
Filing 1205 MOTION in Limine Defendants' Motion in Limine to Preclude Amgen from presenting Testimony of Attorney Ian Crawford by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1204 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Regarding Expected Cumulative Testimony by Amgen's Expert Carlo Brugnara. (Fleming, Thomas) |
Filing 1203 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Gary Rogers by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1202 MOTION for Judgment as a Matter of Law That The Baron-Goldwasser EPO Studies and Their NIH and FDA Grant Applications Are Not Prior Art by Amgen Inc..(Gottfried, Michael) |
Filing 1201 BRIEF by Amgen Inc. = OPPOSITION TO ROCHE'S MEMORANDUM REGARDING BARON-GOLDWASSER PRIOR ART: BARON-GOLDWASSER CLINICAL STUDY, BARON GOLDWASSER IND AND GOLDWASSER NIH GRANTS (D.I. 1141-5 Exhibit D). (Gottfried, Michael) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P;s counsel Day and D's counsel Ben-Ami are present.Jury Trial DAY 13 held on 9/28/2007. P's evidence continues (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P;s counsel Day and D's counsel Ben-Ami are present.Jury Trial DAY 13 held on 9/28/2007. P's evidence continues (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1200 DECLARATION re #1198 MOTION to Quash Subpoena ad Testificandum Served on Third Party Dr. Fu-Kuen Lin, #1199 Memorandum in Support of Motion of Geoffrey M. Godfrey by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Rich, Patricia) |
Filing 1199 MEMORANDUM in Support re #1198 MOTION to Quash Subpoena ad Testificandum Served on Third Party Dr. Fu-Kuen Lin filed by Amgen Inc.. (Rich, Patricia) |
Filing 1198 MOTION to Quash Subpoena ad Testificandum Served on Third Party Dr. Fu-Kuen Lin by Amgen Inc..(Rich, Patricia) |
Filing 1197 DECLARATION re #1196 MOTION to Authenticate by Declaration in Lieu of the Live Testimony of Charles Kung by Amgen Inc.. (Attachments: #1 Exhibit A - Declaration of Charles Kung)(Gottfried, Michael) |
Filing 1196 MOTION to Authenticate by Declaration in Lieu of the Live Testimony of Charles Kung by Amgen Inc..(Gottfried, Michael) |
Filing 1195 REPLY to Response to Motion re #1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay (Leave to File Granted on September 28, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1194 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum Regarding Browne Testifying About Previous Litigations. (Toms, Keith) |
Filing 1193 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum: Dr. Browne Should be Precluded from Testifying About the Specific Claims of the Patents-In-Suit. (Toms, Keith) |
Filing 1192 Opposition/ Response by Amgen Inc. to #1182 Brief to Restrict Dr. Goldwasser to Testifying Only to Opinions Consistent with his Expert Report. (Gottfried, Michael) |
Filing 1191 Opposition/ Response by Amgen Inc. to #1181 Brief to Preclude Amgen from Soliciting Cumulative Trial Testimony from Dr. Eugene Goldwasser. (Gottfried, Michael) |
Filing 1190 Opposition re #1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung filed by Amgen Inc.. (Rich, Patricia) |
Filing 1189 MOTION requesting an instruction ot the jury regarding the fact that Dr. Harlow's statements, as Roche's agent, are admissions by Amgen Inc..(Rich, Patricia) |
Filing 1188 DECLARATION re #1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung (by Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Fleming, Thomas) |
Filing 1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered. "Allowed. Roche may call Dr. Harlow as a live witness in the obviousness double patenting issue." re 1163 MOTION for Leave to File Reply In Further Support of Defendants' Motion In Limine To Preclude Amgen From Introducing the Deposition Testimony of Dr. Edward Harlow, A Roche Expert Witness On the Issue of Obviousness-Type Double Patenting Who Will Not Be Testifying At Trial; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 1175 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH.Denied as moot. See transcript.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. Motion is DENIED(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered "Denied without prejudice to its renewal directed to specific answers that Amgen seeks to introduce." re 1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Motion allowed, it being evident the testimony of Dr. Spinowitz is no longer necessary." re 1099 MOTION to Quash Subpoena Ad Testificandum Served on Third Party Bruce Spinowitz, M.D. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1066 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing that Examples in the Lin Specification Inherently Produce Human EPO with 165 Amino Acid Residues. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1065 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing That Lin Described Human EPO With The 1-165 Amino Acid Residues of Fig. 6. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "So Ordered" re 1186 Letter/request (non-motion) from Thomas F. Fleming re: Agreement between the parties as to trial exchange.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1198 MOTION to Quash Subpoena ad Testificandum Served on Third Party Dr. Fu-Kuen Lin. "Motion allowed as only expert testimony on patent distinguishability is germain to Monday's hearing." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 1181 Brief filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD Motion DENIED, although Goldwasser will not be permitted to repeat earlier testimony.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1118 Motion in Limine to exclude deposition of Dr. Hood (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re #1198 MOTION to Quash Subpoena ad Testificandum Served on Third Party Dr. Fu-Kuen Lin. "Motion allowed as only expert testimony on patent distinguishability is germain to Monday's hearing." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1187 MOTION in Limine Defendants' Motion In Limine to Preclude Amgen From Presenting Testimony of Charles Kung. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "So Ordered" re #1186 Letter/request (non-motion) from Thomas F. Fleming re: Agreement between the parties as to trial exchange.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1065 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing That Lin Described Human EPO With The 1-165 Amino Acid Residues of Fig. 6. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1066 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing that Examples in the Lin Specification Inherently Produce Human EPO with 165 Amino Acid Residues. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Motion allowed, it being evident the testimony of Dr. Spinowitz is no longer necessary." re #1099 MOTION to Quash Subpoena Ad Testificandum Served on Third Party Bruce Spinowitz, M.D. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered "Denied without prejudice to its renewal directed to specific answers that Amgen seeks to introduce." re #1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1118 Motion in Limine to exclude deposition of Dr. Hood (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re #1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. Motion is DENIED(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re #1175 Brief, filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH.Denied as moot. See transcript.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re #1181 Brief filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD Motion DENIED, although Goldwasser will not be permitted to repeat earlier testimony.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. "Allowed. Roche may call Dr. Harlow as a live witness in the obviousness double patenting issue." re #1163 MOTION for Leave to File Reply In Further Support of Defendants' Motion In Limine To Preclude Amgen From Introducing the Deposition Testimony of Dr. Edward Harlow, A Roche Expert Witness On the Issue of Obviousness-Type Double Patenting Who Will Not Be Testifying At Trial; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day and D's counsel Ben-Ami are present.Jury Trial Day 12 held on 9/27/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P;s counsel Day and D's counsel Ben-Ami are present.Jury Trial Day 12 held on 9/27/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #1189 Motion re: Dr. Harlow's statements... (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1189 Motion re: Dr. Harlow's statements... (Smith, Bonnie) |
Filing 1186 Letter/request (non-motion) from Thomas F. Fleming re: Agreement between the parties as to trial exchanges. (Fleming, Thomas) |
Filing 1184 DECLARATION re #1183 Brief Declaration of Alfred H. Heckel In Support of Defendants' Motion to Preclude Dr. Goldwasser From Relying on Exhibit AYS, Declaration of Thomas Heckler by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A part 1 of 2#2 Exhibit A part 2 of 2)(Fleming, Thomas) |
Filing 1183 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Roche's Motion In Limine To Exclude Dr. Eugene Goldwasser From Testifying Regarding Exhibit AYS, Declaration Of Thomas Heckler. (Fleming, Thomas) |
Filing 1182 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Defendants' Motion in Limine to Restrict Goldwasser To Testifying Only to Opinions Consistent With His Expert Report. (Fleming, Thomas) |
Filing 1181 BRIEF by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. Defendants' Motion in Limine to Preclude Amgen From Soliciting Cumulative Trial Testimony From Dr. Eugene Goldwasser. (Fleming, Thomas) |
Filing 1180 DECLARATION re #1179 Opposition to Motion of Kevin Flowers in Support of Amgen's Opposition to Roche's Motion in Limine to Exclude the Testimony of Dr. Adrian Katz by Amgen Inc.. (Rich, Patricia) |
Filing 1179 Opposition re #1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness filed by Amgen Inc.. (Rich, Patricia) |
Filing 1178 DECLARATION re #1177 Opposition to Motion, of Renee Dubord Brown in Support of Amgen's Opposition to Roche's Motion in Limine to Exclude Deposition Testimony of Dr. Leroy Hood by Amgen Inc.. (Attachments: #1 Exhibit 1, Part 1 of 6#2 Exhibit 1, Part 2 of 6#3 Exhibit 1, Part 3 of 6#4 Exhibit 1, Part 4 of 6#5 Exhibit 1, Part 5 of 6#6 Exhibit 1, Part 6 of 6#7 Exhibit 2, Part 1 of 4#8 Exhibit 2, Part 2 of 4#9 Exhibit 2, Part 3 of 4#10 Exhibit 2, Part 4 of 4#11 Exhibit 3#12 Exhibit 4)(Rich, Patricia) |
Filing 1177 Opposition re #1118 MOTION in Limine to Exclude Deposition Testimony of Dr. Leroy Hood, Whom Amgen Did Not Identify as an Expert or Disclose as a Knowledgeable Witness Under Rule 26(A)(1) MOTION in Limine to Exclude Deposition Testimony of Dr. Leroy Hood, Whom Amgen Did Not Identify as an Expert or Disclose as a Knowledgeable Witness Under Rule 26(A)(1) filed by Amgen Inc.. (Rich, Patricia) |
Filing 1176 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Motion in Limine to Preclude Plaintiff Amgen Inc. From Offering Testimony Concerning Assays From Fact Witness Dr. Lin Because He Lacks Personal Knowledge. (Attachments: #1 Exhibit A#2 Exhibit B)(Fleming, Thomas) |
Filing 1175 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Motion in Limine to preclude Plaintiaff Amgen Inc. From Offering Testimony Concerning Epogen From Fact Witness Dr. Lin Who Lacks Personal Knowledge. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E)(Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denying #1170 Supplemental MOTION for Leave to File Under Seal a Document Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Leave to Reply in Further Support of Its Motion In Limine No. 13. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #1174 Motion To Allow Amgen To Use the Deposition Testimony Of Dr. Baron In Its Case-In-Chief On Validity. "Denied. Amgen waived its right to further counter designate when the Court was first obligated to review this deposition. Amgen may, however, call Dr. Baron live." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1172 Motion for Protective Order to Limit Roche's deposition of Jeffrey Browne... (Smith, Bonnie) |
ELECTRONIC NOTICE issued requesting courtesy copy for #1164 Declaration, #1165 Declaration,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 1164 Declaration, 1165 Declaration,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1172 Motion for Protective Order to Limit Roche's deposition of Jeffrey Browne... (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1170 Supplemental MOTION for Leave to File Under Seal a Document Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Leave to Reply in Further Support of Its Motion In Limine No. 13. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1174 Motion To Allow Amgen To Use the Deposition Testimony Of Dr. Baron In Its Case-In-Chief On Validity. "Denied. Amgen waived its right to further counter designate when the Court was first obligated to review this deposition. Amgen may, however, call Dr. Baron live." (Paine, Matthew) |
Filing 1185 Receipt to Defendant Roche for documents returned on September 26, 2007. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Gottfried and D's counsel Fleming are present. Hearing out of the presence of the jury re: appearance of witnesses held on 9/26/2007. After hearing from counsel the Court orders that Brown may testify once his deposition is taken. The deposition is to take place 3 hours today and 4 hours tomorrow or 7 hours tomorrow. The court will review the deposition testimony of Harlow and make rulings on the deposition designations.(Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and d's counsel ben-Ami are presentJury Trial Day 11 held on 9/26/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Gottfried and D's counsel Fleming are present. Hearing out of the presence of the jury re: appearance of witnesses held on 9/26/2007. After hearing from counsel the Court orders that Brown may testify once his deposition is taken. The deposition is to take place 3 hours today and 4 hours tomorrow or 7 hours tomorrow. The court will review the deposition testimony of Harlow and make rulings on the deposition designations.(Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and d's counsel ben-Ami are presentJury Trial Day 11 held on 9/26/2007.P's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1174 MOTION To Allow Amgen To Use the Deposition Testimony Of Dr. Baron In Its Case-In-Chief On Validity by Amgen Inc..(Rich, Patricia) |
Filing 1173 DECLARATION re #1172 MOTION for Protective Order TO LIMIT ROCHE'S DEPOSITION OF JEFFREY BROWNE TO FOUR HOURS BECAUSE OF ROCHE'S REFUSAL TO START THE DEPOSITION ON SEPTEMBER 26, 2007 of Daniel A. Curto by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Rich, Patricia) |
Filing 1172 MOTION for Protective Order TO LIMIT ROCHE'S DEPOSITION OF JEFFREY BROWNE TO FOUR HOURS BECAUSE OF ROCHE'S REFUSAL TO START THE DEPOSITION ON SEPTEMBER 26, 2007 by Amgen Inc..(Rich, Patricia) |
Filing 1171 DECLARATION re #1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay Leave to File Granted on September 26, 2007 by Amgen Inc.. (Attachments: #1 Exhibit 1)(Gottfried, Michael) |
Filing 1170 Supplemental MOTION for Leave to File Under Seal a Document Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Leave to Reply in Further Support of Its Motion In Limine No. 13 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1169 MEMORANDUM in Support re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) (leave to file granted 9/26/07) filed by Amgen Inc.. (Rich, Patricia) |
Filing 1168 DECLARATION re #1167 Opposition to Motion Of Deborah E, Fishman in Support of Amgen Inc's Opposition to Roche Motion in Limine to Preclude Amgen from calling Jeffrey Brown at Trial by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6)(Gottfried, Michael) |
Filing 1167 Opposition re #1149 MOTION in Limine To Preclude Amgen From Calling Jeffrey Browne At Trial After Failing To Produce Him For Deposition Pursuant To Subpoena filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1166 Receipt to Defendant Roche for documents received on September 25, 2007. (Paine, Matthew) |
Filing 1165 DECLARATION re #1162 Brief of Geoffrey M. Godfrey in Support of Amgen's Bench Memorandum and Offer of Proof Regarding No Obviousness-Type Double Patenting by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D-1 OF 2#5 Exhibit D-2 OF 2#6 Exhibit E#7 Exhibit F#8 Exhibit F#9 Exhibit H#10 Exhibit I 1 of 3#11 Exhibit I 2 of 3#12 Exhibit I 3 of 3#13 Exhibit J)(Rich, Patricia) |
Filing 1164 DECLARATION re #1162 Brief of Harvey F. Lodish, Ph.D. in Support of Bench Memorandum and Offer of Proof Regarding No Obviousness-Type Double Patenting by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I#10 Exhibit J#11 Exhibit K#12 Exhibit L#13 Exhibit M#14 Exhibit N#15 Exhibit O)(Rich, Patricia) |
Filing 1163 MOTION for Leave to File Reply In Further Support of Defendants' Motion In Limine To Preclude Amgen From Introducing the Deposition Testimony of Dr. Edward Harlow, A Roche Expert Witness On the Issue of Obviousness-Type Double Patenting Who Will Not Be Testifying At Trial by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Seluga, Kimberly) |
Filing 1162 BRIEF by Amgen Inc. Bench Memorandum and Offer of Proof Regarding No Obviousness-Type Double Patenting. (Rich, Patricia) |
Filing 1161 Opposition re #1061 MOTION for Reconsideration of the Court's Grant of Summary Judgment of Infringement of '422 Claim 1 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1160 Response by Amgen Inc. to #1078 Brief in Opposition to Roche's Memorandum of Law on the Admission of of Mr. Sofocleous' Testimony During the Validity Phase. (Gottfried, Michael) |
Filing 1159 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum No. 5 That Dr. Orkin Should be Precluded Under F.R.E. 802 From Offering Testimony on the Cloning Efforts of Biogen. (Fleming, Thomas) |
Filing 1158 BRIEF by Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum No. 4 That Dr. Orkin Should be Precluded From Testifying That in 1983 There was Uncertainty That There was a Commercial Market for an EPO Drug Product, Because Such Testimony Would Contradict Binding Admissions in Amgen's Patents. (Fleming, Thomas) |
Filing 1157 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum No. 3 that Dr. Orkin Should be Precluded from Testifying That There Was No Known Source of Human EPO MRNA in 1983 Because Such Testimony Contradicts Admissions In the Specifications of Amgen's Patents. (Fleming, Thomas) |
Filing 1156 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum No. 2 that Dr. Orkin Should be Precluded from Testifying to a Claim-By-Claim Analysis of the Patents-In-Suit and/or Offering an Opinion on the Ulitimate Issue of Validity Because These Opinions are not in His Expert Reports. (Fleming, Thomas) |
Filing 1155 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum No. 1 That Dr. Orkin Should be Precluded from Offering Opinions on Topics About Which He Has Expressly Disclaimed Expertise. (Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denied as moot 1096 MOTION in Limine To Exclude The Fact Testimony and Expert Testimony of Dr. Catlin On the Basis That Athlete Doping Is Irrelevant To Any Issue In This Case. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a). "Allowed in part and denied in part. See transcript." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1137 MOTION for Leave to File to File an Oversized Brief in Support of its Motion for Judgment as a Matter of Law Pursuant to Rule 50(a); Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot 1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence. (Paine, Matthew) |
Motions terminated: 1067 MOTION Omnibus Motion Defendants' Omnibus Motion to Admit Party Admissions and Previous Findings of Fact into Evidence filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re #1119 MOTION in Limine to Preclude Opinion Testimony of Amgen's Expert Witness Dr. Friedman Based on Improper Instructions Not to Answer at His Deposition. "Allowed in part and denied in part. See transcript." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1127 MOTION for Leave to File A Declaration in Support of Its Opposition to Defendant Roche's Motion to Preclude the Deposition Testimony of Dr. Edward Everett Harlow; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 1119 MOTION in Limine to Preclude Opinion Testimony of Amgen's Expert Witness Dr. Friedman Based on Improper Instructions Not to Answer at His Deposition. "Allowed in part and denied in part. See transcript." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying #1105 MOTION in Limine to Preclude Plaintiff from Arguing to the Jury that Epogen Improves Quality of Life Where the FDA Does Not Support the Inclusion of Such Claims on the Product Label. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a). "Allowed in part and denied in part. See transcript." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1137 MOTION for Leave to File to File an Oversized Brief in Support of its Motion for Judgment as a Matter of Law Pursuant to Rule 50(a); Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot #1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence. (Paine, Matthew) |
Motions terminated: #1067 MOTION Omnibus Motion Defendants' Omnibus Motion to Admit Party Admissions and Previous Findings of Fact into Evidence filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot #1096 MOTION in Limine To Exclude The Fact Testimony and Expert Testimony of Dr. Catlin On the Basis That Athlete Doping Is Irrelevant To Any Issue In This Case. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1127 MOTION for Leave to File A Declaration in Support of Its Opposition to Defendant Roche's Motion to Preclude the Deposition Testimony of Dr. Edward Everett Harlow; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1105 MOTION in Limine to Preclude Plaintiff from Arguing to the Jury that Epogen Improves Quality of Life Where the FDA Does Not Support the Inclusion of Such Claims on the Product Label. (Paine, Matthew) |
Filing 1154 DECLARATION re #1153 Brief of Daniel A. Curto in Support of SUPPLEMENTAL MEMORANDUM IN SUPPORT OF BENCH MEMORANDA REGARDING: (1) AUTHENTICATION OF JANUARY 16, 1984 LETTER; AND (2) AUTHENTICATION OF JAN. 11, 1984 TELEX by Amgen Inc.. (Attachments: #1 Exhibit A (Declaration of Ian Crawford, Esq.))(Gottfried, Michael) |
Filing 1153 BRIEF by Amgen Inc. to #1048 Brief, #1049 Brief Supplemental Memorandum IN SUPPORT OF BENCH MEMORANDA REGARDING: (1) AUTHENTICATION OF JANUARY 16, 1984 LETTER; AND (2) AUTHENTICATION OF JAN. 11, 1984 TELEX. (Gottfried, Michael) |
Filing 1152 Opposition re #1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence filed by Amgen Inc.. (Rich, Patricia) |
Filing 1151 DECLARATION re #1149 MOTION in Limine To Preclude Amgen From Calling Jeffrey Browne At Trial After Failing To Produce Him For Deposition Pursuant To Subpoena (Declaration of Manvin Mayell) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E)(Seluga, Kimberly) |
Filing 1150 MEMORANDUM in Support re #1149 MOTION in Limine To Preclude Amgen From Calling Jeffrey Browne At Trial After Failing To Produce Him For Deposition Pursuant To Subpoena filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1149 MOTION in Limine To Preclude Amgen From Calling Jeffrey Browne At Trial After Failing To Produce Him For Deposition Pursuant To Subpoena by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1148 Supplemental Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding 102(f) Derivation and Obviousness of Claim 7 of the '349 Patent Raised by Amgen During the September 24th Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1147 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #1143 Declaration, Notice of Service of Confidential Document (Schaffer, Emily) |
Filing 1146 Supplemental Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding the Estoppel Effect of the Chugai Litigation Raised by Amgen During the September 24th Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1145 Supplemental Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding the Oviousness of Claims 11 and 14 of the '933 Patent as Raised by Amgen During the September 24th Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1144 Supplemental Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding Structural Identity Between Amgen's Product Claims and the Prior Art Raised by Amgen During September 24th Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1143 DECLARATION re #1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness (by Emily J. Schaffer) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A, Part 1#2 Exhibit A, Part 2#3 Exhibit B)(Schaffer, Emily) |
Filing 1142 Supplemental Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding Obviousness and the Opinions of Roche's Expert Dr. Lowe Raised by Amgen During September 24th Hearing filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1141 Opposition re #1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) Regarding Roche's Invalidity Defenses filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E)(Fleming, Thomas) |
Filing 1140 MOTION in Limine To Exclude The Testimony Of Dr. Adrian Katz Obtained By Amgen Through Duress And Subterfuge For Lack Of Competence And Improper Expert Testimony From A Fact Witness by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Schaffer, Emily) |
Filing 1139 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. BENCH MEMORANDUM THAT DR. RICHARD FLAVELL PROPERLY TESTIFIED REGARDING HIS OPINION THAT CLAIM 7 OF THE 349 PATENT LACKS ENABLEMENT. (Attachments: #1 Exhibit A#2 Exhibit B)(Rizzo, Nicole) |
Filing 1138 Receipt to Plaintiff Amgen, Inc. for documents returned on September 25, 2007. (Paine, Matthew) |
Filing 1137 MOTION for Leave to File to File an Oversized Brief in Support of its Motion for Judgment as a Matter of Law Pursuant to Rule 50(a) by Amgen Inc.. (Attachments: #1 Exhibit A (Amgen Inc.'s Memorandum in Support of Its Motion for Judgment as a Matter of Law Pursuant to Rule 50(a))(Rich, Patricia) |
Filing 1136 MOTION for Judgment as a Matter of Law Pursuant to Rule 50(a) by Amgen Inc..(Rich, Patricia) |
Filing 1135 Receipt to Defendant Roche for documents received on September 24, 2007. (Paine, Matthew) |
Filing 1134 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. OF PARTIAL WITHDRAWAL OF DEFENDANTS' OMNIBUS MOTION TO ADMIT PARTY ADMISSIONS AND PREVIOUS FINDINGS OF FACT INTO EVIDENCE (D.N. 1067) (Rizzo, Nicole) |
Filing 1133 BRIEF by Amgen Inc. OPPOSITION TO ROCHES MOTION TO ADMIT EXHIBITS INTO EVIDENCE (FILED IN OPEN COURT ON 9/24/07). (Attachments: #1 Exhibit A#2 Exhibit B)(Rich, Patricia) |
Filing 1132 DECLARATION re #1131 Opposition to Motion OF RENEE DUBORD BROWN IN SUPPORT OF AMGENS OPPOSITION TO ROCHES MOTION TO PRECLUDE AMGEN FROM ARGUING TO THE JURY THAT EPOGEN IMPROVES QUALITY OF LIFE by Amgen Inc.. (Attachments: #1 Exhibit 1)(Rich, Patricia) |
Filing 1131 Opposition re #1105 MOTION in Limine to Preclude Plaintiff from Arguing to the Jury that Epogen Improves Quality of Life Where the FDA Does Not Support the Inclusion of Such Claims on the Product Label filed by Amgen Inc.. (Rich, Patricia) |
Filing 1130 RESPONSE to Motion re #1067 MOTION Omnibus Motion Defendants' Omnibus Motion to Admit Party Admissions and Previous Findings of Fact into Evidence AND OBJECTIONS filed by Amgen Inc.. (Rich, Patricia) |
Filing 1129 Opposition re #1119 MOTION in Limine to Preclude Opinion Testimony of Amgen's Expert Witness Dr. Friedman Based on Improper Instructions Not to Answer at His Deposition filed by Amgen Inc.. (Rich, Patricia) |
Remark: Exhibit (A) - Deposition transcript of Nancy Spaeth, added to docket entry 1115 the Declaration of Peter Frantangelo. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Ami are present.Jury Trial Day 10 held on 9/25/2007. Defendant Roche rests as to validity. Plaintiff orally moves for judgment as matter of law. The Court rules the motion is allowed in part and denied in part. Plaintiff's evidence commences. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day and D's counsel Ben-Ami are present.Jury Trial Day 10 held on 9/25/2007. Defendant Roche rests as to validity. Plaintiff orally moves for judgment as matter of law. The Court rules the motion is allowed in part and denied in part. Plaintiff's evidence commences. (Court Reporter Womack.) (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: Docket entry 1106, Declaration in support of motion in limine corrected because: the wrong document was filed and attached to the entry. (Paine, Matthew) |
Filing 1128 NOTICE by Amgen Inc. re #1127 MOTION for Leave to File A Declaration in Support of Its Opposition to Defendant Roche's Motion to Preclude the Deposition Testimony of Dr. Edward Everett Harlow OF SERVICE OF CONFIDENTIAL DOCUMENT (Gottfried, Michael) |
Filing 1127 MOTION for Leave to File A Declaration in Support of Its Opposition to Defendant Roche's Motion to Preclude the Deposition Testimony of Dr. Edward Everett Harlow by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1126 BRIEF by Amgen Inc. AMGENS BENCH BRIEF ON DOCUMENTS ALREADY IN EVIDENCE THAT DEMONSTRATE A NEXUS BETWEEN EPOGEN AND AT LEAST ONE CLAIM OF A PATENT-IN-SUIT. (Gottfried, Michael) |
Filing 1125 NOTICE of Appearance by Emily J. Schaffer on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Schaffer, Emily) |
Filing 1124 DECLARATION re #1123 Reply to Response to Motion, of Aaron R. Hand in Support of Motion in Limine No. 13 - Leave to File Granted on 9/24/07 by Amgen Inc.. (Attachments: #1 Exhibit 1 Coversheet)(Gottfried, Michael) |
Filing 1123 REPLY to Response to Motion re #856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery Leave to File Granted on 9/24/07 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1122 Opposition re #1036 MOTION in Limine to Bind Amgen Inc. to Prior Admissions Relevant to Double Patenting filed by Amgen Inc.. (Rich, Patricia) |
Filing 1121 BRIEF by Amgen Inc. BENCH MEMORANDUM THAT DR. RICHARD A. FLAVELL SHOULD BE PRECLUDED FROM TESTIFYING REGARDING HIS UNTIMELY OPINION THAT CLAIM 7 OF THE 349 PATENT LACKS ENABLEMENT. (Rich, Patricia) |
Filing 1120 DECLARATION re #1119 MOTION in Limine to Preclude Opinion Testimony of Amgen's Expert Witness Dr. Friedman Based on Improper Instructions Not to Answer at His Deposition (of Howard S. Suh) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 1119 MOTION in Limine to Preclude Opinion Testimony of Amgen's Expert Witness Dr. Friedman Based on Improper Instructions Not to Answer at His Deposition by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1118 MOTION in Limine to Exclude Deposition Testimony of Dr. Leroy Hood, Whom Amgen Did Not Identify as an Expert or Disclose as a Knowledgeable Witness Under Rule 26(A)(1) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1117 Opposition re #1096 MOTION in Limine To Exclude The Fact Testimony and Expert Testimony of Dr. Catlin On the Basis That Athlete Doping Is Irrelevant To Any Issue In This Case filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1116 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence (Notice of Service of Confidential Exhibit to the Declaration of Peter Fratangelo) (Toms, Keith) |
Filing 1115 DECLARATION re #1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence (of Peter Fratangelo) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A#2 Exhibit B)(Toms, Keith) Additional attachment(s) added on 9/25/2007 (Paine, Matthew). |
Filing 1114 MEMORANDUM in Support re #1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1113 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth Based on Additional Evidence by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1112 Roche's Opposition to Amgen's Bench Memorandum That it is Improper for Richard A. Flavell to Offer Opinions That Restate Arguments Rejected by Grant of Summary Judgment That Claim 7 of the '349 Patent is Definite Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denying #1083 Motion to allow Amgen to examine Dr. Caitlin.."see transcript"; finding as moot #1088 Motion for Leave to File; (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #876 Motion in Limine #17 (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Hearing Out of Jury Presence re: Directed Verdict held on 9/24/2007. The Court has the defendant outline the patents, claims and defenses that are at issue for directed verdict purposes. The plaintiff argues and will file a motion for Judgment as Matter of Law. Defendant argues. The Court takes the matter Under Advisement. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Jury Trial Day 9 held on 9/24/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1093 MOTION for Leave to File Amgen's Reply in Further Support of Its Motion in Limine No. 13: to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 876 Motion in Limine #17 (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #1093 MOTION for Leave to File Amgen's Reply in Further Support of Its Motion in Limine No. 13: to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #970 MOTION in Limine to Preclude Amgen from Introducing Evidence Regarding the Safety of Mircera. "Motion allowed without prejudice to Amgen's renewal should Roche - in the infringement phase of the case - bring up supposed improvements in its product." (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Jury Trial Day 9 held on 9/24/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day andD's counsel Ben-Ami are present.Hearing Out of Jury Presence re: Directed Verdict held on 9/24/2007. The Court has the defendant outline the patents, claims and defenses that are at issue for directed verdict purposes. The plaintiff argues and will file a motion for Judgment as Matter of Law. Defendant argues. The Court takes the matter Under Advisement. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 1083 Motion to allow Amgen to examine Dr. Caitlin.."see transcript"; finding as moot 1088 Motion for Leave to File; (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re 970 MOTION in Limine to Preclude Amgen from Introducing Evidence Regarding the Safety of Mircera. "Motion allowed without prejudice to Amgen's renewal should Roche - in the infringement phase of the case - bring up supposed improvements in its product." (Paine, Matthew) |
Filing 1111 Opposition re #1065 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing That Lin Described Human EPO With The 1-165 Amino Acid Residues of Fig. 6 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1110 Opposition re #1066 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing that Examples in the Lin Specification Inherently Produce Human EPO with 165 Amino Acid Residues filed by Amgen Inc.. (Rich, Patricia) |
Filing 1109 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum: Amgen Should be Precluded from Cross-Examining Dr. Bertozzi on Comparisons Between Urinary Epo and Recombinant Epo. (Toms, Keith) |
Filing 1108 Opposition re #1099 MOTION to Quash Subpoena Ad Testificandum Served on Third Party Bruce Spinowitz, M.D. filed by Amgen Inc.. (Rich, Patricia) |
Filing 1107 Roche's Opposition to Amgen's Bench Memorandum Regarding Fritsch Deposition Testimony Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1106 DECLARATION re #1105 MOTION in Limine to Preclude Plaintiff from Arguing to the Jury that Epogen Improves Quality of Life Where the FDA Does Not Support the Inclusion of Such Claims on the Product Label (of Keith E. Toms) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Toms, Keith) Additional attachment(s) added on 9/25/2007 (Paine, Matthew). |
Filing 1105 MOTION in Limine to Preclude Plaintiff from Arguing to the Jury that Epogen Improves Quality of Life Where the FDA Does Not Support the Inclusion of Such Claims on the Product Label by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1104 Opposition re #1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay filed by Amgen Inc.. (Rich, Patricia) |
Filing 1103 Roche's Opposition to Amgen's Bench Memorandum That it is Improper for Dr. Richard A. Flavell to Offer Opinions Based on His Improper Rejection of This Court's Claim Construction of the Term "Human Erythropoietin" Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1102 Roche's Opposition to Amgen's Bench Memorandums (D.I. 1048 and 1049) Regarding the Authentication of a Jan. 11, 1984 Telex and a Jan. 16, 1984 Letter Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1101 Opposition re #1026 MOTION in Limine to Preclude Amgen from Using Alleged Claim Features to Distinguish Prior Art when those Claim Features were Not Proven to Establish Infringement, #1046 MOTION in Limine To Preclude Amgen Inc. From Arguing That Source Limitations Distinguish the Prior Art From Its '422 Patent Claim 1, #1047 MOTION in Limine To Preclude Amgen Inc. From Arguing That Process Limitations Distinguish the Prior Art From Its '933 Product-By-Process Claims filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1100 MEMORANDUM in Support re #1099 MOTION to Quash Subpoena Ad Testificandum Served on Third Party Bruce Spinowitz, M.D. filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1099 MOTION to Quash Subpoena Ad Testificandum Served on Third Party Bruce Spinowitz, M.D. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1098 MOTION in Limine to Preclude Amgen from Introducing the Deposition Testimony of Dr. Edward Harlow, a Roche Expert Witness, Because It Is Irrelevant and Is Inadmissible Hearsay by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1097 Opposition re #1088 MOTION for Leave to File Under Seal Confidential Exhibit Submitted in Connection with Amgens Motion to Remove the Confidential Designation from the June 21, 2007 Deposition Transcript of Roches Expert Dr. Thomas Kadesch filed by Amgen Inc.. (Rich, Patricia) |
Filing 1096 MOTION in Limine To Exclude The Fact Testimony and Expert Testimony of Dr. Catlin On the Basis That Athlete Doping Is Irrelevant To Any Issue In This Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1095 Receipt to Plaintiff Amgen, Inc. for documents received on September 20, 2007. (Paine, Matthew) |
Filing 1094 NOTICE by Amgen Inc. re #1093 MOTION for Leave to File Amgen's Reply in Further Support of Its Motion in Limine No. 13: to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery of Service of Confidential Document (Gottfried, Michael) |
Filing 1093 MOTION for Leave to File Amgen's Reply in Further Support of Its Motion in Limine No. 13: to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery by Amgen Inc.. (Attachments: #1 Exhibit A - [Proposed] Reply#2 Exhibit B - [Proposed] Declaration of Aaron Hand in Support of Reply)(Gottfried, Michael) |
Filing 1092 DECLARATION re #1091 Brief, in Support of Defendants' Bench Memorandum Regarding the Relevance of Baron and Goldwasser's Prior Art and Refuting Amgen's Assertiions that the Baron-Goldwasser IND and Goldwasser Grants are Not "Printed Publications," Anticipatory or Enabling Under 35 U.S.C. Section 102 (by Patricia Carson) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Exhibit 1 part 1 of 14#2 Exhibit Exhibit 1 part 2 of 14#3 Exhibit Exhibit 1 part 3 of 14#4 Exhibit Exhibit 1 part 4 of 14#5 Exhibit Exhibit 1 part 5 of 14#6 Exhibit Exhibit 1 part 6 of 14#7 Exhibit Exhibit 1 part 7 of 14#8 Exhibit Exhibit 1 part 8 of 14#9 Exhibit Exhibit 1 part 9 of 14#10 Exhibit Exhibit 1 part 10 of 14#11 Exhibit Exhibit 1 part 11 of 14#12 Exhibit Exhibit 1 part 12 of 14#13 Exhibit Exhibit 1 part 13 of 14#14 Exhibit Exhibit 1 part 14 of 14#15 Exhibit Exhibit 2 part 1 of 3#16 Exhibit Exhibit 2 part 2 of 3#17 Exhibit Exhibit 2 part 3 of 3#18 Exhibit Exhibit 3 part 1 of 5#19 Exhibit Exhibit 3 part 2 of 5#20 Exhibit Exhibit 3 part 3a of 5#21 Exhibit Exhibit 3 part 3b of 5#22 Exhibit Exhibit 3 part 4 of 5#23 Exhibit Exhibit 3 part 5 of 5#24 Exhibit Exhibit 4#25 Exhibit Exhibit 5#26 Exhibit Exhibit 6#27 Exhibit Exhibit 7 part 1 of 2#28 Exhibit Exhibit 7 part 2 of 2#29 Exhibit Exhibit 8)(Fleming, Thomas) |
Filing 1091 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Bench Memorandum Regarding the Relevance of Baron and Goldwasser's Prior Art and Refuting Amgen's Assertions that the Baron-Goldwasser IND and Goldwasser Grants Are Not "Printed Publications," Anticipatory or Enabling Under 35 U.S.C.Section 102. (Fleming, Thomas) |
Filing 1090 DECLARATION re #1089 Opposition to Motion, Declaration of Alfred H. Heckel in Support of Roche's Opposition to Amgen's Emergency Motion to Allow Amgen to Examine Dr. Don Catlin on Monday, September 24, or in the Alternative to Take Depositon De Bene Esse by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Fleming, Thomas) |
Filing 1089 Opposition re #1083 Emergency MOTION to allow Amgen to Examine Dr. Don Catlin on Monday Setember 24, or in the Alternative to take Deposition De Bene Esse filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 1088 MOTION for Leave to File Under Seal Confidential Exhibit Submitted in Connection with Amgens Motion to Remove the Confidential Designation from the June 21, 2007 Deposition Transcript of Roches Expert Dr. Thomas Kadesch by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1087 Opposition re #1063 MOTION to Remove the "Confidential" Designation from the June 21, 2007 Deposition Transcript of Roche's Expert Dr. Thomas Kadesch filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1086 RESPONSE to Motion re #986 MOTION in Limine No. 23: Exclude Testimony of Daniel Shouval Regarding Erythropoietin-Producing Cell Lines and His Work on EOP MRNA filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1085 DECLARATION re #1083 Emergency MOTION to allow Amgen to Examine Dr. Don Catlin on Monday Setember 24, or in the Alternative to take Deposition De Bene Esse of Jonathan D. Loeb by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Gottfried, Michael) |
Filing 1084 DECLARATION re #1083 Emergency MOTION to allow Amgen to Examine Dr. Don Catlin on Monday Setember 24, or in the Alternative to take Deposition De Bene Esse of Dr. Don H. Catlin by Amgen Inc.. (Gottfried, Michael) |
Filing 1083 Emergency MOTION to allow Amgen to Examine Dr. Don Catlin on Monday Setember 24, or in the Alternative to take Deposition De Bene Esse by Amgen Inc..(Gottfried, Michael) |
Filing 1082 Opposition re #970 MOTION in Limine to Preclude Amgen from Introducing Evidence Regarding the Safety of Mircera filed by Amgen Inc.. (Gottfried, Michael) |
Notice of correction to docket made by Court staff. Docket Entry 1075, Brief- Roche's Response to Amgen's Bench Memorandum Regarding Publication Requirements for Section 102 Prior Art, had the incorrect document attached to the entry and was replaced with the correct document. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Docket Entry 1075, Brief- Roche's Response to Amgen's Bench Memorandum Regarding Publication Requirements for Section 102 Prior Art, had the incorrect document attached to the entry and was replaced with the correct document. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel Ben-Ami are present. Jury Trial DAY 8 held on 9/14/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel Ben-Ami are present. Jury Trial DAY 8 held on 9/14/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1081 Receipt for documents returned on September 14, 2007, to Plaintiff Amgen, Inc.. (Paine, Matthew) |
Filing 1080 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #1079 Declaration of Filing with Clerks Office of Exhibits to the Declaration of Krista M. Rycroft in Support of Defendants' Offer of Proof Regarding the Testimony of Michael Sofocleous (Toms, Keith) |
Filing 1079 DECLARATION re #1078 Brief Offer of Proof Regarding the Testimony of Michael Sofocleous (of Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1078 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Offer of Proof Regarding the Testimony of Michael Sofocleous. (Toms, Keith) |
Filing 1077 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Bench Memorandum of Law on Admission of Mr. Sofocleouss Testimony In the Validity Phase. (Toms, Keith) |
Filing 1076 Receipt to Plaintiff Amgen, Inc. for documents received on September 13, 2007. (Paine, Matthew) |
Filing 1075 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1055 Brief Roche's Response to Amgen's Bench Memorandum Regarding Publication Requirements for Section 102 Prior Art. (Fleming, Thomas) Additional attachment(s) added on 9/17/2007 (Paine, Matthew). |
Filing 1074 Proposed Document(s) submitted by Amgen Inc.. Document received: Supplemental Proposed Jury Instructions and Objections to Roche's Supplemental Proposed Jury Instructions Concerning Source and Process Limitations. (Attachments: #1 Exhibit A)(Rich, Patricia) |
Filing 1073 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. OFFER OF PROOF REGARDING EVIDENCE THAT WAS EXCLUDED AT THE VALIDITY PHASE OF THE TRIAL. (Rizzo, Nicole) |
Filing 1072 DECLARATION re #1071 Brief of Daniel A. Curto in Support of Amgen's Bench Memorandum that it is Improper for Richard A. Flavell to Offer Opinionis that Restate Arguments Rejected by Grant of Summary Judgment that Claim 7 of the '349 Patent is Definite by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1071 BRIEF by Amgen Inc. Bench Memorandum that it is Improper for Richard A. Flavell to Offer Opinions that Restate Arguments Rejected by Grant of Summary Judgment that Claim 7 of the '349 Patent is Definite. (Gottfried, Michael) |
Filing 1070 MOTION for Leave to File A SUR-REPLY IN RESPONSE TO PLAINTIFF AMGEN INC.S PROPOSED REPLY IN FURTHER SUPPORT OF ITS MOTION IN LIMINE NO. 17: TO EXCLUDE ROCHE FROM PRESENTING EVIDENCE TO CHALLENGE THE NON-OBVIOUSNESS OF THE DNA SEQUENCE ENCODING FOR HUMAN ERYTHROPOIETIN IN 1983 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 1069 DECLARATION re #1068 Brief Of Daniel A. Curto in Support of Amgen's Bench Memorandum That it is Improper For Dr. Richard A. Flavell To Offer Opinions Based on his Improper Rejection of This Court's Claim Construction of the term "Human Erythropoietin" by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1068 BRIEF by Amgen Inc. Bench Memorandum That it is Improper For Dr. Richard A. Flavell To Offer Opinions Based on his Improper Rejection of This Court's Claim Construction of the Term "Human Erythropoietin". (Gottfried, Michael) |
Filing 1067 MOTION Omnibus Motion Defendants' Omnibus Motion to Admit Party Admissions and Previous Findings of Fact into Evidence by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1066 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing that Examples in the Lin Specification Inherently Produce Human EPO with 165 Amino Acid Residues by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1065 MOTION in Limine Roche's Motion in Limine to Preclude Amgen from Arguing That Lin Described Human EPO With The 1-165 Amino Acid Residues of Fig. 6 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 1064 NOTICE by Amgen Inc. re #1063 MOTION to Remove the "Confidential" Designation from the June 21, 2007 Deposition Transcript of Roche's Expert Dr. Thomas Kadesch Of Confidential Service (Gottfried, Michael) |
Filing 1063 MOTION to Remove the "Confidential" Designation from the June 21, 2007 Deposition Transcript of Roche's Expert Dr. Thomas Kadesch by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2 - Confidential Exhibit Coversheet#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6, Part One#7 Exhibit 6, Part Two)(Gottfried, Michael) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel Ben-Ami are present. Jury Trial DAY 7 held on 9/12/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :P's counsel Day and D's counsel Ben-Ami are present. Jury Trial DAY 7 held on 9/12/2007. D's evidence continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1062 MEMORANDUM in Support re #1061 MOTION for Reconsideration of the Court's Grant of Summary Judgment of Infringement of '422 Claim 1 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 1061 MOTION for Reconsideration of the Court's Grant of Summary Judgment of Infringement of '422 Claim 1 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 1060 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum: The '008 Patent Claims Are Considered Solely for Purposes of Obviousness-Type Double Patenting and Are Not Prior Art for Obviousness Under 103. (Toms, Keith) |
Filing 1059 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum that Later Admissions that the Structure of Recombinant EPO Is Identical to Prior Art Urinary EPO are Relevant and Admissible. (Toms, Keith) |
Filing 1058 DECLARATION re #1057 Response to Motion of James M. Fraser (leave to file granted 9/7/2007) by Amgen Inc.. (Attachments: #1 Exhibit 1)(Gottfried, Michael) |
Filing 1057 Supplemental RESPONSE to Motion re #724 MOTION Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses (leave to file granted on 9/7/2007) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1056 BRIEF by Amgen Inc. Bench Memorandum Regarding Relevance of Dr. Baron and Dr. Goldwasser's Failure to Publish Their Work. (Gottfried, Michael) |
Filing 1055 BRIEF by Amgen Inc. Bench Memorandum Regarding Publication Requirements for Section 102 Prior Art. (Attachments: #1 Attachment 1#2 Attachment 2#3 Attachment 3#4 Attachment 4#5 Attachment 5)(Gottfried, Michael) |
Filing 1054 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #1042 Brief Thomas Fleming. (Fleming, Thomas) |
Filing 1053 DECLARATION re #1049 Brief of Kevin M. Flowers Regarding Genetics Insitute Doucments by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Rich, Patricia) |
Filing 1052 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Thomas F. Fleming. (Fleming, Thomas) |
Filing 1051 DECLARATION re #1048 Brief, #1049 Brief of Aaron R. Hand in Support of Amgen Inc.'s Bench Memoranda Regarding the Authntication of January 11, 1984 Telex & January 16, 1984 Letter by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8)(Rich, Patricia) |
Filing 1050 DECLARATION re #1048 Brief, #1049 Brief of Cherie St. Jean in Support of Amgen Inc.'s Bench Memoranda Regarding The Authentication of January 11, 1984 Telex and January 16, 1984 Letter by Amgen Inc.. (Rich, Patricia) |
Filing 1049 BRIEF by Amgen Inc. Bench Memorandum Regarding Authentication of January 16, 1984 Letter. (Rich, Patricia) |
Filing 1048 BRIEF by Amgen Inc. Bench Memorandum Regarding Authentication of January 11, 1984 Telex. (Rich, Patricia) Additional attachment(s) added on 9/12/2007 (Paine, Matthew). |
Notice of correction to docket made by Court staff. Docket Entry (1048) Bench Memorandum Regarding Authentication of January 11, 1984 Telex Had Typographical Errors and Was Replaced With a Corrected Version on the Docket. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Hearing Out of Jury Presence held on 9/11/2007.Hearing held re: documents. Court excludes Ex. OUX except for pgs. Bate Stamped 3--9,3050,3054,3059. Those pages are admitted as Ex. 2055. Hearing on Motion #1026. Motion taken Under Advisement. Amgen address issues re: Dr. Lin. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 6 held on 9/11/2007. Defendant's evidence re: obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 6 held on 9/11/2007. Defendant's evidence re: obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Hearing Out of Jury Presence held on 9/11/2007.Hearing held re: documents. Court excludes Ex. OUX except for pgs. Bate Stamped 3--9,3050,3054,3059. Those pages are admitted as Ex. 2055. Hearing on Motion #1026. Motion taken Under Advisement. Amgen address issues re: Dr. Lin. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1047 MOTION in Limine To Preclude Amgen Inc. From Arguing That Process Limitations Distinguish the Prior Art From Its '933 Product-By-Process Claims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1046 MOTION in Limine To Preclude Amgen Inc. From Arguing That Source Limitations Distinguish the Prior Art From Its '422 Patent Claim 1 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1045 Letter/request (non-motion) from Lloyd R. Day, Jr.. (Rich, Patricia) |
Filing 1044 BRIEF by Amgen Inc. Bench Memorandum Regarding Inadmissibility of Documents Relevant Only To Allegations Of Inequitable Conduct That Were Not Plead By Roche. (Gottfried, Michael) |
Filing 1043 BRIEF by Amgen Inc. Bench Memorandum Excluding Evidence Regarding Amgen's Clinical Trial and Other Evidence that Roche Intends to Proffer During the Testimony of Dr. Spinowitz. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 1042 BRIEF by Amgen Inc. Bench Memorandum Regarding Eliciting From Dr. Lin Evidence That Violates 35 USC Sec. 103 Statutory Prohibition. (Gottfried, Michael) |
Filing 1041 BRIEF by Amgen Inc. Bench Memorandum Regarding Dr. Lin's Subjective Expectations as Irrelevant to Proper Obviousness Inquiry. (Gottfried, Michael) |
Filing 1040 BRIEF by Amgen Inc. Bench Memorandum Regarding the Relevance and Admissibility of Genentech's 1986 PLA. (Attachments: #1 Attachment A)(Gottfried, Michael) |
Filing 1039 Letter/request (non-motion) from Leora Ben-Ami. (Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered denying #808 Motion in Limine "Motion denied at this level of generality, without prejudice to objection to specific questions. Amgen is, of course, bound by its declarations as to prior art in its patents." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying as moot 1009 Motion in Limine; granting 1028 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying as moot #1009 Motion in Limine; granting #1028 Motion in Limine (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 808 Motion in Limine "Motion denied at this level of generality, without prejudice to objection to specific questions. Amgen is, of course, bound by its declarations as to prior art in its patents." (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Hearing Out of Jury Presence held on 9/10/2007. The Court informs counsel that a juror has called with a personal problem that may require her to be excused. After discussion, counsel prefer to wait some time and keep the juror. After hearing, the court learns of the unavailability of the juror today and decides to release the juror.Counsel concur. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present. Jury Trial Day 5 held on 9/10/2007. Defendant's evidence as to obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Hearing Out of Jury Presence held on 9/10/2007. The Court informs counsel that a juror has called with a personal problem that may require her to be excused. After discussion, counsel prefer to wait some time and keep the juror. After hearing, the court learns of the unavailability of the juror today and decides to release the juror.Counsel concur. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present. Jury Trial Day 5 held on 9/10/2007. Defendant's evidence as to obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1038 DECLARATION re #1036 MOTION in Limine to Bind Amgen Inc. to Prior Admissions Relevant to Double Patenting (of Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1 (Part 1 of 4)#2 Exhibit 1 (Part 2 of 4)#3 Exhibit 1 (Part 3 of 4)#4 Exhibit 1 (Part 4 of 4))(Toms, Keith) |
Filing 1037 MEMORANDUM in Support re #1036 MOTION in Limine to Bind Amgen Inc. to Prior Admissions Relevant to Double Patenting filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1036 MOTION in Limine to Bind Amgen Inc. to Prior Admissions Relevant to Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1035 Response by Amgen Inc. to #1020 Brief, or Roche's Offer of Proof Regarding Claims of US Patent No. 5,441,868 and no. 5.618,698 That Invalidate Claims of US Patent NO. 5,547,933, No. 5,756,349, and No. 5,955,422 Regarding Obviousness-Type Double Patenting. (Gottfried, Michael) |
Filing 1034 RESPONSE to Motion re #1005 MOTION in Limine to Preclude Amgen from Asserting that there Was a Restriction Requirement Separating the '008 Patent Claims From the Claims of the '868 and '698 Patents filed by Amgen Inc.. (Rich, Patricia) |
Filing 1033 REPLY to Response to Motion re #965 Emergency MOTION For an Order Precluding Roche from Arguing that the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and '698 Patent Claims (leave to file granted on September 10, 2007) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1032 REPLY to Response to Motion re #931 MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit (Leave to File Granted on September 10, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1031 BRIEF by Amgen Inc. Bench Memorandum Regarding Fritsch Deposition Testimony and Request for Corrective Instruction. (Attachments: #1 Attachment A#2 Attachment B#3 Attachment C)(Rich, Patricia) |
Filing 1030 Supplemental Proposed Jury Instructions by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Jury Instructions: Product-By-Process Claims))(Toms, Keith) |
Filing 1029 MEMORANDUM in Support re #1028 MOTION in Limine to Preclude Plaintiff from Arguing that the Goldwasser Clinical Study Is Not Prior Art filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1028 MOTION in Limine to Preclude Plaintiff from Arguing that the Goldwasser Clinical Study Is Not Prior Art by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1027 MEMORANDUM in Support re #1026 MOTION in Limine to Preclude Amgen from Using Alleged Claim Features to Distinguish Prior Art when those Claim Features were Not Proven to Establish Infringement filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1026 MOTION in Limine to Preclude Amgen from Using Alleged Claim Features to Distinguish Prior Art when those Claim Features were Not Proven to Establish Infringement by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 1025 Opposition re #1009 MOTION in Limine No. 25: Exclude Deposition Testimony From A Prior Litigation of Takaji Miyake, A Non-Party Witness Whom Roche Did Not Previously Disclose filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 1024 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Addition to Bench Memorandum Regarding Relevance and Admissibility of Genentech's PLA). (Attachments: #1 Exhibit A#2 Exhibit B)(Toms, Keith) |
Filing 1023 Letter/request (non-motion) from Leora Ben-Ami. (Fleming, Thomas) |
Filing 1022 Objection by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Objections to the Court's September 7, 2007 Order That the Issue of Obviousness-Type Double Patenting is a Matter of Law that it is Not to be Presented to the Jury. (Fleming, Thomas) |
Judge William G. Young : Electronic ORDER entered granting 1019 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen From Introducing Into Evidence or Referencing to the Jury: 1) the September 30, 1985 Amgen/Ortho Product License Agreement, and 2) Evidence Concerning Licensing of the Patents-In-Suit; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 1015 MOTION for Leave to File a Reply in Further Support of Its Emergency Motion for Order Precluding Roche from Arguing That the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and "698 Patent Claims; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1019 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen From Introducing Into Evidence or Referencing to the Jury: 1) the September 30, 1985 Amgen/Ortho Product License Agreement, and 2) Evidence Concerning Licensing of the Patents-In-Suit; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #1015 MOTION for Leave to File a Reply in Further Support of Its Emergency Motion for Order Precluding Roche from Arguing That the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and "698 Patent Claims; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 1021 Objection by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. To The Court's Preliminary Jury Instructions. (Fleming, Thomas) |
Filing 1020 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Offer Of Proof Regarding Claims Of U.S. Patent No. 5,441,868 And No. 5,618,698 That Invalidate Claims Of U.S. Patent No. 5,547,933, No. 5,756,349, And No. 5,955,422 Regarding Obviousness-Type Double Patenting. (Toms, Keith) |
Filing 1019 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen From Introducing Into Evidence or Referencing to the Jury: 1) the September 30, 1985 Amgen/Ortho Product License Agreement, and 2) Evidence Concerning Licensing of the Patents-In-Suit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Seluga, Kimberly) |
Filing 1017 Receipt to Defendants Roche for Document(s) received on September 6, 2007. (Paine, Matthew) |
Filing 1016 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Roche's Bench Memorandum Regarding Excluding from the Courtroom Expert Witnesses who Will be Opening with Respect to the Testimony of Other Witnesses. (Fleming, Thomas) |
Filing 1015 MOTION for Leave to File a Reply in Further Support of Its Emergency Motion for Order Precluding Roche from Arguing That the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and "698 Patent Claims by Amgen Inc.. (Attachments: #1 Exhibit A - Amgen's [Proposed] Reply)(Gottfried, Michael) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Yu are present.Hearing Out of Jury Presence re: admittance of evidence held on 9/7/2007. After hearing the Court makes rulings re: issue of double patenting. The issue is a matter of law and is not to be tried to the jury. No further evidence re: double patenting is to be presented to the jury. The Court will receive briefing on the matter. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Yu are present.Hearing Out of Jury Presence re: admittance of evidence held on 9/7/2007. After hearing the Court makes rulings re: issue of double patenting. The issue is a matter of law and is not to be tried to the jury. No further evidence re: double patenting is to be presented to the jury. The Court will receive briefing on the matter. (Court Reporter Womack.) (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Docket Entry 1015 Motion to Leave to File Was Filed in Error By the Attorney and is a Duplicate of Docket Entry 1014 . Please Refer to Docket Entry 1014 for the Correct Motion for Leave to File. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 1012 Motion for Reconsideration of the Court's Ruling with respect to one deposition designation for Joseph M.Baron."Motion denied, not to exalt finality but because the testimony,in context,is impermissibly vague." (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 4 held on 9/7/2007. Defendant's evidence as to obviousness continues.(Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting "MOTION ALLOWED. DENNIS FENTON MAY NOT TESTIFY, HOWEVER, DUE TO HIS LAE DISCLOSURE." 870 Motion for Leave to File Supplememntal Memorandum re: dfts' Motin to Preclude Testimony from Belatedly Disclosed Fact Witnesses and Declaration in support Thereof; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #1012 Motion for Reconsideration of the Court's Ruling with respect to one deposition designation for Joseph M.Baron."Motion denied, not to exalt finality but because the testimony,in context,is impermissibly vague." (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defendant's counsel Ben-Ami are present.Jury Trial Day 4 held on 9/7/2007. Defendant's evidence as to obviousness continues.(Court Reporter Womack.) (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Docket Entry #1015 Motion to Leave to File Was Filed in Error By the Attorney and is a Duplicate of Docket Entry #1014 . Please Refer to Docket Entry #1014 for the Correct Motion for Leave to File. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting "MOTION ALLOWED. DENNIS FENTON MAY NOT TESTIFY, HOWEVER, DUE TO HIS LAE DISCLOSURE." #870 Motion for Leave to File Supplememntal Memorandum re: dfts' Motin to Preclude Testimony from Belatedly Disclosed Fact Witnesses and Declaration in support Thereof; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plaintiff counsel Day and Defense counsel Ben-Ami are present in the courtroom. denying #997 Motion in Limine; Jury Trial DAY 3 held on 9/6/2007.Defense evidence re: obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Gottfried and Defense counsel Fleming are present.Hearing Out of Jury Presence re: rulings on the deposition designations held on 9/6/2007. The Court will review the designations once the parties submit written revisions. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Gottfried and Defense counsel Fleming are present.Hearing Out of Jury Presence re: rulings on the deposition designations held on 9/6/2007. The Court will review the designations once the parties submit written revisions. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young :Plaintiff counsel Day and Defense counsel Ben-Ami are present in the courtroom. denying 997 Motion in Limine; Jury Trial DAY 3 held on 9/6/2007.Defense evidence re: obviousness continues. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 1014 MOTION for Leave to File A REPLY IN FURTHER SUPPORT OF ITS EMERGENCY MOTION FOR ORDER PRECLUDING ROCHE FROM ARGUING THAT THE 933, 422 AND 349 PATENTENT CLAIMS ARE INVALID FOR OBVIOUSNESS-TYPE DOUBLE PATENTING OVER THE 868 AND 698 PATENT CLAIMS by Amgen Inc.. (Attachments: #1 Exhibit A (proposed reply))(Rich, Patricia) |
Filing 1013 NOTICE by Amgen Inc. of Intent to Present Live Testimony of Dr. Strickland in Response to Roche's Deposition Designations (Gottfried, Michael) |
Filing 1012 MOTION for Reconsideration of the Court's Ruling with Respect to One Deposition Designation for Joseph M. Baron by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1011 DECLARATION of Aaron R. Hand, Esq. In Support of Amgen Inc.'s Motion In Limine No. 25: Exclude Deposition Testimony From a Prior Litigation of Takaji Miyake, A Non-Party Witness Whom Roche did Not Previously Disclose by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4)(Gottfried, Michael) |
Filing 1010 MEMORANDUM in Support re #1009 MOTION in Limine No. 25: Exclude Deposition Testimony From A Prior Litigation of Takaji Miyake, A Non-Party Witness Whom Roche Did Not Previously Disclose filed by Amgen Inc.. (Gottfried, Michael) |
Filing 1009 MOTION in Limine No. 25: Exclude Deposition Testimony From A Prior Litigation of Takaji Miyake, A Non-Party Witness Whom Roche Did Not Previously Disclose by Amgen Inc..(Gottfried, Michael) |
Filing 1008 MOTION for Leave to File a Reply in Further Support of Its Motion In Limine No. 3 To Exclude References to Belatedly Produced Documents and Experiments from Barber by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 1007 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #1005 MOTION in Limine to Preclude Amgen from Asserting that there Was a Restriction Requirement Separating the '008 Patent Claims From the Claims of the '868 and '698 Patents (Notice of Service of Confidential Documents) (Seluga, Kimberly) |
Filing 1006 MEMORANDUM in Support re #1005 MOTION in Limine to Preclude Amgen from Asserting that there Was a Restriction Requirement Separating the '008 Patent Claims From the Claims of the '868 and '698 Patents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D (Part 1 of 3)#5 Exhibit D (Part 2 of 3)#6 Exhibit D (Part 3 of 3)#7 Exhibit E)(Seluga, Kimberly) |
Filing 1005 MOTION in Limine to Preclude Amgen from Asserting that there Was a Restriction Requirement Separating the '008 Patent Claims From the Claims of the '868 and '698 Patents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 1004 Letter/request (non-motion) from Lloyd Day regarding Ben Ami letter of 9/5/07 [DN 996]. (Rich, Patricia) |
Filing 1003 MOTION for Leave to File a Reply and Declaration in Further Support of Amgen's Motion in Limine 17: To Exlcude Roche From Presenting Evidence to Challenge the Non-Obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983 by Amgen Inc.. (Attachments: #1 Exhibit A (proposed reply brief)#2 Exhibit B (Proposed William Gaede Declaration in Support of Reply)#3 (Exhibit 1 to Proposed Gaede Declaration)#4 (Exhibit 2 to Proposed Gaede Declaration)#5 Exhibit 3 to Proposed Gaede Declaration#6 Exhibit 4 to Proposed Gaede Declaration)(Gottfried, Michael) |
Filing 1002 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Bench Memorandum on Binding Effect of Representations in the Patent Specification. (Fleming, Thomas) |
Filing 1001 Opposition re #997 MOTION in Limine to Preclude Evidence for Obviousness that Violates 35 USC Sec. 103 Prohibition that "Patentability Shall Not be Negatived By the Manner in Which the Invention was Made" and Which Reflects the Subjective Beliefs of the Inv filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 1000 Opposition re #908 MOTION for Reconsideration (Partial) of the Court's August 27, 2007 Order Regarding Obviousness-Type Double Patenting of Claim 7 of the '349 Patent MOTION for Reconsideration (Partial) of the Court's August 27, 2007 Order Regarding Obviousness-Type Double Patenting of Claim 7 of the '349 Patent filed by Amgen Inc.. (Rich, Patricia) |
Filing 999 DECLARATION re #997 MOTION in Limine to Preclude Evidence for Obviousness that Violates 35 USC Sec. 103 Prohibition that "Patentability Shall Not be Negatived By the Manner in Which the Invention was Made" and Which Reflects the Subjective Beliefs of the Inv, #998 Memorandum in Support of Motion, By WILLIAM G. GAEDE, III by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6)(Gottfried, Michael) |
Filing 998 MEMORANDUM in Support re #997 MOTION in Limine to Preclude Evidence for Obviousness that Violates 35 USC Sec. 103 Prohibition that "Patentability Shall Not be Negatived By the Manner in Which the Invention was Made" and Which Reflects the Subjective Beliefs of the Inv filed by Amgen Inc.. (Gottfried, Michael) |
Filing 997 MOTION in Limine to Preclude Evidence for Obviousness that Violates 35 USC Sec. 103 Prohibition that "Patentability Shall Not be Negatived By the Manner in Which the Invention was Made" and Which Reflects the Subjective Beliefs of the Inventor by Amgen Inc..(Gottfried, Michael) |
Filing 996 Letter/request (non-motion) from Leroa BenAmi. (Fleming, Thomas) |
Notice of correction to docket made by Court staff. Docket Entries 966 and 980 Had Typographical Errors and Were Replaced With Corrected Copies. Docket Entry 939 Had The Incorrect Document Attached to the Entry and Was Replaced With The Correct Document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying as moot 252 Motion for Leave to File; ; denying as moot 173 Motion to Compel (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 824 Motion in Limine; denying without prejudice 828 Motion in Limine; denying without prejudice 843 Motion in Limine; denying without prejudice 871 Motion in Limine (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day, D's counsel Ben-Ami are present in the courtroom.Jury Trial DAY 2 held on 9/5/2007. The Court gives a pretrial charge. Opening remarks by Defendant, by Plaintiff. Defendant's evidence re: obviousness commences. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day, D's counsel Ben-Ami are present in the courtroom.Jury Trial DAY 2 held on 9/5/2007. The Court gives a pretrial charge. Opening remarks by Defendant, by Plaintiff. Defendant's evidence re: obviousness commences. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying as moot #252 Motion for Leave to File; ; denying as moot #173 Motion to Compel (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #824 Motion in Limine; denying without prejudice #828 Motion in Limine; denying without prejudice #843 Motion in Limine; denying without prejudice #871 Motion in Limine (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Docket Entries #966 and #980 Had Typographical Errors and Were Replaced With Corrected Copies. Docket Entry #939 Had The Incorrect Document Attached to the Entry and Was Replaced With The Correct Document. (Paine, Matthew) |
Filing 1018 Questionnaire submitted to prospective jurors prior to the start of empanelment. (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day, D's counsel Ben-Ami are present. The Court rules on certain Motions in Limine as follows:denying without prejudice #801 Motion in Limine; granting wothout prejudice #804 Motion in Limine; denying #822 Motion in Limine; granting #837 Motion in Limine; denying #839 Motion in Limine; granting #847 Motion in Limine; denying #873 Motion in Limine; granting #886 Motion in Limine; denying #889 Motion in Limine; denying #901 Motion for Order; granting #921 Motion in Limine; granting #927 Motion in Limine; denying #981 Motion to Dismiss for Lack of Jurisdiction; Jury Trial DAY 1 held on 9/4/2007. The Court issues a questionnaire as to hardship to the prospective jurors. The Court strikes jurors for cause. The Court addresses the venire. Voir dire conducted. Jury of 12 selected and Sworn.(Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : P's counsel Day, D's counsel Ben-Ami are present. The Court rules on certain Motions in Limine as follows:denying without prejudice 801 Motion in Limine; granting wothout prejudice 804 Motion in Limine; denying 822 Motion in Limine; granting 837 Motion in Limine; denying 839 Motion in Limine; granting 847 Motion in Limine; denying 873 Motion in Limine; granting 886 Motion in Limine; denying 889 Motion in Limine; denying 901 Motion for Order; granting 921 Motion in Limine; granting 927 Motion in Limine; denying 981 Motion to Dismiss for Lack of Jurisdiction; Jury Trial DAY 1 held on 9/4/2007. The Court issues a questionnaire as to hardship to the prospective jurors. The Court strikes jurors for cause. The Court addresses the venire. Voir dire conducted. Jury of 12 selected and Sworn.(Court Reporter Womack.) (Smith, Bonnie) |
Filing 995 DECLARATION re #994 Memorandum in Opposition to Motion, for Order Precluding Roche from Arguing that the '933, 422, and '349 Patent Claims Are Invalid for Obviousness-Type Double Patenting Over the '868 and '698 Patents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Brooks, Kregg) |
Filing 994 MEMORANDUM in Opposition re #965 Emergency MOTION For an Order Precluding Roche from Arguing that the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and '698 Patent Claims filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 993 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #896 Opposition to Motion, (AMGENS CROSS-MOTION TO PRECLUDE ROCHE FROM INTRODUCING THE STATEMENTS LISTED IN EXHIBIT A OF ITS MOTION IN LIMINE TO INVOKE ISSUE PRECLUSION AS TO FINDINGS FROM PRIOR LITIGATION). (Murphy, Timothy) |
Filing 992 Letter/request (non-motion) from Craig H. Casebeer. (Rich, Patricia) |
Filing 991 Opposition re #860 MOTION in Limine No. 14: Exclude PEG-EPO Experiments Conducted by Cords and Criticism of Amgen's Failure to Test Peg-Epo Based Upon Roche's Failure to Produce a Sample of PEG-EPO filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Seluga, Kimberly) |
Filing 990 DECLARATION re #989 Memorandum in Opposition to Motion, in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media (by Kregg T. Brooks) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Brooks, Kregg) |
Filing 989 MEMORANDUM in Opposition re #832 MOTION in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 988 Receipt to Defendant Roche for documents received on August 31, 2007. (Paine, Matthew) |
Filing 987 MEMORANDUM in Support re #986 MOTION in Limine No. 23: Exclude Testimony of Daniel Shouval Regarding Erythropoietin-Producing Cell Lines and His Work on EOP MRNA filed by Amgen Inc.. (Gottfried, Michael) |
Filing 986 MOTION in Limine No. 23: Exclude Testimony of Daniel Shouval Regarding Erythropoietin-Producing Cell Lines and His Work on EOP MRNA by Amgen Inc..(Gottfried, Michael) |
Filing 985 DECLARATION re #983 Opposition to Motion,, OF WILLIAM G. GAEDE, III IN SUPPORT OF AMGEN'S OPPOSITION TO DEFENDANTS' MOTION IN LIMINE TO PRECLUDE AMGEN FROM PRESENTING EVIDENCE REGARDING (1) A 1993 SETTLEMENT AGREEMENT BETWEEN AMGEN AND GENETICS INSTITUTE AND (2) A 1989 DECISION THAT GENETICS INSTITUTE USED CELLS THAT INFRINGED THE '008 PATENT by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Gottfried, Michael) |
Filing 984 Objection to #947 Proposed Document(s) submitted by Amgen Inc. = Amgen's Objections to Defendants' [Proposed] Pre-Trial Jury Instructions. (Gottfried, Michael) |
Filing 983 Opposition re #837 MOTION in Limine to Preclude Amgen from Presenting Evidence Regarding (1) A 1993 Settlement Agreement Between Amgen and Genetics Institute and (2) A 1989 Decision that Genetics Institute Used Cells that Infringed the '008 Patent MOTION in Limine to Preclude Amgen from Presenting Evidence Regarding (1) A 1993 Settlement Agreement Between Amgen and Genetics Institute and (2) A 1989 Decision that Genetics Institute Used Cells that Infringed the '008 Patent filed by Amgen Inc.. (Gottfried, Michael) |
Filing 982 AFFIDAVIT in Support re #981 Emergency MOTION to Dismiss for Lack of Jurisdiction (FOR LACK OF SUBJECT MATTER JURISDICTION) BY PATRICIA R. RICH. (Attachments: #1 Exhibit A)(Rich, Patricia) |
Filing 981 Emergency MOTION to Dismiss for Lack of Jurisdiction (FOR LACK OF SUBJECT MATTER JURISDICTION) by Amgen Inc..(Rich, Patricia) |
Filing 980 NOTICE by Amgen Inc. COVENANT NOT TO SUE PLAINTIFF FOR INFRINGEMENT OF CLAIMS 4 AND 5 OF THE '698 PATENT (Rich, Patricia) Additional attachment(s) added on 9/5/2007 (Paine, Matthew). |
Filing 979 MOTION for Leave to File Reply In Further Support of Its Motion In Limine No. 6: To Exclude Reference to Amgen's Request for Injunctive Relief by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Gottfried, Michael) |
Filing 978 MOTION for Leave to File a Reply Brief in Support of its Motion in Limine NO. 16: Exclude Sofocleous Testimony Regarding the Competence of the Examination Process in the U.S. Patent & Trademark Office by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Gottfried, Michael) |
Filing 977 MOTION for Leave to File a Reply in Further Support of Its Motion In LImine No. 1: To Exclude Roche from Referring to Its Own Patent on Pegylated Erythropoietin by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Gottfried, Michael) |
Filing 976 Opposition re #863 MOTION in Limine No. 15: Exclude Testimony of Roche's In-House Counsel George Johnston Because HisTestimony is Irrelevant and Roche Failed to Identify His Testimony Pursuant to Fed. R. Civ. P. 26(a) During Discovery MOTION in Limine No. 15: Exclude Testimony of Roche's In-House Counsel George Johnston Because HisTestimony is Irrelevant and Roche Failed to Identify His Testimony Pursuant to Fed. R. Civ. P. 26(a) During Discovery filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 975 Opposition re #931 MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit filed by Amgen Inc.. (Gottfried, Michael) |
Filing 974 MOTION for Leave to File to File a Surreply to Roche's Motion in Limine [DN 811] to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Surreply))(Gottfried, Michael) |
Filing 973 Opposition re #927 MOTION in Limine to Preclude Mention of The Court's Grant of Summary Judgment of Infringment of U.S. Patent No. 5,955,422 or on Issues of Validity filed by Amgen Inc.. (Gottfried, Michael) |
Filing 972 Opposition re #856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 971 MEMORANDUM in Support re #970 MOTION in Limine to Preclude Amgen from Introducing Evidence Regarding the Safety of Mircera filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 970 MOTION in Limine to Preclude Amgen from Introducing Evidence Regarding the Safety of Mircera by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 969 DECLARATION re #968 Opposition to Motion OF DANIEL A. CURTO IN SUPPORT OF AMGEN'S OPPOSITION TO ROCHE'S MOTION IN LIMINE TO PRECLUDE TESTIMONY OF PROPOSED AMGEN WITNESS NANCY SPAETH by Amgen Inc.. (Attachments: #1 Exhibit 1)(Gottfried, Michael) |
Filing 968 Opposition re #873 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth filed by Amgen Inc.. (Gottfried, Michael) |
Filing 967 MOTION for Leave to File a Sur-Reply to Defendants' Reply in Support of its Motion in Limine [DN 814] to Preclude Plaintiff from Offering into Evidence or Referencing to the Jury the June 2001 Settlement Agreement by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Sur-Reply))(Gottfried, Michael) |
Filing 966 MOTION for Leave to File Reply in Further Support of Its Motion in Limine No. 20 [DN 886]: Preclude Roche From Making Statements Regarding the Duration of Amgen's Patent Protection by Amgen Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Gottfried, Michael) Additional attachment(s) added on 9/5/2007 (Paine, Matthew). |
Filing 965 Emergency MOTION For an Order Precluding Roche from Arguing that the '933, '422 and '349 Patent Claims are Invalid for Obviousness-Type Double Patenting Over the '868 and '698 Patent Claims by Amgen Inc..(Gottfried, Michael) |
Filing 964 DECLARATION re #963 Opposition to Motion OF AARON R. HAND by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9)(Gottfried, Michael) |
Filing 963 Opposition re #936 MOTION in Limine to Preclude Plaintiff from Objecting to Deposition Designations in Lieu of Live Testimony filed by Amgen Inc.. (Gottfried, Michael) |
Filing 962 Opposition re #835 MOTION in Limine to Preclude Amgen from Arguing that the Manufacture of CERA or MIRCERA Outside of the United States is in Any Way Improper and from Relying Upon Roche's Status as a Foreign Company filed by Amgen Inc.. (Gottfried, Michael) |
Filing 961 Opposition re #929 MOTION in Limine to Preclude Plaintiff from Referring to Its Inventions as "Pioneering" filed by Amgen Inc.. (Gottfried, Michael) |
Filing 960 EXHIBIT Exhibits A, B, C, and D to Amgen's Opposition to Defendants' Emergency Motion for Order Precluding Amgen from Advertising in Eastern Massachusetts Now and During trial [DN 957] by Amgen Inc.. (Attachments: #1 Exhibit B#2 Exhibit C#3 Exhibit D)(Gottfried, Michael) |
Filing 959 NOTICE by Amgen Inc. re #957 Opposition to Motion (Notice of Filing with Clerk's Office of Exhibit B to Amgen Inc.'s Opposition to Defendant's Emergency Motion for Order Precluding Amgen from Advertising in Eastern Massachusetts Now and During Trial) (Gottfried, Michael) |
Filing 958 Opposition re #871 MOTION in Limine No. 19: Exclude Expert Testimony For Supplementation in Violation of the Parties' June 6, 2007, Agreement filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 957 Opposition re #901 Emergency MOTION for Order to Preclude Amgen from Advertising in Eastern Massachusetts Now and During Trial filed by Amgen Inc.. (Gottfried, Michael) |
Filing 956 Letter/request (non-motion) from Craig H. Casebeer. (Attachments: #1 Appendix A (copies of slides referenced in letter))(Rich, Patricia) |
Filing 955 Amended MEMORANDUM in Support re #936 MOTION in Limine to Preclude Plaintiff from Objecting to Deposition Designations in Lieu of Live Testimony filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 954 MOTION for Leave to File Reply in Further Support of Roche's Motion in Limine to Preclude Amgen from Offering Expert Opinions Based on Statements Made During Prior Legal Proceedings by Witnesses Who Will Not Testify at Trial in this Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Rizzo, Nicole) |
Filing 953 MEMORANDUM in Opposition re #889 MOTION in Limine No. 18: Preclude Roche From Referring to Government Funding of Dr. Goldwasser's Research and From Arguing that Dr. Goldwasser's Research Should Not Have Been Shared With Amgen filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 952 MOTION for Leave to File a Reply in Further Support of Their Motion In Limine to Invoke Issue Preclusion as to Findings From Prior Litigation by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Murphy, Timothy) |
Filing 951 Objection to #918 Proposed Document(s) submitted by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. - Defendants' Objections to Amgen's Proposed Pre-Trial Jury Instructions. (Huston, Julia) |
Filing 950 MEMORANDUM in Opposition re #847 MOTION in Limine No. 12: Exclude Reference to Amgen's "Monopoly" and the Patents-in-Suit as Limiting Consumer Choice filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 949 MEMORANDUM in Opposition re #841 MOTION in Limine No. 8: Exclude Roche from Relying on Comparisons Between Roche's PEG-EPO Product and Amgen's ARANESP Product filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 948 MOTION for Leave to File a Reply in Further Support of Their Motion In Limine to Preclude Amgen from Confusing the Jury with Statements Made in Earlier Foreign Proceedings by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Seluga, Kimberly) |
Filing 947 Proposed Document(s) submitted by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. Document received: Defendants' Proposed Preliminary Jury Instructions. (Huston, Julia) |
Filing 946 Opposition re #891 MOTION in Limine No. 21: Exclude Introduction of Opinions or Supporting Evidence Not Previously Identified in Expert Reports filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 945 Opposition re #843 MOTION in Limine No. 9: Exclude the Testimony of Roche's Experts Kadesch and Lowe Regarding Protein Sequencing Due to Their Lack of Expertise filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 944 Opposition re #854 MOTION in Limine No. 10: Exclude Evidence Related to Roche's Antitrust Allegations filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 943 Opposition re #839 MOTION in Limine No. 6: Exclude Reference to Amgen's Request for Injunctive Relief filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 942 Opposition re #828 MOTION in Limine No. 4: Exclude Genetech's PLA Filing [Roche Trial Exh. No. 1072] Because it is not Prior Art filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 941 DECLARATION re #940 Opposition to Motion in Limine No. 3 to Exclude References to Belatedly Produced Documents and Experiments from Barber by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Fleming, Thomas) |
Filing 940 Opposition re #830 MOTION in Limine No. 3: Exclude References to Belatedly Produced Documents and Experiments from Barber filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 939 Opposition re #826 MOTION in Limine No. 2: Exclude Reference to Allegations Against Amgen's Witness Made in Unrelated Securities Litigation filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) Additional attachment(s) added on 9/5/2007 (Paine, Matthew). |
Filing 938 Opposition re #824 MOTION in Limine No. 1: Exclude Roche from Referring to Its Own Patent on Pegylated Erythropoietin filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 937 MEMORANDUM in Support re #936 MOTION in Limine to Preclude Plaintiff from Objecting to Deposition Designations in Lieu of Live Testimony filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 936 MOTION in Limine to Preclude Plaintiff from Objecting to Deposition Designations in Lieu of Live Testimony by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 935 CORRECTED Letter/request (non-motion) from Lee Carl Bromberg. (Bromberg, Lee) |
Filing 934 MOTION for Leave to File a Reply in Support of Its Motion In Limine to Preclude Amgen Inc. from Making Assertions that Contradict Statements Made in the Specifications of the Patents-In-Suit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Brooks, Kregg) |
Filing 933 Letter/request (non-motion) from Lee Carl Bromberg. (Bromberg, Lee) |
Filing 932 MEMORANDUM in Support re #931 MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 931 MOTION in Limine to Preclude Amgen from Introducing into Evidence or Referencing to the Jury: (1) The September 30, 1985 Amgen/Ortho Product License Agreement, and (2) Evidence Concerning Licensing of the Patents-In-Suit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 930 MEMORANDUM in Support re #929 MOTION in Limine to Preclude Plaintiff from Referring to Its Inventions as "Pioneering" filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 929 MOTION in Limine to Preclude Plaintiff from Referring to Its Inventions as "Pioneering" by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 928 MEMORANDUM in Support re #927 MOTION in Limine to Preclude Mention of The Court's Grant of Summary Judgment of Infringment of U.S. Patent No. 5,955,422 or on Issues of Validity filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 927 MOTION in Limine to Preclude Mention of The Court's Grant of Summary Judgment of Infringment of U.S. Patent No. 5,955,422 or on Issues of Validity by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 926 DECLARATION Of William G. Gaede in Support of Amgen Inc.'s Motion In Limine No. 22 to Preclude Roche from Introducing, Including in its Invalidity Opening, Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude Any Proffered Testimony by Dr. Robert Langer During the Trial by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3-1#4 Exhibit 3-2#5 Exhibit 4)(Gottfried, Michael) |
Filing 925 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #924 Declaration, of Kregg T. Brooks - Service of Confidential Exhibits (Brooks, Kregg) |
Filing 924 DECLARATION re #923 Memorandum in Opposition to Motion, in Limine No. 7 (by Kregg T. Brooks) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Brooks, Kregg) |
Filing 923 MEMORANDUM in Opposition re #845 MOTION in Limine No. 7: Exclude Roche from Referencing the Profits or Revenues from Amgen's EPOGEN and ARANESP Products filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 922 MEMORANDUM in Support re #921 MOTION in Limine No. 22: Preclude Roche From Introducing, Including in Its Invalildity Opening, Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude any Proffered Testimony by Dr. Robert Langer During filed by Amgen Inc.. (Gottfried, Michael) |
Filing 921 MOTION in Limine No. 22: Preclude Roche From Introducing, Including in Its Invalildity Opening, Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude any Proffered Testimony by Dr. Robert Langer During the Trial by Amgen Inc..(Gottfried, Michael) |
Filing 920 Opposition re #886 MOTION in Limine No. 20: Preclude Roche From Making Statements Regarding the Duration of Amgen's Patent Protection filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 919 TRIAL BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 918 Proposed Document(s) submitted by Amgen Inc.. Document received: Amgen Inc.'s Proposed Jury Instruction. (Gottfried, Michael) |
Filing 917 Proposed Jury Instructions by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 916 Proposed Document(s) submitted by Amgen Inc.. Document received: Amgen Inc.'s Proposed Voir Dire Questions. (Rich, Patricia) |
Filing 915 Proposed Document(s) submitted by Amgen Inc.. Document received: Amgen Inc.'s Proposed Special Verdict Form. (Attachments: #1 Exhibit A (proposed special verdict form))(Rich, Patricia) |
Filing 914 DECLARATION re #912 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion In Limine No. 13 (of Krishnan Viswanadhan) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 913 MEMORANDUM in Support re #912 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion In Limine No. 13 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 912 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion In Limine No. 13 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 911 Proposed Voir Dire by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
Filing 910 MEMORANDUM in Support re #908 MOTION for Reconsideration (Partial) of the Court's August 27, 2007 Order Regarding Obviousness-Type Double Patenting of Claim 7 of the '349 Patent MOTION for Reconsideration (Partial) of the Court's August 27, 2007 Order Regarding Obviousness-Type Double Patenting of Claim 7 of the '349 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Seluga, Kimberly) |
Filing 909 Proposed Jury Verdict by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 908 MOTION for Reconsideration (Partial) of the Court's August 27, 2007 Order Regarding Obviousness-Type Double Patenting of Claim 7 of the '349 Patent by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 907 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #906 MOTION for Leave to File a Reply in Further Support of Its Motion In Limine to Preclude Plaintiff from Offering Into Evidence or Referencing to the Jury the June 2001 Settlement Agreement (Notice of Service of Confidential Documents) (Toms, Keith) |
Filing 906 MOTION for Leave to File a Reply in Further Support of Its Motion In Limine to Preclude Plaintiff from Offering Into Evidence or Referencing to the Jury the June 2001 Settlement Agreement by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Toms, Keith) |
Filing 905 Opposition re #865 MOTION in Limine No. 16: Exclude Sofocleous Testimony Regarding the Competence of the Examination Process in the U.S. Patent & Trademark Office filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 904 RESPONSE to Motion re #876 MOTION in Limine No. 17: to Exclude Roche from Presenting Evidence to Challenge the Non-obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 903 Opposition to Amgen Inc.'s Motion In Limine No. 11: Exclude the 1986 Lai et al. Paper [Roche Trial Exh. 501] Because It Is Not Prior Art filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 902 REPLY to Response to Motion re #811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious (Leave to File Granted on August 31, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 901 Emergency MOTION for Order to Preclude Amgen from Advertising in Eastern Massachusetts Now and During Trial by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Seluga, Kimberly) |
Judge William G. Young : Electronic ORDER entered granting #900 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of Epo Was Novel and Non-Obvious; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 900 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of Epo Was Novel and Non-Obvious; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 900 MOTION for Leave to File a Reply in Further Support of Roche's Motion In Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of Epo Was Novel and Non-Obvious by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (Proposed Reply))(Toms, Keith) |
Filing 899 Opposition re #822 MOTION in Limine to Preclude Amgen from Confusing the Jury with Statements Made in Earlier Foreign Proceedings filed by Amgen Inc.. (Gottfried, Michael) |
Filing 898 REPLY to Response to Motion re #801 MOTION in Limine to Preclude Amgen Inc. from Contradicting Arguments It Made in Prior Administrative and Judicial Proceedings (Leave to File Granted on August 30, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 897 REPLY to Response to Motion re #804 MOTION in Limine To Preclude Amgen Inc. From Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit As Evidence and Attorney Argument (Leave to File Granted on August 30, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 896 Opposition re #820 MOTION in Limine to Invoke Issue Preclusion as to Findings from Prior Litigation and Cross-Motion to Preclude Roche from Introducing the Statements Listed In Exhibit A of Its Motion to the Jury filed by Amgen Inc.. (Gottfried, Michael) |
Filing 895 MOTION for Leave to File Reply to Plaintiff Amgen Inc.'s Opposition to Defendants' Motion in Limine to Preclude Plaintiff Amgen Inc. from Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit as Evidence and Attorney Argument by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Brooks, Kregg) |
Judge William G. Young : Electronic ORDER entered granting 883 Motion for Extension of Time; granting 893 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting 895 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting #883 Motion for Extension of Time; granting #893 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting #895 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Smith, Bonnie) |
Filing 894 Opposition re #870 MOTION for Leave to File Supplemental Memorandum Regarding Defendants' Motion to Preclude Testimony From Belatedly Disclosed Fact Witnesses and Declaration in Support Therof filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 893 MOTION for Leave to File Reply to Amgen's Opposition to Roche's Motion in Limine to Preclude Amgen Inc. from Contradicting Arguments it Made in Prior Administrative and Judicial Proceedings by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Brooks, Kregg) |
Filing 892 MEMORANDUM in Support re #891 MOTION in Limine No. 21: Exclude Introduction of Opinions or Supporting Evidence Not Previously Identified in Expert Reports filed by Amgen Inc.. (Rich, Patricia) |
Filing 891 MOTION in Limine No. 21: Exclude Introduction of Opinions or Supporting Evidence Not Previously Identified in Expert Reports by Amgen Inc..(Rich, Patricia) |
Filing 890 MEMORANDUM in Support re #889 MOTION in Limine No. 18: Preclude Roche From Referring to Government Funding of Dr. Goldwasser's Research and From Arguing that Dr. Goldwasser's Research Should Not Have Been Shared With Amgen filed by Amgen Inc.. (Gottfried, Michael) |
Filing 889 MOTION in Limine No. 18: Preclude Roche From Referring to Government Funding of Dr. Goldwasser's Research and From Arguing that Dr. Goldwasser's Research Should Not Have Been Shared With Amgen by Amgen Inc..(Gottfried, Michael) |
Filing 888 DECLARATION re #886 MOTION in Limine No. 20: Preclude Roche From Making Statements Regarding the Duration of Amgen's Patent Protection BY GEOFFREY M. GODFREY by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 887 MEMORANDUM in Support re #886 MOTION in Limine No. 20: Preclude Roche From Making Statements Regarding the Duration of Amgen's Patent Protection filed by Amgen Inc.. (Gottfried, Michael) |
Filing 886 MOTION in Limine No. 20: Preclude Roche From Making Statements Regarding the Duration of Amgen's Patent Protection by Amgen Inc..(Gottfried, Michael) |
Filing 885 DECLARATION re #884 Memorandum in Opposition to Motion OF WILLIAM G. GAEDE, III In Support of Plaintiff's Opposition to Defendants' Motion in Limine to Preclude Plaintiff from Offering into Evidence or Referencing to The Jury the June 2001 Settlement Agreement by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Gottfried, Michael) |
Filing 884 MEMORANDUM in Opposition re #814 MOTION in Limine To Preclude Plaintiff From Offering Into Evidence Or Referencing To The Jury the June 2001 Settlement Agreement filed by Amgen Inc.. (Gottfried, Michael) |
Filing 883 MOTION for Extension of Time to August 31, 2007 to File a Motion for Leave to Seal Documents Containing Roche's Trade Secrets Submitted in Connection with Amgen's Motion In Limine No. 13 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 882 MEMORANDUM in Opposition re #816 MOTION in Limine to Preclude Amgen from Offering Expert Opinions Based on Statements Made During Prior Legal Proceedings by Witnesses Who Will Not Testify at Trial in this Case filed by Amgen Inc.. (Gottfried, Michael) |
Motions terminated: #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by Amgen Inc., #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: Ruling on Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaim (#518)is corrected because: the Motion is not denied and remains UNDER ADVISEMENT. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting in part and denying in part #509 Motion for Summary Judgment "Amgen's Motion for Summary Judgment is ALLOWED as to infringement of the '422 patent, Motion otherwise is DENIED. All other pending Motions for Summary Judgment are hereby DENIED." (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: Ruling on Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaim (#518)is corrected because: the Motion is not denied and remains UNDER ADVISEMENT. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting in part and denying in part 509 Motion for Summary Judgment "Amgen's Motion for Summary Judgment is ALLOWED as to infringement of the '422 patent, Motion otherwise is DENIED. All other pending Motions for Summary Judgment are hereby DENIED." (Smith, Bonnie) |
Motions terminated: 620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, 518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by Amgen Inc., 614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, 539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, 624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Smith, Bonnie) |
Filing 881 MEMORANDUM in Opposition re #808 MOTION in Limine To Preclude Amgen Inc. From Making Assertions That Contradict Statements Made in Specifications of Patents-In-Suit filed by Amgen Inc.. (Gottfried, Michael) |
Filing 880 MEMORANDUM in Opposition re #811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious filed by Amgen Inc.. (Gottfried, Michael) |
Filing 879 NOTICE by Amgen Inc. re #878 Declaration,,,, #877 Memorandum in Support of Motion, of Service of Confidential Documents to be Filed in Connection with Amgen Inc.'s Motion in Limine No. 17 (Gottfried, Michael) |
Filing 878 DECLARATION re #876 MOTION in Limine No. 17: to Exclude Roche from Presenting Evidence to Challenge the Non-obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983, #877 Memorandum in Support of Motion, of William G. Gaede, III by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Errata 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13#14 Exhibit 14#15 Exhibit 15, Part One#16 Exhibit 15, Part Two#17 Exhibit 16#18 Exhibit 17#19 Exhibit 18#20 Exhibit 19#21 Exhibit 20#22 Exhibit 21#23 Exhibit 22#24 Exhibit 23#25 Exhibit 24#26 Exhibit 25#27 Exhibit 27#28 Exhibit 28, Part One#29 Exhibit 28, Part Two#30 Exhibit 29, Part One#31 Exhibit 29, Part Two#32 Exhibit 29, Part Three#33 Exhibit 30#34 Exhibit 31, Part One#35 Exhibit 31, Part Two#36 Exhibit 32#37 Exhibit 33#38 Exhibit 36#39 Exhibit 37#40 Coversheet to Confidential Exhibits)(Gottfried, Michael) |
Filing 877 MEMORANDUM in Support re #876 MOTION in Limine No. 17: to Exclude Roche from Presenting Evidence to Challenge the Non-obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983 REDACTED PUBLIC VERSION filed by Amgen Inc.. (Gottfried, Michael) |
Filing 876 MOTION in Limine No. 17: to Exclude Roche from Presenting Evidence to Challenge the Non-obviousness of the DNA Sequence Encoding for Human Erythropoietin in 1983 by Amgen Inc..(Gottfried, Michael) |
Filing 875 DECLARATION re #873 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth (by Peter Fratangelo, Esq.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F)(Brooks, Kregg) |
Filing 874 MEMORANDUM in Support re #873 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 873 MOTION in Limine to Preclude Testimony of Proposed Amgen Witness Nancy Spaeth by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Judge William G. Young : Electronic ORDER entered granting #498 Motion for Summary Judgment; granting,EXCEPT FOR HUMAN ERYTHROPOIETIN, #531 Motion for Summary Judgment... OPINION TO FOLLOW. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 498 Motion for Summary Judgment; granting,EXCEPT FOR HUMAN ERYTHROPOIETIN, 531 Motion for Summary Judgment... OPINION TO FOLLOW. (Smith, Bonnie) |
Filing 872 MEMORANDUM in Support re #871 MOTION in Limine No. 19: Exclude Expert Testimony For Supplementation in Violation of the Parties' June 6, 2007, Agreement filed by Amgen Inc.. (Gottfried, Michael) |
Filing 871 MOTION in Limine No. 19: Exclude Expert Testimony For Supplementation in Violation of the Parties' June 6, 2007, Agreement by Amgen Inc..(Gottfried, Michael) |
Filing 870 MOTION for Leave to File Supplemental Memorandum Regarding Defendants' Motion to Preclude Testimony From Belatedly Disclosed Fact Witnesses and Declaration in Support Therof by Amgen Inc.. (Attachments: #1 Exhibit A (proposed Supplemental Memorandum)#2 Exhibit B (proposed Declaration))(Gottfried, Michael) |
Filing 869 Opposition re #804 MOTION in Limine To Preclude Amgen Inc. From Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit As Evidence and Attorney Argument filed by Amgen Inc.. (Gottfried, Michael) |
Filing 868 DECLARATION re #867 Opposition to Motion in Limine to Preclude Amgen from Contradicting Arguments Made in Prior Administrative and Judicial Proceedings of Geoffrey M. Godfrey by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I#10 Exhibit J#11 Exhibit K#12 Exhibit L#13 Exhibit M)(Gottfried, Michael) |
Filing 867 Opposition re #801 MOTION in Limine to Preclude Amgen Inc. from Contradicting Arguments It Made in Prior Administrative and Judicial Proceedings filed by Amgen Inc.. (Gottfried, Michael) |
Filing 866 MEMORANDUM in Support re #865 MOTION in Limine No. 16: Exclude Sofocleous Testimony Regarding the Competence of the Examination Process in the U.S. Patent & Trademark Office filed by Amgen Inc.. (Gottfried, Michael) |
Filing 865 MOTION in Limine No. 16: Exclude Sofocleous Testimony Regarding the Competence of the Examination Process in the U.S. Patent & Trademark Office by Amgen Inc..(Gottfried, Michael) |
Filing 864 MEMORANDUM in Support re #863 MOTION in Limine No. 15: Exclude Testimony of Roche's In-House Counsel George Johnston Because HisTestimony is Irrelevant and Roche Failed to Identify His Testimony Pursuant to Fed. R. Civ. P. 26(a) During Discovery MOTION in Limine No. 15: Exclude Testimony of Roche's In-House Counsel George Johnston Because HisTestimony is Irrelevant and Roche Failed to Identify His Testimony Pursuant to Fed. R. Civ. P. 26(a) During Discovery filed by Amgen Inc.. (Gottfried, Michael) |
Filing 863 MOTION in Limine No. 15: Exclude Testimony of Roche's In-House Counsel George Johnston Because HisTestimony is Irrelevant and Roche Failed to Identify His Testimony Pursuant to Fed. R. Civ. P. 26(a) During Discovery by Amgen Inc..(Gottfried, Michael) |
Filing 862 DECLARATION re #860 MOTION in Limine No. 14: Exclude PEG-EPO Experiments Conducted by Cords and Criticism of Amgen's Failure to Test Peg-Epo Based Upon Roche's Failure to Produce a Sample of PEG-EPO BY CRAIG H. CASEBEER by Amgen Inc.. (Attachments: # 1 Exhibit 1)(Gottfried, Michael) Additional attachment(s) added on 8/30/2007 (Paine, Matthew). |
Filing 861 MEMORANDUM in Support re #860 MOTION in Limine No. 14: Exclude PEG-EPO Experiments Conducted by Cords and Criticism of Amgen's Failure to Test Peg-Epo Based Upon Roche's Failure to Produce a Sample of PEG-EPO filed by Amgen Inc.. (Gottfried, Michael) |
Filing 860 MOTION in Limine No. 14: Exclude PEG-EPO Experiments Conducted by Cords and Criticism of Amgen's Failure to Test Peg-Epo Based Upon Roche's Failure to Produce a Sample of PEG-EPO by Amgen Inc..(Gottfried, Michael) |
Filing 859 NOTICE by Amgen Inc. of Service of Confidential Documents Related to Amgen's Motion in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications That it Withheld Throughout Fact Discovery (Gottfried, Michael) |
Filing 858 DECLARATION re #857 Memorandum in Support of Motion BY DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: #1 Exhibit 1-5 and 7 submitted in camera# 2 Exhibit 6)(Gottfried, Michael) |
Filing 857 MEMORANDUM in Support re #856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery filed by Amgen Inc.. (Gottfried, Michael) |
Filing 856 MOTION in Limine No. 13: Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery by Amgen Inc..(Gottfried, Michael) |
Filing 855 MEMORANDUM in Support re #854 MOTION in Limine No. 10: Exclude Evidence Related to Roche's Antitrust Allegations filed by Amgen Inc.. (Attachments: #1 Appendix A)(Gottfried, Michael) |
Filing 854 MOTION in Limine No. 10: Exclude Evidence Related to Roche's Antitrust Allegations by Amgen Inc..(Gottfried, Michael) |
Filing 853 DECLARATION of Matthew C. Nielsen in Support of Plaintiff Amgen's Motion #851 in Limine No. 11: Exclude the 1986 Lai et al. Paper [Roche Trial Exh. 501] Because it is Not Prior by Amgen Inc.. (Attachments: #1 Exhibit 1)(Gottfried, Michael) |
Filing 852 MEMORANDUM in Support of Amgen's Motion #851 in Limine No. 11: Exclude the 1986 Lai et al. Paper [Roche Trial Exh. 501] Because it is not Prior Art filed by Amgen Inc.. (Gottfried, Michael) |
Filing 851 MOTION in Limine No. 11: Exclude the 1986 Lai et al. Paper (Roche Trial Exh. 501] Because it is Not Prior Art by Amgen Inc..(Gottfried, Michael) |
Filing 850 TRANSCRIPT of Motion Hearing held on July 17, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Filing 849 TRANSCRIPT of Conference held on June 6, 2007 before Judge Young. Court Reporter: Donald E. Womack. The original transcripts are maintained by the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Scalfani, Deborah) |
Judge William G. Young : Electronic ORDER entered. re #783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential filed by Amgen Inc. "Motion denied as moot, the Court having fully accepted the representations as to Dr. Eshbach made in open court. The sealed material will be returned."(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying 724 Motion preclude testimony..."Spaeth,Ulrich,Berk,Eshbach, and Orkin may all testify as fact witnesses. Whether Fenton and Friedman may testify as fact witnesses is a very close question, one that will turn on a careful review of the mandatory disclosure provisions of Rule 26. A further order as to these two will enter prior to evidence commencing." (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered. re 783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential filed by Amgen Inc. "Motion denied as moot, the Court having fully accepted the representations as to Dr. Eshbach made in open court. The sealed material will be returned."(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #724 Motion preclude testimony..."Spaeth,Ulrich,Berk,Eshbach, and Orkin may all testify as fact witnesses. Whether Fenton and Friedman may testify as fact witnesses is a very close question, one that will turn on a careful review of the mandatory disclosure provisions of Rule 26. A further order as to these two will enter prior to evidence commencing." (Smith, Bonnie) |
Filing 848 MEMORANDUM in Support re #847 MOTION in Limine No. 12: Exclude Reference to Amgen's "Monopoly" and the Patents-in-Suit as Limiting Consumer Choice filed by Amgen Inc.. (Gottfried, Michael) |
Filing 847 MOTION in Limine No. 12: Exclude Reference to Amgen's "Monopoly" and the Patents-in-Suit as Limiting Consumer Choice by Amgen Inc..(Gottfried, Michael) |
Filing 846 MEMORANDUM in Support re #845 MOTION in Limine No. 7: Exclude Roche from Referencing the Profits or Revenues from Amgen's EPOGEN and ARANESP Products filed by Amgen Inc.. (Gottfried, Michael) |
Filing 845 MOTION in Limine No. 7: Exclude Roche from Referencing the Profits or Revenues from Amgen's EPOGEN and ARANESP Products by Amgen Inc..(Gottfried, Michael) |
Filing 844 MEMORANDUM in Support re #843 MOTION in Limine No. 9: Exclude the Testimony of Roche's Experts Kadesch and Lowe Regarding Protein Sequencing Due to Their Lack of Expertise filed by Amgen Inc.. (Gottfried, Michael) |
Filing 843 MOTION in Limine No. 9: Exclude the Testimony of Roche's Experts Kadesch and Lowe Regarding Protein Sequencing Due to Their Lack of Expertise by Amgen Inc..(Gottfried, Michael) |
Filing 842 MEMORANDUM in Support re #841 MOTION in Limine No. 8: Exclude Roche from Relying on Comparisons Between Roche's PEG-EPO Product and Amgen's ARANESP Product filed by Amgen Inc.. (Gottfried, Michael) |
Filing 841 MOTION in Limine No. 8: Exclude Roche from Relying on Comparisons Between Roche's PEG-EPO Product and Amgen's ARANESP Product by Amgen Inc..(Gottfried, Michael) |
Filing 840 MEMORANDUM in Support re #839 MOTION in Limine No. 6: Exclude Reference to Amgen's Request for Injunctive Relief filed by Amgen Inc.. (Gottfried, Michael) |
Filing 839 MOTION in Limine No. 6: Exclude Reference to Amgen's Request for Injunctive Relief by Amgen Inc..(Gottfried, Michael) |
Filing 838 MEMORANDUM in Support re #837 MOTION in Limine to Preclude Amgen from Presenting Evidence Regarding (1) A 1993 Settlement Agreement Between Amgen and Genetics Institute and (2) A 1989 Decision that Genetics Institute Used Cells that Infringed the '008 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) Modified on 8/30/2007 (Paine, Matthew). |
Filing 837 MOTION in Limine to Preclude Amgen from Presenting Evidence Regarding (1) A 1993 Settlement Agreement Between Amgen and Genetics Institute and (2) A 1989 Decision that Genetics Institute Used Cells that Infringed the '008 Patent by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 836 MEMORANDUM in Support re #835 MOTION in Limine to Preclude Amgen from Arguing that the Manufacture of CERA or MIRCERA Outside of the United States is in Any Way Improper and from Relying Upon Roche's Status as a Foreign Company filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 835 MOTION in Limine to Preclude Amgen from Arguing that the Manufacture of CERA or MIRCERA Outside of the United States is in Any Way Improper and from Relying Upon Roche's Status as a Foreign Company by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 834 DECLARATION re #832 MOTION in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media, #833 Memorandum in Support of Motion by Amgen Inc.. (Attachments: #1 Errata 1#2 Exhibit 2)(Gottfried, Michael) |
Filing 833 MEMORANDUM in Support re #832 MOTION in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media filed by Amgen Inc.. (Gottfried, Michael) |
Filing 832 MOTION in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media by Amgen Inc..(Gottfried, Michael) |
Filing 831 MEMORANDUM in Support re #830 MOTION in Limine No. 3: Exclude References to Belatedly Produced Documents and Experiments from Barber filed by Amgen Inc.. (Gottfried, Michael) |
Filing 830 MOTION in Limine No. 3: Exclude References to Belatedly Produced Documents and Experiments from Barber by Amgen Inc..(Gottfried, Michael) |
Filing 829 MEMORANDUM in Support re #828 MOTION in Limine No. 4: Exclude Genetech's PLA Filing [Roche Trial Exh. No. 1072] Because it is not Prior Art filed by Amgen Inc.. (Gottfried, Michael) |
Filing 828 MOTION in Limine No. 4: Exclude Genetech's PLA Filing [Roche Trial Exh. No. 1072] Because it is not Prior Art by Amgen Inc..(Gottfried, Michael) |
Filing 827 MEMORANDUM in Support re #826 MOTION in Limine No. 2: Exclude Reference to Allegations Against Amgen's Witness Made in Unrelated Securities Litigation filed by Amgen Inc.. (Gottfried, Michael) |
Filing 826 MOTION in Limine No. 2: Exclude Reference to Allegations Against Amgen's Witness Made in Unrelated Securities Litigation by Amgen Inc..(Gottfried, Michael) |
Filing 825 MEMORANDUM in Support re #824 MOTION in Limine No. 1: Exclude Roche from Referring to Its Own Patent on Pegylated Erythropoietin filed by Amgen Inc.. (Gottfried, Michael) |
Filing 824 MOTION in Limine No. 1: Exclude Roche from Referring to Its Own Patent on Pegylated Erythropoietin by Amgen Inc..(Gottfried, Michael) |
Filing 823 MEMORANDUM in Support re #822 MOTION in Limine to Preclude Amgen from Confusing the Jury with Statements Made in Earlier Foreign Proceedings filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A, Part 1#2 Exhibit A, Part 2#3 Exhibit A, Part 3#4 Exhibit B#5 Exhibit C#6 Exhibit D)(Brooks, Kregg) |
Filing 822 MOTION in Limine to Preclude Amgen from Confusing the Jury with Statements Made in Earlier Foreign Proceedings by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 821 MEMORANDUM in Support re #820 MOTION in Limine to Invoke Issue Preclusion as to Findings from Prior Litigation filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E)(Brooks, Kregg) |
Filing 820 MOTION in Limine to Invoke Issue Preclusion as to Findings from Prior Litigation by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 819 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Confidential Documents to be Filed in Support of [DN 816] Defendants' Motion In Limine to Preclude Amgen from Offering Expert Opinions Based on Statements Made During Prior Legal Proceedings by Witnesses Who Will Not Testify at Trial in this Case (Toms, Keith) |
Filing 818 MEMORANDUM in Support re #816 MOTION in Limine to Preclude Amgen from Offering Expert Opinions Based on Statements Made During Prior Legal Proceedings by Witnesses Who Will Not Testify at Trial in this Case filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Toms, Keith) |
Filing 817 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #814 MOTION in Limine To Preclude Plaintiff From Offering Into Evidence Or Referencing To The Jury the June 2001 Settlement Agreement (Of Confidential Documents To Be Filed) (Rizzo, Nicole) |
Filing 816 MOTION in Limine to Preclude Amgen from Offering Expert Opinions Based on Statements Made During Prior Legal Proceedings by Witnesses Who Will Not Testify at Trial in this Case by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 815 MEMORANDUM in Support re #814 MOTION in Limine To Preclude Plaintiff From Offering Into Evidence Or Referencing To The Jury the June 2001 Settlement Agreement filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D, Part 1#5 Exhibit D, Part 2#6 Exhibit D, Part 3)(Rizzo, Nicole) |
Filing 814 MOTION in Limine To Preclude Plaintiff From Offering Into Evidence Or Referencing To The Jury the June 2001 Settlement Agreement by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Judge William G. Young : Electronic ORDER entered denying 741 Motion to Strike 741 MOTION to Strike , In the Alternative, Untimely Expert Testimony of Ralph A. Bradshaw Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denying #741 Motion to Strike #741 MOTION to Strike , In the Alternative, Untimely Expert Testimony of Ralph A. Bradshaw Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting (Smith, Bonnie) |
Filing 813 DECLARATION re #811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious (by Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7)(Brooks, Kregg) |
Filing 812 MEMORANDUM in Support re #811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 810 DECLARATION re #808 MOTION in Limine To Preclude Amgen Inc. From Making Assertions That Contradict Statements Made in Specifications of Patents-In-Suit (By Kregg T. Brooks) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B, Part 1#3 Exhibit B, Part 2#4 Exhibit B, Part 3)(Brooks, Kregg) |
Filing 809 MEMORANDUM in Support re #808 MOTION in Limine To Preclude Amgen Inc. From Making Assertions That Contradict Statements Made in Specifications of Patents-In-Suit filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A)(Brooks, Kregg) |
Filing 808 MOTION in Limine To Preclude Amgen Inc. From Making Assertions That Contradict Statements Made in Specifications of Patents-In-Suit by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 807 PRETRIAL MEMORANDUM by F. Hoffmann-LaRoche LTD, Amgen Inc.. (Attachments: #1 Exhibit A (Amgen's Contested Issues of Fact)#2 Exhibit B (Roche's Statement of Contested Issues of Fact)#3 Exhibit C (Amgen's Legal Standards and Burden of Proof)#4 Exhibit D (Roche's Statement of Legal Standards and Burdens of Proof)#5 Exhibit E (Amgen's List of Witnsses for Trial)#6 Exhibit F (Roche's List of Potential Witnesses))(Gottfried, Michael) |
Filing 806 DECLARATION re #804 MOTION in Limine To Preclude Amgen Inc. From Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit As Evidence and Attorney Argument (Declaration of Kimberly J. Seluga) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Seluga, Kimberly) |
Filing 805 MEMORANDUM in Support re #804 MOTION in Limine To Preclude Amgen Inc. From Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit As Evidence and Attorney Argument filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 804 MOTION in Limine To Preclude Amgen Inc. From Asserting Outcomes of Prior Litigations Concerning the Validity and Infringement of Certain Claims of the Patents-in-Suit As Evidence and Attorney Argument by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
Filing 803 DECLARATION re #801 MOTION in Limine to Preclude Amgen Inc. from Contradicting Arguments It Made in Prior Administrative and Judicial Proceedings (by Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2, Part 1#3 Exhibit 2, Part 2#4 Exhibit 2, Part 3#5 Exhibit 3#6 Exhibit 4, Part 1#7 Exhibit 4, Part 2#8 Exhibit 4, Part 3#9 Exhibit 4, Part 4#10 Exhibit 4, Part 5#11 Exhibit 4, Part 6#12 Exhibit 5#13 Exhibit 6#14 Exhibit 7#15 Exhibit 8#16 Exhibit 9#17 Exhibit 10)(Brooks, Kregg) |
Filing 802 MEMORANDUM in Support re #801 MOTION in Limine to Preclude Amgen Inc. from Contradicting Arguments It Made in Prior Administrative and Judicial Proceedings filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Brooks, Kregg) |
Filing 801 MOTION in Limine to Preclude Amgen Inc. from Contradicting Arguments It Made in Prior Administrative and Judicial Proceedings by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Filing 800 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #745 Declaration, #589 Declaration - Defendants' Supplemental Notice of Filing with Clerk's Office of Exhibits Previously Submitted in Support of Roche's Opposition to Amgen's Motion for Summary Judgment on the Antitrust and State Law Counterclaims (Brooks, Kregg) |
Remark: Docket Updated as to entries 540, 541, 542, 634, 695, and 713 With Unredacted Versions of the Documents. (Paine, Matthew) |
Filing 799 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. - Defendants' 35 U.S.C. Section 282 Notice (Brooks, Kregg) |
Filing 798 NOTICE by Amgen Inc. re #634 Declaration, NOTICE OF FILING WITH CLERK'S OFFICE OF EXHIBITS PREVIOUSLY SUBMITTED IN CONNECTION WITH AMGEN'S OPPOSITION TO ROCHE'S MOTION FOR SUMMARY JUDGMENT THAT CLAIM 7 OF THE '349 PATENT IS INVALID UNDER 35 USC SEC. 112 AND IS NOT INFRINGED [DN 628] (Rich, Patricia) |
Filing 797 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #542 Declaration,,, - Filing with Clerk's Office of Exhibits to Declaration of Howard S. Suh Previously Submitted in Support of Roche's Motion for Summary Judgment that Claim 7 of Patent No. 5,756,349 is Invalid Under 35 U.S.C. Section 112 and is Not Infringed (Brooks, Kregg) |
Remark: Docket Updated as to entries 510 - (Color Version Available in the Case File), 512, 513 - (Color Version Available in the Case File), 514, 607, 609, 610, 664, and 665 With Unredacted Versions of the Documents (Paine, Matthew) |
Filing 796 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #607 Response, - Filing with Clerk's Office of Exhibits to Declaration of Keith E. Toms Previously Submitted in Support of Defendants' Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, ' 933 Claim 3, and '698 Claim 6 (Brooks, Kregg) |
Filing 795 NOTICE by Amgen Inc. of Filing with Clerk's Office of Exhibits Previously Submitted in Connection With Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 [DN 509] (Rich, Patricia) |
Filing 794 DECLARATION re #793 Reply to Response to Motion, in Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike (of Jennifer Moore) (Leave to File Granted on July 31, 2007) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G)(Toms, Keith) |
Filing 793 REPLY to Response to Motion re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description (Leave to File Granted on July 31, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 792 REPLY to Response to Motion re #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents (Leave to File Granted on July 31, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 791 REPLY to Response to Motion re #720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits (Leave to File Granted on July 31, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Declaration of Keith E. Toms in Support of Reply)(Toms, Keith) |
Filing 790 DECLARATION re #789 Reply to Response to Motion, in Support of Defenants' Motion Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct (of Thomas F. Fleming) (Leave to File Granted on July 31, 2007) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4)(Toms, Keith) |
Filing 789 REPLY to Response to Motion re #657 MOTION Pursuant to Fed. R. Civ.P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct (Leave to File Granted on July 31, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 788 Receipt to Plaintiff Amgen, Inc. for Documents Received on July 30, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re 750 MOTION for Leave to File Reply in Further Support of Motion for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents for the Asserted Claims of the '933 and '422 Patents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re #752 MOTION for Leave to File Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re #750 MOTION for Leave to File Reply in Further Support of Motion for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents for the Asserted Claims of the '933 and '422 Patents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #749 MOTION for Leave to File a Reply in Further Support of Roche's Emergency Motion to Strike Portions of Eight Exhibits Containing Roche's Manufacturing Trade Secrets that Are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits [DN 720]; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #738 MOTION for Leave to File Reply in Support of Defendants' Motion Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court re #785 Third MOTION to Seal Documents Containing Non-Party DaVita's Trade Secrets that Were Submitted by Roche or, in the Alternative, for a Stay Pending Appeal. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court #783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court re #779 MOTION for Leave to File Under Seal Documents Containing Fresenius' Trade Secrets, Filed By Defendant Roche, or in the Alternative, for a Stay Pending Appeal or Resolution of the Patent Trial; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 738 MOTION for Leave to File Reply in Support of Defendants' Motion Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court re 785 Third MOTION to Seal Documents Containing Non-Party DaVita's Trade Secrets that Were Submitted by Roche or, in the Alternative, for a Stay Pending Appeal. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court 783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING Subject to Further Order of the Court re 779 MOTION for Leave to File Under Seal Documents Containing Fresenius' Trade Secrets, Filed By Defendant Roche, or in the Alternative, for a Stay Pending Appeal or Resolution of the Patent Trial; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 749 MOTION for Leave to File a Reply in Further Support of Roche's Emergency Motion to Strike Portions of Eight Exhibits Containing Roche's Manufacturing Trade Secrets that Are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits [DN 720]; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re 752 MOTION for Leave to File Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 787 DECLARATION re #785 Third MOTION to Seal Documents Containing Non-Party DaVita's Trade Secrets that Were Submitted by Roche or, in the Alternative, for a Stay Pending Appeal, as Instant Motion is Unapposed, by Dennis Kogod by DaVita, Inc.. (Mello, Peter) |
Filing 786 MEMORANDUM in Support re #785 Third MOTION to Seal Documents Containing Non-Party DaVita's Trade Secrets that Were Submitted by Roche or, in the Alternative, for a Stay Pending Appeal, as Instant Motion is Unapposed, filed by DaVita, Inc.. (Mello, Peter) |
Filing 785 Third MOTION to Seal Documents Containing Non-Party DaVita's Trade Secrets that Were Submitted by Roche or, in the Alternative, for a Stay Pending Appeal, as Instant Motion is Unapposed, by DaVita, Inc..(Mello, Peter) |
Filing 784 NOTICE by Amgen Inc. re #783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential was served by hand upon defense counsel at Bromberg & Sunstein and by overnight mail to Kaye Scholer LLP (Gottfried, Michael) |
Filing 783 MOTION to Seal Declaration of Lloyd R. Day in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses Confidential by Amgen Inc..(Gottfried, Michael) (Additional attachment(s) added on 4/21/2022: #1 Sealed Declaration) (Paine, Matthew). |
Filing 782 DECLARATION of Deborah E. Fishman in Support of Amgen's Opposition to Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13#14 Exhibit 14#15 Exhibit 15#16 Exhibit 16#17 Exhibit 17#18 Exhibit 18#19 Exhibit 19#20 Exhibit 20#21 Exhibit 21#22 Exhibit 22#23 Errata 23#24 Exhibit 24#25 Exhibit 25#26 Exhibit 26)(Gottfried, Michael) |
Filing 781 MEMORANDUM in Opposition re #724 MOTION Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses filed by Amgen Inc.. (Gottfried, Michael) |
Filing 780 MEMORANDUM in Support re #779 MOTION for Leave to File Under Seal Documents Containing Fresenius' Trade Secrets, Filed By Defendant Roche, or in the Alternative, for a Stay Pending Appeal or Resolution of the Patent Trial filed by Fresenius Medical Care Holdings, Inc. (FMC). (Attachments: #1 Affidavit Declaration of Robert J. McGorty in Support of Non-Party Fresenius' Unopposed Motion for Leave to File Under Seal Documents Containing Fresenius' Trade Secrets, Filed by Roche, or in the Alternative, for a Stay Pending Appeal of Resolution of Patent Trial#2 Affidavit Declaration of Nicole E. Gage#3 Affidavit Declaration of Mark J. Hebert)(Gage, Nicole) |
Filing 779 MOTION for Leave to File Under Seal Documents Containing Fresenius' Trade Secrets, Filed By Defendant Roche, or in the Alternative, for a Stay Pending Appeal or Resolution of the Patent Trial by Fresenius Medical Care Holdings, Inc. (FMC).(Gage, Nicole) |
Remark: Docket Updated as to entries 519, 520, 556, 557, 586, 587, 594, 596, 597, 667, 698, 739 With Unredacted Versions of the Documents. (Paine, Matthew) |
Filing 778 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #698 Opposition to Motion - Filing with Clerk's Office Of Exhibits To Declaration Of Manvin S. Mayell Previously Submitted In Support Of Roches Memorandum In Opposition To Plaintiff Amgen Inc.s Motion To Exclude The Expert Testimony Of Lauren J. Stiroh (Brooks, Kregg) |
Filing 777 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #586 Memorandum in Opposition to Motion - Filing with Clerk's Office of Exhibits Previously Submitted in Support of Roche's Opposition to Amgen's Motion for Summary Judgment on the Antitrust and State Law Counterclaims (Brooks, Kregg) |
Filing 776 NOTICE by Amgen Inc. AMGENS NOTICE OF FILING WITH CLERKS OFFICE OF EXHIBITS PREVIOUSLY SUBMITTED IN SUPPORT OF AMGENS MOTION TO EXCLUDE THE EXPERT TESTIMONY OF LAUREN J. STIROH #555 (Rich, Patricia) |
Filing 775 NOTICE by Amgen Inc. of Filing with Clerk's Office of Amended Exhibits Previously Submitted in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims (Rich, Patricia) |
Filing 774 NOTICE of Appearance by Nicole E. Gage on behalf of Fresenius Medical Care Holdings, Inc. (FMC) (Gage, Nicole) |
Filing 773 Receipt to Defendant Roche for Documents Returned on July 26, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING as moot #772 MOTION for Leave to File a Reply to Defendants' Opposition to Motion for Admission to Appear Pro Hac Vice of Raphael V. Lupo. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING as moot 772 MOTION for Leave to File a Reply to Defendants' Opposition to Motion for Admission to Appear Pro Hac Vice of Raphael V. Lupo. (Paine, Matthew) |
Filing 772 MOTION for Leave to File a Reply to Defendants' Opposition to Motion for Admission to Appear Pro Hac Vice of Raphael V. Lupo by Amgen Inc.. (Attachments: #1 Exhibit A =Proposed Reply)(Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered GRANTING 767 MOTION to Withdraw 751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #770 Motion for Leave to Appear Pro Hac Vice for Admission of Raphael V. Lupo. "Denied for the Reasons Advanced By Roche. There Are Plenty of Lawyers Already on This Case." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #767 MOTION to Withdraw #751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 770 Motion for Leave to Appear Pro Hac Vice for Admission of Raphael V. Lupo. "Denied for the Reasons Advanced By Roche. There Are Plenty of Lawyers Already on This Case." (Paine, Matthew) |
Motions terminated: 751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Motions terminated: #751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Filing 771 Opposition re #770 MOTION for Leave to Appear Pro Hac Vice for admission of Raphael V. Lupo Filing fee $ 50, receipt number 1605081. Defendants' Opposition Due to Ethical Wall to Plaintiff's Motion For Pro Hac Vice of Raphael V. Lupo, Esq. filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Ex A Part 1#2 Exhibit Ex A Part 2#3 Exhibit A Part 3#4 Exhibit A Part 4#5 Exhibit A Part 5#6 Exhibit A Part 6#7 Exhibit A Part 7#8 Exhibit B Part 1#9 Exhibit B Part 2#10 Exhibit C#11 Exhibit D)(Fleming, Thomas) |
Filing 770 MOTION for Leave to Appear Pro Hac Vice for admission of Raphael V. Lupo Filing fee $ 50, receipt number 1605081. by Amgen Inc.. (Attachments: #1 Certification for Admission Pro Hac Vice#2 Declaration of Raphael V. Lupo)(Gottfried, Michael) |
Filing 769 Receipt for documents returned on July 24, 2007 to plaintiff Amgen, Inc.. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denied as moot #733 Motion to Strike (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered denied as moot 733 Motion to Strike (Smith, Bonnie) |
Filing 768 Objection to 762 Order on Motion for Summary Judgment,,,,,, Motion Hearing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ,,, by Amgen Inc. AMGEN INC.'S OBJECTION TO THE COURT'S RULING THAT THE PATENT CASE SHALL BE TRIED TO A JURY. (Gottfried, Michael) |
Filing 767 MOTION to Withdraw #751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Brooks, Kregg) |
Judge William G. Young : Electronic ORDER entered re 758 Assented to MOTION for Reconsideration of this Court's July 5, 2007 Order Denying Non-Party Fresenius' Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal..."The Motion for Reconsideration and the Motion for Stay are Both Denied. There Is Simply No Adequate Showing Here That the Amount of Fresenius Discount Is A Trade Secret. This is Data Shared With Amgen and Amgen Has Waived Any Protection It may Have - This Court Expresses No Opinion - By Putting These Matters At Issue In This Proceeding. Make No Mistake, After Ebay The Specific Amount of Fresenius Discount Is Extremely Relevant Evidence On the Issues of Injunctive Relief and Potential Antitrust Violation"... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 763 Second MOTION to Seal Documents Containing Trade Secrets of Non-Party DaVita, Inc..."Motion Denied. Amgen's Attempt to Enforce Injunctive Relief Has Waived Any Protection This Data May Conceivably Have - A Matter Upon Which This Court Expresses No Opinion. Court Proceedings are PUBLIC. DaVita's Quarrel is With Amgen and Not this Court"... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 709 MOTION for Reconsideration of Court's July 9, 2007 Order Denying Davita's Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal..."Motion DENIED. The Court Has Considered the Gill Factors With Scrupulous Care and Has Concluded that DeVita Utterly Fails to Demonstrate the Existence of Any Genuine Trade Secret. At Most, the Presentation Suggest the Presence of Evanescent Business Data, Now Stale"... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #758 Assented to MOTION for Reconsideration of this Court's July 5, 2007 Order Denying Non-Party Fresenius' Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal..."The Motion for Reconsideration and the Motion for Stay are Both Denied. There Is Simply No Adequate Showing Here That the Amount of Fresenius Discount Is A Trade Secret. This is Data Shared With Amgen and Amgen Has Waived Any Protection It may Have - This Court Expresses No Opinion - By Putting These Matters At Issue In This Proceeding. Make No Mistake, After Ebay The Specific Amount of Fresenius Discount Is Extremely Relevant Evidence On the Issues of Injunctive Relief and Potential Antitrust Violation"... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #763 Second MOTION to Seal Documents Containing Trade Secrets of Non-Party DaVita, Inc..."Motion Denied. Amgen's Attempt to Enforce Injunctive Relief Has Waived Any Protection This Data May Conceivably Have - A Matter Upon Which This Court Expresses No Opinion. Court Proceedings are PUBLIC. DaVita's Quarrel is With Amgen and Not this Court"... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #709 MOTION for Reconsideration of Court's July 9, 2007 Order Denying Davita's Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal..."Motion DENIED. The Court Has Considered the Gill Factors With Scrupulous Care and Has Concluded that DeVita Utterly Fails to Demonstrate the Existence of Any Genuine Trade Secret. At Most, the Presentation Suggest the Presence of Evanescent Business Data, Now Stale"... (Paine, Matthew) |
Filing 766 RESPONSE to Motion re #727 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with the Pendleton and Galvin Declarations filed by Amgen Inc.. (Rich, Patricia) |
Filing 765 DECLARATION of Dennis Kogod in Support of Non-Party DaVita's Second Assented-to Motion to Seal Documents Containing Trade Secrets of DaVita, Inc. by DaVita, Inc.. (Mello, Peter) |
Filing 764 MEMORANDUM in Support re #763 Second MOTION to Seal Documents Containing Trade Secrets of Non-Party DaVita, Inc., as Assented to, filed by DaVita, Inc.. (Mello, Peter) |
Filing 763 Second MOTION to Seal Documents Containing Trade Secrets of Non-Party DaVita, Inc., as Assented to, by DaVita, Inc..(Mello, Peter) |
Filing 761 DECLARATION re #760 Sur-Reply to Motion, by Keith E. Toms by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Toms, Keith) |
Filing 760 SUR-REPLY to Motion re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (leave granted on July 17, 2007) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Judge William G. Young : Electronic ORDER entered DENYING 681 MOTION to Strike the Declaration of Dr. Sven-Michael Cords. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #631 MOTION to Amend Pleadings to Conform to the Evidence. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #681 MOTION to Strike the Declaration of Dr. Sven-Michael Cords. (Paine, Matthew) |
Judge William G. Young : Electronic DENYING #612 MOTION to Strike Untimely Expert Testimony Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting. (Paine, Matthew) |
Judge William G. Young : Electronic DENYING 612 MOTION to Strike Untimely Expert Testimony Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 631 MOTION to Amend Pleadings to Conform to the Evidence. (Paine, Matthew) |
Filing 762 Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day, et al and Defense counsel Ben-Ami, et al are present in the courtroom.The Court hears argument on the pending motions. The Court Denies some motions and takes the remaining motions UNDER ADVISEMENT. The following is the list of motions Denied.denying #473 Motion for Summary Judgment; denying #478 Motion for Summary Judgment; denying #482 Motion for Summary Judgment; denying #490 Motion for Summary Judgment; denying #505 Motion for Summary Judgment; denying #544 Motion for Summary Judgment; Motion Hearing held on 7/17/2007 re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #544 MOTION for Summary Judgment of No Inequitable Conduct filed by Amgen Inc., #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. The Court adjourns to the conference room for a FINAL PRETRIAL CONFERENCE. The COurt inquires as to settlement. The Court explains to counsel what the trial schedule will be. The Antitrust claim will be tried after the other claims. The jury trial will commence on Sept. 4, 2007. The jury trial will continue until no later than Oct. 17, 2007. The Court will not sit the following dates: 9/13/07, 9/17/-9/21/07, 10/5/07-10/12/07. The Final Pretrial memo is due by Aug. 10, 2007. The Antitrust case will try in December. The September jury trial will commence with the defendants claim as to anticipation, obviousness and written description. There will be 3 series of opening remarks. The Court explains how it empanels a jury. The Court requires exhibits to be marked as follows: All those exhibits that are agreed to are to be numbered 1-infinity. All those exhibits that are objected to are to be marked as follows: A-Z,AA,AZ, BA-BZ, CA-CZ, etc. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 759 MEMORANDUM in Support re #758 Assented to MOTION for Reconsideration of this Court's July 5, 2007 Order Denying Non-Party Fresenius' Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal filed by Fresenius Medical Care Holdings, Inc. (FMC). (Hebert, Mark) |
Filing 758 Assented to MOTION for Reconsideration of this Court's July 5, 2007 Order Denying Non-Party Fresenius' Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
Filing 757 Receipt to Defendant Roche for Documents Received on July 16, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered...."ALLOWED as to the Alternative"... re #723 Opposition re #720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #721 MOTION for Leave to File Sur-Reply in Support of Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto...Motion DENIED. Litigation Is Simply Not Conducted In the Shadows. The Data Here Sought To Be Sealed Either Is Not A Trade Secret Because It Has Been Shared With Governmental Agencies Or Any Secrecy Has Been Waived By Roche's Attempt To Avoid Injunctive Relief... (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 721 MOTION for Leave to File Sur-Reply in Support of Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered...."ALLOWED as to the Alternative"... re 723 Opposition re 720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto...Motion DENIED. Litigation Is Simply Not Conducted In the Shadows. The Data Here Sought To Be Sealed Either Is Not A Trade Secret Because It Has Been Shared With Governmental Agencies Or Any Secrecy Has Been Waived By Roche's Attempt To Avoid Injunctive Relief... (Paine, Matthew) |
Filing 756 NOTICE of Appearance by Kregg T. Brooks on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Brooks, Kregg) |
Filing 755 EXHIBIT re #754 Declaration, by Manvin Mayell in Support of Roche's Motion for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 754 DECLARATION re #753 Memorandum in Support of Motion, for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims (by Manvin Mayell) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1)(Fleming, Thomas) |
Filing 753 MEMORANDUM in Support re #751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 752 MOTION for Leave to File Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Proposed Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike#2 Exhibit Decl. of Jennifer Moore in Support of Proposed Reply in Further Support of Defendants' Motion for SJ that Claim 1 of the '422 Patent is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opp. to Amgen's Alternative Motion to Strike#3 Exhibit A to Declaration of Jennifer Moore#4 Exhibit B to Declaration of Jennifer Moore#5 Exhibit C to Declaration of Jennifer Moore#6 Exhibit D to Declaration of Jennifer Moore#7 Exhibit E to Declaration of Jennifer Moore#8 Exhibit F to Declaration of Jennifer Moore#9 Exhibit G to Declaration of Jennifer Moore)(Toms, Keith) |
Filing 751 MOTION for Leave to File Under Seal Defendants' Trade Secret Contained in Amgen's Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 750 MOTION for Leave to File Reply in Further Support of Motion for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents for the Asserted Claims of the '933 and '422 Patents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Defendants' Proposed Reply)(Huston, Julia) |
Filing 749 MOTION for Leave to File a Reply in Further Support of Roche's Emergency Motion to Strike Portions of Eight Exhibits Containing Roche's Manufacturing Trade Secrets that Are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits [DN 720] by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Proposed Reply#2 Exhibit Declaration of Keith E. Toms in Support of Proposed Reply)(Toms, Keith) |
Filing 748 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #745 Declaration, (Notice of Service of Confidential Fresenius Document) (Seluga, Kimberly) |
Filing 747 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #745 Declaration, (Notice of Service of Confidential Amgen Documents) (Seluga, Kimberly) |
Filing 746 EXHIBIT re #600 Declaration, (Exhibit 4 to Declaration of Dr. Sven-Michael Cords in Support of Roche's Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 4 and '698 Claim 6) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 745 DECLARATION re #586 Memorandum in Opposition to Motion (Supplemental Declaration of David L. Cousineau In Further Support of Roche's Opposition to Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 257#2 Exhibit 258#3 Exhibit 259#4 Exhibit 260#5 Exhibit 261)(Seluga, Kimberly) |
Filing 744 DECLARATION re #743 Memorandum in Opposition to Motion, #741 MOTION to Strike , In the Alternative, Untimely Expert Testimony of Ralph A. Bradshaw Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting (by Timothy M. Murphy) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H)(Toms, Keith) |
Filing 743 MEMORANDUM in Opposition re #612 MOTION to Strike Untimely Expert Testimony Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 742 MEMORANDUM in Support re #741 MOTION to Strike , In the Alternative, Untimely Expert Testimony of Ralph A. Bradshaw Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 741 MOTION to Strike , In the Alternative, Untimely Expert Testimony of Ralph A. Bradshaw Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 740 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #739 Status Report (Notice of Service of Confidential Documents) (Seluga, Kimberly) |
Filing 739 STATUS REPORT (Roche's Memorandum For July 17, 2007 Case Management Conference) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 738 MOTION for Leave to File Reply in Support of Defendants' Motion Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Defendants' Reply in Support of Its Motion for 56(f) Relief from Plaintiff's Motion for Summary Judgment of No Inequitable Conduct#2 Affidavit Declaration of Thomas Fleming#3 Exhibit Exhibit 1 to Declaration of Thomas Fleming#4 Exhibit Exhibit 2 to Declaration of Thomas Fleming#5 Exhibit Exhibit 3 to Declaration of Thomas Fleming#6 Exhibit Exhibit 4 to Declaration of Thomas Fleming)(Toms, Keith) |
Filing 737 DECLARATION re #735 Opposition to Motion by Kimberly J. Seluga by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Huston, Julia) |
Filing 736 DECLARATION re #735 Opposition to Motion by Dr. Sven-Michael Cords by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 735 Opposition re #681 MOTION to Strike the Declaration of Dr. Sven-Michael Cords filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 734 DECLARATION re #733 MOTION to Strike Matters Raising Unpleaded Allegations Regarding Amgen's Motion for Summary Judgment of No Inequitable Conduct and to Strike Untimely Expert Testimony by Amgen Inc.. (Attachments: #1 Exhibit 1)(Gottfried, Michael) |
Filing 733 MOTION to Strike Matters Raising Unpleaded Allegations Regarding Amgen's Motion for Summary Judgment of No Inequitable Conduct and to Strike Untimely Expert Testimony by Amgen Inc..(Gottfried, Michael) |
Filing 732 DECLARATION re #731 Opposition to Motion of Michael Gottfried by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Gottfried, Michael) |
Filing 731 Opposition re #631 MOTION to Amend Pleadings to Conform to the Evidence filed by Amgen Inc.. (Gottfried, Michael) |
Filing 730 Opposition re #721 MOTION for Leave to File Sur-Reply in Support of Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 729 DECLARATION re #727 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with the Pendleton and Galvin Declarations (of Susan Batcha) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 728 MEMORANDUM in Support re #727 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with the Pendleton and Galvin Declarations filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Toms, Keith) |
Filing 727 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with the Pendleton and Galvin Declarations by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 726 DECLARATION re #724 MOTION Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses (of Aldred H. Heckel) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E)(Toms, Keith) |
Filing 725 MEMORANDUM in Support re #724 MOTION Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 724 MOTION Defendants' Motion to Preclude Testimony from Amgen's Belatedly Disclosed Fact Witnesses by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 723 Opposition re #720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits filed by Amgen Inc.. (Attachments: #1 Declaration of Deborah E. Fishman#2 Exhibit 1 to the Declaration of Deborah E. Fishman#3 Exhibit 2 to the Declaration of Deborah E. Fishman#4 Exhibit 3 to the Declaration of Deborah E. Fishman#5 Exhibit 4 to the Declaration of Deborah E. Fishman#6 Declaration of Teresa A. Garcia)(Gottfried, Michael) |
Remark: Docket Updated as to entries 630, 637 (Exhibits B,H, and J), and 647 With Unredacted Versions of the Documents. (Paine, Matthew) |
Filing 722 MEMORANDUM in Support re #720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Civil Cover Sheet A)(Toms, Keith) |
Filing 721 MOTION for Leave to File Sur-Reply in Support of Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Defendants' Surreply in Support of Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6#2 Affidavit Declaration of Keith E. Toms in Support of Defendants' Surreply#3 Exhibit Exhibit A to Toms Declaration#4 Exhibit Exhibit B to Toms Declaration#5 Exhibit Exhibit C to Toms Declaration)(Toms, Keith) |
Filing 720 Emergency MOTION to Strike Portions of Eight Exhibits Containing Roche Manufacturing Trade Secrets that are Not Necessary for Amgen's Infringement Motions or in the Alternative to Seal These Select Exhibits by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 719 DECLARATION re #716 Opposition to Motion (OF CHRISTIAN E. MAMMEN) by Amgen Inc.. (Attachments: #1 Exhibit A (part 1 of 2)#2 Exhibit A (part 2 of 2)#3 Exhibit B#4 Exhibit C#5 Exhibit D#6 Exhibit E#7 Exhibit F#8 Exhibit G#9 Exhibit H#10 Exhibit I#11 Exhibit J#12 Exhibit K#13 Exhibit L#14 Exhibit M#15 Exhibit N)(Gottfried, Michael) |
Filing 718 Response by Amgen Inc. to #622 Statement of facts, filed by Roche in Support of Defendants' Motion for Summary Judgment that Amgen is Estopped From Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents. (Gottfried, Michael) |
Filing 717 STIPULATION Regarding Motions to Seal Trade Secret Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 716 Opposition re #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents filed by Amgen Inc.. (Gottfried, Michael) |
Filing 715 Receipt to Plaintiff Amgen for Documents Received on July 13, 2007. (Paine, Matthew) |
Filing 714 NOTICE by Amgen Inc. - Notice of Service of Confidential Document Related to the Declaration of Deborah E. Fishman in Support of Amgen Inc.s Opposition to Roches Second Motion for Summary Judgment that Claim 1 of 422 is Invalid for Indefiniteness and Lack Written Description, or Alternatively, Amgens Motion to Strike (Rich, Patricia) |
Filing 713 DECLARATION re #711 Opposition to Motion, (OF DEBORAH E. FISHMAN) by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3# 4 Exhibit 4 )(Rich, Patricia) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). Modified on 8/3/2007 (Paine, Matthew). |
Filing 712 Response by Amgen Inc. to #616 Statement of facts filed by Roche in Support of Roche's Second Motion for Summary Judgment that Claim 1 of the '422 Patent is Invalid for Indefiniteness and Lack of Written Description. (Rich, Patricia) |
Filing 711 Opposition re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description , OR IN THE ALTERNATIVE AMGEN'S MOTION TO STRIKE filed by Amgen Inc.. (Rich, Patricia) |
Filing 710 MEMORANDUM in Support re #709 MOTION for Reconsideration of Court's July 9, 2007 Order Denying Davita's Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal filed by DaVita, Inc.. (Mello, Peter) |
Filing 709 MOTION for Reconsideration of Court's July 9, 2007 Order Denying Davita's Motion to Seal, or in the Alternative, to Stay the Order Pending Appeal by DaVita, Inc..(Mello, Peter) |
Filing 708 DECLARATION re #706 Opposition to Motion OF KATIE J. L. SCOTT in Support of Amgen's Opposition to Defendants' Motion for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7)(Rich, Patricia) |
Filing 707 Response by Amgen Inc. to #626 Statement of facts, filed by Roche in Support of Defendants' Motion for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents. (Rich, Patricia) |
Filing 706 Opposition re #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents filed by Amgen Inc.. (Rich, Patricia) |
Filing 705 Receipt to Defendant Roche for Documents Received on July 12, 2007. (Paine, Matthew) |
Filing 704 DECLARATION re #703 Response, #633 Opposition to Motion, by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5 1 of 2#6 Exhibit 5 2 of 2#7 Exhibit 6)(Gottfried, Michael) |
Filing 703 Response by Amgen Inc. to #648 Response, by Roche to Amgen's Separate Statement of Undisputed Facts in Support of its Motion for Summary Judgment of No Inequitable Conduct. (Rich, Patricia) |
Filing 702 REPLY to Response to Motion re #544 MOTION for Summary Judgment of No Inequitable Conduct filed by Amgen Inc.. (Rich, Patricia) |
Filing 701 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #699 Declaration of Manvin S. Mayell in Support of Roche's Opposition to Amgen's Motion to Exclude the Expert Testimony of Lauren J. Stiroh (filing of paper copies of exhibits with the Court) (Toms, Keith) |
Filing 700 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #699 Declaration of Manvin S. Mayell in Support of Roche's Opposition to Amgen's Motion to Exclude the Expert Testimony of Lauren J. Stiroh (filing of confidential exhibits) (Toms, Keith) |
Filing 699 DECLARATION re #698 Opposition to Motion to Exclude the Expert Testimony of Lauren J. Stiroh (Manvin S. Mayell) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 698 Opposition re #555 MOTION To Exclude The Expert Testimony of Lauren J. Stiroh filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 697 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #696 Declaration, Notice of Service of Confidential Documents (Toms, Keith) |
Filing 696 DECLARATION re #695 Reply to Response to Motion, For Summary Judgment that Claim 7 of the '349 Patent is Invalid Under 35 U.S.C. sec. 112 and is Not Infringed (by Howard S. Suh) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 695 REPLY to Response to Motion re #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed (Leave to File Granted in Notice Dated 6/22/07) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). |
Filing 694 Response by Amgen Inc. to Roche's Rule 56.1 Statement in Opposition to Amgen's Motion for Summary Judgment that Dr. Lin's Asserted Claims Are Definite, Adequately Described and Enabled. (Gottfried, Michael) |
Filing 693 REPLY to Response to Motion re #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled filed by Amgen Inc.. (Gottfried, Michael) |
Filing 692 MEMORANDUM in Opposition re #652 MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled filed by Amgen Inc.. (Rich, Patricia) |
Filing 691 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #635 Declaration - Filing of Exhibits Previously Submitted for In Camera to the Declaration of Krista M. Rycroft in Support of Roche's Opposition to Plaintiff Amgen Inc.'s Motion for Summary Judgment of No Inequitable Conduct (Toms, Keith) |
Remark: Docket Updated as to entries 644, 645, 648, 678, 679 (Exhibits 2 and 3), and 680 With Unredacted Versions of the Documents. (Paine, Matthew) |
Filing 690 STIPULATION Regarding Motions to Seal Trade Secret Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 689 DECLARATION of Craig H. Casebeer in Support of Amgen Inc.'s Opposition to Roche's Motion Pursuant to Fed. R. Civ. P. 56(f) For Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3)(Gottfried, Michael) |
Filing 688 Opposition re #657 MOTION Pursuant to Fed. R. Civ.P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct filed by Amgen Inc.. (Gottfried, Michael) |
Filing 687 STATUS REPORT for July 17, 2007 Case Management Conference by Amgen Inc.. (Gottfried, Michael) |
Filing 686 Receipt to Plaintiff for documents received on July 10, 2007. (Paine, Matthew) |
Filing 685 Receipt to Plaintiff for documents received on July 9, 2007. (Paine, Matthew) |
Filing 684 NOTICE by Amgen Inc. of Service of Confidential Documents to be Filed in Connection with the Declaration of Matthew C. Nielsen in Support of Amgen Inc.'s Motion to Strike the Declaration of Dr. Sven-Michael Cords (Rich, Patricia) |
Filing 683 DECLARATION of Matthew C. Nielsen in Support of Amgen Inc.'s Motion to Strike The Declaration of Dr. Sven-Michael Cords by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D - ECF Cover Sheet#5 Exhibit E)(Rich, Patricia) |
Filing 682 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #678 Reply to Response to Motion, Of Service Of Confidential Documents (Rizzo, Nicole) |
Filing 681 MOTION to Strike the Declaration of Dr. Sven-Michael Cords by Amgen Inc..(Rich, Patricia) |
Filing 680 Defendants' Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. To Amgen's Rule 56.1 Statement Of Undisputed Material Facts In Support Of Its Opposition To Roche's Motion For Summary Judgment That Claim 1 Of The '422 Patent Is Invalid Under 35 U.S.C. Section 112. (Rizzo, Nicole) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 679 DECLARATION re #678 Reply to Response to Motion, Of Krista M. Rycroft by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 2# 2 Exhibit 3#3 Exhibit 4 (part 1 of 2)#4 Exhibit 4 (part 2 of 2)#5 Exhibit 5)(Rizzo, Nicole) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 678 REPLY to Response to Motion re #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 - Leave To File Granted On 6/18/07 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 677 DECLARATION of Deborah E. Fishman in Further Support of Amgen Inc.'s Motion for Summary Judgment of No Obviousness-Type Double Patenting by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B 1 OF 2#3 Exhibit B 2 of 2#4 Exhibit C 1 of 2#5 Exhibit C 2 of 2)(Rich, Patricia) |
Filing 676 REPLY to Response to Motion re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting filed by Amgen Inc.. (Rich, Patricia) |
Filing 675 DECLARATION re #672 Reply to Response to Motion, (Declaration of Keith E. Toms in Support of Defendants' Reply Memorandum In Further Support of Defendants' Motion for Summary Judgment That the Asserted Claims of the '933 Patent Are Invalid for Indefiniteness and Lack of Written Description) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Seluga, Kimberly) |
Filing 674 DECLARATION re #673 Reply to Response to Motion, by Kimberly J. Seluga by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit HH#2 Exhibit II)(Huston, Julia) |
Filing 673 REPLY to Response to Motion re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent (Leave to File Granted on 6/18/07) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 672 REPLY to Response to Motion re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description (Leave to File Granted on 6/18/07) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) |
Filing 671 REPLY to Response to Motion re #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 - Leave to File Granted on 6/18/07 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 670 NOTICE by Amgen Inc. of Service of Confidential Documents Related to Amgen Inc.'s Reply Memorandum of Law in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims (Gottfried, Michael) |
Filing 669 DECLARATION of James M. Fraser in Support of Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by Amgen Inc.. (Attachments: #1 Exhibit 45#2 Exhibit 46#3 Exhibit 47#4 Exhibit 48#5 Exhibit 49#6 Exhibit 50#7 Exhibit 51#8 Exhibit 52#9 Exhibit 53#10 Exhibit 54#11 Exhibit 55#12 Exhibit 56)(Gottfried, Michael) |
Filing 668 REPLY to Response to Motion re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 -Leave to File Granted on 6/18/07 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 667 REPLY to Response to Motion re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 666 NOTICE by Amgen Inc. of Service of Confidential Documents to be Filed in Connection with the Declaration of Robert M. Galvin in Support of Amgen Inc.'s Reply in Support of Its Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (Rich, Patricia) |
Filing 665 DECLARATION re #664 Reply to Response to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 by Amgen Inc.. (Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Filing 664 REPLY to Response to Motion re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 filed by Amgen Inc.. (Attachments: #1 Exhibit ECF Cover Sheet)(Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Judge William G. Young : Electronic ORDER entered re 659 Assented to MOTION to Seal Document (s) Containing Non-Party DaVita's Trade Secrets. "Motion DENIED. By Seeking Injunctive Relief Amgen Has Waived The Confidentiality Of Its Pricing Decisions." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 663 Assented to MOTION for Extension of Time to July 13, 2007 to File Motion for Leave to Have a Document Containing Fresenius' Confidential and Trade Secret Information That Was Filed By Roche Protected Under Seal. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #663 Assented to MOTION for Extension of Time to July 13, 2007 to File Motion for Leave to Have a Document Containing Fresenius' Confidential and Trade Secret Information That Was Filed By Roche Protected Under Seal. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #659 Assented to MOTION to Seal Document (s) Containing Non-Party DaVita's Trade Secrets. "Motion DENIED. By Seeking Injunctive Relief Amgen Has Waived The Confidentiality Of Its Pricing Decisions." (Paine, Matthew) |
Filing 663 Assented to MOTION for Extension of Time to July 13, 2007 to File Motion for Leave to Have a Document Containing Fresenius' Confidential and Trade Secret Information That Was Filed By Roche Protected Under Seal by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
Filing 662 NOTICE of Appearance by Christopher J. Petrini on behalf of DaVita, Inc. (Petrini, Christopher) |
Filing 661 DECLARATION re #659 Assented to MOTION to Seal Document (s) Containing Non-Party DaVita's Trade Secrets by DaVita, Inc.. (Mello, Peter) |
Filing 660 MEMORANDUM in Support re #659 Assented to MOTION to Seal Document (s) Containing Non-Party DaVita's Trade Secrets filed by DaVita, Inc.. (Mello, Peter) |
Filing 659 Assented to MOTION to Seal Document (s) Containing Non-Party DaVita's Trade Secrets by DaVita, Inc..(Mello, Peter) |
Filing 658 DECLARATION re #657 MOTION Pursuant to Fed. R. Civ.P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct (by Thomas F. Fleming) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 657 MOTION Pursuant to Fed. R. Civ.P. 56(f) for Relief from Amgen's Motion for Summary Judgment of No Inequitable Conduct by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Fleming, Thomas) |
Filing 656 Receipt to defendant Roche for documents received on July 5, 2007. (Paine, Matthew) |
Filing 655 Receipt to plaintiff Amgen, Inc. for documents received on July 5, 2007. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: #633 Opposition re #544 MOTION for Summary Judgment of No Inequitable Conduct Corrected Because: The Opposition that Was Filed Was the Incorrect Document and Was Replaced With the Correct Opposition. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #646 Motion for Leave to Appear Pro Hac Vice. Added Terrence P. McMahon for Amgen Inc. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 633 Opposition re 544 MOTION for Summary Judgment of No Inequitable Conduct Corrected Because: The Opposition that Was Filed Was the Incorrect Document and Was Replaced With the Correct Opposition. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 646 Motion for Leave to Appear Pro Hac Vice. Added Terrence P. McMahon for Amgen Inc. (Paine, Matthew) |
Filing 654 DECLARATION re #652 MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled (of Jeanna Wacker, Esq.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 653 MEMORANDUM in Support re #652 MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 652 MOTION Pursuant to Fed. R. Civ. P. 56(f) for Relief from Amgen Inc.'s Motion for Summary Judgment that Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 651 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Confidential Documents to be Filed in Support of Roche's Motion for Leave to Amend Its Pleadings to Conform to the Evidence (Toms, Keith) |
Filing 650 EXHIBIT re #636 Declaration of Michael Sofocleous in Support of Roche's Opposition to Plaintiff Amgen Inc.'s Motion for Summary Judgment of No Inequitable Conduct by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 649 STIPULATION Regarding Motion to Seal Roche Confidential Documents Submitted in Connection with Amgen's Motion to Exclude the Expert Testimony of Lauren J. Stiroh by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 648 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #546 Statement of facts in Support of Defendant's Opposition to Amgen Inc.'s Motion for Summary Judgment of No Inequitable Conduct. (Toms, Keith) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 647 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #533 Statement of Material Facts L.R. 56.1 in support of Amgen Inc.'s Motion for Summary Judgment That Dr. Lin's Asserted Claims Are Definite, Aequately Described and Enabled (REDACTED VERSION). (Rizzo, Nicole) Additional attachment(s) added on 7/16/2007 (Paine, Matthew). |
Filing 646 MOTION for Leave to Appear Pro Hac Vice for admission of Terrence P. McMahon Filing fee $ 50, receipt number 1582839. by Amgen Inc.. (Attachments: #1 Certification for Admission)(Rich, Patricia) |
Filing 645 DECLARATION re #633 Opposition to Motion for Summary Judgment of No Inequitable Conduct (by Carolyn Bertozzi, PhD.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 644 DECLARATION re #633 Opposition to Motion for Summary Judgment of No Inequitable Conduct (by Charles G. Zaroulis, M.D.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) Additional attachment(s) added on 7/12/2007 (Paine, Matthew). |
Filing 643 DECLARATION re #631 MOTION to Amend Pleadings to Conform to the Evidence (by Alfred Heckel) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 642 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Filing with Clerk's Office of Exhibits to Declaration of Krista M. Rycroft in Support of Roche's Opposition to Plaintiff Amgen Inc.'s Motion for Summary Judgment of No Inequitable Conduct (Toms, Keith) |
Filing 641 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Confidential Documents to be Filed in Support of Roche's Opposition to Plaintiff Amgen Inc.'s Motion for Summary Judgment of No Inequitable Conduct [DN 633] (Toms, Keith) |
Filing 640 NOTICE by Amgen Inc. re #634 Declaration, OF SERVICE OF CONFIDENTIAL DOCUMENTS TO BE FILED IN SUPPORT OF PLAINTIFF AMGEN INC.'S OPPOSITION TO ROCHE'S MOTION FOR SUMMARY JUDGMENT THAT CLAIM 7 OF THE '349 PATENT IS INVALID UNDER 35 USC SEC. 112 AND IS NOT INFRINGED (Gottfried, Michael) |
Filing 639 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Of Service Of Confidential Documents To Be Filed In Support Of Roche's Opposition To Plaintiff Amgen Inc.'s Motion For Summary Judgment That Dr. Lin's Asserted Claims Are Definite, Adequately Described And Enabled (Rizzo, Nicole) |
Filing 638 EXHIBIT re #634 Declaration, (EXHIBITS 20-35,38-39, 44, 47 AND 53) by Amgen Inc.. (Attachments: #1 Exhibit 20#2 Exhibit 21#3 Exhibit 22#4 Exhibit 23#5 Exhibit 24#6 Exhibit 25#7 Exhibit 26#8 Exhibit 27#9 Exhibit 28#10 Exhibit 29#11 Exhibit 30#12 Exhibit 31#13 Exhibit 32#14 Exhibit 33#15 Errata 43 (part 1 of 2)#16 Exhibit 34 (part 2 of 2)#17 Exhibit 35#18 Exhibit 38#19 Exhibit 39#20 Exhibit 44#21 Exhibit 47#22 Exhibit 53)(Gottfried, Michael) |
Filing 637 DECLARATION re #630 Opposition to Motion, For Summary Judgment That Dr. Lin's Asserted Claims Are Definite, Adequately Described And Enabled, By Keith E. Toms by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A# 2 Exhibit B#3 Exhibit C, part 1#4 Exhibit C, part 2#5 Exhibit C, part 3#6 Exhibit C, part 4#7 Exhibit C, part 5#8 Exhibit C, part 6#9 Exhibit C, part 7#10 Exhibit C, part 8#11 Exhibit D, part 1#12 Exhibit D, part 2#13 Exhibit D, part 3#14 Exhibit D, part 4#15 Exhibit D, part 5#16 Exhibit D, part 6#17 Exhibit D, part 7#18 Exhibit D, part 8#19 Exhibit D, part 9#20 Exhibit D, part 10#21 Exhibit D, part 11#22 Exhibit E#23 Exhibit F, part 1#24 Exhibit F, part 2#25 Exhibit G# 26 Exhibit H#27 Exhibit I#28 Exhibit J)(Rizzo, Nicole) Additional attachment(s) added on 7/16/2007 (Paine, Matthew). |
Filing 636 DECLARATION re #633 Opposition to Motion for Summary Judgment of No Inequitable Conduct (by Michael Sofocleous) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 635 DECLARATION re #633 Opposition to Motion for Summary Judgment of No Inequitable Conduct (by Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 634 DECLARATION re #628 Opposition to Motion OF CULLEN N. PENDLETON by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). Modified on 8/3/2007 (Paine, Matthew). |
Filing 633 Opposition re #544 MOTION for Summary Judgment of No Inequitable Conduct filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A#2 Appendix B)(Toms, Keith) Additional attachment(s) added on 7/6/2007 (Paine, Matthew). |
Filing 632 MEMORANDUM in Support re #631 MOTION to Amend Pleadings to Conform to the Evidence filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Fleming, Thomas) |
Filing 631 MOTION to Amend Pleadings to Conform to the Evidence by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Fleming, Thomas) |
Filing 630 Opposition re #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled (REDACTED - PUBLIC VERSION) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) Additional attachment(s) added on 7/16/2007 (Paine, Matthew). |
Filing 629 Response by Amgen Inc. to #541 Statement of facts. (Gottfried, Michael) |
Filing 628 Opposition re #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed filed by Amgen Inc.. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered DENIED. See Order on Amgen's Motion Dated July 3, 2007 re #549 Assented to MOTION for Leave to File Under Seal Documents Containing Non-Party Fresenius' Trade Secrets Which Were Submitted By Amgen In Connection With Amgen's Motion For Summary Judgment On Roche's Antitrust And State Law Counterclaims (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing on Motion #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents, #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents, #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re #496 MOTION to Compel Continued Deposition Of Michael Borun. "Amgen Shall Produce Borun Within 14 Days of the Date of This Order for One 7 Hour Deposition to Testify As To Items 49 and 50." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered: DENIED. See Order on Amgen's Motion Dated July 3, 2007 re #559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered: DENIED. See Order on Amgen's Motion Dated July 3, 2007 re 559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENIED. See Order on Amgen's Motion Dated July 3, 2007 re 549 Assented to MOTION for Leave to File Under Seal Documents Containing Non-Party Fresenius' Trade Secrets Which Were Submitted By Amgen In Connection With Amgen's Motion For Summary Judgment On Roche's Antitrust And State Law Counterclaims (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing on Motion 620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents, 624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents, 614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re 496 MOTION to Compel Continued Deposition Of Michael Borun. "Amgen Shall Produce Borun Within 14 Days of the Date of This Order for One 7 Hour Deposition to Testify As To Items 49 and 50." (Paine, Matthew) |
Filing 627 DECLARATION re #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents by Nicole A. Rizzo by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1, Part 1#2 Exhibit 1, Part 2#3 Exhibit 1, Part 3#4 Exhibit 1, Part 4#5 Exhibit 2, Part 1#6 Exhibit 2, Part 2#7 Exhibit 2, Part 3#8 Exhibit 2, Part 4#9 Exhibit 3#10 Exhibit 4#11 Exhibit 5#12 Exhibit 6#13 Exhibit 7#14 Exhibit 8#15 Exhibit 9#16 Exhibit 10#17 Exhibit 11#18 Exhibit 12#19 Exhibit 13#20 Exhibit 14#21 Exhibit 15)(Rizzo, Nicole) |
Filing 626 STATEMENT of facts re #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents (Under Local Rule 56.1). (Rizzo, Nicole) |
Filing 625 MEMORANDUM in Support re #624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 624 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of Equivalents of the Asserted Claims of the '698 and '868 Patents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 623 DECLARATION re #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents (by Keith E. Toms) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13#14 Exhibit 14#15 Exhibit 15#16 Exhibit 16#17 Exhibit 17 (part 1 of 2)#18 Exhibit 17 (part 2 of 2)#19 Exhibit 18 (part 1 of 2)#20 Exhibit 18 (part 2 of 2)#21 Exhibit 19 (part 1 of 2)#22 Exhibit 19 (part 2 of 2)#23 Exhibit 20#24 Exhibit 21#25 Exhibit 22)(Toms, Keith) |
Filing 622 STATEMENT of facts re #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents (Pursuant to Local Rule 56.1). (Toms, Keith) |
Filing 621 MEMORANDUM in Support re #620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 620 MOTION for Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of Equivalents of the Asserted Claims of the '933 and '422 Patents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 619 EXHIBIT C, D, E And F To The Declaration Of Peter Fratangelo, Esq. In Support of Roche's Motion For Summary Judgment That Claim 1 of U.S. Patent No. 5,955,422 Is Invalid For Indefiniteness And Lack Of Written Description by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 618 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description Regarding Service Of Confidential Documents (Rizzo, Nicole) |
Filing 617 DECLARATION re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description Of Peter Fratangelo, Esq. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (part 1 of 2)#2 Exhibit A (part 2 of 2)#3 Exhibit B#4 Exhibit C#5 Exhibit D#6 Exhibit E#7 Exhibit F)(Rizzo, Nicole) |
Filing 616 STATEMENT of facts re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description (Under Local Rule 56.1). (Rizzo, Nicole) |
Filing 615 MEMORANDUM in Support re #614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 614 MOTION for Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And Lack Of Written Description by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 613 Judge William G. Young : ORDER entered. MEMORANDUM AND ORDER as to CLAIM CONSTRUCTION. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #523 MOTION to Seal Documents Containing Amgen's Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims. "Motion DENIED. The Data Sought To Be Excluded Goes To The Heart of the Issue Whether it is in the Public Interest to Grant An Injunction In This Case. By Seeking An Injunction, Amgen Cannot Litigate Out of the Public View." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 523 MOTION to Seal Documents Containing Amgen's Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims. "Motion DENIED. The Data Sought To Be Excluded Goes To The Heart of the Issue Whether it is in the Public Interest to Grant An Injunction In This Case. By Seeking An Injunction, Amgen Cannot Litigate Out of the Public View." (Paine, Matthew) |
Filing 612 MOTION to Strike Untimely Expert Testimony Regarding Amgen's Motion for Summary Judgment of No Obviousness-Type Double Patenting by Amgen Inc..(Rich, Patricia) |
Filing 611 Receipt to Defendant Roche for Documents Received on July 2, 2007. (Paine, Matthew) |
Filing 610 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3 and '698 Claim 6 (by Alexander M. Klibanov, Ph.D.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A)(Toms, Keith) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Filing 609 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3 and '698 Claim 6 (by Gregory D. Longmore, M.D.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Filing 608 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service Of Confidential Documents To Be Filed In Support Of Roches Opposition To Amgens Motion For Summary Judgment Of Infringement Of 422 Claim 1, 933 Claim 3, And 698 Claim 4 (Huston, Julia) |
Filing 607 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #512 Statement of Material Facts L.R. 56.1 In Support of Defendants' Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 and Response to Amgen's Statement of Undisputed Material Facts Pursuant to Local Rule 56.1. (Huston, Julia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). Modified on 8/1/2007 (Paine, Matthew). |
Filing 606 STIPULATION Regarding Motion To Seal Confidential Documents Relating To The Parties Oppositions And Replies To Summary Judgment by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 605 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (by William L. Jorgensen, Ph.D.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 604 NOTICE by F. Hoffmann-LaRoche LTD of Service of Confidential Docs to be Filed in Support of Roche's Oppostioin to Amgen's Motion for SJ on Roche's Antitrust & State Law Counterclaims (Toms, Keith) |
Filing 603 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Filing with the Clerk's Office Exhibit to Declaration of Keith E. Toms [DN 593] In Support of Defendants' Opposition to Amgen's Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (Huston, Julia) |
Filing 602 NOTICE by F. Hoffmann-LaRoche LTD of Filing With Clerk's Office of Exhibits to Declaration of David L. Cousineau in Support of Roche's Opposition to Amgen's Motion for SJ (Toms, Keith) |
Filing 601 DECLARATION re #590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto by F. Hoffmann-LaRoche LTD. (Rizzo, Nicole) |
Filing 600 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (by Sven-Michael Cords) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 599 DECLARATION re #590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto by F. Hoffmann-LaRoche LTD. (Rizzo, Nicole) |
Filing 598 DECLARATION re #590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto by F. Hoffmann-LaRoche LTD. (Rizzo, Nicole) Modified on 7/5/2007 (Paine, Matthew). |
Filing 597 DECLARATION of Susa Graf in Support of Roche's Opposition to Amgen's Motion for SJ on Roche's Antitrust & State Law Counterclaims by F. Hoffmann-LaRoche LTD. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 596 DECLARATION of Steven Platt in Support of Roche's Opposition to Amgen's Motion for SJ on Roche's Antitrust & State Law Counterclaims by F. Hoffmann-LaRoche LTD. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 595 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 (by Martin J. Adelman) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 594 DECLARATION of Sonders Beimfohr in Support of Roche's Opposition to Amgen's Motion for SJ on Roche's Antitrust & State Law Counterclaims by F. Hoffmann-LaRoche LTD. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 593 DECLARATION re #588 Opposition to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3 and '698 Claim 6 (by Keith E. Toms) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 592 MEMORANDUM in Support re #590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto filed by F. Hoffmann-LaRoche LTD. (Rizzo, Nicole) Modified on 7/5/2007 (Paine, Matthew). |
Filing 591 DECLARATION of Patricia Rocha-Tramaloni, Esq. in Support of Defendants' Opposition to Amgen's Motion for SJ by F. Hoffmann-LaRoche LTD. (Toms, Keith) |
Filing 590 MOTION to Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims and in Connection with Roche's Opposition Thereto by F. Hoffmann-LaRoche LTD.(Rizzo, Nicole) |
Filing 589 DECLARATION of David L. Cousineau in Support of Roche's Opposition to Amgen's Motion for SJ on Roche's Antitrust & State Law Counterclaims by F. Hoffmann-LaRoche LTD. (Toms, Keith) |
Filing 588 Opposition re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 587 Statement of Material Facts L.R. 56.1 re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by F. Hoffmann-LaRoche LTD. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 586 MEMORANDUM in Opposition re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by F. Hoffmann-LaRoche LTD. (Toms, Keith) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). |
Filing 585 DECLARATION of William G. Gaede in Support of Plaintiff's Opposition to Defendants' Motion for Summary Judgment of Non-Infringement of Claim 1 of the '422 Patent and Claims 9 and 12 of the '933 Patent by Amgen Inc.. (Attachments: #1 Exhibit 1)(Rich, Patricia) |
Filing 584 Response by Amgen Inc. to Roche's Rule 56.1 Statement of Undisputed Material Facts Regarding Its Motion for Summary Judgment of Non-Infringement of Claim 1 of the '422 Patent and Claims 9 and 12 of the '933 Patent. (Rich, Patricia) |
Filing 583 Opposition re #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 filed by Amgen Inc.. (Rich, Patricia) |
Filing 582 DECLARATION of Adam Arthur Bier in Support of Opposition to Defendants' Motion for Summary Judgment that the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description by Amgen Inc.. (Attachments: #1 Exhibit 1-Part 1#2 Exhibit 1-Part 2#3 Exhibit 2#4 Exhibit 3)(Rich, Patricia) |
Filing 581 Response by Amgen Inc. to Roche's Rule 56.1 Statement of Undisputed Material Facts Regarding Its Motion for Summary Judgment that the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description. (Rich, Patricia) |
Filing 580 Opposition re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description filed by Amgen Inc.. (Rich, Patricia) |
Filing 579 DECLARATION of Geoffrey M. Godfrey in Support of Opposition to Roche's Motion for Summary Judgment of Invalidity for Double Patenting Over Claim 10 of the '016 Patent by Amgen Inc.. (Attachments: #1 Exhibit Ex. A#2 Exhibit Ex. B#3 Exhibit Ex. C)(Rich, Patricia) |
Filing 578 DECLARATION of Harvey F. Lodish, Ph.D. in Support of Opposition to Roche's Motion for Summary Judgment of Invalidity for Double Patenting Over Claim 10 of the '016 Patent by Amgen Inc.. (Attachments: #1 Part 2 of Declaration of Lodish#2 Errata Ex. A#3 Exhibit Ex. B#4 Exhibit C#5 Exhibit Ex. D#6 Exhibit Ex. E-I#7 Exhibit Ex. E-II#8 Exhibit Ex. F#9 Exhibit Ex. G#10 Exhibit Ex. H#11 Exhibit Ex. I#12 Exhibit Ex. J#13 Exhibit Ex. K#14 Errata Ex. L#15 Errata Ex. M#16 Exhibit Ex. N#17 Exhibit Ex. O#18 Exhibit Ex. P#19 Exhibit Ex. Q#20 Exhibit Ex. R#21 Exhibit Ex. S-1#22 Exhibit Ex. S-2#23 Exhibit Ex. S-3#24 Exhibit Ex. T#25 Exhibit Ex. U-1#26 Exhibit Ex. U-2#27 Exhibit Ex. V#28 Errata Ex. W#29 Exhibit Ex. X#30 Exhibit Ex. Y-1#31 Exhibit Ex. Y-2#32 Exhibit Ex. Z)(Rich, Patricia) |
Filing 577 Response by Amgen Inc. to Roche's Rule 56.1 Statement of Undisputed Material Facts Regarding Its Motion for Summary Judgment of Invalidity for Double Patenting Over Claim 10 of the '016 Patent. (Rich, Patricia) |
Filing 576 Opposition re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent filed by Amgen Inc.. (Rich, Patricia) |
Filing 575 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #572 Declaration of Kimberly J. Seluga -- Exhibits Filed with Clerk's Office (Huston, Julia) |
Filing 574 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #569 Declaration of Edward Everett Harlow, Jr. - Exhibits filed with Clerk's Office (Huston, Julia) |
Filing 573 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #500 Statement of Material Facts L.R. 56.1 Regarding No Obviousness-Type Double Patenting. (Huston, Julia) |
Filing 572 DECLARATION re #568 Opposition to Motion for Summary Judgment of no Obviousness-Type Double Patenting (by Kimberly J. Seluga) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 571 DECLARATION re #568 Opposition to Motion for Summary Judgment of No Obviousness-Type Double Patenting (by John Lowe, M.D.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Huston, Julia) |
Filing 570 DECLARATION re #568 Opposition to Motion for Summary Judgment of No Obviousness-Type Double Patenting (by Michael Sofocleous) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 569 DECLARATION re #568 Opposition to Motion for Summary Judgment of No Obviousness-Type Double Patenting (by Edward Everett Harlow, Jr.) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 568 Opposition re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 567 DECLARATION of Linda A. Sasaki-Baxley in Support of Amgen Inc.'s Opposition to Roche's Motion for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 by Amgen Inc.. (Attachments: #1 Exhibit Ex. A#2 Exhibit Ex. B#3 Exhibit Ex. C)(Rich, Patricia) |
Filing 566 Response by Amgen Inc. to Roche's Rule 56.1 Statement of Undisputed Material Facts in Support of Roche's Motion for Summary Judgment that Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112. (Rich, Patricia) |
Filing 565 Opposition re #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 filed by Amgen Inc.. (Rich, Patricia) |
Filing 564 Receipt to Plaintiff Amgen, Inc. for Documents Received on June 28, 2007. (Paine, Matthew) |
Filing 563 DECLARATION re #559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 of Susan Batcha by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 562 DECLARATION re #559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 of Krishnan Viswanadhan by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 561 DECLARATION re #559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 of Dr. Michael Jarsch by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 560 MEMORANDUM in Support re #559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A)(Toms, Keith) |
Filing 559 MOTION to Seal Documents Containing Defendants' Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment of Infringment of '422 Claim 1, '933 Claim 3, and '698 Claim 4 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 558 NOTICE by Amgen Inc. of Service of Confidential Documents to be Filed in Support of Plaintiff Amgen Inc.'s Motion to Exclude the Expert Testimony of Lauren J. Stiroh (Gottfried, Michael) |
Filing 557 DECLARATION of Dana M. McSherry In Support of Amgen's Motion to Exclude The Expert Testimony of Lauren J. Stiroh by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). Modified on 7/27/2007 (Paine, Matthew). |
Filing 556 MEMORANDUM in Support re #555 MOTION To Exclude The Expert Testimony of Lauren J. Stiroh filed by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). Modified on 7/27/2007 (Paine, Matthew). |
Filing 555 MOTION To Exclude The Expert Testimony of Lauren J. Stiroh by Amgen Inc..(Gottfried, Michael) |
Filing 554 MEMORANDUM in Opposition re #496 MOTION to Compel Continued Deposition Of Michael Borun filed by Amgen Inc.. (Rich, Patricia) |
Filing 553 MEMORANDUM in Opposition re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 filed by Amgen Inc.. (Rich, Patricia) |
Filing 552 RESPONSE to Motion re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 filed by Amgen Inc.. (Rich, Patricia) |
Filing 551 DECLARATION re #549 Assented to MOTION for Leave to File Under Seal Documents Containing Non-Party Fresenius' Trade Secrets Which Were Submitted By Amgen In Connection With Amgen's Motion For Summary Judgment On Roche's Antitrust And State Law Counterclai by Fresenius Medical Care Holdings, Inc. (FMC). (Hebert, Mark) |
Filing 550 MEMORANDUM in Support re #549 Assented to MOTION for Leave to File Under Seal Documents Containing Non-Party Fresenius' Trade Secrets Which Were Submitted By Amgen In Connection With Amgen's Motion For Summary Judgment On Roche's Antitrust And State Law Counterclai filed by Fresenius Medical Care Holdings, Inc. (FMC). (Hebert, Mark) |
Filing 549 Assented to MOTION for Leave to File Under Seal Documents Containing Non-Party Fresenius' Trade Secrets Which Were Submitted By Amgen In Connection With Amgen's Motion For Summary Judgment On Roche's Antitrust And State Law Counterclaims by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
ELECTRONIC NOTICE issued requesting courtesy copy for #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6, #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims, #513 Declaration, #512 Statement of Material Facts L.R. 56.1, #547 Declaration,,,, #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled, #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting, #540 Memorandum in Support of Motion, #519 Memorandum in Support of Motion, #500 Statement of Material Facts L.R. 56.1, #501 Declaration,,,,, #534 Declaration,,,, #514 Declaration, #510 Memorandum in Support of Motion, #532 Memorandum in Support of Motion, #542 Declaration,,, #544 MOTION for Summary Judgment of No Inequitable Conduct, #521 Declaration, #541 Statement of facts, #499 Memorandum in Support of Motion, #533 Statement of Material Facts L.R. 56.1, #546 Statement of facts, #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed, #520 Statement of Material Facts L.R. 56.1, #545 Memorandum in Support of Motion. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6, 518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims, 513 Declaration, 512 Statement of Material Facts L.R. 56.1, 547 Declaration,,,, 531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled, 498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting, 540 Memorandum in Support of Motion, 519 Memorandum in Support of Motion, 500 Statement of Material Facts L.R. 56.1, 501 Declaration,,,,, 534 Declaration,,,, 514 Declaration, 510 Memorandum in Support of Motion, 532 Memorandum in Support of Motion, 542 Declaration,,, 544 MOTION for Summary Judgment of No Inequitable Conduct, 521 Declaration, 541 Statement of facts, 499 Memorandum in Support of Motion, 533 Statement of Material Facts L.R. 56.1, 546 Statement of facts, 539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed, 520 Statement of Material Facts L.R. 56.1, 545 Memorandum in Support of Motion. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Filing 548 Receipt to Defendant Roche for Documents Received on June 22, 2007. (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing on Motion #544 MOTION for Summary Judgment of No Inequitable Conduct : Motion Hearing set for 7/17/2007 02:00 PM before Judge William G. Young. OPPOSITION is due by 7/5/07. REPLY brief is due by 7/12/07(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion 544 MOTION for Summary Judgment of No Inequitable Conduct : Motion Hearing set for 7/17/2007 02:00 PM before Judge William G. Young. OPPOSITION is due by 7/5/07. REPLY brief is due by 7/12/07(Smith, Bonnie) |
Filing 547 DECLARATION of Craig H. Casebeer in Support of Motion for Summary Judgment of No Inequitable Conduct by Amgen Inc.. (Attachments: #1 Exhibit Ex 1#2 Exhibit Ex 2#3 Exhibit Ex 3#4 Exhibit Ex 4#5 Exhibit Ex. 5#6 Exhibit Ex 6#7 Exhibit Ex 7#8 Exhibit Ex 8#9 Exhibit Ex 9#10 Exhibit Ex 10#11 Exhibit Ex 11#12 Exhibit Ex 12#13 Exhibit Ex 13#14 Errata Ex 14#15 Exhibit Ex 15#16 Exhibit Ex. 16#17 Exhibit Ex 17#18 Exhibit Ex 18#19 Errata Ex 19#20 Exhibit Ex 20#21 Exhibit Ex 21-1#22 Exhibit Ex 21-2#23 Exhibit Ex 22#24 Exhibit Ex 23#25 Exhibit Ex 24#26 Exhibit Ex 25#27 Exhibit Ex 26#28 Exhibit Ex 27#29 Exhibit Ex 28#30 Exhibit Ex 29#31 Exhibit Ex 30#32 Errata 31#33 Errata Ex 32#34 Exhibit Ex 33#35 Exhibit Ex 34#36 Exhibit Ex 35#37 Exhibit Ex 36#38 Exhibit Ex 37#39 Exhibit Ex 38-1#40 Errata Ex 38-2#41 Exhibit Ex 39#42 Exhibit Ex 40#43 Exhibit Ex 41)(Gottfried, Michael) |
Filing 546 STATEMENT of facts in Support of Amgen's Motion for Summary Judgment of No Inequitable Conduct. (Gottfried, Michael) |
Filing 545 MEMORANDUM in Support re #544 MOTION for Summary Judgment of No Inequitable Conduct filed by Amgen Inc.. (Gottfried, Michael) |
Filing 544 MOTION for Summary Judgment of No Inequitable Conduct by Amgen Inc..(Gottfried, Michael) |
Filing 543 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Confidential Documents to be Filed in Support of Roche's Motion for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed (Seluga, Kimberly) |
Filing 542 DECLARATION re #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed (Declaration of Howard S. Suh) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. ( EXHIBITS A - DD ARE AVAILABLE IN HARD COPY IN THE CASE FILE)(Seluga, Kimberly) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). Modified on 8/3/2007 (Paine, Matthew). |
Filing 541 STATEMENT of facts re #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed (Pursuant to Local Rule 56.1). (Seluga, Kimberly) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). |
Filing 540 MEMORANDUM in Support re #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Seluga, Kimberly) Additional attachment(s) added on 8/3/2007 (Paine, Matthew). |
Filing 539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Seluga, Kimberly) |
ELECTRONIC NOTICE of Hearing on Motion 539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed : Motion Hearing set for 7/17/2007 02:00 PM before Judge William G. Young. OPPOSITION IS DUE BY 7/5/07. REPLY BRIEF, IF ANY, IS DUE BY 7/12/07.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion #539 MOTION for Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and Is Not Infringed : Motion Hearing set for 7/17/2007 02:00 PM before Judge William G. Young. OPPOSITION IS DUE BY 7/5/07. REPLY BRIEF, IF ANY, IS DUE BY 7/12/07.(Smith, Bonnie) |
Filing 538 Assented to MOTION for Extension of Time to June 28, 2007 to File Motion for Leave to Have a Document Containing Fresenius' Confidential and Trade Secret Information that was Filed by Amgen Protected Under Seal by Fresenius Medical Care Holdings, Inc. (FMC).(Hebert, Mark) |
Filing 537 STIPULATION Regarding Confidential Roche Documents Submitted by Amgen for In Camera Review on June 15, 2007 in Connection with Amgen's Motions for Summary Judgment of Infringement and on the Antitrust and State Law Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 536 Judge William G. Young : ORDER entered. AMENDED PROCEDURAL ORDER re pretrial/trial Final Pretrial Conference set for 7/17/2007 02:00 PM before Judge William G. Young.(Smith, Bonnie) |
Filing 535 Judge William G. Young : Electronic ORDER entered. PROCEDURAL ORDER re pretrial/trialFinal Pretrial Conference set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 7/5/07. Reply brief, if any, is due by 7/12/07.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion 531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 7/5/07. Reply brief, if any, is due by 7/12/07.(Smith, Bonnie) |
Filing 534 DECLARATION re #532 Memorandum in Support of Motion, #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled BY RENEE DUBORD BROWN by Amgen Inc.. (Attachments: #1 Exhibit Ex. 1#2 Exhibit Ex. 2 - 1#3 Exhibit Ex. 2-2#4 Exhibit Ex. 2-3#5 Exhibit Ex. 2-4#6 Exhibit Ex. 3-1#7 Exhibit Exhibit 3-2#8 Exhibit Ex. 3-3#9 Exhibit Ex. 4-1#10 Exhibit Ex. 4-2#11 Exhibit Ex. 4-3#12 Exhibit Ex. 5-1#13 Exhibit Ex. 5-2#14 Exhibit Ex. 5-3#15 Exhibit Ex. 5-4#16 Exhibit Ex. 6-1#17 Exhibit Ex. 6-2#18 Exhibit Ex. 6-3#19 Exhibit Ex. 6-4#20 Exhibit Ex. 6-5#21 Exhibit Ex. 7#22 Exhibit Ex. 8#23 Exhibit Ex. 9#24 Exhibit Ex. 10#25 Exhibit Ex. 11#26 Exhibit Ex. 12#27 Exhibit Ex. 13#28 Exhibit Ex. 14#29 Exhibit Ex. 14#30 Exhibit Ex. 16#31 Exhibit Ex. 17#32 Exhibit Ex. 18#33 Exhibit Ex. 19#34 Exhibit Ex. 20#35 Exhibit Ex. 21#36 Exhibit Ex. 22#37 Exhibit Ex. 23#38 Exhibit Ex. 24#39 Exhibit Ex. 25)(Gottfried, Michael) |
Filing 533 Statement of Material Facts L.R. 56.1 re #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled filed by Amgen Inc.. (Gottfried, Michael) |
Filing 532 MEMORANDUM in Support re #531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled filed by Amgen Inc.. (Gottfried, Michael) |
Filing 531 MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled by Amgen Inc..(Gottfried, Michael) |
Filing 530 Receipt to Defendant Roche for Documents Returned on June 19, 2007. (Paine, Matthew) |
Filing 529 EXHIBIT re #485 Declaration,, (Exhibits 6 and 7 to the Declaration of Krista M. Rycroft in Support of Roche's Motion for Summary Judgment that Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Section 112) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 6#2 Exhibit 7)(Seluga, Kimberly) |
Filing 528 NOTICE of Appearance by Kimberly J. Seluga on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Seluga, Kimberly) |
Filing 527 Receipt to Plaintiff Amgen for Documents Received on June 15, 2007. (Paine, Matthew) |
ELECTRONIC NOTICE of Hearing on Motion 473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4, 478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933, 498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting, 509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6, 490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent, 518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims, 482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112, 505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Oppositions to all of the above motions are due no later than June 29, 2007. Reply briefs, if any, are due no later than July 9, 2007.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4, #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933, #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting, #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6, #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent, #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims, #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112, #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description : Motion Hearing set for 7/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Oppositions to all of the above motions are due no later than June 29, 2007. Reply briefs, if any, are due no later than July 9, 2007.(Smith, Bonnie) |
Filing 526 EXHIBIT re #507 Declaration,,,, (Exhibits C, D and H to the Declaration of Howard S. Suh in Support of Roche's Motion for Summary Judgment that the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit C#2 Exhibit D#3 Exhibit H)(Toms, Keith) |
Filing 525 DECLARATION of Fred Manak in Support of Amgen's Motion for Leave to File Under Seal Documents Containing Amgen's Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by Amgen Inc.. (Gottfried, Michael) |
Filing 524 MEMORANDUM in Support re #523 MOTION to Seal Documents Containing Amgen's Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims filed by Amgen Inc.. (Gottfried, Michael) |
Filing 523 MOTION to Seal Documents Containing Amgen's Trade Secrets and Submitted in Connection with Amgen's Motion for Summary Judgment on Roche's Antitrust and State Law Counterclaims by Amgen Inc..(Gottfried, Michael) |
Filing 522 NOTICE by Amgen Inc. OF SERVICE OF CONFIDENTIAL DOCUMENTS TO BE FILED IN SUPPORT OF AMGEN'S MOTION FOR SUMMARY JUDGMENT ON ROCHE'S ANTITRUST AND STATE LAW COUNTERCLAIMS (Gottfried, Michael) |
Filing 521 DECLARATION re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Counterclaims OF JAMES M. FRASER by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). Modified on 7/27/2007 (Paine, Matthew). |
Filing 520 Statement of Material Facts L.R. 56.1 re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). Modified on 7/27/2007 (Paine, Matthew). |
Filing 519 MEMORANDUM in Support re #518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims filed by Amgen Inc.. (Gottfried, Michael) Additional attachment(s) added on 7/27/2007 (Paine, Matthew). Modified on 7/27/2007 (Paine, Matthew). |
Filing 518 MOTION for Summary Judgment on Roche's Antitrust and State Law Conterclaims by Amgen Inc..(Gottfried, Michael) |
Filing 517 EXHIBIT re #507 Declaration,,,, (Exhibit I to Declaration of Howard S. Suh in Support of Roche's Motion for Summary Judgment that the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 516 NOTICE by Amgen Inc. OF FILING WITH THE CLERK'S OFFICE (Rich, Patricia) |
Filing 515 NOTICE by Amgen Inc. OF SERVICE OF CONFIDENTIAL DOCUMENTS TO BE FILED IN SUPPORT OF PLAINTIFF AMGEN INC.'S MOTION FOR SUMMARY JUDGMENT OF INFRINGEMENT OF '422 CLAIM 1, '933 CLAIM 3, AND '698 CLAIM 9 (Rich, Patricia) |
Filing 514 DECLARATION re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 OF KATIE J.L. SCOTT (For Exhibits: See Notice of Service of Confidential Documents & Notice of Filing with Clerk's Office) by Amgen Inc.. (Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Filing 513 DECLARATION re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 OF HARVEY F. LODISH, Ph.D. by Amgen Inc..(COLOR VERSION OF THE DECLARATION AVAILABLE IN THE CASE FILE) (Attachments: #1 Exhibit A (part 1 of 2)#2 Exhibit A (part 2 of 2))(Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). Modified on 8/1/2007 (Paine, Matthew). |
Filing 512 Statement of Material Facts L.R. 56.1 re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 filed by Amgen Inc.. (Attachments: #1 Appendix A)(Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). |
Filing 511 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description (Notice of Service of Confidential Documents) (Rizzo, Nicole) |
Filing 510 MEMORANDUM in Support re #509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 filed by Amgen Inc.. (Rich, Patricia) (COLOR VERSION OF THE MEMORANDUM AVAILABLE IN THE CASE FILE) Additional attachment(s) added on 8/1/2007 (Paine, Matthew). Modified on 8/1/2007 (Paine, Matthew). |
Filing 509 MOTION for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 by Amgen Inc..(Rich, Patricia) |
Filing 508 STATEMENT of facts re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description (Pursuant to Local Rule 56.1). (Rizzo, Nicole) |
Filing 507 DECLARATION re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description of Howard S. Suh by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A, Part 1#2 Exhibit A, Part 2#3 Exhibit A, Part 3#4 Exhibit B, Part 1#5 Exhibit B, Part 2#6 Exhibit B, Part 3# 7 Exhibit C# 8 Exhibit D#9 Exhibit E#10 Exhibit F#11 Exhibit G# 12 Exhibit H# 13 Exhibit J, Part 1# 14 Exhibit J, Part 2# 15 Exhibit J, Part 3# 16 Exhibit J, Part 4# 17 Exhibit J, Part 5#18 Exhibit K, Part 1#19 Exhibit K, Part 2#20 Exhibit K, Part 3#21 Exhibit K, Part 4#22 Exhibit K, Part 5#23 Exhibit K, Part 6#24 Exhibit K, Part 7#25 Exhibit K, Part 8#26 Exhibit K, Part 9#27 Exhibit K, Part 10#28 Exhibit K, Part 11#29 Exhibit K, Part 12#30 Exhibit K, Part 13)(Rizzo, Nicole) Additional attachment(s) added on 6/15/2007 (Paine, Matthew). Additional attachment(s) added on 6/18/2007 (Paine, Matthew). |
Filing 506 MEMORANDUM in Support re #505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 505 MOTION for Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and Lack of Written Description by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 504 DECLARATION re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting BY RALPH A. BRADSHAW, Ph.D. by Amgen Inc.. (Attachments: #1 Exhibit A (part 1)#2 Exhibit A (part 2)#3 Exhibit A (part 3)#4 Exhibit B (part 1)#5 Exhibit B (part 2)#6 Exhibit B (part 3)#7 Exhibit C)(Gottfried, Michael) |
Filing 503 DECLARATION re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting BY THOMAS W. STRICKLAND Ph.D. by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Gottfried, Michael) |
Filing 502 DECLARATION re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting BY HARVEY F. LODISH, Ph.D. by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D-1#5 Errata D-2#6 Exhibit D-3#7 Errata D-4#8 Exhibit E-1#9 Exhibit E-2 (part 1)#10 Exhibit E-2 (part 2)#11 Exhibit E-3#12 Exhibit E-4#13 Exhibit E-5 (part 1)#14 Exhibit E-5 (Part 2)#15 Exhibit E-5 (part 3)#16 Exhibit E-6)(Gottfried, Michael) |
Filing 501 DECLARATION re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting BY MARIO MOORE by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B (part 1)#3 Exhibit B (part 2)#4 Exhibit C (part 1)#5 Exhibit C (part 2)#6 Exhibit D (part 1)#7 Exhibit D (part 2)#8 Exhibit E (part 1)#9 Exhibit E (part 2)#10 Exhibit F (part 1)#11 Exhibit F (part 2)#12 Exhibit G (part 1)#13 Exhibit G (part 2)#14 Exhibit H-1 (part 1)#15 Exhibit H-1 (part 2)#16 Exhibit H-2#17 Exhibit H-3#18 Exhibit H-4#19 Exhibit H-5#20 Exhibit H-6#21 Exhibit H-7#22 Exhibit H-8#23 Exhibit H-9#24 Exhibit H-10#25 Exhibit H-11#26 Exhibit H-12#27 Exhibit H-13#28 Exhibit H-14#29 Exhibit H-15#30 Exhibit H-16#31 Exhibit H-17#32 Exhibit H-18#33 Exhibit H-19#34 Exhibit H-20#35 Exhibit H-21#36 Exhibit H-22#37 Exhibit H-23#38 Exhibit H-24#39 Exhibit H-25#40 Exhibit H-26#41 Exhibit H-27#42 Exhibit H-28#43 Exhibit H-29#44 Exhibit H-30#45 Exhibit H-31#46 Exhibit H-32#47 Exhibit I (part 1)#48 Exhibit I (part 2)#49 Exhibit J (part 1)#50 Exhibit J (part 2)#51 Exhibit K#52 Exhibit L#53 Errata M-1#54 Exhibit M-2#55 Exhibit M-3#56 Exhibit M-4#57 Exhibit M-5#58 Exhibit N-1#59 Exhibit N-2#60 Exhibit N-3#61 Exhibit O#62 Exhibit P-1#63 Exhibit P-2#64 Exhibit Q (part 1)#65 Exhibit Q (part 2))(Gottfried, Michael) |
Filing 500 Statement of Material Facts L.R. 56.1 re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting filed by Amgen Inc.. (Gottfried, Michael) |
Filing 499 MEMORANDUM in Support re #498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting filed by Amgen Inc.. (Gottfried, Michael) |
Filing 498 MOTION for Summary Judgment of No Obviousness-Type Double Patenting by Amgen Inc..(Gottfried, Michael) |
Filing 497 MEMORANDUM in Support re #496 MOTION to Compel Continued Deposition Of Michael Borun filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I)(Rizzo, Nicole) |
Filing 496 MOTION to Compel Continued Deposition Of Michael Borun by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Electronic Clerk's Notes for proceedings held before Magistrate Judge Robert B. Collings : Settlement Conference held on 6/12/2007. (Not recorded)(Russo, Noreen) |
Electronic Clerk's Notes for proceedings held before Magistrate Judge Robert B. Collings : Settlement Conference held on 6/12/2007. (Not recorded)(Russo, Noreen) |
Filing 495 DECLARATION re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent of Kimberly J. Seluga by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Notice Of Filing With Clerks Office Of Exhibits to Declaration of Kimberly J. Seluga in support of Defendants Motion For Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent)(Rizzo, Nicole) |
Filing 494 DECLARATION re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent of Dr. Edward Everett Harlow, Jr. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Notice of Filing With Clerks Office Of Exhibits to Declaration of Dr. Edward Everett Harlow, Jr. In support of Defendants Motion For Summary Judgment That the Claims of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent)(Rizzo, Nicole) |
Filing 493 DECLARATION re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent of Michael Sofocleous by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Rizzo, Nicole) |
Filing 492 STATEMENT of facts re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent (Pursuant to Local Rule 56.1). (Rizzo, Nicole) |
Filing 491 MEMORANDUM in Support re #490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 490 MOTION for Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over Amgen 016 Patent by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 489 Joint Letter/request (non-motion) from Counsel for Amgen and Roche. (Rizzo, Nicole) |
Filing 488 Receipt to Defendant Roche for Documents Received on June 12, 2007. (Paine, Matthew) |
Filing 487 REPORT of Alternative Dispute Resolution Provider. (Dolan, Kathleen) |
Filing 486 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Confidential Documents to be Filed in Support of Roche's Motion for Summary Judgment that Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Section 112 (Rizzo, Nicole) |
Filing 485 DECLARATION re #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 of Krista M. Rycroft by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4 (part 1 of 4)#5 Exhibit 4 (part 2 of 4)#6 Exhibit 4 (part 3 of 4)#7 Exhibit 4 (part 4 of 4)#8 Exhibit 5#9 Exhibit 6#10 Exhibit 7#11 Exhibit 8#12 Exhibit 9#13 Exhibit 10 (part 1 of 4)#14 Exhibit 10 (part 2 of 4)#15 Exhibit 10, part 3 of 4#16 Exhibit 10 (part 4 of 4)#17 Exhibit 11#18 Exhibit 12#19 Exhibit 13#20 Exhibit 14#21 Exhibit 15#22 Exhibit 16#23 Exhibit 17)(Rizzo, Nicole) |
Filing 484 STATEMENT of facts re #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 (Pursuant to Local Rule 56.1). (Rizzo, Nicole) |
Filing 483 MEMORANDUM in Support re #482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 482 MOTION for Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 481 DECLARATION re #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 of Howard S. Suh by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit F#6 Exhibit I#7 Exhibit J#8 Exhibit K#9 Exhibit L)(Rizzo, Nicole) |
Filing 480 STATEMENT of facts re #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 (Pursuant to Local Rule 56.1). (Rizzo, Nicole) |
Filing 479 MEMORANDUM in Support re #478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 478 MOTION for Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of Patent No. 5,547,933 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 477 CERTIFICATE OF CONSULTATION re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4. (Toms, Keith) |
Filing 476 STATEMENT of facts re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 (Pursuant to Local Rule 56.1). (Toms, Keith) |
Filing 475 DECLARATION re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 of Howard S. Suh by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Toms, Keith) |
Filing 474 MEMORANDUM in Support re #473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 473 MOTION for Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply with Claim Differentiation Under Section 112, Paragraph 4 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 472 Withdrawal of motion: #439 MOTION for Summary Judgment of Noninfringement of the '080 Patent filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH.. (Rizzo, Nicole) |
Motions terminated: #462 MOTION to Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Strike Roche's Non-Infringement, Invalidity, And Inequitable Conduct Allegations Disclosed After The Close Of Fact Disco filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #465 Motion for Leave to Appear Pro Hac Vice. Added Aaron Stiefel for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 471 Motion for Leave to Appear Pro Hac Vice. Added Craig H. Casebeer for Amgen Inc.. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 465 Motion for Leave to Appear Pro Hac Vice. Added Aaron Stiefel for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Motions terminated: 462 MOTION to Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Strike Roche's Non-Infringement, Invalidity, And Inequitable Conduct Allegations Disclosed After The Close Of Fact Disco filed by Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #471 Motion for Leave to Appear Pro Hac Vice. Added Craig H. Casebeer for Amgen Inc.. (Paine, Matthew) |
Filing 471 MOTION for Leave to Appear Pro Hac Vice for admission of Craig H. Casbeer Filing fee $ 50, receipt number 1551529. by Amgen Inc.. (Attachments: #1 Exhibit Certificate for Admission)(Rich, Patricia) |
Filing 470 NOTICE of Appearance by Christopher S. Kroon on behalf of Amgen Inc. (Kroon, Christopher) |
Judge William G. Young : Electronic ORDER entered DENYING AS MOOT 447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING AS MOOT #447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims. (Paine, Matthew) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day,Defendant's counsel Ben-Ami are present.Scheduling Conference/Case Management Conference held on 6/6/2007. The Court orders the parties to try to agree to a schedule for discovery. The Court reminds the parties that this case is set for trial in SEPTEMBER and unless a criminal matter has to be tried, this case will go forward with trial on September 4,2007. After consultation, the parties inform the court that an agreement has been reached and request the court to put the agreement on the record. The parties agree to 7 supplemental expert reports. June 30 is the end of the expert discovery, excluding the time necessary for Amgen to find a replacement expert for one of the experts who is unavailable. Summary Judgment motions are to be filed no later than July 3, 2007. The parties agree to 10 trial experts. Parties are to identify the trial experts to one another by July 7, 2007.A Final Pretrial Conference is set for July 17, 2007. A Final Pretrial Memo is to be filed by Aug. 1, 2007. The Court adopts the schedule but cautions counsel that some of the dates are too close to the trial date. (Court Reporter Womack.) (Smith, Bonnie) |
Electronic Clerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day,Defendant's counsel Ben-Ami are present.Scheduling Conference/Case Management Conference held on 6/6/2007. The Court orders the parties to try to agree to a schedule for discovery. The Court reminds the parties that this case is set for trial in SEPTEMBER and unless a criminal matter has to be tried, this case will go forward with trial on September 4,2007. After consultation, the parties inform the court that an agreement has been reached and request the court to put the agreement on the record. The parties agree to 7 supplemental expert reports. June 30 is the end of the expert discovery, excluding the time necessary for Amgen to find a replacement expert for one of the experts who is unavailable. Summary Judgment motions are to be filed no later than July 3, 2007. The parties agree to 10 trial experts. Parties are to identify the trial experts to one another by July 7, 2007.A Final Pretrial Conference is set for July 17, 2007. A Final Pretrial Memo is to be filed by Aug. 1, 2007. The Court adopts the schedule but cautions counsel that some of the dates are too close to the trial date. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 469 DECLARATION re #468 Memorandum in Opposition to Motion, to Roche's Motion for Leave to Amend its Answer, by Mario Moore, by Amgen Inc.. (Attachments: #1 Exhibit 1 (Part 1 of 3)#2 Exhibit 1 (Part 2 of 3)#3 Exhibit 1 (Part 3 of 3)#4 Exhibit 2#5 Exhibit 3#6 Exhibit 4#7 Exhibit 5)(Rich, Patricia) |
Filing 468 MEMORANDUM in Opposition re #445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims filed by Amgen Inc.. (Attachments: #1 Appendix A)(Rich, Patricia) |
Filing 467 NOTICE of Appearance by Joel R. Leeman on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Leeman, Joel) |
Filing 466 Opposition re #447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A#2 Exhibit 1)(Toms, Keith) |
Filing 465 MOTION for Leave to Appear Pro Hac Vice for admission of AARON STIEFEL Filing fee $ 50, receipt number 1547815. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 464 DECLARATION re #462 MOTION to Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Strike Roche's Non-Infringement, Invalidity, And Inequitable Conduct Allegations Disclosed After The Close Of Fact Disco very Or, In The Alternative, Motion For Leave To Supplement Amgen's Expert Reports And Motion For Protective Order To Postpone Depositions Of Certain Witnesses by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 463 MEMORANDUM in Support re #462 MOTION to Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Strike Roche's Non-Infringement, Invalidity, And Inequitable Conduct Allegations Disclosed After The Close Of Fact Disco very Or, In The Alternative, Motion For Leave To Supplement Amgen's Expert Reports And Motion For Protective Order To Postpone Depositions Of Certain Witnesses filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 462 MOTION to Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Strike Roche's Non-Infringement, Invalidity, And Inequitable Conduct Allegations Disclosed After The Close Of Fact Discovery Or, In The Alternative, Motion For Leave To Supplement Amgen's Expert Reports And Motion For Protective Order To Postpone Depositions Of Certain Witnesses by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 461 Judge William G. Young : ORDER entered. re #460 STIPULATION of Dismissal FILED JOINTLY FOR DISMISSAL OF AMGEN'S CLAIM FOR DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 5,621,080. (Paine, Matthew) |
Filing 460 STIPULATION of Dismissal FILED JOINTLY FOR DISMISSAL OF AMGEN'S CLAIM FOR DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 5,621,080 by F. Hoffmann-LaRoche LTD, Amgen Inc.. (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered GRANTING #459 Motion for Leave to Appear Pro Hac Vice. Added Kathleen McDermott for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re #449 Emergency MOTION For Expedited Case Management Conference filed by Amgen Inc. MOTION ALLOWED CASE MANAGEMENT CONFERENCE set for 6/6/2007 03:00 PM in Courtroom 18 before Judge William G. Young.(Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered GRANTING 459 Motion for Leave to Appear Pro Hac Vice. Added Kathleen McDermott for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 449 Emergency MOTION For Expedited Case Management Conference filed by Amgen Inc. MOTION ALLOWED CASE MANAGEMENT CONFERENCE set for 6/6/2007 03:00 PM in Courtroom 18 before Judge William G. Young.(Smith, Bonnie) |
Filing 459 MOTION for Leave to Appear Pro Hac Vice for admission of Kathleen McDermott Filing fee $ 50, receipt number 1544286. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 458 RESPONSE to Motion re #449 Emergency MOTION For Expedited Case Management Conference filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
Filing 457 STIPULATION REGARDING CONFIDENTIAL ROCHE DOCUMENTS SUBMITTED BY AMGEN FOR IN CAMERA REVIEW ON MAY 24, 2007 IN CONNECTION WITH AMGEN'S MOTION TO STRIKE ROCHE'S ALLEGATIONS DISCLOSED AFTER THE CLOSE OF FACT DISCOVERY OR, IN THE ALTERNATIVE, MOTION FOR LEAVE TO SUPPLEMENT AMGEN'S EXPERT REPORTS AND MOTION FOR PROTECTIVE ORDER TO POSTPONE DEPOSITIONS OF CERTAIN WITNESSES by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 456 Receipt to Plaintiff Amgen Inc. for Documents Received on May 25, 2007. (Paine, Matthew) |
Filing 455 NOTICE by Amgen Inc. re #454 Notice (Other), Notice (Other), Notice (Other) of Service of Corrected Confidential Document to be Filed in Support of Plaintiff Amgen Inc.'s Motion to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed After the Close of Fact Discovery or, In The Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses (Gottfried, Michael) |
Filing 454 NOTICE by Amgen Inc. re #448 Memorandum in Support of Motion, Filing of Corrected Appendix A to Memorandum #448 in Support of Plaintiff Amgen Inc.'s Motion to Strike Roche's Non-Infringement, invalidity and inequitable conduct allegations disclosed after the close of fact discovery or, in the alternative, motion for leave to supplement Amgen's expert reports and motion for protective order to postpone depositions of certain witnesses #447 (Attachments: #1 Appendix A ((cover page only) submitted for in camera review))(Gottfried, Michael) |
Filing 453 Receipt to Plaintiff Amgen Inc. for Documents Received on May 24, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 452 Emergency MOTION to Expedite the time for Roche to Respond to Amgen Inc.'s Motion to Strike Roche's Non-Infringement, Invalidity and Inequitable Condut Allegations Disclosed After the Close of Fact Discovery or, and in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #452 Emergency MOTION to Expedite the time for Roche to Respond to Amgen Inc.'s Motion to Strike Roche's Non-Infringement, Invalidity and Inequitable Condut Allegations Disclosed After the Close of Fact Discovery or, and in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses (Paine, Matthew) |
Filing 452 Emergency MOTION to Expedite the time for Roche to Respond to Amgen Inc.'s Motion to Strike Roche's Non-Infringement, Invalidity and Inequitable Condut Allegations Disclosed After the Close of Fact Discovery or, and in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses by Amgen Inc..(Rich, Patricia) |
Filing 451 NOTICE by Amgen Inc. Of SERVICE OF CONFIDENTAIL DOCUMENTS TO BE FILED IN SUPPORT OF PLAINTIFF AMGEN INC.S MOTION TO STRIKE ROCHES NON-INFRINGEMENT, INVALIDITY, AND INEQUITABLE CONDUCT ALLEGATIONS DISCLOSED AFTER THE CLOSE OF FACT DISCOVERY OR, IN THE ALTERNATIVE, MOTION FOR LEAVE TO SUPPLEMENT AMGENS EXPERT REPORTS AND MOTION FOR PROTECTIVE ORDER TO POSTPONE DEPOSITIONS OF CERTAIN WITNESSES #447 (Gottfried, Michael) |
Filing 450 DECLARATION re #447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective OF MARIO MOORE by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4-10 (cover page only) submitted for in camera review#5 Errata 11#6 Exhibit 12#7 Exhibit 13#8 Exhibit 14#9 Exhibit 15)(Gottfried, Michael) |
Filing 449 Emergency MOTION For Expedited Case Management Conference by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 448 MEMORANDUM in Support re #447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective filed by Amgen Inc.. (Attachments: #1 Appendix A (cover page only) submitted for in camera review)(Gottfried, Michael) |
Filing 447 MOTION to Strike Roche's Non-Infringement, Invalidity, and Inequitable Conduct Allegations Disclosed after the Close of Fact Discovery or, in the Alternative, Motion for Leave to Supplement Amgen's Expert Reports and Motion for Protective Order to Postpone Depositions of Certain Witnesses by Amgen Inc.. (Attachments: #1 Text of Proposed Order)(Gottfried, Michael) |
Filing 446 MEMORANDUM in Support re #445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 445 MOTION to Amend Its Answer To Amplify Allegations Of Amgen's Inequitable Conduct And To Define Relevant Markets For Purposes Of Antitrust Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 444 NOTICE of Appearance by Robert M. Asher on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Asher, Robert) |
Filing 443 NOTICE of Appearance by Timothy M. Murphy on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Murphy, Timothy) |
ELECTRONIC NOTICE of Hearing on Motion 439 MOTION for Summary Judgment of Noninfringement of the '080 Patent : Motion Hearing set for 6/26/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 6/4/07. Reply brief, if any is due by 6/13/07.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion #439 MOTION for Summary Judgment of Noninfringement of the '080 Patent : Motion Hearing set for 6/26/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 6/4/07. Reply brief, if any is due by 6/13/07.(Smith, Bonnie) |
Filing 442 Statement of Material Facts L.R. 56.1 re #439 MOTION for Summary Judgment of Noninfringement of the '080 Patent (Undisputed Material Facts) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 441 AFFIDAVIT of Kimberly J. Seluga in Support re #439 MOTION for Summary Judgment of Noninfringement of the '080 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2 (1 of 4)#3 Exhibit 2 (2 of 4)#4 Exhibit 2 (3 of 4)#5 Exhibit 2 (4 of 4)#6 Exhibit 3#7 Exhibit 4)(Huston, Julia) |
Filing 440 MEMORANDUM in Support re #439 MOTION for Summary Judgment of Noninfringement of the '080 Patent filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 439 MOTION for Summary Judgment of Noninfringement of the '080 Patent by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 438 Receipt for Documents Returned on May 18, 2007 to Plaintiff Amgen, Inc.. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered GRANTING 437 Motion for Leave to Appear Pro Hac Vice. Added Christian E. Mammen for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80209 for #437 MOTION for Leave to Appear Pro Hac Vice for admission of Christian E. Mammen. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered GRANTING #437 Motion for Leave to Appear Pro Hac Vice. Added Christian E. Mammen for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80209 for 437 MOTION for Leave to Appear Pro Hac Vice for admission of Christian E. Mammen. (Paine, Matthew) |
Filing 437 MOTION for Leave to Appear Pro Hac Vice for admission of Christian E. Mammen by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Judge William G. Young : ElectronicORDER entered re 425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony. "Motion DENIED Without Prejudice Depending On How The Evidence Develops At Trial. No Witness May Rely On Evidence Withheld From Discovery." (Paine, Matthew) |
Judge William G. Young : ElectronicGRANTING 434 Motion for Leave to Appear Pro Hac Vice. Added Aton Arbisser for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : ElectronicGRANTING #434 Motion for Leave to Appear Pro Hac Vice. Added Aton Arbisser for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered re #425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony. "Motion DENIED Without Prejudice Depending On How The Evidence Develops At Trial. No Witness May Rely On Evidence Withheld From Discovery." (Paine, Matthew) |
Filing 436 DECLARATION re #435 Opposition to Motion OF WILLIAM G. GAEDE, III IN SUPPORT OF PLAINTIFF'S OPPOSITION TO DEFENDANTS' MOTION TO STRIKE INFRINGMENT ALLEGATIONS IN AMGEN'S EXPERT REPORTS AND TO PRECULDE TESTIMONY by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6)(Gottfried, Michael) |
Filing 435 Opposition re #425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony filed by Amgen Inc.. (Gottfried, Michael) |
Filing 434 MOTION for Leave to Appear Pro Hac Vice for admission of Aton Arbisser Filing fee $ 50, receipt number 1521107. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Judge William G. Young : ElectronicORDER entered GRANTING 433 Assented to MOTION for Extension of Time to May 15, 2007 to For Amgen to File Its Opposition to Defendants' Motion to Strike Infringement Allegations in Amgen's Expert Reports on Which Amgen Did Not Provide Discovery and to Preclude Testimony. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered GRANTING #431 Motion for Leave to Appear Pro Hac Vice. Added Bobby R. Burchfield for Amgen Inc. and GRANTING #432 Motion for Leave to Appear Pro Hac Vice. Added Richard W. Smith for Amgen Inc.. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered GRANTING #433 Assented to MOTION for Extension of Time to May 15, 2007 to For Amgen to File Its Opposition to Defendants' Motion to Strike Infringement Allegations in Amgen's Expert Reports on Which Amgen Did Not Provide Discovery and to Preclude Testimony. (Paine, Matthew) |
Judge William G. Young : ElectronicORDER entered GRANTING 431 Motion for Leave to Appear Pro Hac Vice. Added Bobby R. Burchfield for Amgen Inc. and GRANTING 432 Motion for Leave to Appear Pro Hac Vice. Added Richard W. Smith for Amgen Inc.. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80054 for #431 MOTION for Leave to Appear Pro Hac Vice for admission of Bobby R. Burchfield. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80053 for #432 MOTION for Leave to Appear Pro Hac Vice for admission of Richard W. Smith. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80054 for 431 MOTION for Leave to Appear Pro Hac Vice for admission of Bobby R. Burchfield. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 80053 for 432 MOTION for Leave to Appear Pro Hac Vice for admission of Richard W. Smith. (Paine, Matthew) |
Filing 433 Assented to MOTION for Extension of Time to May 15, 2007 to For Amgen to File Its Opposition to Defendants' Motion to Strike Infringement Allegations in Amgen's Expert Reports on Which Amgen Did Not Provide Discovery and to Preclude Testimony by Amgen Inc..(Rich, Patricia) |
Filing 432 MOTION for Leave to Appear Pro Hac Vice for admission of Richard W. Smith by Amgen Inc.. (Attachments: #1 Exhibit Ex. A)(Gottfried, Michael) |
Filing 431 MOTION for Leave to Appear Pro Hac Vice for admission of Bobby R. Burchfield by Amgen Inc.. (Attachments: #1 Exhibit Ex. A)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered re 398 MOTION for Order to Amgen To Show Cause Why It Is Not In Contempt Of The Protective Order. "The Motion is Denied Without Prejudice To Its Renewal Should There Be Any Further Violation of The Protective Order. As A Sanction, Amgen Will Pay All The Cost Arising Out of This Violation." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #398 MOTION for Order to Amgen To Show Cause Why It Is Not In Contempt Of The Protective Order. "The Motion is Denied Without Prejudice To Its Renewal Should There Be Any Further Violation of The Protective Order. As A Sanction, Amgen Will Pay All The Cost Arising Out of This Violation." (Paine, Matthew) |
Filing 430 Response by Amgen Inc. to #343 Response, (AMGEN INC.'S RESPONSE TO THE COURT'S QUESTIONS REGARDING PRECEDENTIAL EFFECT TO PRIOR CLAIM CONSTRUCTIONS AND DEFENDANTS' REPLY BRIEF REGARDING CLAIM CONSTRUCTION) Filed By Leave of Court Granted on May 2, 2007. (Attachments: #1 Appendix A)(Gottfried, Michael) |
Filing 429 Receipt for Documents Returned on May 2, 2007 to Plaintiff Amgen, Inc.. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #370 MOTION for Leave to File a Response to the Court's Questions Regarding Precedential Effect of Prior Claim Constructions and a Reply to Defendants' Reply Brief Regarding Claim Construction; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #340 MOTION to Compel Continued Deposition of Dr. Thomas Strickland and Production of Related Documents. "DENIED. Discovery Is Not a Game and Court Orders Are Not Lightly To Be Altered. What Is Expected and Required Is A Cooperative Venture To Ascertain The Truth. Should Any Party Have Wrongfully Failed to Make Discovery, The Appropriate Sanction Is A Preclusion Order, The Drawing of Adverse Inferences, or Both. On The Other Hand, Cooperative Production Of Requested Documents Will Never Be The Ground For Drawing An Inference That They Had Earlier Been Improperly Withheld." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #409 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Preclude Further Interference With Third-Party Discovery; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re #419 JOINT STATEMENT of counsel to Propose Amendments to LR 16.1(D) Scheduling Order is ALLOWED.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 340 MOTION to Compel Continued Deposition of Dr. Thomas Strickland and Production of Related Documents. "DENIED. Discovery Is Not a Game and Court Orders Are Not Lightly To Be Altered. What Is Expected and Required Is A Cooperative Venture To Ascertain The Truth. Should Any Party Have Wrongfully Failed to Make Discovery, The Appropriate Sanction Is A Preclusion Order, The Drawing of Adverse Inferences, or Both. On The Other Hand, Cooperative Production Of Requested Documents Will Never Be The Ground For Drawing An Inference That They Had Earlier Been Improperly Withheld." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 370 MOTION for Leave to File a Response to the Court's Questions Regarding Precedential Effect of Prior Claim Constructions and a Reply to Defendants' Reply Brief Regarding Claim Construction; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 419 JOINT STATEMENT of counsel to Propose Amendments to LR 16.1(D) Scheduling Order is ALLOWED.(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 409 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Preclude Further Interference With Third-Party Discovery; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 428 TRANSCRIPT of Proceedings held on 4/17/07 before Judge Young. Court Reporter: Womack. The original transcripts are maintained in the case file in the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered GRANTING 421 MOTION to Withdraw 385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports. (Paine, Matthew) |
Motions terminated: 385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports filed by Amgen Inc.. (Paine, Matthew) |
Motions terminated: #385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports filed by Amgen Inc.. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #421 MOTION to Withdraw #385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports. (Paine, Matthew) |
Filing 427 DECLARATION re #425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony of Alfred H. Heckel by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I#10 Exhibit J)(Toms, Keith) |
Filing 426 MEMORANDUM in Support re #425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 425 MOTION to Strike Infringement Allegations in Amgen's Expert Reports on which Amgen did not Provide Discovery and to Preclude Testimony by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Judge William G. Young : Electronic ORDER entered DENYING 377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants Defense Under 35 U.S.C. Section 271(e)(1). (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6). (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6). (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants Defense Under 35 U.S.C. Section 271(e)(1). (Paine, Matthew) |
Filing 424 DECLARATION re #423 Opposition to Motion of Defendants to Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony Under Rule 30(B)(6) Withheld on Grounds of Privilege, by William G. Gaede, III, by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6)(Rich, Patricia) |
Filing 423 Opposition re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) filed by Amgen Inc.. (Rich, Patricia) |
Filing 422 Opposition re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Toms, Keith) |
Filing 421 MOTION to Withdraw #385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports by Amgen Inc..(Rich, Patricia) |
Filing 420 STIPULATION Regarding Confidential Roche Documents Submitted By Amgen For In Camera Review On April 19, 2007 In Connection With Amgen's Motion To Permit Submission To The ITC by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 419 JOINT STATEMENT of counsel to Propose Amendments to LR 16.1(D) Scheduling Order. (Toms, Keith) |
Filing 418 Opposition re #405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 417 EXHIBIT re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) Exhibit F by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 416 EXHIBIT re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) Exhibit E by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 415 EXHIBIT re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) Exhibit D by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 414 EXHIBIT re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) Exhibit B (Part 2 of 2) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 413 EXHIBIT re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) Exhibit B (Part 1 of 2) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 412 Receipt to Plaintiff Amgen Inc. for Documents Received on April 19, 2007. (Paine, Matthew) |
Filing 411 DECLARATION re #409 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Preclude Further Interference With Third-Party Discovery Of Richard Beswick by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 410 MEMORANDUM in Support re #409 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Preclude Further Interference With Third-Party Discovery filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 409 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets And Submitted In Connection With Amgen's Motion To Preclude Further Interference With Third-Party Discovery by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 408 NOTICE by Amgen Inc. OF SERVICE OF CONFIDENTIAL DOCUMENTS TO BE FILED IN SUPPORT OF PLAINTIFF AMGEN INC.'S MOTION TO PERMIT SUBMISSION OF MATERIALS PRODUCED IN THIS ACTION TO THE INTERNATIONAL TRADE COMMISSION AND THE FEDERAL CIRCUIT (Rich, Patricia) |
Filing 407 DECLARATION re #405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit BY MARIO MOORE by Amgen Inc.. (Attachments: #1 Exhibit 1 to 13 (Submitted for In Camera Review))(Rich, Patricia) |
Filing 406 MEMORANDUM in Support re #405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit filed by Amgen Inc.. (Rich, Patricia) |
Filing 405 MOTION To Permit Submission of Materials Produced in This Action to the International Trade Commission and The Federal Circuit by Amgen Inc..(Rich, Patricia) |
Filing 404 Receipt for Documents Returned to Plaintiff Amgen on April 19, 2007. (Paine, Matthew) |
Filing 403 Receipt for Documents Returned to Defendant F. Hoffman-La Roche on April 18, 2007. (Paine, Matthew) |
Filing 402 Opposition re #398 MOTION for Order to Amgen To Show Cause Why It Is Not In Contempt Of The Protective Order filed by Amgen Inc.. (Rich, Patricia) |
Filing 401 TRANSCRIPT of Proceedings held on 4/17/07 before Judge Young. Court Reporter: Womack. The original transcripts are maintained in the case file in the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Smith, Bonnie) |
Filing fee: $ 50.00, receipt number 79551 for #396 MOTION for Leave to Appear Pro Hac Vice for admission of Krista M. Rycroft. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #396 Motion for Leave to Appear Pro Hac Vice. Added Krista M. Rycroft for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Remark : A Non-Confidential Version of Exhibit 1 (4 Parts) Added to Docket Entry #368 Declaration of William G. Gaede, III. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 79551 for 396 MOTION for Leave to Appear Pro Hac Vice for admission of Krista M. Rycroft. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 396 Motion for Leave to Appear Pro Hac Vice. Added Krista M. Rycroft for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Remark : A Non-Confidential Version of Exhibit 1 (4 Parts) Added to Docket Entry 368 Declaration of William G. Gaede, III. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 353 Amended MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6). "Motion DENIED. As All Expert Testimony Will Be Limited to the Matters Disclosed In The Expert Reports, There Is No Need For This Deposition." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #353 Amended MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6). "Motion DENIED. As All Expert Testimony Will Be Limited to the Matters Disclosed In The Expert Reports, There Is No Need For This Deposition." (Paine, Matthew) |
Filing 400 Opposition re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege filed by Amgen Inc.. (Rich, Patricia) |
Filing 399 MEMORANDUM in Support re #398 MOTION for Order to Amgen To Show Cause Why It Is Not In Contempt Of The Protective Order filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Huston, Julia) |
Filing 398 MOTION for Order to Amgen To Show Cause Why It Is Not In Contempt Of The Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered GRANTING 395 Motion for Leave to Appear Pro Hac Vice. Added Christopher T. Jagoe for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #395 Motion for Leave to Appear Pro Hac Vice. Added Christopher T. Jagoe for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defense counsel Ben-Ami are present.Hearing re Markman held on 4/17/2007. The Court hears argument on various claim constructions and makes ruling. After the Markman hearing the court addresses some issues pending. The parties agree to the deposition of Strickland.The defendant has 2 weeks to reply to plaintiff's expert report. The defendant has 30 days from today to answer interrogatories. The Court rules Motion to Compel(#336) is allowed in part, denied in part. (Court Reporter Womack.) (Smith, Bonnie) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Plaintiff's counsel Day and Defense counsel Ben-Ami are present.Hearing re Markman held on 4/17/2007. The Court hears argument on various claim constructions and makes ruling. After the Markman hearing the court addresses some issues pending. The parties agree to the deposition of Strickland.The defendant has 2 weeks to reply to plaintiff's expert report. The defendant has 30 days from today to answer interrogatories. The Court rules Motion to Compel(#336) is allowed in part, denied in part. (Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered GRANTING 375 MOTION for Leave to File Reply to Amgen Inc.'s Opposition to Defendants' Motion to Compel Continued Deposition of Dr. Thomas Strickland and Production of Documents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #375 MOTION for Leave to File Reply to Amgen Inc.'s Opposition to Defendants' Motion to Compel Continued Deposition of Dr. Thomas Strickland and Production of Documents; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 397 ANSWER to Counterclaim of Defendants by Amgen Inc..(Gottfried, Michael) |
Filing 396 MOTION for Leave to Appear Pro Hac Vice for admission of Krista M. Rycroft by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 395 MOTION for Leave to Appear Pro Hac Vice for admission of Christopher T. Jagoe Filing fee $ 50, receipt number 1485343. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 394 RESPONSE to Motion re #370 MOTION for Leave to File a Response to the Court's Questions Regarding Precedential Effect of Prior Claim Constructions and a Reply to Defendants' Reply Brief Regarding Claim Construction on the Application of Stare Decisis to the Claim Construction to be held by this Court filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 393 Opposition re #353 Amended MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 392 Receipt to Plaintiff Amgen for documents received on April 16, 2007. (Paine, Matthew) |
Filing 391 NOTICE by Amgen Inc. re #379 Declaration,,, of Service of Confidential Documents (Gottfried, Michael) |
Filing 390 Receipt to Defendants F. Hoffman-La Roche Ltd. et al for documents received on April 13, 2007. (Paine, Matthew) |
Filing 389 Receipt to Plaintiff for documents received on April 13, 2007. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: #379 Declaration Corrected Because: Confidential Exhibits Were Filed With the Declaration in Error and The Exhibits Were Removed From the Docket. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #366 MOTION To Deem Its Opposition To Defendants' Motion To Compel Production of Documents Improperly Withheld on Grounds of Privilege and Exhibit 1 to the Opposition Confidential. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 366 MOTION To Deem Its Opposition To Defendants' Motion To Compel Production of Documents Improperly Withheld on Grounds of Privilege and Exhibit 1 to the Opposition Confidential. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 379 Declaration Corrected Because: Confidential Exhibits Were Filed With the Declaration in Error and The Exhibits Were Removed From the Docket. (Paine, Matthew) |
Filing 388 DECLARATION re #386 Memorandum in Support of Motion,, #385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports OF DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4, Part 1 of 2#5 Exhibit 4, Part 2 of 2#6 Exhibit 5#7 Exhibit 6#8 Exhibit 7#9 Exhibit 8#10 Exhibit 9#11 Exhibit 10#12 Exhibit 11#13 Exhibit 12#14 Exhibit 13#15 Exhibit 14#16 Exhibit 15#17 Exhibit 16#18 Exhibit 17#19 Exhibit 18)(Gottfried, Michael) |
Filing 387 MOTION for Leave to File A Reply To Defendants' Opposition To Amgen Inc's Motion To Deem Its Opposition To Defendants' Motion To Compel Production Of Documents Improperly Withheld On The Grounds Of Privilege And Exhibit 1 To The Opposition Confidential by Amgen Inc.. (Attachments: #1 Exhibit A)(Rich, Patricia) |
Filing 386 MEMORANDUM in Support re #385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports filed by Amgen Inc.. (Attachments: #1 Appendix A#2 Appendix B#3 Appendix C)(Gottfried, Michael) |
Filing 385 MOTION to Strike Belately Disclosed Invalidity and Unenforceability Allegations and for More Time to Respond to Roche's Expert Reports by Amgen Inc..(Gottfried, Michael) |
Filing 384 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Allegedly Confidential Documents to be Filed in Support of Defendants' Motion to Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) (Toms, Keith) |
Filing 383 DECLARATION re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) of Keith E. Toms by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F)(Toms, Keith) |
Filing 382 MEMORANDUM in Support re #381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 381 MOTION To Enforce the Court's March 27, 2007 Order and to Compel Deposition Testimony under Rule 30(b)(6) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 380 NOTICE by Amgen Inc. re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1), #378 Memorandum in Support of Motion,, #379 Declaration,,, (Gottfried, Michael) |
Filing 379 DECLARATION re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1), #378 Memorandum in Support of Motion, OF MARIO MOORE by Amgen Inc.. (Attachments: #1 Confidential Exhibit Coversheet#2 Exhibit 1#3 Exhibit 2#4 Exhibit 3# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7# 8 Exhibit 8# 9 Exhibit 9, Part 1 of 2# 10 Exhibit 9, Part 2 of 2# 11 Exhibit 10# 12 Exhibit 11# 13 Exhibit 12# 14 Exhibit 15# 15 Exhibit 16# 16 Exhibit 17# 17 Exhibit 18#18 Exhibit 19#19 Exhibit 20#20 Exhibit 21#21 Exhibit 22#22 Exhibit 25#23 Exhibit 26#24 Exhibit 27# 25 Exhibit 28# 26 Exhibit 29#27 Exhibit 30)(Gottfried, Michael) Additional attachment(s) added on 4/16/2007 (Paine, Matthew). Additional attachment(s) added on 4/16/2007 (Paine, Matthew). |
Filing 378 MEMORANDUM in Support re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1) by Amgen Inc..(Gottfried, Michael) |
Filing 376 APPENDIX/EXHIBIT re #338 Memorandum in Support of Motion, to Compel Production of Documents Improperly Withheld on Grounds of Privilege [Appendix C] by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 375 MOTION for Leave to File Reply to Amgen Inc.'s Opposition to Defendants' Motion to Compel Continued Deposition of Dr. Thomas Strickland and Production of Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 374 Opposition re #366 MOTION To Deem Its Opposition To Defendants' Motion To Compel Production of Documents Improperly Withheld on Grounds of Privilege and Exhibit 1 to the Opposition Confidential filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 373 Opposition re #370 MOTION for Leave to File a Response to the Court's Questions Regarding Precedential Effect of Prior Claim Constructions and a Reply to Defendants' Reply Brief Regarding Claim Construction filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 372 DECLARATION re #371 Opposition to Motion, OF DR. JONATHAN LOEB IN SUPPORT OF AMGEN INC.'S OPPOSITION TO DEFENDANTS' MOTION TO COMPEL CONTINUED DEPOSITION OF DR. THOMAS STRICKLAND AND PRODUCTION OF RELATED DOCUMENTS by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12)(Gottfried, Michael) |
Filing 371 Opposition re #340 MOTION to Compel Continued Deposition of Dr. Thomas Strickland and Production of Related Documents filed by Amgen Inc.. (Attachments: #1 Appendix A (part 1 of 4)#2 Appendix A (2 of 4)#3 Appendix A (part 3 of 4)#4 Appendix A (part 4 of 4))(Gottfried, Michael) |
Filing 370 MOTION for Leave to File a Response to the Court's Questions Regarding Precedential Effect of Prior Claim Constructions and a Reply to Defendants' Reply Brief Regarding Claim Construction by Amgen Inc.. (Attachments: #1 Exhibit 1, Part 1 of 2 (Response and Reply)#2 Exhibit 1 Part 2 of 2 (Appendix A to Response and Reply))(Rich, Patricia) |
Filing 369 Receipt to Plaintiff for documents received on April 11, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 360 MOTION for Extension of Time to June 5, 2007 to Extend Time to Serve Its Experts' Reports Regarding Testing of Roche's Late-Produced Cell Line (Renewed Motion). "MOTION ALLOWED TO THE EXTENT OF PERMITTING AMGEN UNTIL APRIL 30, 2007 TO PRODUCE THE REQUISITE REPORTS. THERE WILL BE NO FURTHER EXTENSIONS." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #360 MOTION for Extension of Time to June 5, 2007 to Extend Time to Serve Its Experts' Reports Regarding Testing of Roche's Late-Produced Cell Line (Renewed Motion). "MOTION ALLOWED TO THE EXTENT OF PERMITTING AMGEN UNTIL APRIL 30, 2007 TO PRODUCE THE REQUISITE REPORTS. THERE WILL BE NO FURTHER EXTENSIONS." (Paine, Matthew) |
Filing 368 DECLARATION re #367 Opposition to Motion of Defendants' Motion to Compel Production of Documents Improperly Withheld on Grounds of Privilege submitted by William G. Gaede, III, by Amgen Inc.. (Attachments: # 1 Exhibit Exhibit 1 (submitted in camera to the court)#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5)(Gottfried, Michael) Additional attachment(s) added on 4/18/2007 (Paine, Matthew). |
Filing 367 Opposition re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege filed by Amgen Inc.. (Gottfried, Michael) |
Filing 366 MOTION To Deem Its Opposition To Defendants' Motion To Compel Production of Documents Improperly Withheld on Grounds of Privilege and Exhibit 1 to the Opposition Confidential by Amgen Inc..(Gottfried, Michael) |
Filing 365 NOTICE by Amgen Inc. Notice of Service of Confidential Documents to be Filed in Support of Declaration of William G. Gaede, III, in Support of Amgen Inc.'s Opposition to Defendants' Motion to Compel Production of Documents Improperly Withheld on Grounds of Privilege (Gottfried, Michael) |
Filing 364 Opposition re #360 MOTION for Extension of Time to June 5, 2007 to Extend Time to Serve Its Experts' Reports Regarding Testing of Roche's Late-Produced Cell Line (THIS IS A RENEWED MOTION) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7)(Rizzo, Nicole) |
Filing 363 Receipt for Documents Returned on April 10, 2007 to Amgen. (Paine, Matthew) |
ELECTRONIC NOTICE OF RESCHEDULING ****AS TO TIME ONLY*** Markman Hearing set for 4/17/2007 10:00 AM in Courtroom 18 before Judge William G. Young. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered DENYING #349 MOTION to Compel Depositions and Documents. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 349 MOTION to Compel Depositions and Documents. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 356 Opposition re 331 MOTION to Compel Depositions and Documents, Relating to Pegylation and Aranesp Corrected Because: The Opposition Was Linked to Motion 349 on the Docket Incorrectly and Should Have Been Linked to Motion 331 . (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: #356 Opposition re #331 MOTION to Compel Depositions and Documents, Relating to Pegylation and Aranesp Corrected Because: The Opposition Was Linked to Motion #349 on the Docket Incorrectly and Should Have Been Linked to Motion #331 . (Paine, Matthew) |
Filing 362 Receipt to Plaintiff for documents received on April 6, 2007. (Paine, Matthew) |
Filing 361 MEMORANDUM in Support re #360 MOTION for Extension of Time to June 5, 2007 to Extend Time to Serve Its Experts' Reports Regarding Testing of Roche's Late-Produced Cell Line (THIS IS A RENEWED MOTION) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 360 MOTION for Extension of Time to June 5, 2007 to Extend Time to Serve Its Experts' Reports Regarding Testing of Roche's Late-Produced Cell Line (THIS IS A RENEWED MOTION) by Amgen Inc..(Gottfried, Michael) |
Filing 359 NOTICE by Amgen Inc. - Notice of Service of Confidential Document to be Filed in Support of The Declaration of John A. Lee in Support of Amgen Inc.'s Opposition to Defendants' Motion to Compel the Production of Documents, and Deposition Testimony Pursuant to Rule 30(b)(6), Relating to Pegylation and Aranesp (Gottfried, Michael) |
Filing 358 DECLARATION re #356 Opposition to Motion OF JOHN A. LEE In Support of Amgen Inc.'s Opposition to Defendants' Motion to Compel the Production of Documents, and Deposition Testimony Pursuant to Rule 30(b)(6), Relating to Pegylation and Aranesp by Amgen Inc.. (Attachments: #1 Exhibit 1 Cover Sheet (Exhibit Submitted In Camera)#2 Exhibit 2)(Gottfried, Michael) |
Filing 357 DECLARATION re #356 Opposition to Motion OF WENDY A. WHITEFORD In Support of Amgen Inc.'s Opposition to Defendants' Motion to Compel the Production of Documents, and Deposition Testimony Pursuant to Rule 30(b)(6), Relating to Pegylation and Aranesp by Amgen Inc.. (Gottfried, Michael) |
Filing 356 Opposition re #331 MOTION to Compel Depositions and Documents , Relating to Pegylation and Aranesp filed by Amgen Inc.. (Gottfried, Michael) |
Filing 355 NOTICE of Appearance by Lauren M. Papenhausen on behalf of Amgen Inc., Amgen Inc. (Papenhausen, Lauren) |
Filing 354 MEMORANDUM in Support re #353 Amended MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 353 Amended MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered re 336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege. "Motion DENIED As To The Privilege Log Itself. That Is Public. The Remainder Of The Motion Is Taken Under Advisement." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege. "Motion DENIED As To The Privilege Log Itself. That Is Public. The Remainder Of The Motion Is Taken Under Advisement." (Paine, Matthew) |
Filing 352 MOTION for Leave to File a Reply to Defendants' Opposition to Amgen Inc.'s Motion to Deem Documents and Memorandum Confidential That Defendants Filed With Their Motion to Compel Production of Documents Improperly Withheld on the Grounds of Privilege by Amgen Inc.. (Attachments: #1 Exhibit A - Proposed Reply)(Gottfried, Michael) |
Notice of correction to docket made by Court staff. Correction: #349 Motion to Compel Depositions and Documents Corrected Because: The Motion Had Typographical Errors and Was Replaced With a Corrected Version on the Docket. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 349 Motion to Compel Depositions and Documents Corrected Because: The Motion Had Typographical Errors and Was Replaced With a Corrected Version on the Docket. (Paine, Matthew) |
Filing 351 Opposition re #345 MOTION to Deem Documents and Memorandum Confidential that Defendants' Filed re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 350 MEMORANDUM in Support re #349 MOTION to Compel Depositions and Documents and Interrogatory Answers filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G)(Rizzo, Nicole) |
Filing 349 MOTION to Compel Depositions and Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) Additional attachment(s) added on 4/3/2007 (Paine, Matthew). |
Filing 348 DECLARATION re #346 MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) and Other Relief of Mark Izraelewicz by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3)(Gottfried, Michael) |
Filing 347 MEMORANDUM in Support re #346 MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) and Other Relief filed by Amgen Inc.. (Gottfried, Michael) |
Filing 346 MOTION to Compel Roche to Produce Witnesses for Deposition Under Rule 30(b)(6) and Other Relief by Amgen Inc..(Gottfried, Michael) |
Filing 345 MOTION to Deem Documents and Memorandum Confidential that Defendants' Filed re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege by Amgen Inc.. (Attachments: #1 Declaration of William G. Gaede, III)(Gottfried, Michael) |
ELECTRONIC NOTICE issued requesting courtesy copy for #343 Defendants' Reply in Opposition to Amgen Inc.'s Claims Construction Brief [DN 323] - LEAVE TO FILE GRANTED ON 3/30/07,, #344 Amended Answer to Complaint, Counterclaim. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 343 Defendants' Reply in Opposition to Amgen Inc.'s Claims Construction Brief [DN 323] - LEAVE TO FILE GRANTED ON 3/30/07,, 344 Amended Answer to Complaint, Counterclaim. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Filing 344 AMENDED ANSWER to #52 Amended Complaint,, Amended COUNTERCLAIM against Amgen Inc. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 343 Defendants' Reply in Opposition to Amgen Inc.'s Claims Construction Brief [DN 323] - LEAVE TO FILE GRANTED ON 3/30/07 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #323 Response,,,,,. (Attachments: #1 Index of Exhibits#2 Exhibit RR#3 Exhibit SS (part 1)#4 Exhibit SS (part 2)#5 Exhibit TT#6 Exhibit UU#7 Exhibit UU-1#8 Exhibit UU-2#9 Exhibit UU-3)(Rizzo, Nicole) |
Filing 342 Judge William G. Young : ORDER entered. MEMORANDUM AND ORDER: "THIS COURT RULES THAT ROCHE/HOFFMANN HAS STANDING TO BRING COUNTERCLAIMS III, IV, AND V, AND THAT PRUDENCE COUNSELS DENYING THE DISMISSAL OF THE STATE LAW COUNTERCLAIMS AS WELL. AMGEN'S MOTION TO DISMISS THESE COUNTERCLAIMS IS THEREFORE DENIED. FURTHER, COUNTERCLAIM II AND AFFIRMATIVE DEFENSE XII ARE HEREBY DISMISSED." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #339 MOTION for Leave to File Reply in Opposition to Amgen Inc.'s Claims Construction Brief; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 339 MOTION for Leave to File Reply in Opposition to Amgen Inc.'s Claims Construction Brief; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
ELECTRONIC NOTICE RE-SCHEDULING MEDIATION FROM 6/21/07 TO 6/12/2007 10:15 AM in Courtroom 23 before Magistrate Judge Robert B. Collings. (Dolan, Kathleen) |
Filing 341 MEMORANDUM in Support re #340 MOTION to Compel Continued Deposition of Dr. Thomas Strickland and Production of Related Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I)(Rizzo, Nicole) |
Filing 340 MOTION to Compel Continued Deposition of Dr. Thomas Strickland and Production of Related Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 339 MOTION for Leave to File Reply in Opposition to Amgen Inc.'s Claims Construction Brief by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Judge William G. Young : Electronic ORDER entered re 316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche. "MOTION ALLOWED UPON THE FOLLOWING TERMS: THE ANSWER TO THESE THREE INTERROGATORIES SHALL BE SUPPLEMENTED WITHIN 30 DAYS AFTER COMPLETION OF THIS COURT'S CLAIM CONSTRUCTION." (Paine, Matthew) |
ELECTRONIC NOTICE OF RESCHEDULING**** AS TO TIME ONLY***** Markman Hearing set for 4/17/2007 will be at 09:00 AM in Courtroom 18 before Judge William G. Young. (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered re #316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche. "MOTION ALLOWED UPON THE FOLLOWING TERMS: THE ANSWER TO THESE THREE INTERROGATORIES SHALL BE SUPPLEMENTED WITHIN 30 DAYS AFTER COMPLETION OF THIS COURT'S CLAIM CONSTRUCTION." (Paine, Matthew) |
Filing 338 MEMORANDUM in Support re #336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A#2 Appendix B (part 1)#3 Appendix B (part 2)#4 Appendix C#5 Appendix D (part 1)#6 Appendix D (part 2)#7 Appendix D (part 3)#8 Appendix D (part 4))(Kann, Robert) |
Filing 337 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. of Service of Allegedly Confidential Documents to be Filed in Support of Defendants' Motion to Compel Production of Doucments Improperly Withheld on Grounds of Privilege [DN 336] (Kann, Robert) |
Filing 336 MOTION to Compel Production of Documents Improperly Withheld on Grounds of Privilege by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Kann, Robert) |
Filing 335 Opposition re #316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Huston, Julia) |
Filing 334 NOTICE OF AND ORDER REGARDING MEDIATION set for 6/21/2007 at 10:15 AM in Courtroom 23 before Magistrate Judge Robert B. Collings. (Dolan, Kathleen) |
Judge William G. Young : Electronic ORDER entered GRANTING #319 MOTION to Compel Deposition Testimony under Rule 30(b)(6). (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 319 MOTION to Compel Deposition Testimony under Rule 30(b)(6). (Paine, Matthew) |
Filing 333 DECLARATION re #331 MOTION to Compel Production of Documents, and Deposition Testimony Under Rule 30(b)(6), Relating to Pegylation and Aranesp of Keith E. Toms, Esq. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I#10 Appendix A)(Toms, Keith) |
Filing 332 MEMORANDUM in Support re #331 MOTION to Compel Production of Documents, and Deposition Testimony Under Rule 30(b)(6), Relating to Pegylation and Aranesp filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 331 MOTION to Compel Production of Documents, and Deposition Testimony Under Rule 30(b)(6), Relating to Pegylation and Aranesp by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 330 NOTICE of Appearance by Robert L. Kann on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Kann, Robert) |
Filing 329 AFFIDAVIT in Support re #328 Opposition to Motion to Compel Deposition Testimony Under Rule 30(b)(6) and Cross-Motion for a Protective Order. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12)(Gottfried, Michael) |
Filing 328 Opposition re #319 MOTION to Compel Deposition Testimony under Rule 30(b)(6) and Cross-Motion for a Protective Order filed by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B (proposed order))(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING #327 Motion for Leave to Appear Pro Hac Vice Added Erica S. Olson for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 327 Motion for Leave to Appear Pro Hac Vice Added Erica S. Olson for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 78999 for 327 MOTION for Leave to Appear Pro Hac Vice for admission of Erica S. Olson. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 78999 for #327 MOTION for Leave to Appear Pro Hac Vice for admission of Erica S. Olson. (Paine, Matthew) |
Filing 327 MOTION for Leave to Appear Pro Hac Vice for admission of Erica S. Olson by Amgen Inc.. (Attachments: #1 Affidavit of Erica S. Olson)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered denying #258 Motion for Reconsideration, denying #287 Motion to Seal, denying #290 Motion to Seal (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: #322 Objection to 312 Brief,,, by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Opposition to Amgen's Claims Construction Brief Corrected Because: The Exhibits Were Not Placed In the Correct Location Within the Brief. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered denying 258 Motion for Reconsideration, denying 287 Motion to Seal, denying 290 Motion to Seal (Smith, Bonnie) |
Notice of correction to docket made by Court staff. Correction: 322 Objection to 312 Brief,,, by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Opposition to Amgen's Claims Construction Brief Corrected Because: The Exhibits Were Not Placed In the Correct Location Within the Brief. (Paine, Matthew) |
Filing 326 JOINT STATEMENT of counsel on Mediation Issues. (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered re 304 ? MOTION to Amend Defendants' Sixth Affirmative Defense. " Motion ALLOWED But The Time For Discovery and Other Pre-Trial Scheduled Dates Are Not Extended. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #304 ? MOTION to Amend Defendants' Sixth Affirmative Defense. " Motion ALLOWED But The Time For Discovery and Other Pre-Trial Scheduled Dates Are Not Extended. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for #325 Declaration,,,, #323 Response,,,,,, #322 Objection, #324 Withdrawal of motion,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. . (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 325 Declaration,,,, 323 Response,,,,,, 322 Objection, 324 Withdrawal of motion,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. . (Paine, Matthew) |
Filing 325 DECLARATION re #322 Objection in Support of Defnendants' Opposition to Amgen's Claims Construction Brief by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit T#2 Exhibit U Part 1#3 Exhibit U Part 2#4 Exhibit U Part 3#5 Exhibit U Part 4#6 Exhibit V#7 Exhibit W#8 Exhibit X#9 Exhibit Y#10 Exhibit Z#11 Exhibit AA Part 1#12 Exhibit AA Part 2#13 Exhibit BB#14 Errata CC#15 Exhibit DD#16 Exhibit EE#17 Exhibit FF#18 Exhibit GG#19 Exhibit HH#20 Exhibit II Part 1#21 Exhibit II Part 2#22 Exhibit JJ#23 Exhibit KK#24 Exhibit LL#25 Exhibit MM#26 Exhibit NN#27 Exhibit OO#28 Exhibit PP Part 1#29 Exhibit PP Part 2#30 Exhibit QQ)(Fleming, Thomas) |
Filing 324 Withdrawal of motion: #308 Cross MOTION to Compel Third Party Fresenius Medical Care North America to Comply with Subpoena and Agreement to Produce filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,.. (Toms, Keith) |
Filing 323 Response by Amgen Inc. to #311 Brief (Defendants' Claim Construction Brief). (Attachments: #1 Exhibit 1-Declaration of Harvey Lodish in Support of Defendants' Claim Construction Brief#2 Exhibit A-to Lodish Declaration#3 Exhibit B-Part 1 of 2 to Lodish Declaration#4 Exhibit B-Part 2 of 2 to Lodish Declaration#5 Exhibit C-to Lodish Declaration#6 Exhibit D- to Lodish Declaration#7 Exhibit E - Part 1 of 2 - to Lodish Declaration#8 Exhibit E-Part 2 of 2 - to Lodish Declaration#9 Exhibit 2 - Declaration of Vladimir Torchilin, Ph.D, D.Sc.#10 Exhibit A-to Torchilin Declaration#11 Exhibit B-Part 1 of 5 - to Torchilin Declaration#12 Exhibit B- Part 2 of 5 to Torchilin Declaration#13 Exhibit B-Part 3 of 5 to Torchilin Declaration#14 Exhibit B-Part 4 of 5 to Torchilin Declaration#15 Exhibit B-Part 5 of 5 to Torchilin Declaration#16 Exhibit C- Part 1 of 2 to Torchilin Declaration#17 Exhibit C-Part 2 of 2 to Torchilin Declaration#18 Exhibit D-Part 1 of 2 to Torchilin Declaration#19 Exhibit D-Part 2 of 2 to Torchilin Declaration#20 Exhibit E - Part 1 of 3 to Torchilin Declaration#21 Exhibit E-Part 2 of 3 to Torchilin Declaration#22 Exhibit E - Part 3 of 3 to Torchilin Declaration#23 Exhibit F to Torchilin Declaration#24 Exhibit 3)(Gottfried, Michael) |
Filing 322 Objection to #312 Brief,,, by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Opposition to Amgen's Claims Construction Brief. (Fleming, Thomas) Additional attachment(s) added on 3/21/2007 (Paine, Matthew). |
Filing 321 Opposition re #304 MOTION to Amend Defendants' Sixth Affirmative Defense filed by Amgen Inc.. (Rich, Patricia) |
Filing 320 MEMORANDUM in Support re #319 MOTION to Compel Deposition Testimony under Rule 30(b)(6) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G)(Huston, Julia) |
Filing 319 MOTION to Compel Deposition Testimony under Rule 30(b)(6) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
ELECTRONIC NOTICE of Hearing : Markman Hearing set for TUESDAY 4/17/2007 02:00 PM in Courtroom 18 before Judge William G. Young. (Smith, Bonnie) |
Filing 318 DECLARATION re #316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche of William A. Gaede, III by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7)(Gottfried, Michael) |
Filing 317 MEMORANDUM in Support re #316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche filed by Amgen Inc.. (Gottfried, Michael) |
Filing 316 MOTION to Compel a Complete Response to Interrogatories 9, 10, and 11 to Roche by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young : Electronic GRANTING #315 Motion for Leave to Appear Pro Hac Vice. Added David L. Cousineau for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic GRANTING 315 Motion for Leave to Appear Pro Hac Vice. Added David L. Cousineau for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Filing 315 MOTION for Leave to Appear Pro Hac Vice for admission of David L. Cousineau Filing fee $ 50, receipt number 1442307. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 314 MANDATE of USCA as to #149 Notice of Appeal to the Federal Circuit filed by Ortho Biotech Products, L.P. The parties having so agreed, it is ORDERED that the proceedings is DISMISSED under Fed. R. App. P. 42(b). (Mandate issued in the USCA 2/28/2007). (Ramos, Jeanette) |
ELECTRONIC NOTICE issued requesting courtesy copy for #313 Declaration,,, #312 Brief,,,, #311 Brief. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
ELECTRONIC NOTICE issued requesting courtesy copy for 313 Declaration,,, 312 Brief,,,, 311 Brief. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
Filing 313 DECLARATION re #311 Brief in Support of Proposed Claim Construction by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C part 1#4 Exhibit C part 2#5 Exhibit D part 1#6 Exhibit D part 2#7 Exhibit E part 1#8 Exhibit E part 2#9 Exhibit F#10 Exhibit G part 1#11 Exhibit G part 2#12 Exhibit H#13 Exhibit I#14 Exhibit J#15 Exhibit K#16 Exhibit L#17 Exhibit M part 1#18 Exhibit M part 2#19 Exhibit N#20 Exhibit O#21 Exhibit P part 1#22 Exhibit P part 2#23 Exhibit Q#24 Exhibit R#25 Exhibit S)(Fleming, Thomas) |
Filing 312 BRIEF by Amgen Inc. CLAIMS CONSTRUCTION BRIEF. (Attachments: #1 Appendix A#2 Appendix B(part 1 of 4)#3 Appendix B (Part 2 of 4)#4 Appendix B (part 3 of 4)#5 Appendix B (Part 4 of 4)#6 Exhibit 1#7 Exhibit 2#8 Exhibit 3#9 Exhibit 4#10 Exhibit 5#11 Exhibit 6 (Part 1 of 2)#12 Exhibit 6 (Part 2 of 2)#13 Exhibit 7#14 Exhibit 8#15 Exhibit 9 (Part 1 of 2)#16 Exhibit 9 (Part 2 of 2)#17 Exhibit 10#18 Exhibit 11 (Part 1 of 2)#19 Exhibit 11 (Part 2 of 2)#20 Exhibit 12#21 Exhibit 13#22 Exhibit 14 (Part 1 of 2)#23 Exhibit 14 (Part 2 of 2)#24 Exhibit 15#25 Exhibit 16#26 Exhibit 17#27 Exhibit 18#28 Exhibit 19 (Part 1 of 2)#29 Exhibit 19 (Part 2 of 2)#30 Exhibit 20#31 Exhibit 21#32 Exhibit 22#33 Exhibit 23#34 Exhibit 24#35 Exhibit 25#36 Exhibit 26)(Gottfried, Michael) |
Filing 311 BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Opening Brief in Support of Proposed Claim Construction. (Fleming, Thomas) |
Filing 310 DECLARATION re #308 Cross MOTION to Compel Third Party Fresenius Medical Care North America to Comply with Subpoena and Agreement to Produce, #309 Memorandum in Opposition to Motion, of Julian Brew by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A and Exhibit B#2 Exhibit C through Exhibit M)(Toms, Keith) |
Filing 309 MEMORANDUM in Opposition re #307 MOTION for Extension of Time to produce certain documents containing third party information, #306 MOTION for Protective Order and in Support of #308 Defendants' Cross Motion to Compel Third Party Fresenius Medical Care North America to Comply with Subpoena and Agreement to Produce filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 308 Cross MOTION to Compel Third Party Fresenius Medical Care North America to Comply with Subpoena and Agreement to Produce by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Judge William G. Young : Electronic ORDER entered GRANTING 306 Motion for Protective Order and GRANTING 307 Motion for Extension of Time to Produce Certain Documents Containing Third Party Information. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #306 Motion for Protective Order and GRANTING #307 Motion for Extension of Time to Produce Certain Documents Containing Third Party Information. (Paine, Matthew) |
Filing 307 MOTION for Extension of Time to produce certain documents containing third party information by Amgen Inc..(Rich, Patricia) |
Filing 306 MOTION for Protective Order by Fresenius Medical Care Holdings, Inc. (FMC). (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G)(Hebert, Mark) |
Filing 305 MEMORANDUM in Support re #304 MOTION to Amend Defendants' Sixth Affirmative Defense filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 304 MOTION to Amend Defendants' Sixth Affirmative Defense by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered re 281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents. "Motion DENIED. Hoffman-La Roche's Position is Correct." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #303 Motion for Leave to File Excess Pages. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents. "Motion DENIED. Hoffman-La Roche's Position is Correct." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 303 Motion for Leave to File Excess Pages. (Paine, Matthew) |
Filing 303 Joint MOTION for Leave to File Excess Pages of Markman Briefs by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 302 Receipt for Documents Returned on March 1, 2007 to Amgen. (Paine, Matthew) |
Filing 301 Opposition re #281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Judge William G. Young : Electronic ORDER entered GRANTING re #300 Assented to MOTION for Extension of Time to COMPLETE PRODUCTION OF ALL RESPONSIVE DOCUMENTS FROM MARCH 2 TO MARCH 9, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re 300 Assented to MOTION for Extension of Time to COMPLETE PRODUCTION OF ALL RESPONSIVE DOCUMENTS FROM MARCH 2 TO MARCH 9, 2007. (Paine, Matthew) |
Filing 300 Assented to MOTION for Extension of Time to COMPLETE PRODUCTION OF ALL RESPONSIVE DOCUMENTS FROM MARCH 2 TO MARCH 9, 2007 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Judge William G. Young : Electronic ORDER entered re #275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission by Amgen Inc. " Motion Denied, Save That The Responses to Request 3-15, 17, and 18 Shall Be Supplemented Within 30 Days of the Date of the Markman Claim Constructions. This Ruling Has Been Made Without Any Reference to the So-Called Confidential Documents, A Procedure Which - It Is Becoming Increasingly Apparent - Is Being Employed Solely to Harass and Embarrass An Opposing Litigant and Cause Waste of Resources. This Court Will Not Continue to Tolerate Such Litigation Conduct." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission by Amgen Inc. " Motion Denied, Save That The Responses to Request 3-15, 17, and 18 Shall Be Supplemented Within 30 Days of the Date of the Markman Claim Constructions. This Ruling Has Been Made Without Any Reference to the So-Called Confidential Documents, A Procedure Which - It Is Becoming Increasingly Apparent - Is Being Employed Solely to Harass and Embarrass An Opposing Litigant and Cause Waste of Resources. This Court Will Not Continue to Tolerate Such Litigation Conduct." (Paine, Matthew) |
Filing 299 Opposition re #275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 298 Judge William G. Young : ORDER entered."Modified ORDER Regarding Production of the Parties' Cell Lines and Applicable Restrictions of Use." (Paine, Matthew) |
Motions terminated: 296 Cross MOTION to Compel Production Of Amgen's Cell Lines And Related Documents filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,, and 293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line filed by Amgen Inc.,. (Paine, Matthew) |
Motions terminated: #296 Cross MOTION to Compel Production Of Amgen's Cell Lines And Related Documents filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,, and #293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line filed by Amgen Inc.,. (Paine, Matthew) |
Filing 297 Opposition re #293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line, #296 Cross MOTION to Compel Production Of Amgen's Cell Lines And Related Documents and MEMORANDUM IN SUPPORT OF DEFENDANTS? CROSS MOTION TO COMPEL PRODUCTION OF AMGEN?S CELL LINES filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12)(Rizzo, Nicole) |
Filing 296 Cross MOTION to Compel Production Of Amgen's Cell Lines And Related Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Judge Robert B. Collings: Electronic ORDER entered re: #280 Order Referring Case to ADR. Counsel are ORDERED to confer in an effort to reach agreement as to WHEN it would be most advantageous and convenient to convene a mediation session in the above-styled cause, HOW MUCH TIME the Court should allot for the mediation, and WHERE it would be most convenient to counsel and the parties to hold the mediation. If agreement can be reached as to the WHEN, counsel shall also submit to the Court a list of five dates which are convenient to all during the time period agreed upon. Counsel are ORDERED to file and serve a joint report on these issues on or before the close of business on MARCH 20, 2007. |
Judge Robert B. Collings: Electronic ORDER entered re: 280 Order Referring Case to ADR. Counsel are ORDERED to confer in an effort to reach agreement as to WHEN it would be most advantageous and convenient to convene a mediation session in the above-styled cause, HOW MUCH TIME the Court should allot for the mediation, and WHERE it would be most convenient to counsel and the parties to hold the mediation. If agreement can be reached as to the WHEN, counsel shall also submit to the Court a list of five dates which are convenient to all during the time period agreed upon. Counsel are ORDERED to file and serve a joint report on these issues on or before the close of business on MARCH 20, 2007. |
Filing 295 DECLARATION re #293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line BY KRISTA M. CARTER by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13)(Gottfried, Michael) |
Filing 294 MEMORANDUM in Support re #293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line filed by Amgen Inc.. (Attachments: #1 Text of Proposed Order)(Gottfried, Michael) |
Filing 293 MOTION to Enforce the Court's January 23, 2007 Order Compelling Roche to Produce its Cell Line and to Extend the Time for Amgen to Submit its Infringement Expert Report Regarding the Testing of Roche's DN2-3(a)3 Cell Line by Amgen Inc..(Gottfried, Michael) |
Filing 292 DECLARATION re #290 MOTION to Seal Document Containing Defendants' Confidential and Trade Secret Materials of Krishnan Viswanadhan by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 291 MEMORANDUM in Support re #290 MOTION to Seal Document Containing Defendants' Confidential and Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 290 MOTION to Seal Document Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 289 DECLARATION re #287 MOTION to Seal Documents Containing Defendants' Confidential and Trade Secret Materials of Dr. Reinhard Franze by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 288 MEMORANDUM in Support re #287 MOTION to Seal Documents Containing Defendants' Confidential and Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 287 MOTION to Seal Documents Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 286 NOTICE of Appearance by Dana M. McSherry on behalf of Amgen Inc., Amgen Inc. (McSherry, Dana) |
ELECTRONIC NOTICE of assignment to ADR Provider. U.S. Magistrate Judge Robert B. Collings appointed. The Court will contact counsel with regard to scheduling. (Franklin, Yvonne) |
Filing 285 Receipt to Plaintiff for documents received 2/15/2007. (Paine, Matthew) |
Filing 284 NOTICE by Amgen Inc. OF SERVICE OF CONFIDENTIAL DOCUMENT TO BE FILED IN SUPPORT OF THE DECLARATION OF DEBORAH E. FISHMAN (Gottfried, Michael) |
Filing 283 DECLARATION re #281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents OF DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2 (cover page for confidential exhibit 2)#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12)(Gottfried, Michael) |
Filing 282 MEMORANDUM in Support re #281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents filed by Amgen Inc.. (Gottfried, Michael) |
Filing 281 MOTION to Enforce the Court's December 29, 2006 Order and To Compel the Further Production of Documents by Amgen Inc..(Gottfried, Michael) |
Filing 280 REFERRING CASE to Alternative Dispute Resolution.(Paine, Matthew) |
Filing 279 Receipt to Plaintiff for documents received 2/13/2007. (Paine, Matthew) |
Filing 278 NOTICE by Amgen Inc. re #277 Declaration,, #276 Memorandum in Support of Motion of Service of Confidential Documents to be filed in Support of Amgen's Motion to Determine Suffciency of Roche's Responses to Amgen's Requests for Admission (Gottfried, Michael) |
Filing 277 DECLARATION re #275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission of Krista M. Carter by Amgen Inc.. (Attachments: #1 Confidential Exhibits Coversheet#2 Exhibit 1#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 12)(Gottfried, Michael) |
Filing 276 MEMORANDUM in Support re #275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission (REDACTED VERSION) filed by Amgen Inc.. (Gottfried, Michael) |
Filing 275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission by Amgen Inc..(Gottfried, Michael) |
Filing 274 Judge William G. Young : ORDER entered. AMENDED PROTECTIVE ORDER. (Attachments: #1 Attachment A#2 Attachment B#3 Attachment C)(Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re 273 Joint MOTION to Amend 189 Order on Motion for Protective Order. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING re #273 Joint MOTION to Amend #189 Order on Motion for Protective Order. (Paine, Matthew) |
Filing 273 Joint MOTION to Amend #189 Order on Motion for Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered granting #271 Motion for Leave to Appear Pro Hac Vice Added Matthew McFarlane for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Jeanna Wacker for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Monica Contreras for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Alfred H. Heckel for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 271 Motion for Leave to Appear Pro Hac Vice Added Matthew McFarlane for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Jeanna Wacker for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Monica Contreras for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Alfred H. Heckel for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Filing 272 NOTICE of Appearance by Peter Fratangelo on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Attachments: #1 CERTIFICATE OF SERVICE)(Fratangelo, Peter) |
Filing 271 MOTION for Leave to Appear Pro Hac Vice for admission of Matthew McFarlane, Jeanna Wacker, Monica Contreras, and Alfred H. Heckel Filing fee $ 200, receipt number 1397802. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Toms, Keith) |
Judge William G. Young : Electronic GRANTING re #269 Motion for Leave to Appear Pro Hac Vice. Added Erik Haas for Ortho Biotech Products, L.P. (Paine, Matthew) |
Judge William G. Young : Electronic GRANTING re 269 Motion for Leave to Appear Pro Hac Vice. Added Erik Haas for Ortho Biotech Products, L.P. (Paine, Matthew) |
Filing 270 Opposition re #252 MOTION for Leave to File Amended Answer and Counterclaims filed by Amgen Inc.. (Rich, Patricia) |
Filing 269 MOTION for Leave to Appear Pro Hac Vice for admission of Erik Haas Filing fee $ 50, receipt number 1395312. by Ortho Biotech Products, L.P.. (Attachments: #1 Affidavit)(Repicky, Heather) |
Judge William G. Young : Electronic ORDER entered GRANTING #268 Motion for Leave to Appear Pro Hac Vice. Added Richard A. De Sevo for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 268 Motion for Leave to Appear Pro Hac Vice. Added Richard A. De Sevo for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Filing 268 MOTION for Leave to Appear Pro Hac Vice for admission of Richard A. De Sevo Filing fee $ 50, receipt number 1389140. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Judge William G. Young : Electronic ORDER entered re 254 MOTION to Compel the Production of Documents. "Motion ALLOWED as to Requests 61-64, 114-116 But Only Back To January 1, 2000, Requests 70-72, 74 But Not Necessarily In Native Format Although That Would Be Helpful. DENIED as to Requests 42-43, DENIED without Prejudice as to Requests 65,66,69 as Overbroad. Further Discovery is to Be Furnished Within 30 Days of the Date of This Order." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 263 Assented to MOTION for Extension of Time to Complete Production Of All Responsive Documents From February 16 To March 2, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #254 MOTION to Compel the Production of Documents. "Motion ALLOWED as to Requests 61-64, 114-116 But Only Back To January 1, 2000, Requests 70-72, 74 But Not Necessarily In Native Format Although That Would Be Helpful. DENIED as to Requests 42-43, DENIED without Prejudice as to Requests 65,66,69 as Overbroad. Further Discovery is to Be Furnished Within 30 Days of the Date of This Order." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #263 Assented to MOTION for Extension of Time to Complete Production Of All Responsive Documents From February 16 To March 2, 2007. (Paine, Matthew) |
Filing 267 Judge William G. Young : ORDER entered. Stipulated ORDER Regarding Expert Discovery. (Paine, Matthew) |
Filing 266 DECLARATION of William G. Gaede, III, In Support of Amgen Inc.'s Opposition to Defendants' Motion to Compel the Production of Documents by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8)(Gottfried, Michael) |
Filing 265 Opposition re #254 MOTION to Compel the Production of Documents filed by Amgen Inc.. (Gottfried, Michael) |
Filing 264 STIPULATION Of Proposed Order Regarding Expert Discovery by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 263 Assented to MOTION for Extension of Time to Complete Production Of All Responsive Documents From February 16 To March 2, 2007 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 262 Receipt for Documents Returned on January 23, 2007 to Amgen. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 222 MOTION to Compel Production of Roche's Cell Lines filed by Amgen Inc. "The Court Agrees That It Acted Prematurely And Thus Addresses Roche's Submission Not As A Motion For Reconsideration But Rather As A Response to Amgen's Motion to Compel. Upon Careful Consideration All Of The Submissions, the Court Allows Amgen's Motion to Compel Subject To The Extant Protective Order. Naturally, The Court Expects Amgen Will Afford Reciprocal Discovery Without The Necessity of a Motion." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re #222 MOTION to Compel Production of Roche's Cell Lines filed by Amgen Inc. "The Court Agrees That It Acted Prematurely And Thus Addresses Roche's Submission Not As A Motion For Reconsideration But Rather As A Response to Amgen's Motion to Compel. Upon Careful Consideration All Of The Submissions, the Court Allows Amgen's Motion to Compel Subject To The Extant Protective Order. Naturally, The Court Expects Amgen Will Afford Reciprocal Discovery Without The Necessity of a Motion." (Paine, Matthew) |
Filing 261 DECLARATION re #258 MOTION for Reconsideration and Opposition re 222 Motion to Compel Production of Roche's Cell Line and Related Documents by Patricia A. Carson by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C (1 of 3)#4 Exhibit C (2 of 3)#5 Exhibit C (3 of 3)#6 Exhibit D)(Toms, Keith) |
Filing 260 DECLARATION re #258 MOTION for Reconsideration and Opposition re 222 Motion to Compel Production of Roche's Cell Line and Related Documents by Dr. Reinhard Franze by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 259 MEMORANDUM in Support re #258 MOTION for Reconsideration and Opposition re 222 Motion to Compel Production of Roche's Cell Line and Related Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 258 MOTION for Reconsideration and Opposition re 222 Motion to Compel Production of Roche's Cell Line and Related Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Judge William G. Young : Electronic ORDER entered GRANTING #257 Motion for Leave to Appear Pro Hac Vice. Added Vladimir Drozdoff for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #235 Motion for Clarification. "No Clarification is Required. Naturally, No Party May Introduce In Evidence Any Document Called For In Discovery And Not Produced, Nor Any Data Derived From Such Document. Likewise, The Court Will View With Extreme Skepticism Any Late Profferred Discovery." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENNYING #247 MOTION to Seal A Document Containing Defendants' Confidential And Trade Secret Materials. "It Has Been Unnecessary to Consider This Document in Ruling on Amgen's Discovery Motion. Indeed, This Whole Business of Filing Allegedly Confidential Documents Anent Discovery Motions Is Proving A Massive Waste of Time. Amgen's Motion to Produce Cell Lines Docket No. #222 is ALLOWED, Subject to the Protective Order of Course." (Paine, Matthew) |
Motions terminated: #222 MOTION to Compel Production of Roche's Cell Lines filed by Amgen Inc.,. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re #250 MOTION to Seal Document Containing Defendants' Confidential And Trade Secret Materials. " DENIED as MOOT, the Court Having Acted On the Motion for Clarification. There is No Need to Review This Document With Respect to Any Pending Matter." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 257 Motion for Leave to Appear Pro Hac Vice. Added Vladimir Drozdoff for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 235 Motion for Clarification. "No Clarification is Required. Naturally, No Party May Introduce In Evidence Any Document Called For In Discovery And Not Produced, Nor Any Data Derived From Such Document. Likewise, The Court Will View With Extreme Skepticism Any Late Profferred Discovery." (Paine, Matthew) |
Motions terminated: 222 MOTION to Compel Production of Roche's Cell Lines filed by Amgen Inc.,. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 250 MOTION to Seal Document Containing Defendants' Confidential And Trade Secret Materials. " DENIED as MOOT, the Court Having Acted On the Motion for Clarification. There is No Need to Review This Document With Respect to Any Pending Matter." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENNYING 247 MOTION to Seal A Document Containing Defendants' Confidential And Trade Secret Materials. "It Has Been Unnecessary to Consider This Document in Ruling on Amgen's Discovery Motion. Indeed, This Whole Business of Filing Allegedly Confidential Documents Anent Discovery Motions Is Proving A Massive Waste of Time. Amgen's Motion to Produce Cell Lines Docket No. 222 is ALLOWED, Subject to the Protective Order of Course." (Paine, Matthew) |
Filing 257 MOTION for Leave to Appear Pro Hac Vice for admission of Vladimir Drozdoff Filing fee $ 50, receipt number 1376371. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 256 DECLARATION re #254 MOTION to Compel the Production of Documents of Keith E. Toms by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Toms, Keith) |
Filing 255 MEMORANDUM in Support re #254 MOTION to Compel the Production of Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A)(Toms, Keith) |
Filing 254 MOTION to Compel the Production of Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Filing 253 MEMORANDUM in Support re #252 MOTION for Leave to File Amended Answer and Counterclaims filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 252 MOTION for Leave to File Amended Answer and Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C (1 of 3)#4 Exhibit C (2 of 3)#5 Exhibit (3 of 3))(Toms, Keith) |
Filing 251 MEMORANDUM in Support re #250 MOTION to Seal Document Containing Defendants' Confidential And Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 250 MOTION to Seal Document Containing Defendants' Confidential And Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 249 DECLARATION re #247 MOTION to Seal A Document Containing Defendants' Confidential And Trade Secret Materials of Dr. Reinhard Franze by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 248 MEMORANDUM in Support re #247 MOTION to Seal A Document Containing Defendants' Confidential And Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 247 MOTION to Seal A Document Containing Defendants' Confidential And Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 246 Opposition re #235 MOTION for Clarification re Order on Motion to Compel,,,,,, issued on December 29, 2006 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 245 Receipt for Documents Returned on January 17, 2007 to Amgen. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 239 Motion for Leave to Appear Pro Hac Vice Added Julian Brew for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Manvin Mayell for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, GRANTING 240 Motion for Leave to Appear Pro Hac Vice Added Julian Brew for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Manvin Mayell for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 241 Assented to MOTION for Extension of Time to File Motion To File Under Seal A Document Containing Defendants' Confidential and Trade Secret Materials. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts. "Roche's Opposition Raises No Matters With Which This Court Ought Concern Itself. Presumably the Purported Experts Are Themselves Familiar With Their Legal Duties." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #239 Motion for Leave to Appear Pro Hac Vice Added Julian Brew for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Manvin Mayell for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, GRANTING #240 Motion for Leave to Appear Pro Hac Vice Added Julian Brew for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Manvin Mayell for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #241 Assented to MOTION for Extension of Time to File Motion To File Under Seal A Document Containing Defendants' Confidential and Trade Secret Materials. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts. "Roche's Opposition Raises No Matters With Which This Court Ought Concern Itself. Presumably the Purported Experts Are Themselves Familiar With Their Legal Duties." (Paine, Matthew) |
Filing 244 DECLARATION re #242 Opposition to Motion to Overrule Roche's Objections to Amgen's Designation of Economics Experts of Manvin S. Mayell by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H)(Toms, Keith) |
Filing 243 DECLARATION re #242 Opposition to Motion to Overrule Roche's Objections to Amgen's Designation of Economic Experts of Jane Y.C. Mathews by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Toms, Keith) |
Filing 242 Opposition re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 241 Assented to MOTION for Extension of Time to File Motion To File Under Seal A Document Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 240 MOTION for Leave to Appear Pro Hac Vice for admission of Manvin Mayell Filing fee $ 50, receipt number 1368681. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 239 MOTION for Leave to Appear Pro Hac Vice for admission of Julian Brew Filing fee $ 50, receipt number 1368636. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 238 NOTICE by Amgen Inc. re #237 Declaration, of Service of Confidential Document to be filed in Support of the Declaration of Deborah E. Fishman (Gottfried, Michael) |
Filing 237 DECLARATION re #236 Memorandum in Support of Motion, #235 MOTION for Clarification re Order on Motion to Compel,,,,,, issued on December 29, 2006 of DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: #1 Exhibit 1 submitted in Camera#2 Exhibit 2)(Gottfried, Michael) |
Filing 236 MEMORANDUM in Support re #235 MOTION for Clarification re Order on Motion to Compel,,,,,, issued on December 29, 2006 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 235 MOTION for Clarification re Order on Motion to Compel,,,,,, issued on December 29, 2006 by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING re 232 Assented to MOTION for Extension of Time to File Motion to File Under Seal a Document Containing Defendants' Confidential and Trade Secret Materials. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 232 Motion for Extension of Time, denying 78 Motion to Dismiss, denying 87 Motion to Seal Document, denying 128 Motion for Protective Order, granting 160 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document., denying 191 Motion for Reconsideration (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered GRANTING re #232 Assented to MOTION for Extension of Time to File Motion to File Under Seal a Document Containing Defendants' Confidential and Trade Secret Materials. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #232 Motion for Extension of Time, denying #78 Motion to Dismiss, denying #87 Motion to Seal Document, denying #128 Motion for Protective Order, granting #160 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document., denying #191 Motion for Reconsideration (Smith, Bonnie) |
Filing 234 DECLARATION re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts OF DR. ERIC GAIER by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Gottfried, Michael) |
Filing 233 DECLARATION OF RENEE DUBORD BROWN by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H (PART 1 OF 3)#9 Exhibit H (PART 2 OF 3)#10 Exhibit H (PART 3 OF 3))(Gottfried, Michael) |
Filing 232 Assented to MOTION for Extension of Time to File Motion to File Under Seal a Document Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 231 DECLARATION re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts OF CHRISTOPHER STOMBERG by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 230 DECLARATION re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts OF BENJAMIN SCHER by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B)(Gottfried, Michael) |
Filing 229 DECLARATION re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts OF RENEE DUBORD BROWN by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H)(Gottfried, Michael) |
Filing 228 MEMORANDUM in Support re #227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts filed by Amgen Inc.. (Gottfried, Michael) |
Filing 227 Emergency MOTION for Discovery to Overrule Roche's Objections to Amgen's Designation of Economic Experts by Amgen Inc..(Gottfried, Michael) |
Filing 226 Receipt to Plaintiff for documents received 1/11/07. (Paine, Matthew) |
Filing 225 NOTICE by Amgen Inc. of Service of Confidential Document to be Filed in Support of the Declaration of Deborah E. Fishman In Support of Amgen Inc.'s Motion to Compel Production of Roche's Cell Lines (Gottfried, Michael) |
Filing 224 DECLARATION re #222 MOTION to Compel Production of Roche's Cell Lines, #223 Memorandum in Support of Motion BY DEBORAH E. FISHMAN by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5 (submitted in camera)#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13)(Gottfried, Michael) |
Filing 223 MEMORANDUM in Support re #222 MOTION to Compel Production of Roche's Cell Lines and related documents filed by Amgen Inc.. (Gottfried, Michael) |
Filing 222 MOTION to Compel Production of Roche's Cell Lines by Amgen Inc..(Gottfried, Michael) |
Filing fee: $ 100.00, receipt number 77528 for 221 MOTION for Leave to Appear Pro Hac Vice for admission of Aaron R. Hand, 220 MOTION for Leave to Appear Pro Hac Vice for admission of Berrie R. Goldman. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 220 Motion for Leave to Appear Pro Hac Vice Added Berrie R. Goldman for Amgen Inc., Aaron R. Hand for Amgen Inc., granting 221 Motion for Leave to Appear Pro Hac Vice Added Berrie R. Goldman for Amgen Inc., Aaron R. Hand for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 219 Motion for Leave to Appear Pro Hac Vice Added George W. Johnston for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Patricia Rocha-Tramaloni for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, , Nancy DiLella for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH,. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 77530 for 219 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of George W. Johnston, Patricia Rocha-Tramaloni, Nancy DiLella. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 77530 for #219 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of George W. Johnston, Patricia Rocha-Tramaloni, Nancy DiLella. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #219 Motion for Leave to Appear Pro Hac Vice Added George W. Johnston for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Patricia Rocha-Tramaloni for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, , Nancy DiLella for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH,. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #220 Motion for Leave to Appear Pro Hac Vice Added Berrie R. Goldman for Amgen Inc., Aaron R. Hand for Amgen Inc., granting #221 Motion for Leave to Appear Pro Hac Vice Added Berrie R. Goldman for Amgen Inc., Aaron R. Hand for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 100.00, receipt number 77528 for #221 MOTION for Leave to Appear Pro Hac Vice for admission of Aaron R. Hand, #220 MOTION for Leave to Appear Pro Hac Vice for admission of Berrie R. Goldman. (Paine, Matthew) |
Filing 221 MOTION for Leave to Appear Pro Hac Vice for admission of Aaron R. Hand by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 220 MOTION for Leave to Appear Pro Hac Vice for admission of Berrie R. Goldman by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 219 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of George W. Johnston, Patricia Rocha-Tramaloni, Nancy DiLella by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Toms, Keith) |
Judge William G. Young : Electronic ORDER entered granting 216 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc., granting 217 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc., granting 218 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #216 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc., granting #217 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc., granting #218 Motion for Leave to Appear Pro Hac Vice Added Raymond A. Jacobsen for Amgen Inc., Jon B. Dubrow for Amgen Inc., William Diaz for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 77462 for 216 MOTION for Leave to Appear Pro Hac Vice for admission of Raymond A. Jacobsen, Jr., 217 MOTION for Leave to Appear Pro Hac Vice for admission of Jon B. Dubrow, 218 MOTION for Leave to Appear Pro Hac Vice for admission of William Diaz. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 77462 for #216 MOTION for Leave to Appear Pro Hac Vice for admission of Raymond A. Jacobsen, Jr., #217 MOTION for Leave to Appear Pro Hac Vice for admission of Jon B. Dubrow, #218 MOTION for Leave to Appear Pro Hac Vice for admission of William Diaz. (Paine, Matthew) |
Judge William G. Young : Electronic GRANTING #214 Emergency MOTION for Extension of Time to Serve Additional Document Requests from January 8 to January 22, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic GRANTING 214 Emergency MOTION for Extension of Time to Serve Additional Document Requests from January 8 to January 22, 2007. (Paine, Matthew) |
Filing 218 MOTION for Leave to Appear Pro Hac Vice for admission of William Diaz by Amgen Inc.. (Attachments: #1 Certification for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 217 MOTION for Leave to Appear Pro Hac Vice for admission of Jon B. Dubrow by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 216 MOTION for Leave to Appear Pro Hac Vice for admission of Raymond A. Jacobsen, Jr. by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 215 MEMORANDUM in Support re #214 Emergency MOTION for Extension of Time to Serve Additional Document Requests from January 8 to January 22, 2007 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Rizzo, Nicole) |
Filing 214 Emergency MOTION for Extension of Time to Serve Additional Document Requests from January 8 to January 22, 2007 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 213 NOTICE of Appearance by James M. Fraser on behalf of Amgen Inc., Amgen Inc. (Fraser, James) |
Filing 212 NOTICE of Appearance by Peter M. Acton on behalf of Amgen Inc., Amgen Inc. (Acton, Peter) |
Filing 211 NOTICE of Appearance by Joshua A. Munn on behalf of Amgen Inc., Amgen Inc. (Munn, Joshua) |
Filing 210 NOTICE of Appearance by Nicole A. Colby on behalf of Amgen Inc., Amgen Inc. (Colby, Nicole) |
Filing 209 NOTICE of Appearance by Daniel A. Curto on behalf of Amgen Inc., Amgen Inc. (Curto, Daniel) |
Filing 208 NOTICE of Appearance by Michael Kendall on behalf of Amgen Inc., Amgen Inc. (Kendall, Michael) |
Filing 207 Receipt for Documents Returned on January 3, 2007 to Amgen. (Paine, Matthew) |
Filing 206 Receipt for Documents Returned on January 3, 2007 to Hoffman-LaRoche. (Paine, Matthew) |
Filing 205 TRANSCRIPT of Proceedings held on 12/20/06 before Judge Young. Court Reporter: Womack. The original transcripts are maintained in the case file in the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Smith, Bonnie) |
Filing 204 NOTICE of Withdrawal of Appearance by Michael R. Gottfried filed on behalf of MarySusan Howard, withdrawing her pro hac vice appearance as counsel to Amgen Inc. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered re #170 Motion to Compel. "Motion Denied as to Requests 20, 33-35, 58-59, 70, 105-112. The Case Involves EPO, Including Pegylated EPO, Not Other Pegylated Compounds. In View of Amgen?s Proffer as to Aranesp, The Motion is Otherwise Denied Without Prejudice to its Renewal Should That Discovery Not Be Sufficiently Comprehensive. The Documents Submitted by Amgen In Camera Shall Be Returned to it." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 170 Motion to Compel. "Motion Denied as to Requests 20, 33-35, 58-59, 70, 105-112. The Case Involves EPO, Including Pegylated EPO, Not Other Pegylated Compounds. In View of Amgen?s Proffer as to Aranesp, The Motion is Otherwise Denied Without Prejudice to its Renewal Should That Discovery Not Be Sufficiently Comprehensive. The Documents Submitted by Amgen In Camera Shall Be Returned to it." (Paine, Matthew) |
Filing 203 Receipt to Plaintiff for documents received 12/29/06. (Paine, Matthew) |
Filing 202 NOTICE by Amgen Inc. of Service of Confidential Documents to Be Filed in Support of Amgen Inc.'s Opposition to Defendant's Motion to Compel Production of Documents (Gottfried, Michael) |
Filing 201 Opposition re #170 MOTION to Compel the Production of Documents filed by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 3#3 Exhibit 5#4 Exhibit 6)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered re #165 Motion to Compel Production of Documents. " The Court Adopts Roche's Compromise Position Save That Where Request are Allowed Herein Roche Must Produce All Documents Responsive to Such Request. Where Request Are Denied, Roche Nevertheless Must Produce the Documents Falling Within its Compromise Portion. Motion Allowed as to Requests 1 (to the extent not already produced), 5, 14, 16, 21-22, 24, 41, 137-138, 158-160. Motion Denied as to Requests 45-109, 111, 113-126, 148-150, 154-155, 162-167, and 176 as Amgen Does Not Seek Damages. Should Amgen Need These Documents for its Injunction Presentation, However, to the Extent These Request Are Not Overbroad (many are) it May Renew Its Requests After First Producing All the Counterpart Sales and Production Documents From Its Own Files. A Spirit of Cooperation Will Assist the Parties Here. Requests 15, 17, 18, 19-20, 23, 37-40, 42, 139, 146, 200-205, 218-220 are Denied As Overbroad Without Prejudice to Their Renewal Upon the Drafting of More Narrow and Focused Requests. The Discovery Ordered Herein Shall Be Furnished Within 30 Days of the Date of This Order. As This Court Has Made This Without the Need for Reference to the Supposed "Trade Secret" Documents, Roche's Motion for Reconsideration Will Be Denied As Moot and The Documents Returned To It. Preliminary Review of the Documents Reveals, However, That Some of Them Are Deserving of Putative Trade Secret Protection Although Many Are Not." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered re 165 Motion to Compel Production of Documents. " The Court Adopts Roche's Compromise Position Save That Where Request are Allowed Herein Roche Must Produce All Documents Responsive to Such Request. Where Request Are Denied, Roche Nevertheless Must Produce the Documents Falling Within its Compromise Portion. Motion Allowed as to Requests 1 (to the extent not already produced), 5, 14, 16, 21-22, 24, 41, 137-138, 158-160. Motion Denied as to Requests 45-109, 111, 113-126, 148-150, 154-155, 162-167, and 176 as Amgen Does Not Seek Damages. Should Amgen Need These Documents for its Injunction Presentation, However, to the Extent These Request Are Not Overbroad (many are) it May Renew Its Requests After First Producing All the Counterpart Sales and Production Documents From Its Own Files. A Spirit of Cooperation Will Assist the Parties Here. Requests 15, 17, 18, 19-20, 23, 37-40, 42, 139, 146, 200-205, 218-220 are Denied As Overbroad Without Prejudice to Their Renewal Upon the Drafting of More Narrow and Focused Requests. The Discovery Ordered Herein Shall Be Furnished Within 30 Days of the Date of This Order. As This Court Has Made This Without the Need for Reference to the Supposed "Trade Secret" Documents, Roche's Motion for Reconsideration Will Be Denied As Moot and The Documents Returned To It. Preliminary Review of the Documents Reveals, However, That Some of Them Are Deserving of Putative Trade Secret Protection Although Many Are Not." (Paine, Matthew) |
Filing 200 NOTICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #199 Opposition to Motion, of Service of Confidential Documents (Rizzo, Nicole) |
Filing 199 Opposition re #173 MOTION to Compel Production of Documents, #165 MOTION to Compel Production of Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 9)(Rizzo, Nicole) |
Filing 198 SUR-REPLY to Motion re #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII - Leave to File Granted on 12/27/06 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Judge William G. Young : Electronic ORDER entered GRANTING 190 MOTION for Leave to File Surreply to Amgen's Reply Brief in Support of Its Motion to Dismiss Roche's Counterclaims Counts I-IX and XII; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #190 MOTION for Leave to File Surreply to Amgen's Reply Brief in Support of Its Motion to Dismiss Roche's Counterclaims Counts I-IX and XII; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
Filing 197 Opposition re #190 MOTION for Leave to File Surreply to Amgen's Reply Brief in Support of Its Motion to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.. (Gottfried, Michael) |
Filing 196 TRANSCRIPT of Proceedings held on 12/20/06 before Judge YOUNG. Court Reporter: Womack. The original transcripts are maintained in the case file in the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Smith, Bonnie) |
Filing 195 Receipt to Defendant for documents received 12/22/06. (Smith, Bonnie) |
Filing 194 MEMORANDUM in Support re #191 MOTION for Reconsideration re Order on Motion for Order, Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 193 DECLARATION re #191 MOTION for Reconsideration re Order on Motion for Order, Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials of Richard Beswick by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 192 DECLARATION re #191 MOTION for Reconsideration re Order on Motion for Order, Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials of Krishnan Viswanadhan by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 191 MOTION for Reconsideration re Order on Motion for Order, Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 190 MOTION for Leave to File Surreply to Amgen's Reply Brief in Support of Its Motion to Dismiss Roche's Counterclaims Counts I-IX and XII by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Affidavit)(Huston, Julia) |
Filing 189 Judge William G. Young : ORDER entered GRANTING re #188 Motion for Protective Order AS MODIFIED. (Attachments: #1 Exhibit A -Protective Order) (Paine, Matthew) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Motions terminated: 150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.,, 153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 filed by Amgen Inc.,, 175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by Amgen Inc.,, Motion Hearing held on 12/21/2006 re 150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.,, 153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 filed by Amgen Inc.,, 175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by Amgen Inc.,. After hearing the Court Allows in part and Denies in part the Motion to Strike Affirmative Defenses; Allows in part and Denies in part the Motion to Dismiss the Counterclaims; Denies the Motion to Bifurcate. The defendant has 30 days within which to file an amended counterclaim. The Court explains to the parties how confidential matters are to be received by the court. Counsel are encouraged to speak to Clerk Smith for further details.(Court Reporter Womack.) (Smith, Bonnie) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Motions terminated: #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.,, #153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 filed by Amgen Inc.,, #175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by Amgen Inc.,, Motion Hearing held on 12/21/2006 re #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.,, #153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 filed by Amgen Inc.,, #175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by Amgen Inc.,. After hearing the Court Allows in part and Denies in part the Motion to Strike Affirmative Defenses; Allows in part and Denies in part the Motion to Dismiss the Counterclaims; Denies the Motion to Bifurcate. The defendant has 30 days within which to file an amended counterclaim. The Court explains to the parties how confidential matters are to be received by the court. Counsel are encouraged to speak to Clerk Smith for further details.(Court Reporter Womack.) (Smith, Bonnie) |
Judge William G. Young : Electronic GRANTING 185 MOTION to Stay re Order on Motion for Order, Dated December 19, 2006, Denying Leave to File Confidential and Trade Secret Materials Under Seal. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 188 Joint Motion for Protective Order Corrected Because: Exhibit A Contained Two Copies of the Same Document. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: #188 Joint Motion for Protective Order Corrected Because: Exhibit A Contained Two Copies of the Same Document. (Paine, Matthew) |
Judge William G. Young : Electronic GRANTING #185 MOTION to Stay re Order on Motion for Order, Dated December 19, 2006, Denying Leave to File Confidential and Trade Secret Materials Under Seal. (Paine, Matthew) |
Filing 188 Joint MOTION for Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A)(Huston, Julia) Additional attachment(s) added on 12/20/2006 (Paine, Matthew). |
Filing 187 Objection to #168 Notice (Other), #178 Notice (Other), #169 Notice (Other) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Regarding Service of Confidential Documents. (Rizzo, Nicole) |
Filing 186 Opposition re #185 MOTION to Stay re Order on Motion for Order, Dated December 19, 2006 Denying Leave to File Confidential and Trade Secret Materials Under Seal filed by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C)(Gottfried, Michael) |
Filing 185 MOTION to Stay re Order on Motion for Order, Dated December 19, 2006 Denying Leave to File Confidential and Trade Secret Materials Under Seal by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered: re #179 Emergency MOTION for Order Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials. "Motion DENIED. The Defendant Makes No Adequate Showing That Any of These Materials Are Actually Trade Secrets Ad Hominem Conclusory Assertions Will Not Do So. This is a Public Litigation." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered: re 179 Emergency MOTION for Order Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials. "Motion DENIED. The Defendant Makes No Adequate Showing That Any of These Materials Are Actually Trade Secrets Ad Hominem Conclusory Assertions Will Not Do So. This is a Public Litigation." (Paine, Matthew) |
Filing 184 Opposition re #175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 183 USCA Case Number 07-1096 for #149 Notice of Appeal to the Federal Circuit filed by Ortho Biotech Products, L.P.,. (Ramos, Jeanette) |
Filing 182 REPLY to Response to Motion re #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII and Memorandum in Opposition to Roche's Motion for Leave to Amend its Counterclaim filed by Amgen Inc.. (Gottfried, Michael) |
Filing 181 MEMORANDUM in Support re #179 Emergency MOTION for Order Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Filing 180 DECLARATION re #179 Emergency MOTION for Order Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials of Patricia Rocha-Tramaloni by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 179 Emergency MOTION for Order Requiring Plaintiff to File Under Seal Documents Containing Defendants' Confidential and Trade Secret Materials by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Rizzo, Nicole) |
Notice of correction to docket made by Court staff. Correction: #172 MEMORANDUM in Support re #170 MOTION to Compel the Production of Documents Corrected Because: The Appendix (A) PDF Document Did Not Upload into the CM/ECF System Properly. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: 172 MEMORANDUM in Support re 170 MOTION to Compel the Production of Documents Corrected Because: The Appendix (A) PDF Document Did Not Upload into the CM/ECF System Properly. (Paine, Matthew) |
Filing 178 NOTICE by Amgen Inc. re #174 Memorandum in Support of Motion, #177 Declaration, of Service of Confidential Documents to be Filed in Support of Plaintiff's Motion to Compel (Gottfried, Michael) |
Filing 177 DECLARATION re #173 MOTION to Compel Production of Documents of Krista M. Carter (REDACTED VERSION) by Amgen Inc.. (Attachments: #1 Confidential Exhibit Coversheet#2 Exhibit 4, part one#3 Exhibit 4, part two#4 Exhibit 4, part three#5 Exhibit 5#6 Exhibit 17#7 Exhibit 22#8 Exhibit 29#9 Exhibit 30)(Gottfried, Michael) |
Filing 176 MEMORANDUM in Support re #175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims filed by Amgen Inc.. (Rich, Patricia) |
Filing 175 MOTION to Bifurcate Roche's antitrust and unfair competition counterclaims from Amgen's patent Infringement Claims for Trial and Discovery and to Stay Discovery on those Claims by Amgen Inc..(Rich, Patricia) |
Filing 174 MEMORANDUM in Support re #173 MOTION to Compel Production of Documents (REDACTED VERSION) filed by Amgen Inc.. (Attachments: #1 Appendix A)(Gottfried, Michael) |
Filing 173 MOTION to Compel Production of Documents by Amgen Inc.. (Attachments: #1 Proposed Order)(Gottfried, Michael) |
Filing 172 MEMORANDUM in Support re #170 MOTION to Compel the Production of Documents filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E (1 of 2)#6 Exhibit E (2 of 2)#7 Exhibit F#8 Exhibit G#9 Exhibit H#10 Exhibit I#11 Exhibit J#12 Exhibit K#13 Exhibit L# 14 Appendix A)(Toms, Keith) Additional attachment(s) added on 12/18/2006 (Paine, Matthew). |
Filing 171 Opposition re #160 MOTION for Leave to File Amended Answer and Counterclaims and Reply in Support of #153 Motion to Strike filed by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Filing 170 MOTION to Compel the Production of Documents by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing fee: $ 50.00, receipt number 77001 for #163 MOTION for Leave to Appear Pro Hac Vice for admission of Mark S. Popofsky (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #164 Motion for Leave to File. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #163 Motion for Leave to Appear Pro Hac Vice. Added Mark S. Popofsky for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 77001 for 163 MOTION for Leave to Appear Pro Hac Vice for admission of Mark S. Popofsky (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 163 Motion for Leave to Appear Pro Hac Vice. Added Mark S. Popofsky for Hoffmann LaRoche Inc., F. Hoffmann-LaRoche LTD, and Roche Diagnostics GmbH. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 164 Motion for Leave to File. (Paine, Matthew) |
Filing 169 NOTICE by Amgen Inc. re #168 Notice (Other) Of Service Of Confidential Documents To Be Filed In Support Of Plaintiff's Motion To Compel (Amended Notice) (Rich, Patricia) |
Filing 168 NOTICE by Amgen Inc. re #167 Declaration,, #166 Memorandum in Support of Motion of Service of Confidential Documents to be Filed in Support of Plaintiff's Motion to Compel (Gottfried, Michael) |
Filing 167 DECLARATION re #166 Memorandum in Support of Motion of Krista M. Carter (REDACTED VERSION) by Amgen Inc.. (Attachments: #1 Confidential Exhibits Coversheet#2 Exhibit 4, part one#3 Exhibit 4, part two#4 Exhibit 4, part three#5 Exhibit 5#6 Exhibit 17#7 Exhibit 22#8 Exhibit 29#9 Exhibit 30)(Gottfried, Michael) |
Filing 166 MEMORANDUM in Support re #165 MOTION to Compel Production of Documents filed by Amgen Inc.. (Attachments: #1 Appendix A)(Gottfried, Michael) |
Filing 165 MOTION to Compel Production of Documents by Amgen Inc.. (Attachments: #1 Proposed Order)(Gottfried, Michael) |
Filing 164 MOTION for Leave to File Over-Length Memorandum by Amgen Inc..(Gottfried, Michael) |
Filing 163 MOTION for Leave to Appear Pro Hac Vice for admission of Mark S. Popofsky by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Toms, Keith) |
Filing 162 Opposition re #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 161 Opposition re #153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 and in Support of Roche's Motion for Leave to Amend Its Answer and Counterclaims #160 filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Toms, Keith) |
Filing 160 MOTION for Leave to File Amended Answer and Counterclaims by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Toms, Keith) |
Transmission of Notice of Appeal, Memorandum & Order and Docket Sheet to US Court of Appeals for the Federal Circuit re #149 Notice of Appeal to the Federal Circuit. (Ramos, Jeanette) |
Transmission of Notice of Appeal, Memorandum & Order and Docket Sheet to US Court of Appeals for the Federal Circuit re 149 Notice of Appeal to the Federal Circuit. (Ramos, Jeanette) |
Filing 159 Judge William G. Young : ORDER entered. The Motion for Reconsideration #155 is DENIED. In Clarification, the Court Makes the Remarks Noted Below:Table of Contents Section (III) Letter (A) is SO ORDERED; Letter (B) In House Counsel at Amgen May Have Access to the BLA and INDA; Letter (C) - Number (1) is DENIED and Letter (C) - Number (2) This is a Discovery Issue, Not Appropriate for a Clarification Ruling; Letter (D) NO DOCUMENTS Shall Be Filed in the Court Under Seal Absent Allowance of a Particularized Motion to Seal Which Would Be Allowed ONLY if the Filing Would Reveal a Trade Secret. THIS LITIGATION IS PUBLIC; Letter (E) This Dispute Is Not Amenable to Resolution on a Motion for Clarification. (Paine, Matthew) |
Filing 158 TRANSCRIPT ORDER FORM by Ortho Biotech Products, L.P. for proceedings held on May 10, 2006 before Judge Young, re #149 Notice of Appeal to the Federal Circuit (Repicky, Heather) |
Filing 157 EXHIBIT re #156 Memorandum in Support of Motion, (EXHIBIT #12) by Amgen Inc.. (Gottfried, Michael) |
Filing 156 MEMORANDUM in Support re #155 MOTION for Reconsideration re #142 Order on Motion for Protective Order, OR FOR CLARIFICATION, filed by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11 (part 1 of 2)#12 Exhibit 11 (part 2 of 2))(Gottfried, Michael) |
Filing 155 MOTION for Reconsideration re #142 Order on Motion for Protective Order, OR FOR CLARIFICATION, by Amgen Inc..(Gottfried, Michael) |
ELECTRONIC NOTICE of Hearing on Motion #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII: Motion Hearing set for 12/20/2006 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 12/11/06. Reply brief, if any, is due by 12/18/06.(Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion 150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII: Motion Hearing set for 12/20/2006 02:00 PM in Courtroom 18 before Judge William G. Young. Opposition is due by 12/11/06. Reply brief, if any, is due by 12/18/06.(Smith, Bonnie) |
Filing 154 MEMORANDUM in Support re #153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 filed by Amgen Inc.. (Gottfried, Michael) |
Filing 153 MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 by Amgen Inc..(Gottfried, Michael) |
Filing 152 DECLARATION re #151 Memorandum in Support of Motion to Dismiss by Renee Dubord Brown filed by Amgen Inc.. (Gottfried, Michael) |
Filing 151 MEMORANDUM in Support re #150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII filed by Amgen Inc.. (Gottfried, Michael) |
Filing 150 MOTION to Dismiss Roche's Counterclaims Counts I-IX and XII by Amgen Inc..(Gottfried, Michael) |
Filing fee: $ 455.00, receipt number 76507 for #149 Notice of Appeal to the Federal Circuit (Paine, Matthew) |
Filing fee: $ 455.00, receipt number 76507 for 149 Notice of Appeal to the Federal Circuit (Paine, Matthew) |
Filing 149 NOTICE OF APPEAL to the Federal Circuit as to #121 Memorandum & ORDER, by Ortho Biotech Products, L.P.. Appeal Record due by 12/11/2006. (Repicky, Heather) |
Filing fee: $ 250.00, receipt number 76279 for #145 MOTION for Leave to Appear Pro Hac Vice by Geoffrey M. Godfrey, #146 MOTION for Leave to Appear Pro Hac Vice by Adam Arthur Bier, #144 MOTION for Leave to Appear Pro Hac Vice by Robert M. Galvin, #148 MOTION for Leave to Appear Pro Hac Vice by Andy H. Chan, #147 MOTION for Leave to Appear Pro Hac Vice by Susan M. Krumplitsch (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #144 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting #145 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting #146 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting #147 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting #148 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 144 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting 145 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting 146 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting 147 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc., granting 148 Motion for Leave to Appear Pro Hac Vice Added Robert M. Galvin for Amgen Inc., Geoffrey M. Godfrey for Amgen Inc., Adam Arthur Bier for Amgen Inc., Susan M. Krumplitsch for Amgen Inc., Andy H. Chan for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 250.00, receipt number 76279 for 145 MOTION for Leave to Appear Pro Hac Vice by Geoffrey M. Godfrey, 146 MOTION for Leave to Appear Pro Hac Vice by Adam Arthur Bier, 144 MOTION for Leave to Appear Pro Hac Vice by Robert M. Galvin, 148 MOTION for Leave to Appear Pro Hac Vice by Andy H. Chan, 147 MOTION for Leave to Appear Pro Hac Vice by Susan M. Krumplitsch (Paine, Matthew) |
Filing 148 MOTION for Leave to Appear Pro Hac Vice by Andy H. Chan by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 147 MOTION for Leave to Appear Pro Hac Vice by Susan M. Krumplitsch by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 146 MOTION for Leave to Appear Pro Hac Vice by Adam Arthur Bier by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 145 MOTION for Leave to Appear Pro Hac Vice by Geoffrey M. Godfrey by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 144 MOTION for Leave to Appear Pro Hac Vice by Robert M. Galvin by Amgen Inc.. (Attachments: #1 Certificate for Admission to Practice)(Gottfried, Michael) |
Filing 143 Judge William G. Young : ORDER entered. re #138 JOINT STATEMENT is SO ORDER as the Case Management Scheduling Order. DISCOVERY DUE May 11, 2007 and DISPOSITIVE MOTIONS DUE May 18, 2007. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #137 MOTION for Leave to File Under Seal Document In Support of Defendants' Cross-Motion for Entry of a Protective Order and Oppositon to Amgen's Motion for a Protective Order. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING 137 MOTION for Leave to File Under Seal Document In Support of Defendants' Cross-Motion for Entry of a Protective Order and Oppositon to Amgen's Motion for a Protective Order. (Paine, Matthew) |
Filing 142 Judge William G. Young : ORDER entered re #136 Cross MOTION for Protective Order and OPPOSITION to Amgen's Motion for Entry of Protective Order. "Motion ALLOWED on Terms. See pp. 6-7 infra. The Parties Shall Settle the Final Form of the Order and Submit it the Court." (Paine, Matthew) |
Filing 141 CORPORATE DISCLOSURE STATEMENT by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Rizzo, Nicole) |
Filing 140 Defendants' ANSWER to Amended Complaint and, COUNTERCLAIM against Amgen Inc. by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Rizzo, Nicole) |
Filing 139 NOTICE of Appearance by Nicole A. Rizzo on behalf of F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. (Rizzo, Nicole) |
Filing 138 JOINT STATEMENT of counsel to Propose Amendments to LR 16.1(D) Scheduling Order. (Toms, Keith) |
Filing 137 MOTION for Leave to File Under Seal Document In Support of Defendants' Cross-Motion for Entry of a Protective Order and Oppositon to Amgen's Motion for a Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 136 Cross MOTION for Protective Order and OPPOSITION to Amgen's Motion for Entry of Protective Order #128 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H)(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered. "Motions for Leave to Appear Pro Hac Vice ALLOWED." re 127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely filed by Amgen Inc.,, 125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson filed by Amgen Inc.,, 124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray filed by Amgen Inc.,, 123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford filed by Amgen Inc.,, 122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt filed by Amgen Inc.,, 126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard filed by Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 122 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting 123 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting 124 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting 125 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting 126 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting 127 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #122 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting #123 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting #124 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting #125 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting #126 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc., granting #127 Motion for Leave to Appear Pro Hac Vice Added Stuart L. Watt for Amgen Inc., Wendy A. Whiteford for Amgen Inc., Monique L. Corday for Amgen Inc., Darrell G. Dotson for Amgen Inc., Mary Susan Howard for Amgen Inc., Kimberlin L. Morely for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. "Motions for Leave to Appear Pro Hac Vice ALLOWED." re #127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely filed by Amgen Inc.,, #125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson filed by Amgen Inc.,, #124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray filed by Amgen Inc.,, #123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford filed by Amgen Inc.,, #122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt filed by Amgen Inc.,, #126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard filed by Amgen Inc. (Paine, Matthew) |
Filing 135 DECLARATION re #128 MOTION for Protective Order BY MONIQUE L. CORDRAY by Amgen Inc.. (Gottfried, Michael) |
Filing 134 DECLARATION re #128 MOTION for Protective Order BY KIMBERLIN L. MORLEY by Amgen Inc.. (Gottfried, Michael) |
Filing 133 DECLARATION re #128 MOTION for Protective Order BY MARYSUSAN HOWARD by Amgen Inc.. (Gottfried, Michael) |
Filing 132 Opposition re #127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely, #125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson, #124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray, #123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford, #122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt, #126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing fee: $ 100.00, receipt number 75922 for 127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely, 126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard (Paine, Matthew) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Scheduling Conference held on 10/23/2006. The Court explains the requirements of the session and inquires as to whether the parties want to proceed before a magistrate judge. The case is to go to ADR as of,MARCH, 07 Final Pretrial Conference set for NO SOONER THAN 7/2/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Jury Trial set for RUNNING TRIAL LIST AS OF 9/4/2007 09:00 AM before Judge William G. Young. Court hold conference in the lobby re: filing of confidential material and trial. (Smith, Bonnie) |
Filing fee: $ 200.00, receipt number 75921 for 125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson, 124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray, 123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford, 122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt (Paine, Matthew) |
Filing fee: $ 200.00, receipt number 75921 for #125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson, #124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray, #123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford, #122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt (Paine, Matthew) |
Filing fee: $ 100.00, receipt number 75922 for #127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely, #126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard (Paine, Matthew) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Scheduling Conference held on 10/23/2006. The Court explains the requirements of the session and inquires as to whether the parties want to proceed before a magistrate judge. The case is to go to ADR as of,MARCH, 07 Final Pretrial Conference set for NO SOONER THAN 7/2/2007 02:00 PM in Courtroom 18 before Judge William G. Young. Jury Trial set for RUNNING TRIAL LIST AS OF 9/4/2007 09:00 AM before Judge William G. Young. Court hold conference in the lobby re: filing of confidential material and trial. (Smith, Bonnie) |
Filing 131 DECLARATION re #128 MOTION for Protective Order BY DARRELL G. DOTSON by Amgen Inc.. (Gottfried, Michael) |
Filing 130 DECLARATION re #128 MOTION for Protective Order BY WENDY A. WHITEFORD by Amgen Inc.. (Gottfried, Michael) |
Filing 129 DECLARATION re #128 MOTION for Protective Order BY STUART L. WATT by Amgen Inc.. (Gottfried, Michael) |
Filing 128 MOTION for Protective Order by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Errata F#7 Exhibit G#8 Exhibit H (Redacted Version)#9 Exhibit I (Redacted Version))(Gottfried, Michael) |
Filing 127 MOTION for Leave to Appear Pro Hac Vice by Kimberlin L. Morely by Amgen Inc.. (Attachments: #1 Affidavit Kimberlin L. Morely for Admission)(Gottfried, Michael) |
Filing 126 MOTION for Leave to Appear Pro Hac Vice by MarySusan Howard by Amgen Inc.. (Attachments: #1 Affidavit MarySusan Howard for Admission)(Gottfried, Michael) |
Filing 125 MOTION for Leave to Appear Pro Hac Vice by Darrell G. Dotson by Amgen Inc.. (Attachments: #1 Affidavit Darrell G. Dotson for Admission)(Gottfried, Michael) |
Filing 124 MOTION for Leave to Appear Pro Hac Vice by Monique L. Cordray by Amgen Inc.. (Attachments: #1 Affidavit Monique L. Cordray for Admission)(Gottfried, Michael) |
Filing 123 MOTION for Leave to Appear Pro Hac Vice by Wendy A. Whiteford by Amgen Inc.. (Attachments: #1 Affidavit Wendy A. Whiteford for Admission)(Gottfried, Michael) |
Filing 122 MOTION for Leave to Appear Pro Hac Vice by Stuart L. Watt by Amgen Inc.. (Attachments: #1 Affidavit of Stuart L. Watt for Admission)(Gottfried, Michael) |
Filing 121 Judge William G. Young : ORDER entered. MEMORANDUM AND ORDER: "Amgen's Claim of Current Infringement is Properly Pleaded and the Motion to Dismiss Pursuant to Rule 12(b)(6) Doc. No. #44 is DENIED. The Motion to Dismiss Pursuant to Rule 12(b)(1) Doc. No. 44 is DENIED. Ortho's Motion to Intervene Doc. No. #16 is DENIED Without Prejudice, Subject to the Determination of the Issue of Contract Interpretation by an Arbitral Panel." (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 75864 for #120 Assented to MOTION for Leave to Appear Pro Hac Vice by Richard O. Jackson (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 120 Motion for Leave to Appear Pro Hac Vice. Added Richard O. Jackson for Ortho Biotech Products, L.P. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 75864 for 120 Assented to MOTION for Leave to Appear Pro Hac Vice by Richard O. Jackson (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #120 Motion for Leave to Appear Pro Hac Vice. Added Richard O. Jackson for Ortho Biotech Products, L.P. (Paine, Matthew) |
Filing 120 Assented to MOTION for Leave to Appear Pro Hac Vice by Richard O. Jackson by Ortho Biotech Products, L.P.. (Attachments: #1 Affidavit)(Repicky, Heather) |
Filing 119 Judge William G. Young : ORDER entered. re #118 JOINT STATEMENT is SO ORDERED AS MODIFIED as the Case Management Scheduling Order. DISCOVERY DUE April 30, 2007 and DISPOSITIVE MOTIONS DUE April 9, 2007.(Paine, Matthew) |
Filing 118 JOINT STATEMENT re scheduling conference. (Gottfried, Michael) |
Filing 117 Recommendations for Scheduling Order By Ortho Biotech Products, LP. (Repicky, Heather) |
Filing 116 NOTICE of Appearance by Heather B. Repicky on behalf of Ortho Biotech Products, L.P. (Repicky, Heather) |
Filing 115 NOTICE of Withdrawal of Appearance by Michelle Chassereau Jackson (Jackson, Michelle) |
Filing 114 NOTICE of Scheduling Conference 16.1 Scheduling Conference set for 10/23/2006 02:00 PM in Courtroom 18 before Judge William G. Young. cc/cl(Smith, Bonnie) |
Filing 113 Recommendations for Scheduling Order Motion to Schedule Rule 16 Conference. (Attachments: #1 Exhibit A)(Rich, Patricia) |
Filing 112 Supplemental MEMORANDUM in Support re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim and to Inform the Court of the ITC's Decision Not to Review the Initial Determination of the Administrative Law Judge filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
Filing 111 CERTIFICATE OF SERVICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. With Respect to ITC Papers Filed Under Seal. (Huston, Julia) |
Judge William G. Young : Electronic ORDER entered GRANTING #107 Motion for Leave to File ITC Papers Under Seal; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 107 Motion for Leave to File ITC Papers Under Seal; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Filing 110 CERTIFICATE OF SERVICE by Amgen Inc. OF SEALED DOCUMENTS. (Rich, Patricia) |
Judge William G. Young : Electronic ORDER entered GRANTING 108 Motion to Seal Document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #108 Motion to Seal Document. (Paine, Matthew) |
Filing 109 Opposition re #108 MOTION to Seal Document filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Appendix A)(Huston, Julia) |
Filing 108 MOTION to Seal Document by Amgen Inc..(Gottfried, Michael) |
Filing 107 MOTION for Leave to File ITC Papers Under Seal by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 106 CERTIFICATE OF SERVICE by Amgen Inc. re Order on Motion to Seal Document. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING 105 Motion to Seal Document by Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #105 Motion to Seal Document by Amgen Inc. (Paine, Matthew) |
Filing 105 MOTION to Seal Document by Amgen Inc..(Gottfried, Michael) |
Filing 104 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #101 Memorandum in Opposition to Motion filed pursuant to leave of Court granted July 21, 2006. (Attachments: #1 Exhibit A#2 Exhibit B)(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered GRANTING 103 Motion for Leave to File Reply to Amgen Inc.'s Post-Hearing Memorandum; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #103 Motion for Leave to File Reply to Amgen Inc.'s Post-Hearing Memorandum; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Filing 103 MOTION for Leave to File Reply to Amgen Inc.'s Post-Hearing Memorandum by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1#2 Exhibit A#3 Exhibit B)(Huston, Julia) |
Filing 102 CERTIFICATE OF SERVICE by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim, #100 MOTION for Leave to File Under Seal the Recent Decision of the ITC Regarding Defendants' Section 271(e) Safe Harbor Defense, Order on Motion for Leave to File,. (Huston, Julia) |
Filing 101 MEMORANDUM in Opposition re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by Amgen Inc.. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING 100 MOTION for Leave to File Under Seal the Recent Decision of the ITC Regarding Defendants' Section 271(e) Safe Harbor Defense; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #100 MOTION for Leave to File Under Seal the Recent Decision of the ITC Regarding Defendants' Section 271(e) Safe Harbor Defense; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Filing 100 MOTION for Leave to File Under Seal the Recent Decision of the ITC Regarding Defendants' Section 271(e) Safe Harbor Defense by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
Filing 99 Supplemental MEMORANDUM in Support re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim and to Apprise the Court of the Recent ALJ Decision Before the ITC filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A (1 of 3)#2 Exhibit A (2 of 3)#3 Exhibit A (3 of 3)#4 Exhibit B#5 Exhibit C)(Huston, Julia) |
Judge William G. Young : Electronic ORDER entered granting 95 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting 96 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting 97 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting 98 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #95 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting #96 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting #97 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc., granting #98 Motion for Leave to Appear Pro Hac Vice Added Firasat Ali for Amgen Inc., Jeremy D. Protas for Amgen Inc., Jennifer E. Flory for Amgen Inc., Cullen N. Pendleton for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 200.00, receipt number 73314 for 98 MOTION for Leave to Appear Pro Hac Vice by Cullen N. Pendleton, 95 MOTION for Leave to Appear Pro Hac Vice by Firasat Ali, 96 MOTION for Leave to Appear Pro Hac Vice by Jeremy D. Protas, 97 MOTION for Leave to Appear Pro Hac Vice by Jennifer E. Flory. (Paine, Matthew) |
Filing fee: $ 200.00, receipt number 73314 for #98 MOTION for Leave to Appear Pro Hac Vice by Cullen N. Pendleton, #95 MOTION for Leave to Appear Pro Hac Vice by Firasat Ali, #96 MOTION for Leave to Appear Pro Hac Vice by Jeremy D. Protas, #97 MOTION for Leave to Appear Pro Hac Vice by Jennifer E. Flory. (Paine, Matthew) |
Filing 98 MOTION for Leave to Appear Pro Hac Vice by Cullen N. Pendleton by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 97 MOTION for Leave to Appear Pro Hac Vice by Jennifer E. Flory by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 96 MOTION for Leave to Appear Pro Hac Vice by Jeremy D. Protas by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 95 MOTION for Leave to Appear Pro Hac Vice by Firasat Ali by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 94 Response by Amgen Inc. to #92 Response of Defendants' to Amgen Inc.'s Report Pursuant to the Court's May 11, 2006 Order and Motion and Memoramnudm for Additional Discovery. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING 93 Motion for Leave to File a Reply to Defendants' Response to Amgen Inc.'s Report Pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery by Amgen Inc; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #93 Motion for Leave to File a Reply to Defendants' Response to Amgen Inc.'s Report Pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery by Amgen Inc; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Paine, Matthew) |
Filing 93 MOTION for Leave to File to file a Reply to Defendants' Response to Amgen Inc.'s Report Pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery by Amgen Inc.. (Attachments: #1 Proposed Amgen Inc. Reply to Defendants' Response to Amgen Inc.'s Report Pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery)(Gottfried, Michael) |
Filing 92 Response by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. to #90 Status Report, and Opposition to Amgen's Motion for Additional Discovery. (Attachments: #1 Exhibit A)(Huston, Julia) |
Filing 91 CERTIFICATE OF CONSULTATION re #90 Status Report, pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery by Michael R. Gottfried on behalf of Amgen Inc.. (Gottfried, Michael) |
Filing 90 STATUS REPORT Pursuant to the Court's May 11, 2006 Order and Motion and Memorandum for Additional Discovery by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D-I#5 Text of Proposed Order Proposed Order)(Gottfried, Michael) |
Filing 89 STATUS REPORT Pursuant to Court's Order Dated May 11, 2006 by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 88 RESPONSE to Motion re #87 MOTION to Seal Document filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 87 MOTION to Seal Document by Amgen Inc..(Gottfried, Michael) |
Filing 86 STIPULATION for a Temporary Protective Order by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 85 Letter/request (non-motion) from Lee Carl Bromberg. (Paine, Matthew) |
Filing 84 Withdrawal of motion: #38 MOTION to Dismiss for Lack of Jurisdiction filed by Roche Diagnostics GmbH,.. (Huston, Julia) |
Filing 83 Withdrawal of motion: #41 MOTION to Dismiss for Lack of Jurisdiction filed by F. Hoffmann-LaRoche LTD,.. (Huston, Julia) |
Mail Returned as Undeliverable. Mail sent to Eugene M. Gelernter. (Paine, Matthew) |
Filing 81 MEMORANDUM in Support re #16 MOTION to Intervene filed by Ortho Biotech Products, L.P.. (Jackson, Michelle) |
Filing 80 Judge William G. Young : ORDER entered. MEMORANDUM AND ORDER. "The Court Orders the Parties to Confer as to the Corporate Relationship Between the Various Roche/Hoffman-LaRoche Corporate Entities and the Allegedly Infringing Drug. The Parties are to Report Back to the Court Within 10 Days as to the Nature of the Corporate Relationship of These Entities." (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #64 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered granting 64 Motion for Leave to File; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures (Smith, Bonnie) |
Filing 82 TRANSCRIPT of Proceedings held on 5/10/06 before Judge Young. Court Reporter: Womack. The original transcripts are maintained in the case file in the Clerk's Office. Copies may be obtained by contacting the court reporter at womack@megatran.com or the Clerk's Office. (Smith, Bonnie) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Motion Hearing held on 5/10/2006 re #78 MOTION to Dismiss the Amended Complaint filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,, #38 MOTION to Dismiss for Lack of Jurisdiction filed by Roche Diagnostics GmbH,, #16 MOTION to Intervene filed by Ortho Biotech Products, L.P.,, #41 MOTION to Dismiss for Lack of Jurisdiction filed by F. Hoffmann-LaRoche LTD,, #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,. After hearing the Court takes all Motions UNDER ADVISEMENT. (Court Reporter Womack.) (Smith, Bonnie) |
ElectronicClerk's Notes for proceedings held before Judge William G. Young : Motion Hearing held on 5/10/2006 re 78 MOTION to Dismiss the Amended Complaint filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,, 38 MOTION to Dismiss for Lack of Jurisdiction filed by Roche Diagnostics GmbH,, 16 MOTION to Intervene filed by Ortho Biotech Products, L.P.,, 41 MOTION to Dismiss for Lack of Jurisdiction filed by F. Hoffmann-LaRoche LTD,, 44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by F. Hoffmann-LaRoche LTD,, Roche Diagnostics GmbH,, Hoffmann LaRoche Inc.,. After hearing the Court takes all Motions UNDER ADVISEMENT. (Court Reporter Womack.) (Smith, Bonnie) |
Filing 79 NOTICE by Amgen Inc. of United States International Trade Commission Investigation (Attachments: #1 Exhibit A)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING #76 Motion for Leave to Appear Pro Hac Vice Added Eugene M. Gelernter for Ortho Biotech Products, L.P. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #77 Motion for Leave to Appear Pro Hac Vice. Added Steven A. Zalesin for Ortho Biotech Products, L.P. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 77 Motion for Leave to Appear Pro Hac Vice. Added Steven A. Zalesin for Ortho Biotech Products, L.P. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 76 Motion for Leave to Appear Pro Hac Vice Added Eugene M. Gelernter for Ortho Biotech Products, L.P. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72380 for 77 MOTION for Leave to Appear Pro Hac Vice by Steven A. Zalesin. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72379 for 76 MOTION for Leave to Appear Pro Hac Vice by Eugene M. Gelernter. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72379 for #76 MOTION for Leave to Appear Pro Hac Vice by Eugene M. Gelernter. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72380 for #77 MOTION for Leave to Appear Pro Hac Vice by Steven A. Zalesin. (Paine, Matthew) |
Filing 78 MOTION to Dismiss the Amended Complaint by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 77 MOTION for Leave to Appear Pro Hac Vice by Steven A. Zalesin by Ortho Biotech Products, L.P.. (Attachments: #1 Certificate under Local Rule 83.5.3)(Jackson, Michelle) |
Filing 76 MOTION for Leave to Appear Pro Hac Vice by Eugene M. Gelernter by Ortho Biotech Products, L.P.. (Attachments: #1 Certificate under Local Rule 83.5.3)(Jackson, Michelle) |
Judge William G. Young : Electronic ORDER entered granting 68 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 69 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 70 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 71 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 72 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 73 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 74 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting 75 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72294 for 75 MOTION for Leave to Appear Pro Hac Vice by Jonathan D. Loeb. (Paine, Matthew) |
Filing fee: $ 350.00, receipt number 72297 for 74 MOTION for Leave to Appear Pro Hac Vice by Michelle E. Moreland, 68 MOTION for Leave to Appear Pro Hac Vice by Mark Izraelewicz, 69 MOTION for Leave to Appear Pro Hac Vice by Katie J.L. Scott, 70 MOTION for Leave to Appear Pro Hac Vice by Andrew Kumamoto, 71 MOTION for Leave to Appear Pro Hac Vice by Mary Boyle, 72 MOTION for Leave to Appear Pro Hac Vice by Darcy A. Paul, 73 and MOTION for Leave to Appear Pro Hac Vice by Rebecca J. Wais. (Paine, Matthew) |
Filing fee: $ 350.00, receipt number 72297 for #74 MOTION for Leave to Appear Pro Hac Vice by Michelle E. Moreland, #68 MOTION for Leave to Appear Pro Hac Vice by Mark Izraelewicz, #69 MOTION for Leave to Appear Pro Hac Vice by Katie J.L. Scott, #70 MOTION for Leave to Appear Pro Hac Vice by Andrew Kumamoto, #71 MOTION for Leave to Appear Pro Hac Vice by Mary Boyle, #72 MOTION for Leave to Appear Pro Hac Vice by Darcy A. Paul, #73 and MOTION for Leave to Appear Pro Hac Vice by Rebecca J. Wais. (Paine, Matthew) |
Filing fee: $ 50.00, receipt number 72294 for #75 MOTION for Leave to Appear Pro Hac Vice by Jonathan D. Loeb. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #68 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #69 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #70 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #71 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #72 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #73 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #74 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc., granting #75 Motion for Leave to Appear Pro Hac Vice Added Mark Izraelewicz for Amgen Inc., Katie J.L. Scott for Amgen Inc., Andrew Kumamoto for Amgen Inc., Mary Boyle for Amgen Inc., Darcy A. Paul for Amgen Inc., Rebecca J. Wais for Amgen Inc., Michelle E. Moreland for Amgen Inc., Jonathan D. Loeb for Amgen Inc. (Paine, Matthew) |
Filing 75 MOTION for Leave to Appear Pro Hac Vice by Jonathan D. Loeb by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 74 MOTION for Leave to Appear Pro Hac Vice by Michelle E. Moreland by Amgen Inc.. (Attachments: #1 Affidavit of Michelle E. Moreland in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 73 MOTION for Leave to Appear Pro Hac Vice by Rebecca J. Wais by Amgen Inc.. (Attachments: #1 Affidavit of Rebecca J. Wais in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 72 MOTION for Leave to Appear Pro Hac Vice by Darcy A. Paul by Amgen Inc.. (Attachments: #1 Affidavit of Darcy A. Paul in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 71 MOTION for Leave to Appear Pro Hac Vice by Mary Boyle by Amgen Inc.. (Attachments: #1 Affidavit of Mary Boyle in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 70 MOTION for Leave to Appear Pro Hac Vice by Andrew Kumamoto by Amgen Inc.. (Attachments: #1 Affidavit of Andrew Kumamoto in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 69 MOTION for Leave to Appear Pro Hac Vice by Katie J.L. Scott by Amgen Inc.. (Attachments: #1 Affidavit of Katie J.L. Scott in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 68 MOTION for Leave to Appear Pro Hac Vice by Mark Izraelewicz by Amgen Inc.. (Attachments: #1 Affidavit of Mark Izraelewicz in Support of Application for Admission Pro Hac Vice)(Gottfried, Michael) |
Filing 67 NOTICE of Appearance by Patricia R. Rich on behalf of Amgen Inc. (Rich, Patricia) |
Filing 66 DECLARATION re #60 Reply to Response to Motion (Submitted by Leave of Court Order Dated 4/19/06) by Roche Diagnostics GmbH. (Huston, Julia) |
Filing 65 DECLARATION re #64 MOTION for Leave to File Reply Memorandum in Further Support of Ortho's Motion to Intevene of Steven A. Zalesin by Ortho Biotech Products, L.P.. (Attachments: #1 Exhibit A#2 Exhibit B)(Jackson, Michelle) |
Filing 64 MOTION for Leave to File Reply Memorandum in Further Support of Ortho's Motion to Intevene by Ortho Biotech Products, L.P.. (Attachments: #1 Exhibit Reply Memorandum in Further Support of Ortho's Motion to Intervene)(Jackson, Michelle) |
Filing 63 DECLARATION re #62 Reply to Response to Motion, to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim (Submitted by Leave of Court Order Dated 4/19/06) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit 1, Part 1#2 Exhibit 1, part 2#3 Exhibit 2, part 1#4 Exhibit 2, part 2#5 Exhibit 3#6 Exhibit 4#7 Exhibit 5#8 Exhibit 6#9 Exhibit 7#10 Exhibit 8#11 Exhibit 9#12 Exhibit 10#13 Exhibit 11#14 Exhibit 12#15 Exhibit 13)(Huston, Julia) |
Filing 62 REPLY to Response to Motion re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim (Submitted by Leave of Court Order Dated 4/19/06) filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 61 DECLARATION re #60 Reply to Response to Motion to Dismiss (Submitted by Leave of Court Order Dated 4/19/06) by Roche Diagnostics GmbH. (Attachments: #1 Exhibit 1#2 Exhibit 2)(Huston, Julia) |
Filing 60 REPLY to Response to Motion re #38 MOTION to Dismiss for Lack of Jurisdiction (Submitted by Leave of Court Order Dated 4/19/06) filed by Roche Diagnostics GmbH. (Huston, Julia) |
Filing 59 REPLY to Response to Motion re #41 MOTION to Dismiss for Lack of Jurisdiction (Submitted by Leave of Court Order Dated 4/19/06) filed by F. Hoffmann-LaRoche LTD. (Huston, Julia) |
Filing 58 EXHIBIT 13 (CD-ROM Audio Disk) Received in re #54 Declaration of Michael R. Gottfried in Support of Amgen Inc.'s Opposition to Defendants' Motion to Dismiss for Lacl of Subject matter Jurisdiction and Failure to State a Claim for Which Relief May Be Granted, by Amgen Inc.. (Paine, Matthew) |
Filing 57 DECLARATION re #56 Opposition to Motion, to Dismiss for Lack of Personal Jurisdiction (And Alternative Request for Leave to Take Jurisdictional Discovery) by Amgen Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D#5 Exhibit E#6 Exhibit F#7 Exhibit G#8 Exhibit H#9 Exhibit I#10 Exhibit J#11 Exhibit K#12 Exhibit L)(Gottfried, Michael) |
Filing 56 Opposition re #38 MOTION to Dismiss for Lack of Jurisdiction, #41 MOTION to Dismiss for Lack of Jurisdiction (And Alternative Request for Leave to Take Jurisdictional Discovery) filed by Amgen Inc.. (Attachments: #1 Text of Proposed Order)(Gottfried, Michael) |
Filing 55 DECLARATION re #53 Memorandum in Opposition to Motion of Bette A. Goldman in Support of Amgen Inc.'s Opposition and Memorandum to Roche's Motion to Dismiss Under Rule 12(b)(1) and (6) by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3 (part 1 of 2)#4 Exhibit 3 (part 2 of 2)#5 Exhibit 4 (part 1 of 2)#6 Exhibit 4 (part 2of 2))(Gottfried, Michael) |
Filing 54 DECLARATION re #53 Memorandum in Opposition to Motion of Michael R. Gottfried in Support of Amgen Inc.'s Opposition to Defendants' Motion to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State A Claim for Which Releif May be Granted by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9#10 Exhibit 10#11 Exhibit 11#12 Exhibit 12#13 Exhibit 13#14 Exhibit 14#15 Exhibit 15#16 Exhibit 16#17 Exhibit 17#18 Exhibit 18#19 Exhibit 19#20 Exhibit 20 (part 1 of 2)#21 Exhibit 20 (part 2 of 2))(Gottfried, Michael) |
Filing 53 MEMORANDUM in Opposition re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by Amgen Inc.. (Attachments: #1 Appendix A)(Gottfried, Michael) |
Filing 52 AMENDED COMPLAINT for Declaratory Judgment of Infringement of U.S. Patent Nos. 5,441,868, 5,547,933, 5,618,698, 5,621,080, 5,756,349 and 5,955,422 against F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc., filed by Amgen Inc..(Gottfried, Michael) |
Filing 51 DECLARATION re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim (Supplemental Declaration) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A)(Huston, Julia) |
ELECTRONIC NOTICE of Hearing on Motion #41 MOTION to Dismiss for Lack of Jurisdiction, #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim, #16 MOTION to Intervene, #38 MOTION to Dismiss for Lack of Jurisdiction: Motion Hearing set for 5/10/2006 02:00 PM in Courtroom 18 before Judge William G. Young. Oppositions to the Motions to Dismiss are due by 4/25/06. Reply, if any, is due by 5/1/06. cc/cl (Smith, Bonnie) |
ELECTRONIC NOTICE of Hearing on Motion 41 MOTION to Dismiss for Lack of Jurisdiction, 44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim, 16 MOTION to Intervene, 38 MOTION to Dismiss for Lack of Jurisdiction: Motion Hearing set for 5/10/2006 02:00 PM in Courtroom 18 before Judge William G. Young. Oppositions to the Motions to Dismiss are due by 4/25/06. Reply, if any, is due by 5/1/06. cc/cl (Smith, Bonnie) |
Judge William G. Young : Electronic ORDER entered DENYING 35 Motion to Seal Document. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered DENYING #35 Motion to Seal Document. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: Docket Entries 37 and 40 Corrected Because Both Entries had the Incorrect PDF File Attached to Each Entry. For Entry 37 Please see Docket Entry 50 and for Entry 40 Please see Docket Entry 47 for the Correct Filings. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: Docket Entries #37 and #40 Corrected Because Both Entries had the Incorrect PDF File Attached to Each Entry. For Entry #37 Please see Docket Entry #50 and for Entry #40 Please see Docket Entry #47 for the Correct Filings. (Paine, Matthew) |
Filing 50 Opposition re #16 MOTION to Intervene by Ortho Biotech Products, L.P. filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 49 DECLARATION re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Exhibit 1, Part 1#2 Exhibit Exhibit 1, Part 2#3 Exhibit Exhibit 1, Part 3#4 Exhibit Exhibit 1, Part 4#5 Exhibit Exhibit 1, Part 5#6 Exhibit 2#7 Exhibit 3#8 Exhibit 4#9 Exhibit 5#10 Exhibit 6#11 Exhibit 7#12 Exhibit 8)(Huston, Julia) |
Filing 48 NOTICE of Appearance by David L. Ferrera on behalf of Ortho Biotech Products, L.P. (Ferrera, David) |
Filing 47 DECLARATION re #38 MOTION to Dismiss for Lack of Jurisdiction by Roche Diagnostics GmbH. (Huston, Julia) |
Filing 46 DECLARATION re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 45 MEMORANDUM in Support re #44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 44 MOTION to Dismiss for Lack of Subject Matter Jurisdiction and Failure to State a Claim by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc..(Huston, Julia) |
Filing 43 DECLARATION re #41 MOTION to Dismiss for Lack of Jurisdiction by F. Hoffmann-LaRoche LTD. (Huston, Julia) |
Filing 42 MEMORANDUM in Support re #41 MOTION to Dismiss for Lack of Jurisdiction filed by F. Hoffmann-LaRoche LTD. (Huston, Julia) |
Filing 41 MOTION to Dismiss for Lack of Jurisdiction by F. Hoffmann-LaRoche LTD.(Huston, Julia) |
Filing 40 DECLARATION re #38 MOTION to Dismiss for Lack of Jurisdiction by Roche Diagnostics GmbH. (Huston, Julia) |
Filing 39 MEMORANDUM in Support re #38 MOTION to Dismiss for Lack of Jurisdiction filed by Roche Diagnostics GmbH. (Huston, Julia) |
Filing 38 MOTION to Dismiss for Lack of Jurisdiction by Roche Diagnostics GmbH.(Huston, Julia) |
Filing 37 Opposition re #16 MOTION to Intervene by Ortho Biotech Products, L.P. filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia) |
Filing 36 DECLARATION re #34 Memorandum in Opposition to Motion, #35 Assented to MOTION to Seal Document OF LINDA A. SASAKI-BAXLEY by Amgen Inc.. (Attachments: # 1 Exhibit A #2 Exhibit B)(Gottfried, Michael) Additional attachment(s) added on 4/14/2006 (Paine, Matthew). Modified on 4/14/2006 (Paine, Matthew). |
Filing 35 Assented to MOTION to Seal Document by Amgen Inc..(Gottfried, Michael) |
Filing 34 MEMORANDUM in Opposition re #16 MOTION to Intervene filed by Amgen Inc.. (Gottfried, Michael) |
Filing fee: $ 200.00, receipt number 71585 for 31 Assented to MOTION for Leave to Appear Pro Hac Vice by Deborah E. Fishman, 32 Assented to MOTION for Leave to Appear Pro Hac Vice by Krista M. Carter, 33 Assented to MOTION for Leave to Appear Pro Hac Vice by Mario Moore, 30 Assented to MOTION for Leave to Appear Pro Hac Vice by Renee DuBord Brown. (Paine, Matthew) |
Filing fee: $ 200.00, receipt number 71585 for #31 Assented to MOTION for Leave to Appear Pro Hac Vice by Deborah E. Fishman, #32 Assented to MOTION for Leave to Appear Pro Hac Vice by Krista M. Carter, #33 Assented to MOTION for Leave to Appear Pro Hac Vice by Mario Moore, #30 Assented to MOTION for Leave to Appear Pro Hac Vice by Renee DuBord Brown. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 30 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING 31 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING 32 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING 33 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #30 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING #31 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING #32 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc., GRANTING #33 Motion for Leave to Appear Pro Hac Vice Added Renee DuBord Brown for Amgen Inc., Deborah E. Fishman for Amgen Inc., Krista M. Carter for Amgen Inc., Mario Moore for Amgen Inc. (Paine, Matthew) |
Filing 33 Assented to MOTION for Leave to Appear Pro Hac Vice by Mario Moore by Amgen Inc.. (Attachments: #1 Certification for Admission)(Gottfried, Michael) |
Filing 32 Assented to MOTION for Leave to Appear Pro Hac Vice by Krista M. Carter by Amgen Inc.. (Attachments: #1 Certifcation for Admission)(Gottfried, Michael) |
Filing 31 Assented to MOTION for Leave to Appear Pro Hac Vice by Deborah E. Fishman by Amgen Inc.. (Attachments: #1 Certification for Admission)(Gottfried, Michael) |
Filing 30 Assented to MOTION for Leave to Appear Pro Hac Vice by Renee DuBord Brown by Amgen Inc.. (Attachments: #1 Certificate for Admission)(Gottfried, Michael) |
Filing 29 SUMMONS Returned Executed Roche Diagnostics GmbH served on 3/22/2006, answer due 4/11/2006. (Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING #28 Motion for Leave to Appear Pro Hac Vice. Added Sandip H. Patel for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 26 Motion for Leave to Appear Pro Hac Vice. Added Matthew C. Nielsen for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #26 Motion for Leave to Appear Pro Hac Vice. Added Matthew C. Nielsen for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING #27 Motion for Leave to Appear Pro Hac Vice. Added Thomas I. Ross for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 28 Motion for Leave to Appear Pro Hac Vice. Added Sandip H. Patel for Amgen Inc. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 27 Motion for Leave to Appear Pro Hac Vice. Added Thomas I. Ross for Amgen Inc. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 71290 for #26 Assented to MOTION for Leave to Appear Pro Hac Vice by Matthew C. Nielsen, #27 Assented to MOTION for Leave to Appear Pro Hac Vice by Thomas I. Ross, and #28 Assented to MOTION for Leave to Appear Pro Hac Vice by Sandip H. Patel. (Paine, Matthew) |
Filing fee: $ 150.00, receipt number 71290 for 26 Assented to MOTION for Leave to Appear Pro Hac Vice by Matthew C. Nielsen, 27 Assented to MOTION for Leave to Appear Pro Hac Vice by Thomas I. Ross, and 28 Assented to MOTION for Leave to Appear Pro Hac Vice by Sandip H. Patel. (Paine, Matthew) |
Filing 28 Assented to MOTION for Leave to Appear Pro Hac Vice by Sandip H. Patel by Amgen Inc.. (Attachments: #1 Certification for Admission)(Gottfried, Michael) |
Filing 27 Assented to MOTION for Leave to Appear Pro Hac Vice by Thomas I. Ross by Amgen Inc.. (Attachments: #1 Certification for Admission)(Gottfried, Michael) |
Filing 26 Assented to MOTION for Leave to Appear Pro Hac Vice by Matthew C. Nielsen by Amgen Inc.. (Attachments: #1 Certification for Admission)(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered GRANTING #25 Motion for Extension of Time to File Response/Reply as to #16 MOTION to Intervene. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered GRANTING 25 Motion for Extension of Time to File Response/Reply as to 16 MOTION to Intervene. (Paine, Matthew) |
Filing 25 Assented to MOTION for Extension of Time to File Response/Reply as to #16 MOTION to Intervene by Amgen Inc..(Gottfried, Michael) |
Judge William G. Young : Electronic ORDER entered. re #24 STIPULATION for Enlargement of Time to Respond to the Motion to Intervene filed by F. Hoffmann-LaRoche LTD and Hoffmann LaRoche Inc., is ALLOWED. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered. re 24 STIPULATION for Enlargement of Time to Respond to the Motion to Intervene filed by F. Hoffmann-LaRoche LTD and Hoffmann LaRoche Inc., is ALLOWED. (Paine, Matthew) |
Filing 24 STIPULATION for Enlargement of Time to Respond to the Motion to Intervene by F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 23 STIPULATION for Enlargement of Time to Respond to Complaint by Hoffmann LaRoche Inc.. (Toms, Keith) |
Filing 22 NOTICE of Appearance by Lee C. Bromberg on behalf of Hoffmann LaRoche Inc. (Bromberg, Lee) |
Filing 21 NOTICE of Appearance by Julia Huston on behalf of Hoffmann LaRoche Inc. (Huston, Julia) |
Filing 20 NOTICE of Appearance by Keith E. Toms on behalf of F. Hoffmann-LaRoche LTD, Hoffmann LaRoche Inc. (Toms, Keith) |
Filing 19 CORPORATE DISCLOSURE STATEMENT by Ortho Biotech Products, L.P.. (Jackson, Michelle) |
Filing 18 DECLARATION re #17 Memorandum in Support of Motion of Harman Avery Grossman by Ortho Biotech Products, L.P.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8)(Jackson, Michelle) |
Filing 17 MEMORANDUM in Support re #16 MOTION to Intervene filed by Ortho Biotech Products, L.P.. (Attachments: #1 Exhibit A)(Jackson, Michelle) |
Filing 16 MOTION to Intervene by Ortho Biotech Products, L.P..(Jackson, Michelle) |
Filing 15 STATUS REPORT on service by Amgen Inc.. (Gottfried, Michael) |
Filing 14 SUMMONS Returned Executed Hoffmann LaRoche Inc. served on 3/6/2006, answer due 3/27/2006. (Gottfried, Michael) |
Filing 13 RETURN OF SERVICE Executed by Amgen Inc. as to Defendant F. Hoffmann-LaRoche LTD served on 1/31/2006. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: The Electronic Order Granting Pro Hac Vice on 2/21/2006 was Edited to Include Language from the Pro Hac Vice Motion 12 filed on 2/17/2006. (Paine, Matthew) |
Remark: The Parties Hoffman LaRoche Inc. and Roche Diagonostics GMHB Have Not Made an Appearance and Will Not become Active Until Served with Process. (Paine, Matthew) |
Notice of correction to docket made by Court staff. Correction: The Electronic Order Granting Pro Hac Vice on 2/21/2006 was Edited to Include Language from the Pro Hac Vice Motion #12 filed on 2/17/2006. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting #12 Motion for Leave to Appear Pro Hac Vice for Defendant F. Hoffman-La Roche LTD. and any Other Defendant which May Be Served in this Case, Collectively the "Defendants". Added Leora Ben-Ami for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Patricia A. Carson for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Thomas F. Fleming for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Howard Suh for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH (Paine, Matthew) Modified on 2/22/2006 (Paine, Matthew). |
Filing fee: $ 200.00, receipt number 70462 regarding Motion #12 to Admit Pro Hac Vice Leora Ben-Ami, Patricia A. Carson, Thomas F. Fleming, and Howard Suh for the Defendants. (Paine, Matthew) |
Judge William G. Young : Electronic ORDER entered granting 12 Motion for Leave to Appear Pro Hac Vice for Defendant F. Hoffman-La Roche LTD. and any Other Defendant which May Be Served in this Case, Collectively the "Defendants". Added Leora Ben-Ami for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Patricia A. Carson for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Thomas F. Fleming for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH, Howard Suh for F. Hoffmann-LaRoche LTD and Roche Diagnostics GmbH (Paine, Matthew) Modified on 2/22/2006 (Paine, Matthew). |
Filing fee: $ 200.00, receipt number 70462 regarding Motion 12 to Admit Pro Hac Vice Leora Ben-Ami, Patricia A. Carson, Thomas F. Fleming, and Howard Suh for the Defendants. (Paine, Matthew) |
Filing 12 Assented to MOTION for Leave to Appear Pro Hac Vice by Leora Ben-Ami, Patricia A. Carson, Thomas F. Fleming, Howard Suh by F. Hoffmann-LaRoche LTD. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C#4 Exhibit D)(Bromberg, Lee) |
Filing 11 STIPULATION for Enlargement of Time to Respond to Complaint by F. Hoffmann-LaRoche LTD. (Bromberg, Lee) |
Filing 10 NOTICE of Appearance by Lee C. Bromberg on behalf of F. Hoffmann-LaRoche LTD (Bromberg, Lee) |
Filing 9 NOTICE of Appearance by Julia Huston on behalf of F. Hoffmann-LaRoche LTD (Huston, Julia) |
Judge William G. Young : Electronic ORDER entered granting #6 Motion for Leave to Appear Pro Hac Vice, granting #7 Motion for Leave to Appear Pro Hac Vice, granting #8 Motion for Leave to Appear Pro Hac Vice. Added Michael F. Borun for Amgen Inc., William Gaede, III for Amgen Inc., Kevin M. Flowers for Amgen Inc. cc/cl. (Bell, Marie) |
Judge William G. Young : Electronic ORDER entered granting 6 Motion for Leave to Appear Pro Hac Vice, granting 7 Motion for Leave to Appear Pro Hac Vice, granting 8 Motion for Leave to Appear Pro Hac Vice. Added Michael F. Borun for Amgen Inc., William Gaede, III for Amgen Inc., Kevin M. Flowers for Amgen Inc. cc/cl. (Bell, Marie) |
Filing fee: $ 150.00, receipt number 68318 regarding Motions Pro Hac Vice (Bell, Marie) |
Filing fee: $ 150.00, receipt number 68318 regarding Motions Pro Hac Vice (Bell, Marie) |
Filing 8 MOTION for Leave to Appear Pro Hac Vice by William Gaede III by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 7 MOTION for Leave to Appear Pro Hac Vice by Kevin M. Flowers by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 6 MOTION for Leave to Appear Pro Hac Vice by Michael F. Borun by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing fee: $ 150.00, receipt number 68231 regarding Motions Pro Hac Vice (Bell, Marie) |
Judge William G. Young : Electronic ORDER entered granting 3 Motion for Leave to Appear Pro Hac Vice Added Lloyd R. Day, Jr for Amgen Inc., granting 4 Motion for Leave to Appear Pro Hac Vice Added David M. Madrid for Amgen Inc., granting 5 Motion for Leave to Appear Pro Hac Vice Added Linda Sasaki-Baxley for Amgen Inc.,. cc/cl. (Bell, Marie) |
Filing fee: $ 150.00, receipt number 68231 regarding Motions Pro Hac Vice (Bell, Marie) |
Judge William G. Young : Electronic ORDER entered granting #3 Motion for Leave to Appear Pro Hac Vice Added Lloyd R. Day, Jr for Amgen Inc., granting #4 Motion for Leave to Appear Pro Hac Vice Added David M. Madrid for Amgen Inc., granting #5 Motion for Leave to Appear Pro Hac Vice Added Linda Sasaki-Baxley for Amgen Inc.,. cc/cl. (Bell, Marie) |
Filing 5 MOTION for Leave to Appear Pro Hac Vice by Linda A. Sasaki-Baxley by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 4 MOTION for Leave to Appear Pro Hac Vice by David M. Madrid by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 3 MOTION for Leave to Appear Pro Hac Vice by Lloyd R. Day, Jr. by Amgen Inc.. (Attachments: #1 Certification for Admission to Practice)(Gottfried, Michael) |
Filing 2 CORPORATE DISCLOSURE STATEMENT by Amgen Inc.. (Gottfried, Michael) |
Filing 1 COMPLAINT against F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Filing fee: $ 250, receipt number 68108, filed by Amgen Inc.. (Attachments: #1 Civil Cover Sheet #2 EXHIBITS 1-6)(Bell, Marie) |
Filing 1 COMPLAINT against F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Filing fee: $ 250, receipt number 68108, filed by Amgen Inc.. (Attachments: # 1 Civil Cover Sheet # 2 EXHIBITS 1-6)(Bell, Marie) |
If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Dein. (Bell, Marie) |
Summons Issued as to F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Bell, Marie) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.